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T cell immunoglobulin and mucin (Tim) family molecules are cell membrane 
proteins with four functional Tim family members in mouse, and three in human. 
They are preferentially expressed on immune cells with Tim1 on Th2 cells, Tim3 on 
Th1 cells and Tim4 on antigen-presenting cells (APCs). They have several roles, 
including regulating immune responses and mediating phagocytosis of dead cells. 
However, little is known about them beyond these two species, and nothing outside 
mammals. To investigate the Tim family in the chicken, the genes were identified 
and cDNAs cloned. Differently to mammals, the chicken genome only contains 
genes for Tim1 and Tim4. Chicken Tim1 (chTim1) has similar mRNA expression 
patterns to those of mammalian Tim1 in lymphoid tissues and immune cells. 
Interestingly, chTim4 has at least four splice variants – an extra short isoform 
(chTimeS) lacking exons 5, 6, 7 and 8, a short isoform (chTim4S) without exons 3, 4 
and 5, a long isoform (chTim4L) with all exons and an extra long isoform 
(chTim4eL), which is similar to chTim4L but with a longer exon 3. The chTim4S is 
a homologue of mammalian Tim4 with constitutive expression in lymphoid tissues 
and immune cells; other chTim4 variants showed inducible or cell-specific 
expression patterns. Like mammalian Tim4, chTim4S is expressed by APCs; but 
differently to mammals, chTim4S is also expressed by γδ T cells, suggesting a 
unique role for chTim4 in this population of T cells.  
The biological activities of the chicken Tim family molecules were also 
investigated using chTim-Ig fusion proteins. Like mammals, chTim1 and chTim4S 
fusion proteins can specifically recognise phosphatidylserine (PS), an indicator of 
apoptotic cells, suggesting they are PS receptors. Pre-incubation with PS blocked 
binding of the chTim4S fusion protein to PS-exposing apoptotic cells. 
Physiologically, recognition of PS by the chTim proteins mediates apoptotic cell 
clearance, which was demonstrated using chTim-transfected fibroblast cells (3T3), 
which significantly increased their uptake of apoptotic cells compared with 
untransfected cells. The chTim4-Ig fusion protein also had costimulatory activity on 
chicken T cells.  
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Monoclonal antibodies against the chTim proteins were generated. They 
specifically recognise their own antigen tested intensively by different 
immunological assays. ChTim4L is expressed intracellularly in freshly-isolated 
splenocytes rather than on the surface, whereas PMA-stimulated splenocytes express 
chTim4S and chTim4L on the cell surface. Like mammals, chicken splenic 
macrophages also express chTim4S and chTim4L. Both of them are also expressed 
by bone marrow-derived macrophages but not bone marrow-derived DCs. The 
chTim1 protein was detected at high levels in bursal cells and splenocytes by western 
blot analysis using polyclonal anti-chTim1 serum, which is consistent with its 
mRNA expression pattern through qRT-PCR analysis, suggesting B and T cells may 
express chTim1, consistent with its expression in mammals. Mammalian Tim1 is 
expressed on Th2 cells, its ligand, Tim4, on APCs; the interaction between them 
drives Th2 cell proliferation. The knowledge from this study will help to further 
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Chapter 1.    General Introduction. 
1.1 The chicken 
The origin of the domestic chicken has been under debate for centuries, the 
most common theory being that modern domestic chickens are descendents of the 
Southeast Asian Jungle Fowl (Eriksson et al., 2008). Huge achievements in chicken 
production have been made by the few world-leading chicken breeders. For example, 
constant genetic selection and improvement in nutrition have led to very fast body 
growth rate in modern broiler strains. Nowadays, a broiler chicken only needs about 
40 days to reach a target 2 kg body weight. Moreover, high rates of egg production 
by layers have also been selected based on genetic traits; selection of a growth 
hormone gene allele resulting in a delayed onset of ovulation led to an overall 
increase of egg production by 15% (age at first egg to 497 days) in white leghorn 
chickens (Kuhnlein et al., 1997).  As well as progress in chicken breeding, other 
improvements in the poultry industry, such as nutrition and the industrial processing 
of chicken food, intensive rearing techniques, disease control programmes, etc. have 
resulted in a sustainable and massive output of chicken production, putting poultry 
production central to the food security agenda. Chicken meat consumption has 
increased to around 91 million tonnes in 2012. On a per-person basis, average 
poultry meat consumption on a global basis has continued to rise from 11.1 kg in 
2000 to around 14.6 kg in 2012 (http://www.thepoultry site.com/articles/2640/global-
poultry-trends-2012). Chicken meat is the most frequently eaten meat (>40%) in the 
UK, where consumption has doubled in the past 20 years, resulting in the UK 
producing 850 million chickens per year (Kaiser, 2010). Additionally, the 
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environmental impacts of meat production have become a factor that affects policy 
making. The production of chicken products has much lower greenhouse-gas 
emissions (McMichael et al., 2007) and water usage (Hoekstra et al., 2003) than the 
other two major meat products, pork and beef. To balance the environmental impact 
of increased meat supplies, increasing chicken production will become the primary 
option in the future. In developing countries, especially in their poor rural areas, eggs 
from free-range birds become an affordable daily protein source to resolve the 
problem of child malnutrition. 
Efficient poultry production requires a rapid expansion of the poultry 
production chain, and poultry health and welfare are also vital to the supply and 
safety of food, which can also significantly influence economic and societal 
prosperity. For example, salmonellosis does not generally cause severe symptoms in 
poultry, but the eggs and meat of infected animals can become a reservoir of 
infection for the human consumer. Legislation discontinuing the use of antibiotics 
and other drugs increases the risks to the poultry industry of pathogens, such as 
bacterial and parasitic infections. Virus infections also persistently threaten the 
poultry industry, such as Marek's disease. In spite of the success of vaccines in 
reducing losses from the disease in the last 30 years, the use of these vaccines is 
thought to have driven the virus to evolve to higher virulence to overcome the 
immune responses induced by the vaccines (Nair et al., 2005). Highly pathogenic 
avian influenza virus (AIV), for example H5N1, can cause mortality in chickens as 
high as 100% and can also be fatal to humans (Peiris et al., 2007). Even a lowly 
pathogenic avian influenza, H7N9, can become a significant pandemic threat to 
public health (Gao et al., 2013). Migratory waterfowl are a carrier for highly 
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pathogenic AIV and promote virus transmission across continents (Liu et al., 2005). 
Increasing zoonotic threats, especially currently from avian influenza, necessitate the 
search for alternative control methods. These must be based on the development of 
detailed knowledge of the mechanisms that the host uses to resolve infection with 
pathogens and that vaccination, genetics or other means can manipulate the 
capability of host to resist pathogen invasion.  
1.2 Overview of the human immune system 
The human immune system is crucial in protecting the host from pathogen 
infection. This task is fulfilled by a well-organised system, composed of different 
organs that are networked with lymphatic vessels, in which immune cells are 
collected from peripheral tissues and pass through the lymph nodes before being put 
back into the blood. The bone marrow and the thymus are the primary lymphoid 
organs (also called central lymphoid organs); the former is for the generation of 
primitive immune cells and the maturation of B cells, and the latter for T cell 
maturation (Schultz et al., 1987). The secondary lymphoid structures, also called 
peripheral lymphoid organs, include the spleen, lymph nodes, tonsils, Peyer’s 
patches and diffuse lymphoid aggregates in mucous membranes, such as gut- and 
lung-associated lymphoid tissues, to which immune cells are homed, become 
activated and cross-talk to each other (Schultz et al., 1987).  
Two systems are used to defend the host’s body against foreign invaders. A 
non-specific defence system relies on the body's natural ability to form physical 
barriers to prevent foreign matter entry, such as skin and mucous membranes and 
fluids, e.g. tears and saliva. However, when pathogens break through the physical 
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defence barriers and enter the body, another defence system, the immune system, is 
then initiated to combat the threatening invader. The major function of the immune 
system is to protect the host from environmental agents such as microbes or 
chemicals, thereby preserving the integrity of the body. This is done by the 
recognition of self and response to non-self (Beutler et al., 2004; Janeway et al., 
2002). The immune response has been somewhat artificially divided into innate and 
adaptive immunity. 
1.2.1 The human innate immune response  
The human innate immune system is a universal form of host defence against 
infection, and the innate immune response is not altered upon repeat exposure to the 
same pathogen. The innate immune response requires immune cells, as shown in 
Figure 1.1, including mast cells, basophils, eosinophils and phagocytic cells, such as 
macrophages, neutrophils and dendritic cells (DCs). Natural killer (NK) and γδ T 
cells are involved in not only innate immunity but also adaptive immune responses. 
These cells express soluble and cell-associated germline-encoded pattern recognition 
receptors (PRRs), which are already encoded in the genome without any DNA 
rearrangement. Innate immune cells can respond to pathogens through the 
recognition by PRRs of pathogen-associated molecular patterns (PAMPs), which are 
evolutionarily conserved microbial components present in pathogens, such as cell 
wall components, flagella, lipoproteins, and nucleic acids of bacterial, fungal, and 
viral origin (Janeway et al., 2002; Takeuchi et al., 2010). The complement system is 
a large number of distinct plasma proteins that react with one another to opsonize 








Figure 1.1. Innate and adaptive immune responses. The innate immune response 
functions as the first line of defence against infection. It consists of soluble factors, 
such as complement proteins, and diverse cellular components including 
granulocytes (basophils, eosinophils and neutrophils), mast cells, macrophages, 
dendritic cells and natural killer cells. The adaptive immune response is slower to 
develop, but manifests as increased antigenic specificity and memory. It consists of 




 T lymphocytes. Natural killer T cells and γδ 
T cells are cytotoxic lymphocytes that straddle the interface of innate and adaptive 





Based on their molecular structure, PRRs can be classified into several 
families, including Toll-like receptors (TLRs), C-type lectin receptors (CLRs), 
nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs), and RIG-
I-like receptors (RLRs) (O’Neill and Bowie, 2010). The TLRs recognise a 
remarkably broad spectrum of PAMPs expressed by viral, bacterial, fungal, and 
parasitic pathogens. In human, as shown in Figure 1.2, TLR1, TLR2, TLR4, TLR5 
and TLR6 are primarily expressed on the plasma membrane, where they sense 
specific molecules on the surface of microbes. In contrast, TLR3, TLR7 and TLR9 
traffic from the endoplasmic reticulum to endolysosomal compartments, where they 
recognize RNA and DNA derived from pathogens (Macagno et al., 2007; Nowarski 
et al., 2013). TLR8 was initially thought to be non-functional in mice; however, 
human TLR8 can sense bacterial RNA released within phagosomal vacuoles, as do 
other endosomal TLRs (Davila et al., 2008; Gantier et al., 2010). TLR10 is the only 
family member without a defined agonist or function (Guan et al., 2010). CLRs 
include at least 17 transmembrane proteins, which are either membrane-bound or 
secreted, binding to carbohydrate moieties such as mannose, fucose, and β-glucan on 
pathogens (Takeuchi et al., 2010; Osorio et al., 2011). Differently to the TLRs and 
CLRs, the NLRs and RLRs lack transmembrane domains and function as 
cytoplasmic sensors for intracellular pathogen invasion. RLRs are cytoplasmic 
helicases that sense viral single- or double-stranded RNA as non-self and bind to 
them through recognition of the PAMP motifs within viral RNAs (Ramos et al., 
2011). More than 20 NLRs are predicted in the human genome. All NLRs contain a 
NH2-terminal nucleotide-binding oligomerization domain that mediates the 













Figure 1.2. TLRs and NLRs involved in human innate immune response. TLRs, 
expressed on the cell surface or intracellular vesicular membranes of innate immune 
cells and epithelial cells, sense and capture danger signals. Cell surface TLRs, 
including TLR1, 2, 4, 5 and 6, sense exogenous pathogens through recognition of 
PAMPs on their surface and TLRs, including TLR3, 7 and 9, expressed on 
endolysosomal compartments recognize endogenous ligands, such as RNA and DNA 
derived from pathogens. NLRs are cytosolic PRRs. Sensing endogenous PAMPs 
through their leucine-rich repeat domain (LRR) trigger a cascade process to assemble 
an inflammasome, which in turn promotes the maturation of bioactive caspase-1. 
Activated caspase-1 has proteolytical activity on pro-IL-1β and IL-18, whose 
expression is driven by TLR signalling, converting them into mature forms, and 






which is responsible for detection of PAMPs (Elinav et al., 2011). As shown in 
Figure 1.2, TLR signalling triggers pro-IL-1β synthesis, which requires a 
proteolytical activation by a ternary protein complex, called an inflammasome, to 
become the mature form of IL-1β. Sensing of PAMPs leads to NLRs assembling into 
inflammasomes. NLRs are composed of a LRR domain, a central nucleotide-binding 
domain (NBD), and an NH2-terminal pyrin domain (PYD). The LRR and NBD 
modules are involved in ligand sensing and autoregulation, respectively. PYD is 
usually involved in the recruitment of the adaptor protein apoptosis-associated speck-
like protein (ASC) containing a caspase-associated and recruitment domain (CARD), 
which in turn is associated with pro-caspase-1. Activation of the inflammasome 
complex leads to autocleavage and activation of pro-caspase-1, which in turn is 
responsible for processing and secretion of the mature forms of the pro-inflammatory 
cytokines IL-1β and IL-18, and the secretion of IL-33 and fibroblast growth factor-2 
(FGF-2) (Nowarski et al., 2013). 
Macrophages are important phagocytes, the latter also including neutrophils, 
in the innate immune system and are widely present in peripheral tissues. DCs are 
also phagocytes, but don’t have killing capacity of pathogen; their role in innate 
immune response is to phagocytose foreign antigens derived from pathogens for 
presenting them to T cells (Hashimoto et al., 2011). Pathogen invasion can cause 
inflammatory responses at infection sites, which are initiated by phagocytic 
processing of pathogens by macrophages. The pathogens are engulfed by 
macrophages through PRRs and destroyed in phagolysosomes by acid and enzymes 
(Janeway et al., 2002). Phagocytosed pathogens also stimulate the macrophage to 
produce cytokines and chemokines, thereby attracting other cells to the infection site 
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and promoting inflammation. The inflammatory response in infected tissue causes 
vasodilation of the blood vessels, facilitating access of phagocytes, especially 
neutrophils, to the pathogens. The mast cells, basophils and eosinophils at the 
infection site are also involved in the inflammation. When these cells are activated at 
the infectious site, they produce histamines and chemokines; the former dilate blood 
vessels, causing the leakage of immune cells into tissues, and the latter then direct 
these cells, especially neutrophils and macrophages, through a chemotaxis process, to 
move towards infection sites (Janeway et al., 2002; Takeuchi et al., 2010). NK cells 
also are a component of the innate immune system which does not directly attack 
invading microbes. However, they destroy pathogen-infected host cells to release 
pathogen components, facilitating pathogen clearance by phagocytes (Vivier, 2006). 
Pathogen-activated macrophages produce cytokines, including the pro-
inflammatory cytokines IL-1β, IL-6, IL-12 and TNF-α, which promote and control 
early inflammatory responses, and type I interferons, IFN-α and IFN-β, to primarily 
block viral replication. PAMPs also induce DC maturation with upregulation of most 
of the requisite molecules, including costimulatory molecules, MHC class II, and 
CCR7 surface expression, to prime effectively the adaptive response by presenting 
antigen to T cells (Janeway et al., 2002, Macagno et al., 2007).  
1.2.2 The human adaptive immune response 
When pathogens overwhelm the innate immune responses and are 
persistently present in the host, a more effective and specific immune response, 
called the adaptive immune response, is triggered, consisting of antibody responses, 
also called humoral immunity, and cell-mediated responses, carried out by B cells 
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and T cells (Zielinski et al., 2011). B cells are involved in humoral immune 
responses through creating antigen-specific antibodies that circulate in the host to 
bind specifically to foreign antigens. Binding of antibody can inhibit virus 
replication, inactivate viral and microbial toxins and initiate other immune cells to 
attack the pathogens (Sallusto et al., 2010). T cells are involved in cell-mediated 
immunity, where activated T cells release various cytokines to enhance other cell 
activities, including macrophages, natural killer cells (NK), antigen-specific 
cytotoxic T lymphocytes, as well as B cells (Sallusto et al., 2010). A key feature of 
the adaptive immune response is to develop immunological memory to a pathogen, 
whereby when the same pathogen invades, the host can rapidly recall the previous 
response to battle the infection (Sallusto et al., 2010; Zielinski et al., 2011). 
B cell development in human starts in the bone marrow with the commitment 
of haematopoietic stem cells to the B cell lineage. The B cell progenitors sequentially 
express and assemble the components of the B cell antigen receptor (BCR), including 
immunoglobulin (Ig) heavy and light chains as well as the signalling proteins Igα and 
Igβ, resulting in immature B cells with surface-bound IgM differentiated in the bone 
marrow. These immature B cells migrate to secondary lymphoid tissues (such as the 
spleen, lymph nodes, Peyer's patches, etc.) where they are called transitional B cells. 
Immature B cells, which have never been exposed to an antigen, are known as naïve 
B cells and express only the IgM isotype on a cell surface in a membrane-bound 
form. When B cells begin to express both membrane-bound IgM and IgD, they reach 
maturity and are called mature B cells.  These B cells are ready to respond to antigen 
(Hardy et al., 2000). 
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Mature B cells are activated by antigens from pathogens through cell surface-
bound IgM or IgD in a T cell-independent manner or through the CD40-CD40L 
pathway and cytokines in a T cell-dependent manner (Lanzavecchia et al., 2002). 
Activated B cells divide and differentiate into antibody-producing cells, called 
plasma cells, that produce secreted antibody, including IgE, IgA or IgG, or memory 
cells that survive for years afterwards to allow the immune system to remember and 
rapidly respond to the same antigen upon future exposure. An antibody is a large Y-
shaped protein, consisting of two heavy chains and two light chains. Antibody can 
specifically recognise foreign antigens from bacteria and virus through its variable 
domain (Manz et al., 2005). However, microbes are highly diverse, thus successful 
recognition and eradication of them requires a high diversity of antibodies. Three 
ways are used to produce a sufficient number of different antibodies by the host. The 
variable domain of the Ig heavy chain is encoded by several pieces, called variable 
(V), diversity (D) and joining (J) genes, each of these genes having multiple 
segments.  Somatic recombination of segments from the V, D and J genes, also 
known as V(D)J recombination, results in a variety of Ig heavy chains (Figure 1.3). 
The light chain of Ig has similar recombination between variable (VL), joining (JL) 
and constant (CL) gene segments, resulting in a variety of light chains. The different 
combinations of heavy and light chains also introduce more diversity. Another way is 
that the genes encoding the variable domains undergo a high rate of point mutation, 
by a process called somatic hypermutation (SHM), during expansion of activated B 
cells upon antigen stimulation, also allowing a vast antibody repertoire to be 
generated (Manz et al., 2005; Corcoran, 2010). 





Figure 1.3. Schematic diagram showing somatic recombination of the Ig heavy 
chain. The Ig heavy chain is encoded by several genes, including a gene encoding the 
constant region and variable (V), diversity (D) and joining (J) genes encoding the 
variable domain. V(D)J recombination of their multiple segments results in a large 
variety of Ig heavy chain variable domain to recognise a diversity of antigens. The 
two heavy chains are assembled with two Ig light chains (shown in white boxes) to 







and a chemotaxis process to the thymus. These early T cell progenitors (ETP) neither 
express CD4 nor CD8, and are also called double negative (DN). At an early stage of 
T lineage development, these ETPs experience differential expression of cell surface 
CD markers and rearrangement of T cell receptor (TCR) genes in the environment of 






 and αβ T 






. This stage of differentiation within the 
thymus requires intimate contact with the epithelial stromal cells, which express 
notch ligands, essential growth factors (IL-7) and morphogens (sonic hedgehog 
proteins) important for T cell development (Shortman et al., 1996; Koch et al., 2011). 
When αβ T cell progenitors lose their dependence on Notch ligand, IL-7 and sonic 




 double positive cells (DP). 
The cells that are not able to generate a functional TCR will die through apoptosis. 
Those DP cells with a functional TCR are then exposed to endogenous peptides 
presented by MHC molecules expressed on thymic cells, resulting in positive and 
negative selection. In positive selection, TCR interaction with a self peptide-MHC 
complex leads DP cells to lose one of the co-receptor molecules (CD4 or CD8), also 









) then undergo negative selection by affinity with self 
peptide-MHC. Those cells strongly bound to an MHC complex will die. Following 
selection, surviving αβ T cells migrate from the thymus to secondary lymphoid 
organs (Gameiro et al., 2010; Koch et al., 2011). 
Dendritic cells (DCs) are antigen-presenting cells crucial for bridging the 
innate and adaptive immune response to infection. In human, DC subtypes include 
type I IFN-producing plasmacytoid DCs (pDCs) and conventional DCs (cDCs). 
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pDCs are innate immune cells present in the blood and peripheral lymphoid organs 
with a different cell surface phenotype to cDCs. They play crucial roles in anti-viral 
infection by producing large amounts of IFN-α and IFN-β (McKenna et al., 2005; 
Tversky et al., 2008). cDCs are widely present in lymphoid tissues, such as the 
thymus, spleen and lymph nodes, and non-lymphoid tissues, such as skin and 
mucosal-associated tissues. They are crucial for presenting foreign antigen to T cells 
(Wu et al., 2007). Immature cDCs differentiate from haematopoietic bone marrow 
progenitor cells. Once they recognise foreign antigens derived from pathogens by 
surface PRRs, the pathogenic proteins are then internalised and degraded into small 
pieces, which can be presented on the DC cell surface in the context of MHC 
molecules. Simultaneously, costimulatory molecules, such as CD80, CD86 and 
CD40, are upregulated on the DC surface. Mature DCs also upregulate expression of 
CCR7, a chemotactic receptor that guides trafficking of the DCs to the spleen or 
lymph nodes, where DCs then present foreign antigens to T cells, and stimulate T 
cell proliferation along with costimulatory molecules (Suciu-Foca et al., 2005). MHC 
molecules are highly polymorphic to be suitable for presenting diverse peptides. 
They can be divided into class I and class II. MHC class I molecules are expressed 
by nearly every nucleated cell, whereas MHC class II molecules are normally 
expressed on antigen-presenting cells (APCs), including DCs, macrophages and B 
cells (Martinsohn et al., 1999). 
As described before, after T cell lineage development in the thymus, they 




T cells. After activation by antigen-
armed DCs, naïve T cells can rapidly expand and differentiate into effector T cells to 
cope with the infection. Most of the effector cells will die when the host recovers 
15 
 
from the infection, but a few of these cells are retained as memory cells to mount an 
effective response when reencountering the same antigen in future. CD8
+
 T cells 
normally are cytotoxic T lymphocytes (CTL) and activated through peptide-loaded 
MHC class I molecules. The effector CTL can induce the death of cells infected with 
viruses or other pathogens (Harty et al., 2000). CD4
+
 T cells are helper T (Th) cells, 
which are immune response mediators and play roles in directing other immune cells 
to establish and maximise the capabilities of the acquired immune response. APCs 
present foreign antigen through MHC class II to naive CD4
+
 T cells. Activated CD4
+
 
T cells further differentiate into different effector T helper subsets, as shown in 
Figure 1.4, including Th1, Th2, Th17, Th9, Th22, Treg and Tfh (Zielinski et al., 2011). 
The Th1/Th2 paradigm is the best-studied model for T helper subset differentiation, 
and will be specifically described later. Th17 cells produce IL-17 as their signature 
cytokine and specifically express a transcpritional factor, RORγt, which regulates 
Th17 cell differentiation. Th17 cells play potent roles in the elimination of fungi and 
extracellular bacteria (Basu et al., 2013). Th22 cells are a recently characterised 
subset, based on the expression of IL-22 and the transcription factor aryl 
hydrocarbon receptor (AHR). IL-22 can stimulate production of antimicrobial 
peptides by keratinocytes and Th22 cells can also recognise lipid antigens presented 
by Langerhans cells in the skin, suggesting these cells may be responsible for skin 
health and homeostasis (Zielinski et al., 2011). Th9 cells, which are characterized by 
IL-9 production, are specialized in the elimination of helminths and driven by the 
master regulator Pu.1 (Sallusto et al., 2009). Natural regulatory T cells (Treg) are 
defined by expression of cell surface markers CD4 and CD25, as well as the 






Figure 1.4.  T helper cell subsets in adaptive immunity. Activated naïve CD4
+
 T cells 
differentiate into different T helper (Th) cell subsets driven by cell-specific 
transcription factors and particular cytokines. The effector T helper subsets produce 
signature cytokines. The cytokines then target other immune cells to regulate 







immune system and prevent pathological self-reactivity, such as autoimmune disease 
(Schmitt et al., 2013). Some pathogens may have evolved to manipulate Treg cells to 
immunosuppress the host to potentiate their own survival. IL-10 produced by Treg 
cells favours the persistence of intracellular bacteria and the establishment of a 
pathogen carrier state, while deletion or blockade of IL-10 leads to clearance of 
parasites, such as Leishmania major in mice (Belkaid et al., 2001). Follicular Th cells 
(Tfh) are found within B cell follicles of lymphoid tissue and help memory B cell 
responses to antigen. They produce IL-21 and express the specific transcription 
factor Bcl-6 (Fazilleau et al., 2009).  
1.2.3 The Th1/Th2 paradigm 
The Th1/Th2 paradigm was first coined three decades ago by Mosmann and 
Coffman (Mosmann et al., 1986; Mosmann and Coffman, 1989) and has been central 
to our understanding of adaptive immune responses. Early innate immune response 
result in a cytokine environment, which can instruct naïve CD4
+
 T cells to 
differentiate into at least two distinct subtypes, Th1 and Th2, to coordinate the 
immune response in clearance of the insulting pathogens. Th1 cells, through the 
secretion of IFN-γ, regulate immune responses against intracellular pathogens, such 
as viruses or certain bacteria. Th2 cells produce the signature cytokines IL-4, -5 and -
13. Th2 responses are associated with protection against extracellular infections, 
such as with certain parasites (Murphy and Reiner, 2002). Th1 and Th2 cell 
differentiation is a complicated process (for details see Figure 1.5). The cytokines IL-
12 and IL-4, through activation of signal transducer and activator of transcription 4 
(STAT4) and STAT6 respectively, determine the outcome, respectively driving Th1 





Figure 1.5. IL-12 and IL-4 drive Th1/Th2 cell differentiation.  
Th1 induction by IL-12: initial TCR activation induces low level expression of IFN-γ 
and T-box21 (Tbx21 or T-bet) genes (1). IL-12 signalling results in activation of 
STAT4 to promote IFN-γ expression (2). IFN-γ receptor signalling activates STAT1 
(3), which strongly promotes T-bet expression (4). T-bet then enhances transcription 
of IFN-γ (5) leading to increased production of this cytokine (6). In addition, T-bet 
prevents Th2 differentiation by inhibiting GATA-3 (7). T-bet also promotes 
expression of the IL-12 receptor β2 chain (8), resulting in greater IL-12 
responsiveness (9) and yet further elevated production of IFN-γ (10).  
Th2 induction by IL-4: initial TCR signalling induces low level expression of the IL-
4 and GATA-3 genes (11). IL-4 receptor signalling strongly promotes expression of 
these two genes (12). GATA-3 then enhances transcription of IL-4, IL-5 and IL-13, 
(13). Increased IL-4 production further enhances Th2 cell differentiation (14). 
GATA-3 also prevents Th1 cell differentiation by inhibiting expression of the IL-12 
receptor β2 chain (14). Primary events are indicated with black arrows, secondary 
events with red arrows and tertiary events with blue arrows (Amsen et al., 2009). 
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transduce the signals from APCs to positively modulate differentiation and 
proliferation of these cells (Amsen et al., 2009). Certain crucial transcriptional 
factors play key roles in the regulation of Th1/Th2 differentiation. The T-box 
transcriptional factor, T-bet, selectively responds to IL-12 stimulation and controls 
IFN-γ production as well as Th1 cell differentiation (Szabo et al., 2000). By contrast, 
the zinc-finger transcription factor, GATA-3, enhances the production of the Th2 
cytokines IL-4, -5 and -13 (Hosoya et al., 2010). Accumulated IFN-γ and IL-4 
regulate the differentiation of Th1 and Th2 in positive and negative feedback loops. 
Through IFN-γ signalling, IFN-γ not only reinforces Th1 cell differentiation, but also 
inhibition of GATA-3 activity to suppresses Th2 lineage development. By contrast, 
IL-4 positively regulates Th2 cell differentiation but suppresses Th1 cell 
development (Murphy and Reiner, 2002; Amsen et al., 2009). 
1.3 Overview of the chicken immune system 
Similarly to that of the human, the immune system in the chicken has 
evolutionarily developed an innate and adaptive response to cope with a wide 
diversity of pathogens. Although birds and mammals evolved from a common 
ancestor more than 300 million years ago, many aspects of mammalian immune 
responses also apply to the chicken immune system. Nevertheless, the chicken 
immune system has unique features, including certain lymphoid organs and a 
different immune cell repertoire. 
The chicken also has a well-organised structure of lymphoid tissues (Figure 
1.6), including both central and peripheral lymphoid tissues. The central lymphoid 






Figure 1.6. The chicken immune system. The central immune organs include the 
bone marrow for generation of immune cell progenitors, the thymus for T cell 
development and the bursa of Fabricius for B cell development. The peripheral 
immune organs include the Harderian glands, spleen, bronchus-associated lymphoid 
tissues and gut-associated lymphoid tissues (including Meckel’s diverticulum, caecal 





cells in the bone marrow are the origins of peripheral lymphoid or myeloid cells. 
Immunologically mature chicken T cells develop in the thymus. Differently to 
mammalian B cell maturation in bone marrow, chicken B cells develop in the bursa, 
which is a unique lymphoid organ found only in avian species (Miller et al., 2002; 
Scott at al., 2004; Ratcliffe, 2006). In peripheral lymphoid tissues, the spleen is a key 
lymphoid organ as in mammals, but the chicken lacks encapsulated lymph nodes like 
those of mammals and instead has diffuse lymphoid tissues, mucosa-associated 
lymphoid tissues, which are widely present in the digestive, respiratory and 
reproductive systems. Some of these tissues have well-organised structures with T-
dependent zones and B-dependent zones (also called germinal centres (GC)), such as 
the caecal tonsils, Meckel’s diverticulum and Peyer’s patches in gut-associated 
lymphoid tissues (GALT) and the Harderian gland behind the eye. Less-organised 
lymphoid tissues, such as nodules, aggregates of lymphocytes and a heterogeneous 
population of intra-epithelial leukocytes (IEL), are also present in mucosal areas and 
involved in immune responses (Befus et al., 1980; Jeurissen et al., 1989; Withanage 
et al., 1997; Casteleyn et al., 2010). 
The first generation of macrophages is derived from the yolk sac, and 
probably acts more in organ development (Cuadros et al., 1992). After hatching, 
chicken macrophages originate from bone marrow stem cells. Bone marrow cells 
develop into a pro-monocyte and then into a monocyte under the influence of colony 
stimulating factor(s). Monocytes enter the blood stream where they constitute a 
major phagocytic cellular component. Blood monocytes migrate to a variety of the 
body’s tissues and develop into macrophages (Qureshi, 2003). 
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Although identification of natural chicken DCs has been attempted, progress 
is limited. Chicken DCs differentiated from the bone marrow have been 
characterised. They possess similar characteristics as mammalian DCs in expression 
of functional molecules, such as PRRs, costimulatory molecules, MHC class II, 
cytokines, chemokines and chemokine receptors (Wu et al., 2010). As immune cells, 
they are competent in phagocytosis and endocytosis and once mature become potent 
activator of naïve T cells (Wu et al., 2010; 2011). Bone marrow-derived DCs also 
show anti-viral responses with increased cytokine production (Vervelde et al., 2013; 
de Geus et al., 2013). 
Chicken heterophils, the counterparts of mammalian neutrophils, are 
polymorphonuclear granulocytes (Kogut et al., 1994; Stabler et al., 1994). 
Heterophils are important phagocytes of invading microbial pathogens. Activation of 
hererophils by pathogens induces pro-inflammatory cytokines and chemokines, such 
as IL-1β, IL-6 and CXCLi2 (Kogut et al., 2005). Chicken heterophils express a 
variety of TLRs to recognise pathogens, including both TLR2 variants, TLR4, TLR5, 
TLR7 and TLR21 (Kogut et al., 2005). Differently to mammalian neutrophils, 
chicken heterophils lack myeloperoxidase, resulting in less bactericidal activity by 
oxidative burst (Kogut et al., 2005). Furthermore, the chicken possesses nucleated 
thrombocytes, important phagocytes in the chicken but not present in mammals. 
Although the primary function of thrombocytes is in haemostasis, they are capable of 
phagocytosing bacteria and producing an oxidative burst response (Wigley et al., 
1999). Thrombocytes may also play a role in innate immunity through the expression 
of a range of TLRs, resulting in increased pro-inflammatory cytokine production 
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following stimulation with agonists such as LPS and CpG oligonucleotides (St. Paul 
et al., 2012). 
The chicken appears to lack functional eosinophils (Maxwell, 1987). 
Eosinophils in mammals are key components of allergic and anti-helminthic 
reactions, mediated by Th2 responses. There are many components of the 
mammalian Th2 response, and in particular those that control the response and 
function of eosinophils, are absent in the chicken (Kaiser, 2012). Th2 responses in 
mammals involve IL-4, -13 and -5, all of which are upregulated following infection 
with an extracellular pathogen. Amongst other functions, they drive antibody isotype 
switching towards IgA and IgE, the latter being crucial in eosinophil function as it 
binds the Fc-εR on eosinophils, triggering their degranulation. IgE production is 
driven by IL-5, after IL-4 induces isotype switching to IgE. In the chicken, IL-13 and 
IL-4 (the former up to 100-fold more than the latter) are both induced following 
infection with extracellular pathogens (Degen et al., 2005; Powell et al., 2009), but 
IL-5 expression is switched off (Powell et al., 2009). IgE is not produced in birds - 
chickens only have IgM, IgY (the functional equivalent of mammalian IgG), which 
does not have sub-types, and IgA. The eotaxins (chemokines) and the eotaxin 
receptor, which control migration of eosinophils in mammals, are absent in the 
chicken genome (Kaiser, 2012). 
Chicken NK cells are of a different lymphoid lineage from T and B cells, and 
develop in a bursa- and thymus-independent manner. Chicken NK cells are defined 
as CD3
+
 CD8αα+ TCR- MHC II- Ig- lymphocytes. They have large intracellular 
granules, with roles in spontaneous cytotoxicity (Roger et al., 2008). The number of 
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chicken NK cells in the blood, spleen and caecal tonsils is extremely low, ranging 
from 0.5 to 1% (Gobel et al., 2001); by contrast, in many mammals, 10% of the 
blood lymphocytes are NK cells (Cooper et al., 2001). 
1.3.1 The chicken innate immune response 
Similarly to mammals, the chicken innate immune system has its own 
receptors (PRRs) on effector cells (e.g. macrophages, DCs, heterophils and NK 
cells). The cytokines and chemokines resulting from an innate response drive 
inflammatory responses and influence subsequent adaptive responses through 
antigen-presenting cells (APC) presenting pathogen antigen to the adaptive immune 
response. 
The best characterized family of chicken PRRs are the TLRs. There are ten 
chicken TLRs and six of these, TLR1, 2, 3, 4, 5 and 7, are clearly orthologous to 
mammalian TLRs (Brownlie and Allan, 2011; St. Paul et al., 2013). However, 
duplication of genes has led to the chicken having two TLR1s (TLR1a and b) and 
two TLR2s (TLR2a and b). Dimerisation between either of the two chicken TLR1 
and TLR2 variants forms cell surface receptors to recognise at lease the same range 
of cell-surface PAMPs on pathogens as recognized by mammalian TLR2, which 
dimerises with either TLR1, 6 or 10 (Higuchi et al., 2008; Keestra et al., 2007). 
Similarly to mammals, chicken TLR3 (Iqbal et al., 2005) and TLR7 (Philbin et al., 
2005) are intracellular receptors, and recognise pathogen RNA. However, TLR8 is a 
pseudogene, being disrupted by the insertion of a large CR1 repeat at some point 
during evolutionary history (Philbin et al., 2005). Murine TLR9 recognizes microbial 
DNA through unmethylated CpG motifs (Hemmi et al., 2000). Although chicken 
cells respond readily to CpG motifs (Vleugels et al., 2002; Xie et al., 2003; He et al., 
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2006), TLR9 is absent from the chicken genome (Roach et al., 2005; Brownlie et al., 
2009). There are two chicken-specific TLRs, TLR15 and TLR21 (Roach et al., 2005; 
Higgs et al., 2006). Chicken TLR21 has recently been shown to recognize CpG 
motifs (Brownlie et al., 2009; Keestra et al., 2010; St Paul et al., 2011).  The mRNA 
expression levels of TLR15 were significantly increased in response to live, heat-
killed or formalin-killed Salmonella Enteritidis, Escherichia coli or Enterococcus 
gallinarum (Nerren et al., 2010). In a separate study, its mRNA expression levels 
were significantly upregulated after induction with B- and C-type CpG 
oligonucleotides (ODN), tripalmitoylated lipopeptide (PAM3CSK4), E. coli- and 
Enteritidis-derived LPS in the chicken macrophage cell line, HD11 (Ciraci and 
Lamont, 2011). Together, this suggests that its ligand is a hitherto undescribed, heat-





(Nerren et al., 2010), as would be predicted from the pattern of leucine-rich repeats 
in its extracellular domain (Kaiser, 2010; Kaiser et al., 2009). Recent evidence also 
indicated that TLR15 can be a sensor for secreted virulence-associated fungal and 
bacterial proteases and activation of TLR15 involves proteolytic cleavage of the 
receptor ectodomain and stimulation of NF-κB-dependent gene transcription (de 
Zoete et al., 2011). A yeast-derived agonist could also trigger TLR15 activation and 
resulted in TLR15-dependent activation of NF-κB (Boyd et al., 2012). Mycoplasma 
synoviae, specifically the NH2-terminal diacylated lipopeptide (MDLP) representing 
the NH2-terminal portion of its mature haemagglutinin protein, can also significantly 
upregulate the expression levels of TLR15 and activated TLR15 eventually triggers 




The chicken appears to have a smaller repertoire of endocytic PRRs. For 
example, the chicken genome only contains NOD1, and NOD2 is absent. Chickens 
also lack RIG-I-like receptors (NLRs) (Kaiser, 2010). Recently, two cell surface C-
type lectin receptors have been identified in chicken. DEC-205 was characterised and 
is expressed on chicken DCs and macrophages (Staines et al., 2013) and a partial 
cDNA of DC-SIGN (Acc. No. BU125096) has been identified in an EST library 
(Boardman et al., 2002; Schultz and Magor, 2013). 
1.3.2 The chicken adaptive immune response 
Chicken T and B lymphocytes, like their mammalian equivalents, play key 
roles in adaptive immune responses, through cell-mediated and humoral responses, 
to efficiently clear invading pathogens.  
B cells use surface Igs as antigen receptors and differentiate into plasma cells 
to secrete antibodies. Differently to those of mammals, the chicken Ig light chain is 
encoded by a single copy of functional VL and JL genes. Therefore, diversity is very 
limited and the effects of VJ rearrangement are minimal (Reynaud et al., 1985). The 
chicken Ig heavy chain locus also possesses only single functional VH and JH genes, 
meaning little diversity can be generated through V(D)J rearrangement (Ratcliffe et 
al., 1994). However, clusters of pseudogenes, upstream of the heavy and light chain 
loci, are involved in somatic gene conservation to substitute VL and VH. The donor V 
pseudogenes (80-100 pseudo VH and 26 pseudo VL) effectively generate an 
enormous diversity of Ig variable regions (Ratcliffe et al., 1994). Activated chicken 
effector B cells produce three classes of antibodies, IgM, IgY (also called IgG), and 
IgA. IgM is the only isotype present on the surface of chicken B cell and is expressed 
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during B cell development in the bursa. Similarly to mammals, chicken IgA is 
predominantly a secretory Ig isotype. IgY is equivalent to mammalian IgG, but 
without subclasses. There are no equivalents of mammalian IgD and IgE documented 
in any avian species (Ratcliffe et al., 2006).  
Chicken T progenitors differentiate into TCRγδ+ and TCRαβ+ T cell lineages 
in the thymus. TCRγδ+ T cells can be distinguished by the antibody TCR1 (Sowder 
et al., 1988). In peripheral blood, TCRγδ+ T cells do not express both of the co-
receptors CD4 and CD8, whereas, when they migrate to the gut and spleen, the 
majority of TCRγδ+ T cells express CD8 (Sowder et al., 1988; Davidson and Boyd, 
1992), and a very low number of TCRγδ+ T cells also express CD4 (Erf et al., 1998). 
Although the γδ T cell frequency increases with age, even up to 50% of the 
circulating T cells in adult birds, their immunological functions are still poorly 
understood (Chen et al., 1996). Chicken TCRαβ+ T cells have two subsets, 
expressing either αVβ1 or αVβ2, which can be distinguished by the antibodies TCR2 
and TCR3 respectively (Davidson and Boyd, 1992). Mature TCRαβ+ T cells express 
either CD4 or CD8. CD8 is composed of two chains, CD8α and CD8β, which can 
form two isoforms, CD8αα and CD8αβ. As in mammals, most peripheral chicken 
CD8
+
 T cells bear CD8αβ heterodimers, whereas CD8αα homodimers are expressed 
by the majority of chicken intestinal CD8
+
 T cells (Imhof et al., 2000). Functionally, 
CD8
+
 T cells serve as cytotoxic T cells, whereas CD4
+
 T cells act as T helper cells. 
Through their secreted cytokines, CD4
+ 
T helper cells modulate the activity of 
cytotoxic CD8
+
 T cells, NK cells, macrophages and other effector immune cells, 
including B cells in the humoral response (Zhu and Paul, 2008). Progress has been 
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made in determining if the chicken has similar range of the newly identified CD4
+
 T 
helper subsets as seen in mammals. For example, the signature cytokines and cell 
surface markers for chicken Th17 (IL-17A, IL-17F, IL-21, IL-22 and IL-23R), Th9 
(IL-9) and Treg (IL-10, TGF-β4 and CD25) cells have been identified and 
characterised (Kaiser et al., 2005; Kaiser, 2010; Kaiser and Staheli, 2013). Certain 
cytokines are crucial in driving mammalian T helper lineage development. For 
example, TGF-β either with IL-6 and IL-23 or IL-4 can drive naïve CD4+ T cells to 
differentiate into Th17 and Th9 respectively; TGF-β and IL-10 are critical for 
differentiation of inducible Treg (also known as Th3 or Tr1); IL-21 is important for 
differentiation of the Tfh lineage (Cohn, 2008; Zhu and Paul, 2008). All of these 
cytokines are also present in the chicken. A precise spectrum of chicken CD4
+
 T 
helper subsets will soon be unveiled with characterisation of the transcription factors, 
such as T-bet (Th1), GATA-3 (Th2) and RORγt (Th17), although Foxp3 (Treg) 
remains to be identified in the chicken genome (Kaiser, 2010). 
1.3.3 The chicken Th1/Th2 paradigm 
The Th1/Th2 paradigm, originally defined according to different profiles of 
secreted cytokines in response to infection with intracellular or extracellular 
pathogens (Mosmann et al., 1986; Mosmann and Coffman, 1989), has been extended 
beyond mammals to the chicken, 20 years since the first chicken T helper cytokine, 
IFN-γ, was cloned (Digby et al., 1995). So far, chicken Th1/Th2 signature cytokines 
have been identified and characterised, such as Th1 cytokines, including IL-2 
(Sundick et al., 1997; Kaiser et al., 1999; Rothwell et al., 2001), IFN-γ, IL-12 (Balu 
et al., 2003; Degen et al., 2004; Balu et al., 2011) and IL-18 (Schneider et al., 2000), 
and Th2 cytokines, including IL-4, IL-13 and IL-5 (Avery et al., 2004). Th1/Th2 
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cells critically determine the outcome of any given infection and direct the ongoing 
immune response through the secretion of cytokines, which act as growth and 
differentiation factors for themselves and other cell types (Szabo et al., 2003). The 
cytokines predominating adaptive responses in the chicken have been intensively 
investigated in infectious diseases, such as bacterial (Kogut et al., 2005; Beeckman et 
al., 2010), viral (Degen et al., 2005; Eldaghayes et al., 2006) and parasitic (Rothwell 
et al., 2004; Powell et al., 2009; Andersen et al., 2013) infections. Th1 cytokines 
predominate during infections with intracellular pathogens, and Th2 cytokines 
predominate during infections with extracellular pathogens, although, as in the pig, 
IL-13 seems to play a more important role than IL-4 in the chicken during Th2 
responses (Degan et al., 2005; Powell et al., 2009; Raymond and Wilkie, 2004). 
In mammals, T helper cell immune dysfunction leads to tissue injury and 
autoimmune disease. Although autoimmune diseases are not a major problem in 
domestic poultry, experimental observations in chicken disease models have shown 
Th1/Th2 dysregulation-related autoimmune diseases similar to those in mammals. 
Several laboratory-established chicken lines as animal models for autoimmune 
disease have manifested all of the clinical and biological symptoms of human 
disease. The Smyth line chicken (SL) is used to study the etiopathology of the 
autoimmune disease pigmentation disorder vitiligo. T cell infiltration of the feather 
pulp is involved in disease onset, with 15-times higher infiltration than those 
observed in feathers from non-vitiligous controls and the CD4:CD8 ratio decreases to 
levels below 0.4 (the ratio in non-vitiligous chickens is 1:1) (Wick et al., 2006). The 
Obese strain (OS) chicken, as a model of human Hashimoto’s thyroiditis, has shown 
a role for IL-15 in driving the onset of spontaneous autoimmune thyroiditis (SAT) 
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and the Th1 cytokine, IFN-γ, plays a central role in inflammatory cell-mediated 
immune activities (Kaiser et al., 2002). Scleroderma, also known as systemic 
sclerosis (SSc), manifests in the UCD-200/206 chicken line, with a major role for T 
cells in the pathogenesis of the disease (Wick et al., 2006). Other autoimmune 
diseases caused by T cell dysregulation have been reported in the chicken, including 
experimental viral arthritis (Pertile et al., 1996), experimental allergic 
encephalomyelitis (Blaszczyk et al., 1978) and ovarian autoimmune disease (Barua 
and Yoshimura, 2001). These chicken autoimmune disease models also demonstrate 
that chicken Th1/Th2 cells are crucial in modulating self-immune tolerance.  
1.4 The Tim gene family 
As described before, distinguishing Th1 and Th2 cells is still largely based on 
their cytokine profiles and the expression of specific transcription factors. 
Classification of Th1/Th2 subsets based on cell surface phenotype has been difficult. 
Certain chemokine and costimulatory receptors are associated with Th1 and Th2 
cells; however, expression differences are quantitative rather than qualitative 
(Zielinski et al., 2011; Sallusto et al., 2012). The lack of T helper subset-specific cell 
surface markers has limited their study. 
A novel family of molecules, the T cell immunoglobulin and mucin domain 
(Tim) family, which encodes cell surface anchor proteins, are now known to be 
involved in the regulation of immune responses by modulating effector Th1 and Th2 
cell functions. The Tim gene family has three members (Tim1, 3 and 4) in human 
(Kuchroo et al., 2003) and eight (Tim1-8) in mouse (Kuchroo et al., 2003; McIntire 
et al., 2001). Mouse Tim1-4 are known to be expressed but Tim5-8 are so far only 
31 
 
predicted genes (Kuchroo et al., 2003). Tim1 is predominantly expressed by 
activated Th2 cells with an important role to enhance T cell expansion and cytokine 
production (Umetsu et al., 2005). Tim3, a negative regulator of the Th1 response, is 
preferentially expressed by Th1 cells (Monney et al., 2002). Tim4, in contrast, is 
primarily found on APCs, and costimulates T cell proliferation by interacting with its 
natural ligand, Tim1 (Kuchroo et al., 2008; Mizui et al., 2008).  
Tim1 is highly associated with asthma susceptibility in a simplified trait study 
for investigating asthma susceptible genes using mice as a model. The mouse Tim 
gene family was found by positional cloning, lying on chromosome 11B1.1. In 
human, the three Tim genes are encoded on chromosome 5q33.2, a region that has 
been linked with asthma, allergy and autoimmune disease (McIntire et al., 2004). 
There are no intervening genes in the human chromosome region, and there is 
conserved synteny between the human and mouse loci between the genes encoding 
IL-2-inducible T cell kinase (ITK) and a regulator of the transcription factor SP-1 
(Crsp9). Murine Tim1, Tim3 and Tim4 are orthologues of human Tim1, Tim3 and 
Tim4 respectively, and therefore they have received the most attention to date 
(Meyers et al., 2005b). 
1.4.1 The features of Tim family molecules 
The Tim genes encode type I cell surface glycoproteins with common 
structural features, including an NH2-terminal Ig-variable (IgV)-like domain, a mucin 
domain with O-linked glycosylation, a transmembrane domain and a cytoplasmic tail 
containing a tyrosine kinase phosphorylation motif, the latter absent in Tim4 (Figure 
















Figure 1.7.  The features of Tim family proteins. (A) The mouse Tim family proteins, 
short lines are O-linked glycosylation sites, blue triangles are N-linked glycosylation 
sites. Red circles are tyrosine-phosphorylation sites (modified from Kuchroo et al., 
2003). (B) Ribbon diagram of the mouse Tim IgV domain. β-strands of the GFC β-
sheet are red and those in the BED face are pink, Cys residues and disulfide bonds 
are shown as green cylinders (Rofriguez-Manzanet et al., 2009). (C) Surface 
representation of the top region of the domain with bound PS and the sodium ion 







play a critical role in binding to their ligands, whereas the mucin domains have no 
detectable ligand but are thought to enhance the affinity of interaction of Tim 
molecules with their ligands (McIntire et al., 2001; Meyers et al., 2005a). Tim 
molecules are highly glycosylated proteins. Except for differential levels of N-linked 
glycosylation, the mucin domains of Tim molecules have abundant serine and 
threonine residues which serve as sites for O-linked glycosylation (Kuchroo et al., 
2003).  
The crystal structures of the Ig domains of four murine Tim family members 
have been determined (Cao et al., 2007; Santiago et al., 2007a; 2007b). The NH2-
terminal Tim IgV domains are composed of two anti-parallel β-sheets with 
particularly short β-strands, B, E and D in one sheet (BED β-sheet) and A, G, F, C, 
C’ and C’’ β-strands in the other sheet (GFC β-sheet). All Tim IgV domains contain 
six conserved Cys residues, and the first and last of these six Cys residues bridge the 
β-sheets, as the IgV domains in other Ig superfamily (IgSF) molecules. The four 
additional Cys residues form two additional disulphide bonds that fix the long CC’’ 
loop upwards onto the GFC β-sheet (Figure 1.7B) (Freeman et al., 2010).  
Co-crystalization of mouse Tim4 IgV with phosphatidylserine (PS) (Figure 
1.7C) revealed it to be a PS receptor. The PS binding cavity is between the CC` loop 
and the neighbouring FG loop and there are four conserved amino acids (WFND) in 
this cavity with a critical binding role (Santiago et al., 2007a). PS is an indicator of 
apoptotic cells and is involved in the phagocytosis of apoptotic cells by 
macrophages. PS is normally expressed on the inner surface of a live cell’s lipid 
bilayer membrane. During apoptosis, PS is exposed on the outer surface of the lipid 
bilayer membrane (Zwaal et al., 2005). The subsequent interaction of PS with Tim4, 
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expressed on the surface of DCs and macrophages, bridges clearance of the dead cell 
by the APCs (Santiago et al., 2007a). 
Tim4-mediated phagocytosis was further proven by two other groups. 
Miyanishi et al. (2007) generated a library of hamster monoclonal antibodies against 
mouse peritoneal macrophages. One mAb, Kat5-18, strongly inhibited PS-dependent 
engulfment of apoptotic cells in vitro. The antigen recognized by this antibody was 
identified by expression cloning as Tim4. Kobayashi et al. (2007) also demonstrated 
that Tim4 binds PS and mediates uptake of apoptotic cells. Expression of Tim4 in 
fibroblasts (NIH-3T3 cells) resulted in efficient phagocytosis of apoptotic cells 
which could be blocked by an anti-Tim4 mAb (21H12). Mutations in the binding 
cavity of Tim4 eliminated PS binding and phagocytosis (Kobayashi et al., 2007).  
Anti-Tim4 mAbs (Kat5-18) that blocked PS binding and phagocytosis mapped to 
epitopes in this binding cavity (Miyanishi et al., 2007).  
Tim1 shares similar properties to Tim4 (Kobayashi et al., 2007); it has a PS 
binding site in the IgV domain and Tim1-transfected 3T3 cells had increased uptake 
of apoptotic cells. Similar phagocytotic activity is also possessed by Tim3, although 
its PS-binding motif is slightly different to those of Tim1 and Tim4 (Nakayama et 
al., 2009).  Tim2 seems to be the only member of the murine Tim family that does 
not mediate binding of PS (Santiago et al., 2007a; 2007b; Kobayashi et al., 2007). 
Tim1 and Tim3 are expressed on T cells, and it remains to be seen what the effects 
are of PS binding to these molecules on T cells, which are not phagocytes.  
The cytoplasmic tails of Tim molecules, except for Tim4, possess a 
consensus tyrosine kinase phosphorylation site through which downstream signalling 
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pathways are initiated. There is a costimulatory role for Tim1 in T cell activation and 
differentiation under the stimulation of anti-Tim1 antibodies (Umetsu et al., 2005) or 
the interaction between Tim1 and Tim4 (the Tim1 receptor) (Meyers et al., 2005a). 
de Souza et al. (2005) reported that Tim1 could provide costimulatory signals for 
increased transcription of IL-4 through activation of the IL-4 promoter, but had no 
effect on IFN-γ production, and could also augment levels of nuclear factor of 
activated T cells and activator protein-1 (NFAT/AP-1), a critical transcription factor 
for Th2 development and IL-4 production, suggesting that Tim1 enhances Th2 
cytokine production, consistent with the preferential expression of Tim1 on Th2 
cells.  Tim1 signalling was dependent on Y276 in the Tim1 cytoplasmic tail. The p85 
subunit of phosphoinositide-3 kinase (PI3K) is recruited directly to Y276 by the p85 
SH2 domain, after lymphocyte-specific protein tyrosine kinase (Lck)-dependent 
phosphorylation of the Tim1 cytoplasmic tail, and subsequently activates the 
downstream effector thymoma viral proto-oncogene (Akt) (de Souza et al., 2008). 
Tim1 therefore exerts an effect on NFAT/AP-1, at least in part, through the PI3K/Akt 
pathway.  
Human Tim1 colocalizes on the T cell surface with CD3, and is recruited to 
the T cell receptor (TCR)-signalling complex (Binne et al., 2007). Stimulation with 
agonistic Tim1 mAbs led to rapid tyrosine phosphorylation of Tim1, phosphorylation 
of zeta-chain-associated protein kinase 70 (Zap-70) and IL-2-inducible T cell kinase 
(ITK), and recruitment of ITK and PI3K (Binne et al., 2007). ITK is crucial for 
commitment of T helper progenitors towards Th2 cells, with increasing expression 
levels during Th2 proliferation, and the ITK promoter contains binding sites for the 
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canonical regulator of Th2 differentiation, GATA-3 (Schwartzberg et al., 2005). 
Tim1 might therefore drive Th2 cell differentiation partially through activity of ITK. 
The interaction of Tim1 with Tim4 in the presence of anti-CD3 and anti-
CD28 mAbs leads to phoshorylation of Tim1, phosphorylation of thymoma viral 
proto-oncogene 1 (Akt1) and mitogen-activated protein kinase1/2 (Erk1/2), and 
induction of B-cell chronic lymphocytic leukemia/lymphoma 2 (Bcl-2), suggesting 
that Tim4 treatment can promote T cell survival (Rodriguez-Manzanet et al., 2008).  
1.4.2 Tim1 
Tim1 was originally identified in the African green monkey as a receptor for 
hepatitis A virus (HAV), named HAVCR1 and associated with virus invasion 
(Kaplan et al., 1996). Later, Tim1 was also described as kidney injury molecule 1 
(Kim1), associated with kidney injury. Tim1 can act as a marker for acute kidney 
injury, because it is upregulated on renal epithelial cells and shed into the urine after 
kidney injury (Ichimura et al., 1998). Tim1 on renal epithelial cells plays an 
important role in tissue homeostasis by facilitating clearance of apoptotic and 
necrotic cells of injured tubules (Han et al., 2002; Ichimura et al., 2008). Tim1 is 
associated with kidney cancer, as Tim1 is upregulated in urine and tissue samples 
from patients with renal cell carcinoma (Vila et al., 2004).  
In the immune system, Tim1 is expressed on activated but not naïve CD4 T 
cells (Umetsu et al., 2005). Following differentiation, Tim1 is mainly expressed on 
Th2 cells and regulates Th2-biased immune responses, while Th1 and Th17 cells 
express little or no Tim1 (Meyers et al., 2005a; Nakae et al., 2007b; Umetsu et al., 
2005). NKT cells also express Tim1 on their cell surface, where it plays a similar 
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role as on CD4 T cells. Tim1 engagement on invariant NKT cells in the presence of 
TCR stimulation increased GATA-3 expression but reduced T-bet expression, 
resulting in enhancement of IL-4 production and inhibition of IFN-γ production (Kim 
et al., 2010). Murine Tim1 can be detected on the surface of peritoneal mast cells and 
bone marrow-derived cultured mast cells (Nakae et al., 2007a). In addition, in vitro 
activated murine B cells express low levels of Tim1 (Sizing et al., 2007). 
Human Tim1 also acts as a cellular HAV receptor (Feigelstock et al., 1998) 
and is associated with susceptibility to asthma. An association study of HAV with 
asthma showed, before 1970, that the seroprevalence of antibodies against HAV 
approached 100% in western countries, and infection with HAV may have protected 
many individuals against atopy (Matricardi et al., 2002). However, significant 
improvements in public health have caused anti-HAV seroprevalence to fall to 25-
30%, while the prevalence of atopic disease has doubled. Interestingly, HAV 
infection is merely a marker of poor hygiene, because it is transmitted through the 
faecal-oral route. As HAV is not a respiratory pathogen, how can it regulate 
development of atopy disease (Umetsu and Dekruyff, 2004)? A hygiene hypothesis 
was proposed to explain the association of Tim1 with atopy. HAV might interact 
with Tim1 on T cells, reduce Th2 cell differentiation, and thereby diminish the 
likelihood of developing asthma and other atopic diseases (McIntire et al., 2003; 
2004; Bach, 2002). Polymorphisms in murine Tim1 genes have shown association 
with asthma and atopic disease. In DBA/2 and C57/BL6 mouse strains, there are 
major single nucleotide polymorphisms (SNPs) and deletion variants in the Tim1 
mucin domain, explaining the tendency of these strains to develop reduced Th2 and 
air-way hyperreactivity (AHR) responses compared to the AHR susceptible BALB/c 
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stain (McIntire et al., 2001). Genetic studies of human Tim1 also revealed that the 
insertion of six amino acids (157insMTTTVP) and a depletion of one amino acid 
(195delT) were associated with protection from atopy, but this protection was only 
observed in individuals with HAV seropositivity (McIntire et al., 2003), which 
further supports the hygiene hypothesis. A similar pattern of association between 
Tim1 and atopy has also been confirmed in studies of large populations from 
different human genetic backgrounds (Chae et al., 2003; Gao et al., 2005; Page et al., 
2006; Wu et al., 2009). However, one study in a Japanese population, where the 
incidence of HAV infection is close to zero, showed an absence of association of 
Tim1 with asthma (Freeman et al., 2010).   
Several ligands for Tim1 have been identified.  Except for the above 
described hepatitis virus A and PS, Tim1 also binds to itself (Santiago et al., 2007), 
IgAλ (Tami et al., 2007), and leukocyte mono-immunoglobulin (Ig)-like receptor 5 
(LMIR5)/CD300b (Yamanishi et al., 2010). Crystal structure analysis revealed the 
homophilic murine Tim1-Tim1 interaction is through the BED faces of the two Tim1 
IgV domains (Santiago et al., 2007).  IgAλ binds Tim1 on a different site to HAV 
and their association has a synergistic effect in virus-receptor interaction (Tami et al., 
2007). The Ig-like domain of LMIR5 binds to Tim1 in the vicinity of the PS-binding 
site within the IgV domain of Tim1 and this interaction plays a physiological role in 
immune regulation by myeloid cells (Yamanishi et al., 2010).   
1.4.3 Tim3 
Tim3 was originally characterised as having a specific expression pattern on 
Th1 but not on Th2 cells through a screen for Th1-specific cell surface markers 
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(Monney et al., 2002). Tim3 is expressed on cytotoxic CD8
+
 T cells (Wang et al., 
2007) and at low levels on Th17 cells (Nakae et al., 2007a; Hastings et al., 2009), 
monocytes, DCs (Anderson et al., 2007), macrophages and mast cells (Frisancho-
Kiss et al., 2006; Nakae et al., 2007b). 
Galectin-9 was identified as a receptor for Tim3, recognising a carbohydrate 
structure on the IgV domain of Tim3 (Zhu et al., 2005). Tim3, through its ligand 
galectin-9, negatively regulates Th1 immunity. Galectin-9-induced intracellular 
calcium flux, aggregation and death of Th1 cells were Tim3-dependent in vitro, and 
administration of galectin-9 in vivo resulted in selective loss of IFN-γ-producing cells 
and suppression of Th1 autoimmunity (Zhu et al., 2005). These suppression effects 
on Th1 cells had decreased severity of diseases caused by Th1-mediated immunity. 
In a murine experimental autoimmune encephalomyelitis (EAE), a mouse model for 
human multiple sclerosis (MS), in vivo administration of galectin-9 fusion protein 
selectively reduced the number of IFN-γ-producing cells and resulted in ameliorated 
disease severity (Zhu et al., 2005). Galectin-9 showed effects on amelioration of 
collagen-induced murine arthritis through inhibition of the generation of Th17 cells 
and induction of Treg cells (Seki et al., 2008). In transplantation models, in vivo 
administration of galectin-9 prolonged survival of fully mismatched cardiac 
allografts through suppression of Th1 and Th17 immune responses (He et al., 2009), 
and improved survival of fully allogeneic skin grafts though activation of the Tim3-
galectin-9 pathway (Wang et al., 2008). Consistent with its role as an inhibitory 
molecule, blockage of Tim3 resulted in an exacerbation of autoimmune disease. In 
vivo administration of specific mAb to murine Tim3 during induction of EAE 
deteriorated disease progression and resulted in higher numbers of activated 
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macrophages (Monney et al., 2002). In a non-obese diabetic mice model, Tim3 
pathway blockade, through treatment with either a Tim3-Ig fusion protein or an anti-
Tim3 mAb, accelerated the onset of diabetes (Sanchez-Fueyo et al., 2003). 
Moreover, in vivo administration of mTim3-Ig fusion protein to mice, previously 
immunised with antigen, caused hyperproliferation of Th1 cells and increased 
production of IFN-γ, explained as the interaction of Tim3 with its ligand inhibiting 
effector Th1 cells during a normal immune response, whereas disruption of this 
pathway resulted in impaired peripheral tolerance (Sabatos et al., 2003).  
As mentioned earlier, innate immune cells, such as DCs, macrophages and 
mast cells, also express Tim3. Tim3 was rapidly expressed on mast cells and 
macrophages in mice following viral infection, whereas treatment with anti-Tim3 
mAb resulted in decreased activities of mast cells and macrophages with 
downregulation of CD80, suggesting Tim3 could be involved in the early stages of 
immune responses against pathogen invasion (Frisancho-Kiss et al., 2006). However, 
cross-linking Tim3 on the surface of mast cells with anti-Tim3 antibody increased 
IL-4, IL-6 and IL-13 production, resulting in an enhancement of Th2 immunity 
(Nakae et al., 2007b). When compared with wild type DCs, DCs from Tim3-
deficient mice less efficiently produced the inflammatory cytokine tumor necrosis 
factor (TNF)-α, after LPS and galectin-9 stimulation, suggesting an agonistic effect 
was present between Tim3 pathway and TLR signalling (Anderson et al., 2007). 
During induction of EAE, cross-linking Tim3 with anti-Tim3 antibody worsened 
disease progression, explained as triggering Tim3 on macrophages leading to 
promotion of inflammatory Th1 responses (Monney et al., 2002). So far, the data 
suggest that Tim3 plays distinct roles in innate and adaptive immunity. Tim3 on cells 
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of the innate immune response synergizes with TLR signals to activate these cells, 
which in turn drive Th1 and Th2 responses. However, Tim3 can also terminate Th1 
cell responses in adaptive immunity through its receptor galectin-9. 
Tim3 is highly expressed on exhausted CD8
+
 T cells in chronic viral  
infections to suppress the immune function of these cells. CD8
+
 T cell exhaustion 
describes a state of T cell dysfunction after chronic viral infection, with loss of 
capability to proliferate and effector function, such as cytotoxicity and cytokine 
secretion in response to antigen stimulation (Moskophidis et al., 1993; Zajac et al., 
1998). Tim3 is upregulated on CD8
+
 T cells from HIV patients. These Tim3-
expressing cells failed to produce cytokines or proliferate in response to antigen. 
However, blocking the Tim3 signalling pathway restored proliferation and enhanced 
cytokine production in HIV-1-specific T cells (Jones et al., 2008). Similar 
phenomena with Tim3 expression on exhausted CD8
+
 T cells were also observed in 
patients with chronic hepatitis B (HBV) (Ju et al., 2010) and C (HCV) (Golden-
Mason et al., 2009) virus infection. Tim3-expressing cells were the most abundant 
fraction among virus-specific CD8
+
 T cells. With treatment with antibody against 
Tim3, exhausted CD8
+
 T cells can be partially recovered to proliferate and produce 
IFN-γ (Golden-Mason et al., 2009; Ju et al., 2010). 
Allelic variants in mouse Tim3 are clustered in the Ig domain and are thought 
to affect interactions between PS and Tim3, resulting in variable PS binding affinity 
and phagocytic capacities.  An allele of Tim3 in BALB/c mice bound to PS with 
higher affinity and mediated more efficient phagocytosis of apoptotic cells than an 
allele of Tim3 in HBA mice (DeKruyff et al., 2010). Two alternative splice variants 
of murine Tim3 were also identified, which encoded a membrane-anchored protein 
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and a soluble protein with only the IgV domain. The membrane-bound Tim3 had 
normal roles as described previously. However, the function of soluble Tim3 is not 
clear; it may also be involved in Tim3-mediated immune responses but in a 
competitive way to bind Tim3 ligand (Sabatos et al., 2003). Genetic studies showed 
SNPs in human Tim3 were associated with idiopathic thrombocytopaenic purpura 
disease (Du et al., 2009) and type 1 diabetes (Bruck et al., 2008). 
1.4.4 Tim4 
Unlike other members of the Tim family in mouse and human, Tim4 is not 
expressed on T cells but is instead expressed on APCs, particularly on DCs and 
macrophages (Meyers et al., 2005a). Tim4 plays a role in regulation of T cell 
responses. Administration of Tim4-Ig fusion protein increased basal T cell 
proliferation and cytokine production (Meyers et al., 2005a). However, in vivo, 
Tim4-induced T cell activation seems to be in a dose-dependent manner. For mice 
treated with high-dose of Tim4-Ig fusion protein, in vitro analysis of their 
splenocytes indicated high levels of IL-2 and IFN-γ production, whereas there were 
high levels of IL-4 and IL-10 production from low-dose Tim4-Ig treated mice 
(Meyers et al., 2005a). Tim4 also plays bimodal roles in the regulation of naïve and 
activated T cell responses. Tim4-Ig fusion protein bound to naïve CD4
+
 T cells 
through an unknown ligand and inhibited activation and proliferation of these cells 
(Mizui et al., 2008; Cao et al., 2011). However, for pre-activated CD4
+
 T cells, Tim4 
plays a role in costimulation of these cells in the presence of anti-CD3 and -CD28 
antibodies (Meyers et al., 2005a).  
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Murine Tim4 was found to be a ligand of murine Tim1 using a stably 
transfected CHO cell model, where CHO transfectants overexpressing Tim1, Tim3 
or Tim4 on the cell surface were stained with various Tim fusion proteins (Tim1-Ig, 
Tim2-Ig and Tim4-Ig) (Meyers et al., 2005a). Tim4-Ig bound to Tim1 transfectants 
but not to Tim3 or Tim4 transfectants. Conversely, Tim1-Ig bound to Tim4 
transfectants but not to Tim1 or Tim3 transfectants. This interaction could be blocked 
by a specific anti-Tim1 mAb (Meyers et al., 2005a). Therefore, the Tim4-induced 
proliferation of pre-activated CD4
+
 T cells was thought to be through surface 
expressed Tim1 on activated cells, because Tim1, as a receptor of Tim4, is 
upregulated on activated T cells (Meyers et al., 2005a; Mizui et al., 2008). A Tim4-Ig 
fusion protein also stained higher proportions of in vitro-polarised Th2 cells than Th1 
cells (Meyers et al., 2005a), which is consistent with the observation that Tim1 is 
specifically expressed on Th2 cells. Tim4-induced T cell activation resulted in the 
phosphorylation of Tim1, along with increased phosphorylation of key signalling 
components for the activation of T cells, Akt1 and Erk1/2 (Rodriguez-Manzanet et 
al., 2008). 
However, binding with highly purified proteins failed to detect a direct 
interaction between Tim1 and Tim4 (Sizing et al., 2007). Contrary findings were also 
reported by Wilker et al. (2007).  Murine Tim1, Tim3 and Tim4 fusion proteins non-
specifically bound to the surface of cells overexpressing murine Tim1, Tim3 and 
Tim4, and authors interpreted these results as homotypic and heterotypic Tim 
interactions. Miyanishi et al. (2007) suggested exosomes may bridge Tim4/Tim1 
interaction, because Tim1 and Tim4 can bind to separate sites on the surface of an 
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exosome. Exosomes expose PS at their outer leaflet and Tim proteins might serve as 
receptors for exosomes via PS. 
In addition, Tim4 lacks a tyrosine in its cytoplasmic tail, suggesting Tim4 
lacks the ability to transduce signals. Studies have confirmed that Tim4 does not 
mediate direct downstream signalling, as a version of Tim4 without its cytoplasmic 
tail still promoted the uptake of apoptotic cells via PS recognition (Park et al., 2009). 
Cross-linking Tim4 expressed on RAW264.7 cells, a murine macrophage cell line, 
with Tim1-Ig fusion protein can regulate cytokine production and B7 family member 
expression (Hein and Woods, 2007). All these findings suggest that Tim4-Tim1 
interactions might transduce activation signals one-way through Tim1. If two-way 
transduction occurs, Tim4 would need other transmembrane protein(s) to transmit a 
cytoplasmic signal.  
1.4.5 Tim2 
Tim2 is present in mouse, but not present in human. Similarly to Tim1, Tim2 
expression was upregulated on activated T cells, and exclusively maintained on the 
surface of differentiated Th2 cells (Kumanogoh et al., 2002; Chakravarti et al., 
2005).  Germinal centre B cells in the spleen have high surface expression levels of 
Tim2 (Chen et al., 2005). Tim2 has two different ligands, H-ferritin and Sema4A. H-
ferritin is secreted by macrophages in a soluble form. Interaction of Tim2 with H-
ferritin increased internalisation of H-ferritin and had a physiological role in the 
regulation of iron mineralisation and sequestration (Chen et al., 2005). Sema4A is a 
class IV semaphore, expressed in DCs and B cells, and plays a role in the regulation 
of T cell responses (Kumanogoh et al., 2002). Tim2 seems to be a specific regulator 
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of Th2 immune responses. Administration of Tim2-Ig fusion protein resulted in the 
preferential induction of Th2 cell responses, inhibition of Th1 responses, and 
administration of Tim2-Ig fusion protein during the induction phase reduced the 
severity of EAE (Chakravarti et al., 2005). Sema4A-dificient mice resulted in 
dysregulated Th cell proliferation and impaired Th1 responses, suggesting that Tim2 
served to downregualte establishment of Th2 responses (Kumanogoh et al., 2005). 
Other evidence also showed that Tim2 plays a role in suppressing Th2 responses. 
CD4
+
 T cells from Tim2-deficient mice showed higher levels of proliferation in 
response to antigen stimulation than those of wild-type cells and markedly higher 
levels of IL-5, IL-10, and IL-13, suggesting the inhibitory activity of Tim2 was 
turned off, resulting in an Th2 over-response (Rennert et al., 2006). Tim2 
overexpressed in T cell lines also showed a significantly impaired induction of 
NFAT/AP-1 transcription reporters, suggesting that Tim2 signalling induces 
inhibitory activities in T cell responses (Knickelbein et al., 2006). 
1.4.6 Tim molecules in other animals 
So far there have been no reports of Tim family molecules in species beyond 
human and mouse, resulting in a suggestion by Ohtani et al. (2012) that the Tim 
family are mammalian-specific molecules. Analysis of Tim molecules in 24 different 
primates, including Prosimians, New World monkeys, Old World monkeys and 
Hominoids (including human), indicated that Tim1 became a pseudogene in multiple 
lineages of the New World monkey, caused by the insertion of deleterious sequences 
or base substitutions leading to a termination codon. In other monkeys, Tim1 has 
undergone positive selection in the IgV domain (with more variations) during the 
course of primate evolution. However, in Old World monkeys, more polymorphisms 
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can be seen in the mucin domain, suggesting they might be under balanced selection. 
By contrast, no significant positive selection occurred in the Tim3 and Tim4 genes in 
all primates (Ohtani et al., 2012). 
1.5 Hypothesis and aim of this project 
Mammalian Tim family of molecules are specifically expressed on Th1, Th2 
and APCs and play immunological and physiological roles on these cells. Blasting 
searches of chicken genome found only chicken Tim1 and Tim4. Like mammals, 
chicken Th1/Th2 cells by producing distinct cytokines determine the outcomes of 
intracellular and extracellular pathogens. A hypothesis is that chicken Tim molecules 
may evolutionarily conserved certain functions as those of their mammalian 
counterparts, such as specific expression patterns on immune cells and biological 
roles in phagocytosis of dead cells and costimulatory activity; on the other hand, 
mammalian Tims, especially Tim1, are highly associated with autoimmune diseases, 
while autoimmune diseases are rare events in chicken, implying diverse roles of Tim 
molecules may be present between chicken and mammal species.  
Therefore, the aim of this project is to clone and characterise the Tim family 
genes in the chicken and to determine if they have similar biological activities, and 






Chapter 2.    Materials and Methods. 
2.1 General reagents 
2.1.1 General chemicals 
General chemicals were of analytical or molecular biology grade supplied by 
Sigma-Aldrich (Poole, UK) or Invitrogen (Paisley, UK). 
2.1.2 Solutions 
All solutions were made up in Milli-Q (reverse osmosis; ion-exchanged; 
activated charcoal filtration) water unless otherwise stated. All solutions for RNA-
related work were made in RNase-free water or 0.1% diethyl pyrocarbonate (DEPC)-
treated water.  
2.1.3 Vectors 
1. pGEM-T Easy                   Used in TA cloning (Promega) 
2. pKW06-Ig                       A kind gift from John Young (Institute for 
Animal Health, Compton, UK) (Figure 2.1) 
3. pKW06-his6                         Constructed by replacing the Ig tag in pKW06-Ig 
with a his6 tag (Figure 2.2) 
4. Signal pKW06-Ig                 A kind gift from John Young (Institute for 
Animal Health, Compton, UK) (Figure 2.3) 
2.1.4 Antibodies 
Antibodies used in this study are shown in Table 2.1. 
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Table 2.1. Antibodies used in this study. Ch: chicken; hu: human; m: mouse.  
 
 
Antigen Species Clone/Subclass Conjugation Supplier 
chCD4 Mouse CT-4/IgG1 ----- SouthernBiotech 
chCD4 Mouse CT-4/IgG1 FITC SouthernBiotech 
chBu-1 Mouse AV20/IgG1 ----- SouthernBiotech 
chBu-1 Mouse AV20/IgG1 FITC SouthernBiotech 
chCD28 Mouse AV7/IgG1 ----- SouthernBiotech 
chCD3 Mouse CT-3/IgG1 ----- SouthernBiotech 
Chicken monocyte/ 
macrophages 
Mouse KUL01/IgG1 ----- SouthernBiotech 
Chicken monocyte/ 
macrophages 
Mouse KUL01/IgG1 FITC SouthernBiotech 
Rat PDI Mouse RL90/IgG2a ----- Thermal Scientific 
Rat GM130 Mouse 35GM130/IgG1 ----- BD Biosciences 
Penta-his Mouse IgG1 ----- QIAGEN 
huIgG Rabbit Polyclonal FITC SouthernBiotech 
huIgG Goat Polyclonal HRP SouthernBiotech 
huIgG Goat Polyclonal Biotin SouthernBiotech 
huIgG Goat Polyclonal ----- SouthernBiotech 
mIgG Goat Polyclonal Alexa fluor 647 SouthernBiotech 
mIgG Goat Polyclonal Alexa fluor 488 SouthernBiotech 
mIgG Goat Polyclonal HRP SouthernBiotech 















Figure 2.1. pKW06-Ig vector map. This is a mammalian expression vector with a 
COOH-terminal human IgG Fc tag. cDNAs to be expressed are cloned between NheI 































Figure 2.2. pKW06-His6 vector map. This is a mammalian expression vector with a 
COOH-terminal His6 tag. cDNAs to be expressed are cloned between NheI and BglII 























Figure 2.3.  Signal pKW06-Ig vector map. This is a mammalian expression vector 
with a signal peptide from the mouse CD8α gene (green box) and a COOH-terminal 
human Ig Fc tag. cDNAs to be expressed are cloned between NheI and BglII enzyme 






All the animals used in the work reported in this thesis were handled and 
killed in accordance with the Animals (Scientific Procedures) Act 1986. 
2.2.1 Chickens 
The chickens used in this study were Brown Leghorn J line birds, bred in the 
poultry unit, The Roslin Institute, or specified-pathogen-free (SPF) inbred line 72 
chickens, bred  in the Poultry Production Unit at the Institute for Animal Health, 
Compton, UK. 
2.2.2 Mice 
Biozzi or BALB/c strain mice were isolated in cages with free access to food 
and water. 
2.3 Cells 
2.3.1 Reagents for cell culture 
Cell culture media were purchased from Gibco Life Technologies (Paisley, 
UK) or Sigma-Aldrich (Poole, UK). 100× penicillin-streptomycin containing 5,000 
Units of penicillin and 5 mg of streptomycin per ml, 100× L-glutamine (200 mM), 
100× non-essential amino acids (NEAA), 100 mM sodium pyruvate, foetal bovine 
serum (FBS, EU-approved, South American origin), chicken serum (CS, New 
Zealand origin), 2.5% trypsin and 1× versene were all purchased from Gibco Life 
Technologies. 0.4% Trypan-blue solution was obtained from Sigma-Aldrich. FBS 
and CS were thawed and incubated at 56ºC for 30 min in a water-bath for heat-
inactivation of serum. 
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2.3.2 General conditions for maintenance of mammalian cell lines 
COS-7 and NIH-3T3 cells were cultured in Dulbecco's Modified Eagle’s 
Medium (DMEM), CHO cells in Ham’s F12 medium and SP2/0 in RPMI 1640 
medium. All cell growth media were supplemented with 10% FCS, 2 mM L-
glutamine, 1× NEAA and 1 mM sodium pyruvate unless otherwise stated. 
Mammalian cell lines were cultured at 37ºC in a humidified incubator with 5% CO2. 
To resurrect the cell lines from liquid nitrogen storage, the cells were thawed 
at 37ºC in a water-bath, washed once with cell growth medium and resuspended in 
15 ml of this medium. The cell suspension was then transferred to a T75 tissue 
culture flask and returned to a CO2 incubator.  Three days later, when the cells were 
fully confluent, they were ready for passaging. Adherent cells, such as COS-7, 3T3 
and CHO, were detached from the flask by trypsinisation. In brief, the cell layer was 
washed once with PBS, 5 ml of 0.25% trypsin/versene mix were then added to cells, 
incubating at 37ºC for 5 min. Tapping the flask to loosen the cells, 10 ml of cell 
growth medium were added to the flask to stop trysinization and the cell suspension 
was collected in a Universal. Pelleting cells by spinning at 1,000 g for 4 min, the 
cells were resuspended in the respective cell growth medium. To count cells, a small 
aliquot of the cell suspension was mixed with an equal volume of 0.4% trypan blue 
solution, and counted with a haemocytometer. Cells were seeded at 7.5×10
5
 cells in 
15 ml cell growth medium in a T75 flask and cultured at 37ºC, 5% CO2. Semi-
adherent cells, such as SP2/0, were detached from the flask by shaking the flask 
vigorously and the cell suspension was collected in a Universal for pelleting the 
cells. Cells were seeded at 2×10
6
 cells in 15 ml cell growth medium in a T75 flask 
and cultured at 37ºC, 5% CO2. 
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2.3.3 General conditions for isolation and culture of chicken primary 
cells  
All chicken tissues for cell isolation were removed aseptically post-mortem, 
placed in Universals in cold sterile PBS and delivered to the laboratory on ice or ice 
packs in a polystyrene box. Chicken primary cells were cultured in complete RPMI 
1640 medium supplemented with 8% FCS, 2% CS, 50 Units/ml penicillin, 50 µg/ml 
streptomycin, 1× L-glutamine, 1× NEAA and 1× sodium pyruvate unless otherwise 
stated, and incubated at 41ºC in a humidified incubator with 5% CO2. 
2.3.4 Cell lines 
2.3.4.1 COS-7 cells  
The COS-7 cell line is an African Green Monkey kidney cell line. It is an 
adherent cell line derived from the CV-1 cell line by transformation of an origin-
defective mutant of SV40 virus that can produce large T antigen but not replicate 
itself. When a plasmid with an SV40 promoter is introduced into COS-7 cells, the 
vector can be replicated substantially by the large T antigen, enabling transient 
expression of a recombinant gene (Gluzman, 1981).  
2.3.4.2 CHO-K1 cells  
CHO-K1 cells were derived from the ovary of a Chinese hamster. The CHO 
cell line is an adherent cell line with a requirement for proline in its growth medium 
due to the lack of the gene for proline synthesis. This cell line possesses a small 
number of chromosomes (2n = 22) and is normally used as a model system in the 
quantitative study of the genetic action of various agents on cells cultivated in vitro 
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(Tjio, 1958). CHO cells are the most commonly used mammalian hosts to express 
recombinant protein, especially when long-term and high yields of proteins are 
required. 
2.3.4.3 NIH-3T3 cells  
3T3 cells come from a cell line established in 1962 by George Todaro and 
Howard Green. 3T3 cells were originally obtained from Swiss mouse embryonic 
tissue. This cell line has become the standard fibroblast cell line. The '3T3' refers to 
the fact that primary mouse embryonic fibroblast cells were transferred (the "T") 
every 3 days (the first "3"), and inoculated at the rigid density of 3×10
5
 cells per 20 
cm² dish (the second "3") continuously. Spontaneously immortalized cells with a 
stable growth rate were established after 20-30 generations in culture (Todaro, 1963). 
2.3.4.4 SP2/0 cells  
Sp2/0-Ag14 was isolated as a re-clone of Sp2/HL-Ag, itself derived in 
several steps from Sp2/HLGK, a hybrid between a BALB/c spleen cell contributing a 
γ2b (H) and κ (L) chains with anti-sheep red blood cell activity and the myeloma cell 
line X63-Ag8. Sp2/0-Ag is resistant to 20 µg/ml 8-azaguanine, dies in HAT-
supplemented medium and does not synthesise Ig chains. It has about 73 
chromosomes which is only eight more than the chromosome number of X63-Ag8, a 
cell line commonly used to generate hybridomas (Shulman, 1981). 
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2.3.5 Chicken primary cells  
2.3.5.1 Isolation of chicken splenocytes 
Spleens were sampled from J line or line 72 chickens aged 4-8 weeks. For 
splenocyte isolation, in brief, the spleen was placed in a petri dish with 10 ml cold 
PBS. A single cell suspension was prepared by repeatedly squeezing the spleen with 
forceps. The cell suspension was carefully aspirated by plastic pipette, passed 
through a 100 µm pore size cell strainer (BD Bioscience, Oxford, UK) and collected 
in a 50 ml Falcon tube. The cells were pelleted by centrifugation at 1,500 g for 10 
min. To remove the red blood cells, the cell pellet was resuspended in 5 ml 
Histopaque 1083 (Sigma-Aldrich), and then 5 ml PBS carefully layered on top. The 
tube containing the cell suspension was centrifuged at 2,000 g for 25 min without 
braking. The white fluffy layer at the PBS and Histopaque interface can be visualized 
after centrifugation. This layer was carefully collected and transferred to a new 
Universal. The cells were washed by adding 15 ml PBS to the cells and pelleted by 
centrifugation at 1,500 g for 10 min. The cells were resuspended in complete RPMI 
1640 medium, and then counted.  
2.3.5.2 Preparation of B cells from the bursa of Fabricius  
Bursae of Fabricius were sterilely removed from J line chickens aged 4 weeks 
old or less, because younger birds have larger bursae than older birds. The bursae 
was then placed in a petri dish with 10 ml cold PBS and cut into small pieces. These 
pieces were repeatedly squeezed with forceps to release single bursal cells. The cell 
suspension was collected and passed through a 100 µm pore size cell strainer to 
remove big tissue clumps. The cells were then pelleted by centrifugation at 1,500 g 
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for 10 min. The cell pellet was resuspended in complete RPMI 1640 medium and 
then counted. 
2.3.5.3 Isolation of chicken bone marrow cells 
Femur bones were taken from J line chickens aged 4-8 weeks. The ends of 
the femur bones were cut off and the bones placed in a petri dish. The bone marrow 
was flushed out with a 21G needle attached to a 20 ml syringe, which was filled 15 
ml RPMI 1640. Repeatedly flushing of the bones released as many single cells as 
possible. The cell suspension was then collected, passed through a 100 µm cell 
strainer and collected in a Universal. The Universal was centrifuged at 1,500 g for 10 
min at 4ºC to pellet the bone marrow cells. Removing the supernatant, the cell pellet 
was resuspended in 10 ml of Histopaque 1.077 (Sigma-Aldrich) and 10 ml PBS were 
carefully overlaid. After centrifugation at 2,000 g for 30 min without braking, a 
fluffy layer can be seen at the interfaces between the Histopaque layer and PBS. This 
cell layer was carefully aspirated with a plastic pipette, transferred to a 50 ml Falcon 
tube, topped up to 50 ml by PBS, mixed thoroughly and the cells pelleted by 
centrifugation at 1,500 g for 10 min. The cells were resuspended in complete RPMI 
1640 medium and then counted. 
2.3.5.4 Stimulation of chicken splenocytes 
Splenocytes or bursal cells were prepared as described before (section 2.3.5.1 
and 2.3.5.2) and cultured in complete RPMI 1640 medium. To stimulate the cells, 5 
ml cell suspension at a cell density 2×10
6
 cells/ml were added to a T25 flask with or 
without 3 µg/ml Concanavalin A (ConA), 5 µg/ml phytohaemagglutinin (PHA) or 1 
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µg/ml phorbol-12-myristate-13-acetate (PMA), and incubated at 41ºC, 5% CO2. The 
duration of culture depends upon the experiment, as detailed in the Results Chapters. 
2.3.5.5 Preparation of chicken bone marrow-derived macrophages  
Recombinant chicken CSF-1 (rchCSF-1) fused with a COOH-terminal His6-
V5 tag was transiently expressed from COS-7 cells (section 2.7.1) and a dot-blotting 
assay (section 2.6.3) was utilized to estimate the protein concentration. To obtain 
bone marrow-derived macrophages, the bone marrow cells, prepared as described in 
section 2.3.5.3, were suspended and adjusted to 2×10
6
 cells/ml in complete RPMI 
1640 medium. The cell suspension (15 ml) was added to a Sterilin square tissue 
culture dish (Thermal Scientific) with the addition of 75 µl COS-7 supernatant 
containing rchCSF-1 and incubated at 41ºC, 5% CO2 for 6 days, changing the media 
for fresh rchCSF-1 medium every two days. The cells were harvested by repeatedly 
blowing the cell layer with a sterile plastic pipette. Transferring the cell suspension 
to a Universal, the cells were pelleted by centrifugation at 1,500 g for 10 min. The 
cell pellet was resuspended in an appropriate volume of complete RPMI 1640 
medium and then counted.   
2.3.5.6 Chicken bone marrow-derived dendritic cells (DCs)  
Recombinant chicken IL-4 (rchIL-4) and GM-CSF (rchGM-CSF) were 
transiently expressed from COS-7 cells as described in section 2.7.1. The bone 
marrow cells, prepared as in section 2.3.5.3, were suspended and adjusted to 2×10
6
 
cells/ml in complete RPMI 1640 medium. Cell suspension (5 ml) supplemented with 
25 µl rchIL-4 and 25 µl rchGM-CSF was added to each well of 6-well plates and 
incubated at 41ºC, 5% CO2 for 6 days, changing the media for fresh rchIL-4 and 
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rchGM-CSF medium every two days. The cells were harvested as described in 
section 2.3.5.5 
2.3.6 Bacterial strains 
E.coli strain JM109: endA1, recA1, gyrA96, thi, hsdR17 (rk–, mk+), relA1, 
supE44, Δ( lac-proAB), [F´ traD36, proAB, laqIqZΔM15], was used for routine 
propagation of plasmids. 
2.4 RNA manipulation 
Chicken tissue samples were preserved in RNAlater (Ambion, Huntingdon, 
UK) for 1 week at 4ºC to stabilize RNA as per the manufacturer’s instructions, prior 
to isolation of total RNA, using an RNeasy Mini kit (QIAGEN, East Crawley, UK) 
according to the manufacturer’s instructions. In brief, the tissues were cut and 
weighed. Each sample (25-30 mg) was transferred to a 2 ml safe-lock Eppendorf 
tube with a 5 mm stainless steel bead. Lysis buffer RLT (600 µl) was added to the 
sample, and the tissue was thoroughly disrupted and homogenized on a bead mill, 
Mixer Mill MM 300 (RETSCH, Hunslet, UK),  for 4 min at 20 Hz. The lysate was 
pipetted onto a QIAshredder spin column and the column was centrifuged at 10,000 
g for 2 min. For total RNA from cells, 600 µl RLT buffer were added to 5×10
6
 
pelleted cells, vortexing vigorously to lyse the cells. An equal volume of 70% 
ethanol was added to tissue or cell lysate and mixed thoroughly by pipetting. This 
mixture was then transferred to an RNeasy spin column and the column was 
centrifuged at 10,000 g for 1 min. After washing the column with 700 µl buffer RW1 
once and 500 µl RPE twice, the column was then removed and placed into a new 1.5 
ml collection tube. To elute the RNA, 50 µl RNase-free water were added to the spin 
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column membrane, incubated for 1 min at room temperature and centrifuged at 
10,000 g for 1 min. RNA samples were stored at -20ºC until later use. 
2.5 Molecular Biology Methods 
2.5.1 First-strand cDNA synthesis 
First-strand cDNA was synthesised using SuperScript
TM
 II (Invitrogen). 
Following the manufacturer’s instructions, briefly, 5 μg of spleen total RNA from a 
4-weeks-old line 72 chicken were mixed with 1 μl 500 μg/ml oligo (dT)12-18, 1 μl 10 
mM dNTP mix, bringing the total volume to 12 μl with DEPC-treated water. The 
mixture was heated to 65ºC for 5 min and immediately chilled on ice. The tube was 
briefly centrifuged to collect the contents on the tube wall. The follows were then 
added: 4 μl 5× first-strand buffer (250 mM Tris-HCl (pH 8.3), 375 mM KCl, 15 mM 
MgCl2), 2 μl 0.1 M DTT and 1 μl RNase inhibitor (40 Units/μl), gently mixed and 
incubated at 42ºC for 2 min. One μl SuperScript
TM
 II (200 Units) was added and 
gently mixed by pipetting. The tube was incubated at 42ºC for 50 min and the 
reaction was stopped by heating at 75ºC for 15 min. 
2.5.2 Polymerase chain reaction (PCR)  
The PCRs were performed on a Mastercycler Thermo cycler (Eppendorf, 
UK) using Invitrogen’s recombinant Taq DNA polymerase purified from E. coli 
expressing a cloned Thermus aquaticus DNA polymerase gene. According to the 
manufacturer’s instructions, the reaction mixture contained 2 μl 10× PCR buffer 
minus Mg
2+
, 0.4 μl 10 mM dNTP mixture, 0.6 μl 50 mM MgCl2, 1 μl 10 μM forward 
primer, 1 μl 10 μM reverse primer, 0.2 μl Taq polymerase (5 Units/μl), 1 μl cDNA 
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template and H2O to 20 μl. Cycling conditions were: denaturation at 94ºC for 3 min, 
then amplification with 25 cycles of 95ºC for 45 s, 55ºC for 30 s, 72ºC for 2 min. 
The PCR was extended for 10 min at 72ºC, and the sample stored at 25ºC. This 
standard PCR condition was used to subclone target cDNA from a TA cloning vector 
into an expression vector, or for colony PCR to screen positive bacterial colonies. 
For particular cDNA amplification, the PCR conditions will be described in the 
relevant Results Chapters. 
2.5.3 DNA gel electrophoresis 
PCR products were resolved on a 1.0% agarose gel (made up with 0.5× TBE 
buffer, Ambion, UK) containing 1× GelRed (Cambridge Bioscience, Cambridge, 
UK). Electrophoresis was at a constant voltage of 150 V for 1 h in 0.5× TBE buffer. 
The resolved DNA was visualised on a UVP dual-intensity UV transilluminator. 
2.5.4 DNA fragment extraction 
A QIAquick gel extraction kit (QIAGEN) was used to extract DNA 
fragments from agarose gels according to the manufacturer’s instructions. Briefly, 
the target DNA band was excised from an agarose gel and placed in a 1.5 ml 
Eppendorf tube, 3 gel volumes of buffer QG added and heated at 50ºC for 10 min 
until the gel slice was completely dissolved in buffer. One gel volume of 100% 
isopropanol was added to the gel solution and mixed. The mixture was transferred to 
a spin column and centrifuged at 10,000 g for 1 min. The column was washed once 
with 750 µl buffer PE. Finally, the DNA bound on the column was eluted by the 
addition of 20 µl Milli Q water.  
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2.5.5 TA cloning  
DNA fragments extracted from agarose gels were cloned into a TA cloning 
vector, pGEM-T Easy (Promega, Southampton, UK). The ligation mixture contained 
5 µl 2× rapid ligation buffer (60 mM Tris-HCl (pH 7.8), 20 mM MgCl2, 20 mM 
DTT, 2 mM ATP and 10% PEG), 1 µl (3 Units) T4 ligase, 1µl vector and 3 µl DNA 
to be cloned, gently mixed and incubated at 16ºC overnight. 
2.5.6 Transformation of ligation products into competent cells by heat-
shock  
Competent E. coli JM109 cells (Promega) were retrieved from a -80ºC 
freezer and thawed on ice. Ligation product (5 μl) was mixed with 50 µl competent 
cells in a sterile 1.5 ml Eppendorf tube and incubated on ice for 20 min. The cells 
were then heat-shocked at 42ºC for 45 s and returned to ice again for 5 min, followed 
by the addition of 1 ml SOC medium (Microbiology Services, IAH Compton) and 
incubation at 37ºC for 1 h in a shaking incubator at 200 rpm. LB agar plates 
supplemented with 100 μg/ml of ampicillin (Microbiology Services, IAH Compton) 
were spread with 40 μl 40 mg/ml 5-bromo-4-chloro-3-indolyl β-D-galactopyranoside 
(X-gal) (Sigma-Aldrich) and 100 μl 100 mM isopropyl-β-thiol-galactopyranoside 
(IPTG) (Sigma-Aldrich) for blue/white colony selection. The transformed competent 
cells were pelleted with centrifugation at 7,000 g for 3 min and resupended in 100 µl 
SOC, 50 µl of which were then spread on the X-gal and IPTG agar plates. The plates 
were incubated at 37ºC overnight. 
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2.5.7 Isolation of plasmid DNA 
White colonies were picked, incoculated into 5 ml LB broth (Microbiology 
Services, IAH Compton) in Universals and cultured at 37ºC overnight in a shaking 
incubator at 200 rpm. A QIAGEN QIAprep spin miniprep kit was used to isolate 
plasmid DNA according to the manufacturer’s instructions. Briefly, the bacterial 
cultures were centrifuged at 3,000 g for 30 min. The bacterial pellet was resuspended 
in 250 μl P1 buffer and transferred to a 1.5 ml Eppendorf tube. P2 buffer (250 μl) 
was added to lyse the bacterial suspension, mixed by inverting the tube 4-5 times, 
followed by the addition of 350 μl N3 buffer to stop the lysis reaction. The tubes 
were centrifuged at 10,000 g for 10 min. The supernatant was decanted to a spin 
column. The column was centrifuged at 10,000 g for 1 min. After washing the 
column once with 750 μl buffer PE, the plasmid DNA bound to column was eluted 
with 50 μl Milli-Q water. 
2.5.8 DNA sequencing 
In-house DNA sequencing was performed using a Dye Terminator Cycle 
Sequencing (DTCS) Quickstart kit (Beckman Coulter, High Wycombe, UK) for the 
sequencing reaction and read on a Beckman Coulter Capillary Sequencer CEQ8000. 
For each reaction, 200 ng of plasmid DNA were diluted to 15.5 μl with Milli-Q 
water, heated at 95ºC for 1 min and immediately cooled down on ice. The following 
reagents were then added to the PCR mixture: 1 μl 4 pmol sequencing primer, 2 μl 
Quickstart reagent and 1.5 μl reaction buffer. The thermal cycling was performed as 
follows: denaturation at 96ºC for 30 s, annealing at 50ºC for 30 s and extension at 
60ºC for 4 min. A stop solution was made up with 2 volumes 100 mM EDTA 
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(Sigma-Aldrich), 2 volumes 3 M sodium acetate (Sigma-Aldrich) and 1 volume 
glycogen (provided in the kit). For clean-up of the reaction product, 5 μl of stop 
solution were firstly added to the reaction, the PCR product was then precipitated by 
the addition of 60 μl pure ethanol, mixed thoroughly and centrifuged at 10,000 g for 
15 min at 4ºC. The pellet was washed with 200 μl 70% ethanol twice, air-dried and 
then resuspended in 40 μl sample loading solution (SLS).  
2.5.9 Restriction enzyme digestion 
Restriction enzyme sites were introduced to ends of cDNA fragments by PCR 
(section 5.2.1) via primer pairs designed to contain a NheI at the 5’ end of the 
forward primer and a BglII enzyme site at the 5’ end of the reverse primer. The PCR 
product was then ligated into a TA cloning vector (section 2.5.5), followed by 
transformation of competent E. coli JM109 cells and blue/white screening (section 
2.5.6). Plasmids from positive clones were prepared at a small scale (section 2.5.7), 
and subjected to DNA sequencing (section 2.5.8) to confirm the DNA sequence of 
the insert in these plasmids. 
A plasmid containing the expected cDNA sequence with enzyme sites was 
subjected to double restriction enzyme digestion. The digestions were carried out 
separately due to the fact that NheI and BglII utilise different buffers. Briefly, 1 μg 
plasmid DNA was digested with NheI enzyme by mixing 2 μl 10× NEBuffer 2 (100 
mM Tris-HCl, 500 mM NaCl, 100 mM MgCl2, 10 mM dithiothreitol), 1 μl NheI (10 
Units) (NEB, Herts, UK), 0.2 µl 100 µg/ml BSA and Milli-Q water to 20 μl. After 
incubation at 37ºC for 2 h, the buffer and enzyme were removed using a QIAquick 
PCR purification kit (QIAGEN), according to the manufacturer’s instructions. Buffer 
PB (100 μl) was added to the digestion mixture, mixed and then transferred to a spin 
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column. After centrifugation at 10,000 g for 1 min, the column was washed once 
with 750 μl buffer PE. The DNA bound to the column was eluted with 20 μl Milli-Q 
water. The BglII enzyme digestion was performed as follows: 15 μl eluted DNA, 3 μl 
10× NEBuffer 3 (500 mM Tris-HCl, 1M NaCl, 100 mM MgCl2, 10 mM 
dithiothreitol), 1 μl BglII (10 Units) (NEB), and 11 μl Milli-Q water. Mixing 
thoroughly, the mixture was incubated at 37ºC for 2 h. 
To separate the target cDNA fragment from the digested mixture, the 
digested product was resolved on a 1% agarose gel as described in section 2.5.3 and 
extracted as described in section 2.5.4. 
2.5.10 Ligation of gene fragment with sticky ends into expression vector 
The above double-enzyme digestion was also applied to the relevant 
mammalian expression vectors, maps of which are shown in section 2.1.3. To 
construct the expression plasmids, cDNA fragments were ligated in these expression 
vectors by mixing the following components: 5 µl 2× rapid ligation buffer 
(Promega), 1 µl (3 Units) T4 ligase (Promega), 3 µl cDNA fragment and 1 µl 
digested vector, gently mixed and then incubated at 16ºC overnight. 
2.5.11 Large-scale preparation of endotoxin-free plasmid DNA 
Endotoxin-free plasmids were prepared using an Endo-free plasmid Maxi kit 
purchased from QIAGEN. According to the manufacturer’s instructions, briefly, 
bacteria containing plasmids of interest were inoculated into 100 LB broth with the 
addition of 100 µg/ml of ampicillin and cultured overnight at 37ºC on a shaking 
incubator at 200 rpm. The cells were pelleted and resuspended in 10 ml resuspension 
buffer P1. To lyse the cells, 10 ml lysis buffer P2 were added to the cell suspension, 
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mixed and incubated for 5 min at room temperature. Finally, 10 ml buffer P3 were 
added to stop the reaction and release the plasmids from the bacterial genomic DNA 
and protein. A QIAfilter maxi cartridge barrel was used to remove the genomic DNA 
and protein from the lysate, the flowthrough was collected in a 50 ml Falcon tube, 
followed by the addition of 2.5 ml buffer ER and incubation on ice for 30 min to 
remove the endotoxin. Meantime, a QIAGEN-tip 500 column was equilibrated by 
passing through 10 ml buffer QBT. The ER-treated plasmid solution pass through the 
column by gravity and plasmids bind to the column. After washing the column twice 
with 30 ml wash buffer QC, the plasmid DNA was eluted with 15 ml buffer QN. To 
precipitate the plasmid DNA, 10.5 ml isopropanol were added to the elution solution. 
The DNA was then pelleted by centrifugation for 1 h at 4,000 g. After washing the 
DNA pellet twice with 2.5 ml 70% ethanol and drying, the plasmid DNA was 
resuspended in an appropriate volume of sterile Milli-Q water. 
2.6 Protein detection and analysis methods  
2.6.1 Capture enzyme-linked immunosorbent assay (ELISA)   
The capture antibody, an unlabelled goat anti-human IgG polyclonal 
antibody, was diluted to 1 µg/ml in coating buffer (15 mM sodium carbonate, 35 mM 
sodium bicarbonate), added to 96-well microtitre plates, 50 µl/well, and incubated at 
4ºC overnight. The plates were washed three times and blocked with 100 µl/well 1% 
casein/PBS (w/v) for 1 h at room temperature. The plates were washed again and 
recombinant protein to be measured was added to the plates, 50 µl/well, and 
incubated for 1 h. The plates were washed again as before. 0.5% casein/PBS solution 
was added to the plates at 50 µl/well and then the primary antibodies, mouse anti-
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chicken antibodies, were titrated on the plates, along with a negative control 
antibody. After incubation for 1 h and washing the plates again, the HRP-conjugated 
goat anti-mouse IgG antibody, 1 µg/ml dilution in 0.5% casein/PBS, 50 µl/well, was 
added to the plates and incubated for 1 h. Meanwhile, O-phenylenediamine 
dihydrochloride (OPD) substrate solution was prepared by dissolving an OPD tablet 
(Invitrogen) in 10 ml of substrate buffer, composed of 5 ml Milli-Q water, 2.5 ml 0.2 
M disodium hydrogen phosphate and 2.5 ml 0.1 M citric acid, prior to use, adding 10 
µl of 30% hydrogen peroxide (H2O2). After the plates were washed again, 50 µl/well 
of substrate solution was added to the plates and incubated for 2 min. The reactions 
were stopped by the addition of 50 µl/well of 2N H2SO4. Optical density (OD) was 
measured on an ELISA microtitre plate reader at a wavelength of 490 nm. 
2.6.2 Modified capture ELISA  
A modified capture ELISA assay was designed to test the presence of 
recombinant IgG Fc protein expressed in tissue culture supernatants. The capture 
antibody, an unlabelled goat anti-human IgG polyclonal antibody, was coated onto 
96-well micro-titre plates as described in section 2.6.1. After blocking the plates as 
described in section 2.6.1, 50 µl per well of 0.5% casein/PBS solution were added to 
the plates and then tissue culture supernatants containing chicken Ig fusion proteins 
were titrated on the plates; negative controls were cell culture medium only, positive 
controls were purified IgG Fc fusion protein diluted in cell culture medium to 
different concentrations, e.g. 1, 5 and 10 µg/ml. The plates were incubated for 1 h at 
room temperature, followed by three washes. A goat anti-human IgG antibody 
conjugated with HRP (1:1,000 dilution in 0.5% casein/PBS, 50 µl/well) was added to 
the plates, and incubated for 1 h. The colorimetric reaction of HRP was detected by 
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OPD substrate as before. This method was also used to estimate protein expression 
levels. Recombinant Ig protein in the supernatant should bind to the capture antibody 
at the same ratio as the positive controls, so that identical concentrations of protein in 
supernatant and positive control will produce the same optical density. Based on this, 
the fusion protein concentration in a supernatant can be roughly calculated by 
comparison with that in the positive control. 
2.6.3 Dot- or slot-blotting assays to detect expression of His6 fusion 
proteins 
A Hibri-Dot 96 device (Whatman) was used to isolate protein on 
nitrocellulose membrane. The device was assembled by laying a membrane support 
plate on a waste reservoir plate, followed by a sheet of nitrocellulose membrane to 
cover every hole on the support plate. Finally, a cover plate with 96 wells and a 
sample reservoir was carefully placed on the membrane. When all three plates were 
in the correct position, they were tightened by 8 screws.  
Protein samples were added to wells on the cover plate of the Hibri-Dot 96.  
A vacuum connector in the waste reservoir plate was linked to a vacuum pump. 
When the vacuum pump was switched on, the protein solution was aspirated from 
the sample reservoir in the cover plate, through the membrane and then the holes in 
membrane support plate, finally collecting in the waste reservoir plate. The 
membrane was removed, washed in PBST buffer for 30 min and blocked in 1% 
casein/PBS solution for 1 h on a rocking shaker. The membrane was then transferred 
into a Penta-His antibody solution, 1:2,000 dilution in 1% casein/PBS, and incubated 
for 1 h at room temperature on the rocking shaker. After three washes with PBST, 10 
min per wash on the rocking shaker, a goat anti-mouse IgG-HRP antibody, 1:1,000 
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dilution in 1% casein/PBS, was added to the membrane, incubating for 1 h on the 
rocking shaker. The membrane was washed three times again as before. The binding 
secondary Ab was detected using enhanced chemiluminescence (ECL) Western 
Blotting Detection Reagents (GE Healthcare), as per the manufacturer’s instructions. 
Equal volumes of luminol substrate and peroxide solution from the ECL kit were 
directly mixed before use, homogeneously distributed on the membrane, incubated 
for 5 min and dried with tissue paper. The membrane was developed by 
autoradiography. A digital image of the autoradiograph was taken by scanning the 
film with a scanner (EPSON Perfection V700). 
2.6.4 SDS-polyacrylamide gel electrophoresis (SDS-PAGE)  
Proteins were resolved in 4-12% discontinuous polyacrylamide gels using a 
Mini-PROTEAN Tetra system (Bio-Rad). To cast a polyacrylamide gel, a resolving 
gel monomer solution was prepared by combining the following reagents to make a 
12% gel: 3.4 ml Milli-Q water, 4 ml 30% acrylamide/Bis, 2.5 ml 4× resolving gel 
buffer, 0.1 ml 10% SDS. Prior to casting the gel, 0.1 ml 10% APS and 10 μl TEMED 
were added and mixed gently to avoid bubbles. The solution was smoothly poured 
into the space between the two glass plates, which were assembled on a casting 
stand. The surface was immediately overlaid with water-saturated isobutanol. The 
gel was allowed to polymerise for 45 min. A 4% stacking monomer solution was 
prepared by mixing the following reagents: 6.1 ml Milli-Q water, 1.3 ml 30% 
acrylamide/Bis, 2.5 ml 4× resolving gel buffer, 0.1 ml 10% SDS. As before, prior to 
casting the gel, 0.1 ml 10% APS and 10 μl TEMED were added. After completely 
removing the overlay solution, the stacking gel solution was continuously poured 
until the surface reached the top of the short glass plate. The desired comb was then 
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inserted into the space between the glass plates. When the stacking gel had 
polymerised, the gel was mounted into the electrode assembly, lowered into the Mini 
tank, and the tank filled with 1× running buffer (3.0 g Tris base, 14.4 g glycine, 1.0 g 
SDS dissolved in 1 litre Milli-Q water). 
2× SDS sample buffer was made as follow: 1) for non-reducing buffer, 1.25 
ml 0.5 M Tris/HCl, pH6.8, 2.5 ml glycerol, 2.0 ml 10% SDS, 0.2 ml 0.5% 
bromophenol blue with H2O to 9.5ml; 2) for reducing buffer, 50 µl β-
mercaptoethanol were added to 950 µl of the non-reducing buffer.  Protein samples 
were prepared by mixing equal volumes of protein solution and 2× SDS-PAGE 
sample buffer and then heated at 95ºC for 5 min. Gel electrophoresis was carried out 
at a constant voltage of 150 V for 1 h. The gel was then stained with Coomassie blue 
or the protein was transferred to nitrocellulose membrane for western blot analysis. 
2.6.5 Coomassie blue staining 
To visualise separated proteins in an SDS-PAGE gel, Coomassie Brilliant 
Blue R-250 (National Diagnostics, Hessle, UK) was used to stain the gel. This is an 
anionic dye, which non-specifically binds to proteins. Proteins in the gel are fixed by 
acetic acid and simultaneously stained. The excess dye incorporated into the gel can 
be removed by destaining buffer. The proteins are detected as blue bands on a clear 
background. Coomassie blue staining solution was made by dissolving 0.25 g 
Coomassie Brilliant Blue R-250 in 45 ml methanol, and then adding 45 ml H2O and 
10 ml acetic acid, stirring on a magnetic stirrer for 1 h to ensure the Coomassie blue 
dye was completely dissolved and finally filtering the solution through Whatman No 
1 filter paper to remove particles of undissolved dye. The gel was immersed in 
Coomassie blue staining solution in a suitable container and incubated for 1 h on a 
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rocking shaker. The gel was then briefly rinsed with Milli-Q water and transferred to 
Coomassie destaining buffer (30 ml methanol, 10 ml acetic acid, 60 ml H2O). The 
wet gel was then scanned with an EPSON scanner to generate a digital image. 
2.6.6 Western blotting 
After protein samples were resolved by electrophoresis on an SDS-PAGE gel, 
the slab gel was equilibrated in trans-blotting buffer (25 mM Tris/HCl, 192 mM 
glycine and 25% methanol in Milli-Q water) for 20 min to remove SDS. The protein 
was trans-blotted to nitrocellulose membrane using a Trans-Blot Semi-Dry 
Electrophoretic Transfer Cell (Bio-Rad). Four sheets of 7×8 cm Whatman 3 MM 
filter paper and a sheet of the same size of reinforced nitrocellulose membrane 
(Sigma-Aldrich) were pre-wetted in trans-blotting buffer for 2 min. The gel sandwich 
was piled up in the Transfer Cell by placing two sheets of filter paper on the bottom, 
covering them with a sheet of nitrocellulose membrane, carefully placing the gel on 
top of the membrane and then covering the gel with another two sheets of filter 
paper. The gel was trans-blotted at 10 V for 60 min. The membrane was blocked in 
1% casein/PBS solution for 1 h, and then transferred to primary Ab solution (1 µg/ml 
in 0.5% casein/PBS solution), incubating at room temperature for 1 h on a rocking 
shaker. The membrane was washed 3 times with PBST, 10 min per wash, and then 
HRP-conjugated secondary Ab solution (1:1,000 dilution in 0.5% casein/PBS) was 
added to the membrane, incubating for 1 h. After three washes as before, the bound 
second Ab was detected by ECL reagent, as described in section 2.6.3. 
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2.7 Recombinant protein expression by mammalian expression 
systems 
2.7.1 Transient transfection of COS-7 cells by DEAE/dextran  
One day prior to transfection, COS-7 cells were trypsinised, reseeded at a 
density of 6×10
6
 cells per T75 (75 cm
2
 growth surface) tissue culture flask and 
cultured in a humidified 5% CO2 incubator at 37ºC. When the cells were ready for 
transfection, a transfection mix for a T75 flask was prepared, in 15 ml DMEM 
medium, by diluting 114 µg endotoxin-free plasmid DNA, 0.1 mM chloroquine and 
600 µg/ml DEAE/dextran. Washing the cell layer twice with sterile PBS to remove 
any trace of FCS, the DNA/DEAE complex was added to the cells and the flask was 
returned to the incubator for 3.5 h. The supernatant in the flask was removed, the cell 
layer was washed once with sterile PBS, and then the cells were shocked by adding 
10 ml of 10% DMSO/PBS for 2 min. Discarding the DMSO solution and replacing it 
with 15 ml of complete DMEM medium, the flask was returned to the incubator and 
the cells were cultured overnight. The growth medium was then replaced with serum-
free medium. Three days later, the supernatant containing fusion protein was 
harvested. 
2.7.2 Transient transfection of COS-7 cells by electroporation 
Full-length cDNA in expression vectors were electroporated into COS-7 cells 
using a Gene Pulser Xcell electroporation system (Bio-Rad). One day before 
transfection, the COS-7 cells were split and reseeded in new tissue culture flasks, as 
described in section 2.7.1. On the day of transfection, the cells were trypsinized, 
pelleted and washed with RPMI 1640 medium once. The cells were then resuspended 
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in RPMI 1640 medium without any supplements, counted and adjusted to a cell 
density of 1×10
7
 cells/ml. For a single transfection, 100 µl of cell suspension were 
mixed with 10 µg of plasmid DNA and the mixture transferred to a 0.2 cm cuvette 
(Bio-Rad, UK). Electrophoration was performed using the pre-set protocol for COS-
7 cells: 110 V for 20 msec. After electrophoration, 500 µl pre-warmed complete 
DMEM medium were added to the cuvette and the whole of the cell suspension was 
transferred to a Universal. The volume of cell suspension was brought up to 5 ml 
with complete DMEM medium and the viable cells were counted. Cells (2×10
3
) were 
then grown on 13 mm round coverslips (VRW, UK) in 24-well plates for 48 h. 
2.8 Immunostaining of transfected COS-7 cells on cover slides  
In brief, after tipping off the supernatant, the cells were washed once with 1 
ml per well of PBS and then fixed by addition of 200 µl per well of 4% 
paraformaldehyde/PBS solution for 30 min at room temperature on a rocking shaker. 
After washing the cells three times, the cells were permeablized with 1% Triton X-
100 (Sigma-Aldrich) in PBS (200 µl per well) for 15 min. After washing the wells 
three times again, primary mAb solution (1µg/ml in 1% BSA/PBS, 200 µl/well) was 
added and incubated for 1 h at room temperature.  After 3 washes, a second antibody, 
HRP-conjugated goat anti-mouse IgG antibody in 1:1,000 dilution in 1% BSA/PBS, 
200 µl/well, was added and incubated for 1 h. The HRP activity was detected by an 
AEC substrate kit (BD Pharmingen, UK). The AEC substrate solution was made up 
by diluting a drop of AEC chromogen in 1 ml AEC buffer, and then brought up to 10 
ml with Milli-Q water. After 3 washes, 200 µl/well AEC solution were added to the 
plate, incubating for 5-20 min. Washing the plate 3 times again, Mayer’s 
haematoxylin solution (Sigma-Aldrich), 500 µl/well, was added to the plate and 
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incubated for 2-5 min. The plate was washed with normal tap water until the water 
was colourless and then washed three times with Scott’s water (20 g/l MgSO4·7H2O, 
2 g/l NaHCO3). The coverslips were picked out from the wells with fine-tip forceps, 
dried on tissue paper and then mounted onto glass slides with the cell-side facing 
down. The coverslips were sealed with nail vanish and labelled, and the results were 
observed under a microscope. 
2.9 Affinity chromatography 
Affinity chromatography was used to deplete bovine IgG from FBS, purify 
recombinant Ig protein from tissue culture supernatant or monoclonal antibodies 
from hybridoma culture supernatants. Protein G columns (1 ml or 5 ml, GE 
Healthcare, Amersham, UK) were used as immunoaffinity tools and connected to an 
EP-1 Econo peristaltic pump, (Bio-Rad) to continuously inject fluid. 
Prior to the samples being injected into the column, they were aliquoted in 50 
ml Falcon tubes and then centrifuged at 3,000 g for 30 min to remove large particles. 
The sample was then filtered through a Nalgene filtration unit with a 0.45 µm pore 
size membrane (Thermal Scientific) to remove smaller particles. Adjusting flow rate 
to 1 ml/min for a 1 ml column or 5 ml/min for a 5 ml column, the column was 
washed with a 20-column volume of PBS. The sample was then pumped through the 
column. To remove any trace of non-binding contamination, the column was washed 
again with a 20-column volume of PBS. Meanwhile, the collecting tubes were 
prepared by adding 100 µl of 1 M Tris/HCl (pH 9), to neutralize the elution buffer to 
pH 7. The protein was then eluted from the column with 0.1 M glycine, pH 2.7, and 
1 ml of elution fractions were collected in the prepared tubes. The protein fractions 
were measured with a NanoDrop (Thermal Scientific). If the total eluted protein was 
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beyond the column maximum binding capacity, the flowthrough went through the 
column again. 
For bovine IgG depletion, 500 ml serum normally went through a 5 ml 
protein G column twice to remove as much IgG as possible. The flowthrough was 
then filtered through a filtration unit, aliquoted and stored at -20ºC. For purification 
of recombinant Ig protein or antibody, the elution fractions containing protein were 
pooled and dialyzed in a Slide-A-Lyzer dialysis cassette (Thermal Scientific) against 
PBS on a magnetic stirer. After changing the PBS three times, the protein in the 
dialyzer was harvested, filtered through a 0.22 µm syringe filter, aliquoted and stored 
at 4ºC for short term, or -20ºC for long term, storage. 
2.10 Flow cytometric analysis  
For immunostaining, cells were washed twice with cold PBS and resuspended 
in 1% BSA/PBS. After counting, the cell density was adjusted to 2×10
6
 cells/ml. 
Cells were plated at 100 µl/well in a U-bottomed 96-well plate and incubated on ice 
for 30 min to allow BSA blocking any non-specific binding. The cells were then 
pelleted by centrifugation at 450 g for 1 min, and 50 µl per well of primary mAb in 
1% BSA/PBS at appropriate dilution added to the wells, mixed thoroughly on a plate 
shaker and incubated on ice for 1 h. The cells were pelleted as before and washed 
twice with 200 µl 1% BSA/PBS. Secondary Abs (conjugated with different 
fluorescent dyes) were added to wells (50 µl/well), incubating on ice for 1 h. The 
cells were pelleted again and the cell pellet washed twice as before. The cells in each 
well were then resupended in 100 µl 1% BSA/PBS, transferred to a FACs tube and 
topped up to 200 µl with 1% BSA/PBS. The cells were analysed by flow cytometry 
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using a FacsCalibur instrument (BD Becton Dickinson). The resulting data were 

































Chapter 3.    Identification and characterisation of the chicken 
Tim family molecules. 
3.1 Introduction 
Effector Th1/Th2 cells orchestrate immune responses against a wide variety 
of pathogenic microorganisms, and regulate/suppress immune responses both to 
control autoimmunity and to adjust the magnitude and persistence of responses. As 
described in Chapter 1, when naïve CD4
+
 T cells encounter antigen-activated APCs, 
they differentiate into Th1 and Th2 cells driven by different transcription factors, and 
produce different pattern of cytokines. Th1 cells produce IFN-γ, which is modulated 
by T-bet. IL-4, -5 and -13 are Th2 cell signature cytokines which are regulated by 
GATA-3.  The Th2 locus, including the genes for IL-4, -5 and -13, lies on human 
chromosome 5q23-35 and a homologous chromosomal region of the mouse genome 
11B1.3. Both regions are strongly associated with asthma susceptibility, allergy and 
autoimmunity (Loots et al., 2000; Yokouchi et al., 2000; Walley et al., 2001). An 
intensive study of this chromosomal region in a mouse model of human asthma 
identified a T cell and airway phenotype regulator (Tapr) locus, which controls the 
development of airway hyperreactivity and T cell production of IL-4 and IL-13. The 
Tim family genes lie in this locus (McIntire et al., 2001). As described in Chapter 1, 
the murine Tim family has 8 genes, Tim1-4 encode proteins but Tim5-8 are 
pseudogenes. The human Tim family has 3 members, Tim1, Tim3 and Tim4, which 
are homologous to murine Tim1, Tim3 and Tim4 respectively. The Tim molecules 
are type I proteins with a common structure, containing IgV, mucin and 
transmembrane domains and a cytoplasmic tail. Human Tim1 and Tim3 are 
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preferentially expressed on Th2 and Th1 cells respectively, and play crucial roles in 
regulation of Th1 and Th2 cell proliferation. Human Tim4 is specifically expressed 
on APCs, especially on macrophages, and plays a role in enhancement of 
phagocytosis of dead cells by macrophages. 
 The chicken genome sequence was released in 2004 in public databases, 
simplifying identification of new genes. To identify the chicken Tim (chTim) genes, 
the human and murine Tim amino acid sequences were used to search the chicken 
genome in ENSEMBL. Based on information obtained from the blast searches, the 
chTim cDNAs were then amplified by RT-PCR. To study their roles in the immune 
system, recombinant chicken Tim proteins were expressed in mammalian expression 
systems. 
3.2 Materials and Methods 
3.2.1 Cloning chicken Tim family genes by PCR  
The amino acid sequences of human Tim1 (NP_036338), Tim4 
(NP_001140198) or Tim3 (NP_116171) were used as sequences in Blast searches 
(http://www.ensembl.org/Gallus_gallus/blastview) against the chicken EST and 
genome databases (v.38) in ENSEMBL. The blasting hits matched two clusters of 
overlapping chicken EST sequences, which are homologous to human Tim1 and 
Tim4 respectively. More confidence was gained by further analysis of the 
chromosomal region, where several marker genes surrounding the genes of interest 
are conserved in syntenical location between chicken and human. Therefore, primers 
were designed based on the longest EST sequences and synthesised by Sigma. The 
primer sequences are as listed in Table 3.1.   
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Primer  Sequence (5’-3’) 
Tim1-F1  AAT AAG AGT GTT CCT CAT C 
Tim1-R1  AAG TTT TTA ATT AGA ATT GTA GC 
Tim1-F2  ATG TCT TCT CAT TTC TTC C 
Tim1-R2  TTA ATT AGA ATT GTA GCT TTT ATT TG 
Tim4-F1  AGC CAA AAT GTC CCA CTT T 
Tim4-R1  ACA CAG ATC CCA GAA ATA CTA CTG 
Tim4-F2  ATG TCC CAC TTT GTG TTG TTT C 
Tim4-R2  TCA CAG CAC AAA AAG GTT GT 
  Table 3.1. Primers used to amplify chicken Tim family cDNAs. 
cDNA generated from splenic total mRNA from a 6-week-old line 72 bird, as 
described in section 2.5.1, was used as PCR template to clone the Tim cDNA, as 
described in section 2.5.2.  A nested PCR strategy was used to clone each cDNA 
with touch-up or touch-down settings to increase the efficiency of primer binding. 
The chicken Tim1 cDNA was amplified using the primer pair Tim1-F1/R1. 
After denaturation of the cDNA template at 94°C for 3 min, a touch-up PCR was 
carried out with cycling conditions of 94°C for 1 min, 50°C for 30 s and 72°C for 90 
s for 3 cycles; 94°C for 1 min, 52°C for 30 s and 72°C for 90 s for 3 cycles; 94°C for 
1 min, 54°C for 30 s and 72°C for 90 s for 30 cycles. The first-round PCR product 
was then used as template for amplification with a nested primer pair, Tim1-F2/R2. 
The reaction involved denaturation at 94°C for 3 min, followed by 34 cycles of 94°C 
for 1 min, 50°C for 30 s and 72°C for 2 min.  
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 For the chicken Tim4 cDNA, Tim4-F1/R1 primers were used in the first-
round amplification, followed by a touch-down PCR with cycling conditions of  
94°C for 3 min; 94°C for 1 min, 60°C for 30 s and 72°C for 2 min for 3 cycles; 94°C 
for 1 min, 58°C for 30 s and 72°C for 2 min for 3 cycles; 94°C for 1 min, 57°C for 
30 s and 72°C for 2 min for 30 cycles. Again the first-round PCR product was used 
as template for amplification with a nested primer pair, Tim4-F2/R2. The PCR 
conditions were as follows: 94°C for 3 min; 94°C for 1 min, 60°C for 30 s and 72°C 
for 2.5 min for 3 cycles; 94°C for 1 min, 61°C for 30 s and 72°C for 2.5 min for 30 
cycles. 
Nested PCR products were electrophoresed through 1% agarose gels (section 
2.5.3). The bright and clear bands were excised from the gel and extracted using a 
gel extraction kit (section 2.5.4). Subsequently, the PCR amplicons were ligated into 
the vector pGEM-T Easy (Promega) and transformed into E. coli JM109 competent 
cells (sections 2.5.5 and 2.5.6). Plasmids isolated from positive colonies were 
sequenced (section 2.5.8). 
3.2.2 Construction of expression plasmids 
The full-length chTim1, chTim4S and chTim4L amino acid sequences were 
input into SMART software (http://smart.embl-heidelberg.de/) to predict their signal 
peptide, IgV, mucin, transmembrane and cytoplasmic domains. Based on this 
information, primers with restriction enzyme sites (Table 3.2) were designed to 
amplify different domains, which in turn were subcloned into a relevant expression 
vector for expression of fusion proteins using different expression systems, as 






 Primer  Sequence (5’-3’) 
Tim1-IgVF  GCT AGC ATG TCT TCT CAT TTC TTC 
Tim1-IgVR  AGA TCT TCA ACC ACC ACC TGG AGG TT 
Tim1-mucinF  GCT AGC AGA GCT AGG GTC TCT ACT 
Tim1-mucinR  AGA TCT TTT TCT GAA TAC TGC TGA CT 
Tim4S-IgVF  GCT AGC ATG TCC CAC TTT GTG TT 
Tim4S-IgVR  AGA TCT AGC ACC ACC AGC TGA ATG TT 
Tim4S-mucinF  GCT AGC GAA GCA CCT CCA TTG ATG 
Tim4S-mucinR  AGA TCT GGA AAG GAA AGT TTC ATC CC 
Tim4L-HF  GCT AGC GAA GTA TTT GAT GAG ACA 
Tim4L-HR  AGA TCT GAT GCA GTG TTC ATT GC 
Table 3.2.  Primers used to generate expression constructs. The bold italic  










Table 3.3. Summary of expression of recombinant chTim proteins. The chTim 
domains to be expressed were cloned as different fragments by PCR with the listed 
primer pairs (Table 3.2). The resulting PCR products were then subcloned into 
relevant expression vectors. The tagged-fusion proteins were eventually expressed 
from stably transfected CHO or transiently transfected COS-7 cells. 
Different domains of the chicken Tim molecules were amplified by PCR and 
NheI and BglII restriction enzyme cleavage sites were introduced to the ends of the 
PCR products (section 2.5.2). The PCR products were then purified from agarose 
gels (sections 2.5.3 and 2.5.4). The purified DNA fragments were cloned into 
pGEM-T Easy and the plasmids transformed into E.coli JM109 competent cells 
(sections 2.5.5 and 2.5.6). Inserts were confirmed by DNA sequencing (section 2.5.8) 
and then excised from the plasmid with NheI and BglII (section 2.5.9). The digested 

































































Signal pKW06-Ig chTim4S-h-Ig Stable CHO 
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DNA fragments were then ligated into mammalian expression vectors (section 
2.5.10). 
For chTim1, chTim4S and chTim4L, the IgV domains (two repeat IgV 
domains for chTim4L) with gene-specific signal peptides were inserted into the 
pKW06-Ig vector (Figure 2.1); the mucin domains of chTim1 and chTim4S, as well 
as the hinge part of chTim4L (between two IgV domains) were ligated into the 
Signal pKW06-Ig vector (Figure 2.3). The extracellular domains of chTim1, 
chTim4S and chTim4L, containing gene-specific signal peptides, IgV and mucin 
domains, were ligated into pKW06-Ig for all three genes or into the pKW06-His6 
vector (Figure 2.2) for chTim1 and chTim4S.  
Again, the resultant expression plasmids were then transformed into E.coli 
JM109 competent cells. Cloned plasmids were prepared from the resulting colonies 
and sequenced to confirm the plasmid constructs.  DNA plasmids were then prepared 
with large-scale endotoxin-free Maxiprep kits (QIAGEN) (section 2.5.11). 
3.2.3. Establishment of stably transfected CHO cell cultures 
CHO cells were cultured in complete Ham’s F12 medium, as described in 
section 2.3.2, split and reseeded in T25 tissue culture flasks with 1×10
6
 cells/flask. 
After overnight culture, CHO cells were transfected with plasmid DNA (or 
untransfected as controls) using Lipofectamine 2000 (Invitrogen), as per the 
manufacturer’s instructions. Briefly, two 1.5 ml Eppendorf tubes were filled with 
250 µl of Ham’s F12 medium without any supplements. Plasmid DNA (10 µg) was 
added to one tube and the lipofectamine reagent (25 µl) to the other. After incubation 
for 5 min at room temperature, the solutions were combined and further incubated 
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for 25 min. The DNA complex was then added to the CHO cells and mixed by 
swirling the flasks. One day after transfection, the medium was changed for selective 
medium, complete Ham’s F12 medium plus 20 µg/ml puromycin. The medium was 
changed every two days to remove dead cells until any untransfected CHO control 
cells were all dead and the transfected cells appeared to be growing in colonies (foci 
with hundreds of cells). Ten to twelve days after the cells were placed in selective 
media, the number of foci in transfected flasks was estimated by counting the clones 
on a 1 cm
2
 growing surface.  
To screen for high-yield protein clones, the cells were split, counted and 
reseeded into 96-well flat tissue culture plates at approximately 1 cell/well. After 6 
days growth at 37ºC, 5% CO2, the number of cell clones in each well was counted. 
Early stage scoring of the clones has the benefit of avoiding multiple clones merging 
into a large single clone in some wells. After 10 days growth in selective medium, 
when the diameter of cell clones was about 1 mm, the screening process was 
performed. CHO cell transfectants expressing hIgG Fc-tagged fusion proteins were 
screened by capture ELISA, as described in section 2.6.2, except without titration of 
the samples. CHO clones expressing His6-tagged proteins were screened by dot-blot 
analysis, as described in section 2.6.3. The selected positive clones were split and 
cultured in 24-well plates at 37ºC, 5% CO2. Multiple clones were selected to grow 
up, in case of false positives in the first round screening. When the cells were fully 
confluent in 24-well plates, the supernatants were subjected to a second round of 
screening. The highly-ranked clones were frozen down at this stage, and several 
clones chosen to grow up in T25 tissue culture flasks. When the cells were fully 
confluent, the supernatants were re-tested. The highest yielding clone was chosen to 
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grow up firstly in T75 flasks, then in T150 flasks. Stable CHO clones producing high 
yields of protein were established. 
3.2.4. Large-scale protein expression by miniPERM culture 
A miniPERM is a bioreactor designed for the culture of hybridomas 
(Falkenberg, 1998) and other cells, e.g. stable CHO transfectants (Shutt et al., 1997), 
at high densities (“high density culture”). The culture apparatus is composed of two 
modules: a 40 ml disposable cell culture and protein production chamber (the 
'production module') and a 550 ml medium reservoir (the 'nutrition module'). The 
two modules are separated from each other by a dialysis membrane (molecular 
weight cut off 12.5 kDa) allowing passage of low molecular mass nutrients and 
metabolites. To start the culture, briefly, cells were trypsinized from two T175 flasks 
at full confluence, pelleted by centrifugation at 1,000 g for 5 min and the cell pellet 
resuspended in 40 ml Ham’s F12 medium plus 5% Ig-depleted FBS (section 2.9) and 
15 µg/ml puromycin. The cell suspension was injected into the production module 
through ports in a silicone rubber bung and the nutrition module was topped up with 
400 ml Ham’s F12 medium plus 5% normal FBS. The bioreactor was rolled at 0.2 
rolls/min on a roller apparatus at 37ºC, 5% CO2 for 4 days. The sample was 
harvested from the production module from injection port and the cells were 
separated by centrifugation at 1,000 g for 5 min. Keeping the supernatant for protein, 
the cells were resupended in Ham’s F12 medium plus 5% Ig-depleted FBS and 15 
µg/ml puromycin and the cell density adjusted to 5×10
6
 cells/ml. The cell suspension 
(40 ml) was then injected into the production module for the next round of culture. 
The medium in the nutrition module was changed every two harvests. 
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3.2.5. Purification of human IgG Fc-tagged fusion protein  
Ig fusion proteins in supernatants from the miniPERM cultures were purified 
on a 1 ml protein G column, as described in section 2.9.  
3.2.6. Purification of His6-tagged fusion protein 
The supernatants from the miniPERM cultures, containing His6-tagged 
fusion proteins, were aliquoted in 50 ml Falcon tubes, centrifuged at 3,000 g for 30 
min, and then filtered through a filtration unit with a 0.4 μm pore size membrane 
(Thermal Scientific). Ni-NTA (50% nickel bead slurry, GE Healthcare) slurry (20 
ml) was transferred to a 50 ml Falcon tube, the beads separated from the liquid by 
centrifugation at 2,000 g for 5 min, and washed twice with 30 ml PBS. The resin was 
then added to the supernatant and stirred on a magnetic stirrer overnight at 4ºC. The 
nickel resin-bearing protein was allowed to settle by gravity. The supernatant was 
carefully removed. The beads were resuspened in 20 ml PBS, and then transferred to 
a 20 ml gravity-flow column (Bio-Rad). After the beads were allowed to settle, the 
column was washed with 20 ml PBS, and then 50 ml 20 mM imidazole/PBS (pH 
8.0). The protein bound to the column was dissociated with the addition of 15 ml 150 
mM imidazole/PBS (pH 8.0). The elution was collected in 0.5 ml fractions in 1.5 ml 
Eppendorf tubes. The amount of protein in each fraction was measured using a 
Nanodrop. The fractions containing the protein were then pooled together. Any 
imidazole in the protein solution was removed by dialysis against PBS (section 2.9). 




3.3.1 Identification of the chicken Tim family genes 
The amino acid (aa) sequences of human Tim1, Tim4 or Tim3 were used as 
sequences in Blast searches against the chicken EST and genome databases in 
ENSEMBL. Two clusters of overlapping chicken EST sequences were found which 
were highly homologous with human Tim1 and Tim4 respectively (Figure 3.1) and 
were located on chicken chromosome 13. Further analysis of the sequences around 
this locus showed conserved synteny with mammals, in that chicken Tim1 and Tim4 
genes lie next to each other between ITK and SGCD (Figure 3.2). The murine Tim 
locus lies on chromosome 11 with several intervening pseudogenes, and the human 
Tim family genes are next to each other on chromosome 5. Analysis of the available 
genomes of other avian species showed that the turkey has the same number of Tim 
family molecules flanked by the same genes as the chicken, but they are located on 
chromosome 15. Similarly to the human Tim family, the zebra finch Tim family has 
three members, Tim1, Tim3 and Tim4, on chromosome 13, but unlike human, Tim3 
lies between ITK and Med7. 
3.3.2 Amplification of the chicken Tim family genes 
Based on the longest ESTs identified in the Blast searches, primers were 
designed to clone cDNAs encoding the predicted chicken Tim1 and Tim4 proteins, 
as described in section 3.2.1, using splenic cDNA as a template. An approximate 1 
kb band was amplified for chicken Tim1 (Figure 3.3A). Interestingly, two bands of 
1.1 kb and 1.5 kb were amplified for chicken Tim4 (Figure 3.3B). The purified PCR 






Figure 3.1. Schematic diagram of annotation of and evidence for the chicken Tim 
family members from ENSEMBL, release version 38 (April 2006). ENSEMBL’s 
annotations are shown in dark red. Two clusters of chicken Tim EST sequences are 
boxed and labelled. The supportive evidence, mammalian Tim1 and Tim4 mRNAs 
from different databases, are boxed and shown in different colours, including mRNA 
from EMBL and Unigene in red, UniProtkb in yellow and Genscan annotation in 










































































Figure 3.2. Tim family genes. (A). Genomic location and arrangement of Tim family 
genes in different species. The primary data for mouse, human and chicken are 
derived from the NCBI database, for turkey from the pre-ENSEMBL database and 
zebra finch from the ENSEMBL database. (B). Phylogenetic tree of human (h), 
mouse (m) and chicken (ch) Tim family molecules. Full-length Tim protein 
sequences were aligned using ClustalW2. Sequence similarity is proportional to the 
length of the line that connects two sequences, as estimated by phylogeny.fr program 
(http://www.phylogeny.fr/version2_cgi/). The protein sequences of hTim1 
(NP036338), hTim3 (NP_116171), hTim4 (NP_001140198), mTim1 (AAL35775), 
mTim2 (NP_001154827), mTim3 (NP_599011) and mTim4 (NP_848874) were 
obtained from NCBI database. The numbers next to each node, in red, represent a 
measure of support for the node, where 1 represents maximal support. Scale bar 












Figure 3.3. Amplification of chicken Tim cDNAs by RT-PCR. Splenic cDNA from a 
line 72 bird was used as template. (A). Lane 1 is PCR product (chicken Tim1) 
amplified with primers Tim1-F2/R2. (B). Lane 2 is PCR product (chicken Tim4) 














and transformation into competent cells. Ten cloned plasmids from each 
transformation were then sequenced. Sequencing confirmed that the chicken Tim4 
molecule has two variants, described as long and short isoforms, which will be 
explained further below.  
3.3.3 Structure of the chicken Tim1 molecule 
The phylogenetic tree showed that chicken Tim1 is homologous to human 
and mouse Tim1 (Figure 3.2B). The sequence of the chicken Tim1 (chTim1) cDNA 
encodes an open reading frame of 275 aa (Figure 3.4). SMART (http://smart. 
emblheidelberg.de/), SignalP (http://www.cbs.dtu.dk/services/SignalP/) and 
TMHMM (www.cbs.dtu. dk/services/ TMHMM-2.0/) programs were used to predict 
the structure of chTim1. ChTim1 is a type I protein with a signal peptide consisting 
of 21 aa and a transmembrane domain spanning aa 208–230. The extracellular 
domain of chTim1 is 176 aa in length and contains two distinctive domains. 
Similarly to human and mouse Tim1, the NH2 terminus of the chTim1 extracellular 
domain (aa 22-127) is homologous to Ig superfamily (IgSF) variable domains, such 
as those of TCR and Ig (Barclay et al., 1993), and a similar structure to those seen in 
mammalian Tim family members, where it is named an IgV domain. Like other IgSF 
molecules, the chTim1 IgV domain contains two typical cysteine residues (Cys37 
and Cys110) to presumably form an intramolecular disulfide bond, as demonstrated 
by the crystal structure of the murine Tim1 protein (Santiago et al., 2007b). ChTim1 
also possesses four additional cysteines in the IgV domain, as seen in the Ig domain 
of murine Tim1, where the crystal structure indicated that they form two additional 
disulphide bonds, resulting in a novel structure different from the Ig domain of other 
IgSF members (Santiago et al., 2007b). This novel structure forms a pocket, where a  
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           signal peptide       ♦ IgV domain →                                                      
moTim1 MNQIQVFISGLILLLPGAVDSYVEVKGVVGHPVTLPCTYSTY--RGITTT  48 
huTim1 -MHPQVVILSLILHLADSVAGSVKVGGEAGPSVTLPCHYS----GAVTSM  45 
chTim1 MSSHFFLDWILLIWLTGPTVSGLLVKGEVGQNVTVPCFYRVKTEYDITSM  50 
                                      ●●●  ▲                         
                                                                                                                               
moTim1 CWGRGQCPSSACQNTLIWTNGHRVTYQKSSRYNLKGHISEGDVSLTIENS  98 
huTim1 CWNRGSCSLFTCQNGIVWTNGTHVTYRKDTRYKLLGDLSRRDVSLTIENT  95 
chTim1 CWGRDACPASKCSQPIIWTDGRKVTERHHTKYVLKGDLLKGNVSLTILNA 100 
       ▲     ▲    ▲                             ●●●                 
                                    ♦  mucin domain →                                                                                                                                  
moTim1 VESDSGLYCCRVEIPGWFNDQKVTFSLQVKP----------EIPTRPPRR 138 
huTim1 AVSDSGVYCCRVEHRGWFNDMKITVSLEIVPPKVTTTPIVTTVPTVTTVR 145 
chTim1 QETDSGTYCCRVEIPGWFNDETTNLQVVVER------------ARVSTAS 138 
               ▲▲      ∆∆∆∆                                                      ÔÔ  Ô 
                                                                                                                                 
moTim1 ----------------PTTTRPTATGRPT--------TISTRS------- 157 
huTim1 TSTTVPTTTTVPMTTVPTTTVPTTMSIPTTTTVLTTMTVSTTTSVPTTTS 195 
chTim1 ----------------PLTHTSPPTSAPG--------------------- 151 
                         Ô ÔÔ  ÔÔ                                         
                                                                                                                                
moTim1 ----THVPTSTRVSTSTP-------------------------------- 171 
huTim1 IPTTTSVPVTTTVSTFVPPMPLPRQNHEPVATSPSSPQPAETHPTTLQGA 245 
chTim1 ----SASEESFTVSTWPP-------------------------------- 165 
           Ô Ô  Ô Ô ÔÔ                                                       
                                                      ♦                                                                          
moTim1 ----PTSTHTWTHKPDWNGTVTSSGD-TWSNHTEAIPPGK--PQKNPTKG 214 
huTim1 IRREPTSSPLYSYTTDGNDTVTESSDGLWNNNQTQLFLEHSLLTANTTKG 295 
chTim1 -----VSVSEAPETASGPYSSTSDYPEVTSSLQNSSISTHSQQYSEKTVY 210 
             Ô Ô    Ô Ô   ÔÔÔÔ     Ô                                                  
        TM domain  →         ♦ cytoplasmic →                                                                                                                                                  
moTim1 FYVGICIAALLLLLLVSTVAITRYILMKRKSASLSVVAFRVSKIEALQNA 264 
huTim1 IYAGVCISVLVLLALLG-VIIAKKYFFKKEVQQLS-VSFSSLQIKALQNA 343 
chTim1 LRTGLCVAFLVILVVGLFLGRRYLRNMKKLSKFASSVAFWRTERAGNQSA 260 
                                                      ●●●              
                                                                      
moTim1 AVVHSRAEDNIYIVEDRP--- 282 
huTim1 VEKEVQAEDNIYIENSLYATD 364 
chTim1 LEVEIHAEENIYTIH------ 275 
              *****                   
 
Figure 3.4. Alignment of chicken Tim1 with human (hu) (NP036338) and mouse 
(mo) Tim1 (AAL35775.1). Identical residues are shaded in black, less homologous 
residues in grey. The 6 conserved cysteines are identified with filled triangles, and 
empty triangles indicate PS binding sites. Asterisks indicate tyrosine kinase 
phosphorylation sites. N-linked glycosylation sites in chicken Tim1 are highlighted 
by solid dots and O-linked glycosylation sites labelled as Ô. Filled diamonds label the 




phosphatidylserine (PS) binding site is present, including a PS binding motif (WFND 
residues). The second distinctive structure in the chTim1 extracellular domain is a 
mucin domain from aa 130 to 207, containing high numbers of serine, threonine and 
proline residues (T/S/P-rich), among which 23 potential O-linked glycosylation sites 
are predicted by NetOGlyc (http://www. cbs.dtu.dk/services /NetOGlyc/), as shown 
in Figure 3.4. ChTim1 also has three potential N-linked glycosylation sites, two (N32 
and N92) in the IgV domain and one (N257) in the cytoplasmic region, predicted by 
NetNGlyc (http://www.cbs.dtu.dk/services/ NetNGlyc/) (Figure 3.4). The 
cytoplasmic domain of the chTim1 consists of 45 aa and contains two tyrosines, one 
of which (Y272) is present in a conserved motif (NED/ENIY).  This conserved 
tyrosine in murine Tim1 is a phosphorylation site and initiates downstream signalling 
pathways (de Souza et al., 2005). Multiple sequence alignment showed that chicken 
and mouse Tim1 have 33% aa identity and chicken and human Tim1 32%. The 
chTim1 IgV domain is highly homologous and shares 47.7% identity with that of 
human Tim1, and 53.2% identity with that of mouse Tim1.  
3.3.4 Structure of the chicken Tim4S molecule 
The phylogenetic tree also showed that chTim4S is homologous to 
mammalian Tim4 (Figure 3.2B). However, unlike mammals, two forms of chicken 
Tim4, a short isoform (chTim4S) and a long isoform (chTim4L), were initially 
identified. ChTim4S encodes a 359 aa membrane-bound type I protein with a signal 
peptide (aa 1-21) and a transmembrane domain spanning aa 300-320 (Figure 3.5). In 
the extracellular domain of chTim4S, an NH2-terminal IgV domain (aa 22-130) 
contains a PS-binding motif (WFND) and six conserved cysteines (Figure 3.5). The 




               signal peptide       ♦ IgV domain →                             
moTim4   MSKGLLLLWLVTELWWLYLTPAASEDTIIGFLGQPVTLPCHY-LSWSQS  48 
huTim4   MSKEPLILWLMIEFWWLYLTPVTSETVVTEVLGHRVTLPCLY-SSWSHN  48 
chTim4   MSHFVLFHWIVIQTFIVHT---MSEAVVQGVIGQPVTLPCSYRVAREKD  46 
                                                ▲                                                      
                                                                                                                         
moTim4   RNSMCWGKGSCPNSKCNAELLRTDGTRIISRKSTKYTLLGKVQFGEVSL  97 
huTim4   SNSMCWGKDQCPYSGCKEALIRTDGMRVTSRKSAKYRLQGTIPRGDVSL  97 
chTim4   ISDMCWGRGPCPNSKCNGKLLHTTGNRVTFRTSQRYNLQGYISYGDVSL  95 
             ▲     ▲    ▲                                                                                                    
                                            ♦ mucin domain →                   
moTim4   TISNTNRGDSGVYCCRIEVPGWFNDVKKNVRLELRRATTT--KKPTTTT 144 
huTim4   TILNPSESDSGVYCCRIEVPGWFNDVKINVRLNLQRASTTTHRTATTTT 146 
chTim4   TIQEVKAEDAGTYCCRVEIPGWFNDIKKNIQLVVLEAPPL-MTTTTGKA 143 
                      ▲▲      ∆∆∆∆                                
                                                                                                                           
moTim4   RPTTTPYVTTT-----TPELLPTTVMTTSVLPTTTPPQTLATTAFSTAV 188 
huTim4   RRTTTTSPTTTRQMTTTPAALPTTVVTTPDLTTGTPLQMTTIAVFTTAN 195 
chTim4   LTSPNHFRTTTFALQETSDLQATTWAAVPTVAPTTTGSPPTFDETTSDN 192 
                         Ô     ÔÔ     Ô   ÔÔÔ Ô  Ô   ÔÔ                                                                                      
                                                              
moTim4   TTCPSTTPGSFSQETT---------KGSAFTTESETLPASNHSQRSMMT 228 
huTim4   -TCLSLTPSTLPEEATGLLTPEPSKEGPILTAESETVLPS-DSWSSVES 242 
chTim4   VMEEVMTISALPDFSTNFETSDAWIEGEPVFCATQPEVTTEFPSILLTT 241 
                                                              
                                                                                                                           
moTim4   ISTDIAVLRPTGSNPGILPSTSQLTTQKTTLTTSESLQKTTKSHQINSR 277 
huTim4   TSADTVLLTSKASDTAVP------EQNKTTKTGQMDGIPMSMKNEMPIS 285 
chTim4   DRTEEANSSLLADDVPTVATALPEPTTLQTPKLTLGPSETSVSSDSNTE 290 
               ●●●       Ô  Ô     ÔÔ  Ô   Ô   Ô Ô       Ô                                                                                 
                  ♦ TM domain →        ♦ cytoplasmic →                   
moTim4   QTILIIACCVGFVLMVLLFLAFLLRGKVTGANCLQRHKRPDNTEDSD-- 324 
huTim4   QLLMIIAPSLGFVLFA-LFVAFLLRGKLMETYCSQKHTRLDYIGDSK-- 331 
chTim4   KTGMKLSFPISTILTVSLIGISIILMLIVLSLPWKRRHTRKFILKSLRP 339 
          Ô                                                    
                                 
moTim4   -SVLNDMSHGRDDEDGIFTL 343 
huTim4   -NVLNDVQHGREDEDGLFTL 350 
chTim4   AEDLEKVFSGSEGENNLFVL 359 
 
Figure 3.5. Alignment of chicken Tim4S (chTim4) with mouse (mo) Tim4 
(NP848874.3) and human (hu) Tim4 (NP001140198.1). Identical residues are shaded 
in black, less homologous residues in grey. Filled triangles emphasized the 6 
conserved cysteines and empty triangles indicate PS binding sites. Potential N-linked 
glycosylation sites in chTim4 are highlighted by solid dots and O-linked 
glycosylation sites labelled as Ô. Filled diamonds label the start-points of each 
domain.   
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other IgSF Ig domains, and four additional cysteines presumably form two additional 
disulphide bonds to create a cleft where PS binds, as shown in the IgV domain of 
murine Tim4 (Santiago et al., 2007a). Following the IgV domain in the extracellular 
domain, a mucin domain spans aa 131-299 and also contains a high number of 
threonine, serine and proline residues with 20 predicted O-linked glycosylation sites 
(Figure 3.5). A single potential N-linked glycosylation site (N248) is found in the 
mucin domain. The cytoplasmic tail (aa 321-359) of chTim4S lacks tyrosine 
residues, suggesting, like its mammalian equivalents, that chTim4S does not have a 
signal transduction role. The highly homologous IgV domain has 50.5% aa identity 
with human and 51.4% aa identity with mouse Tim4 (Figure 3.5).  
3.3.5 Structure of the chicken Tim4L molecule 
ChTim4L is a novel isoform of the chicken Tim4 molecule, not yet described 
in mammals. The structure of the chTim4L protein was predicted by SMART, as 
shown in Figure 3.6. The chTim4L cDNA encodes a membrane-bound type I protein 
of 545 aa, containing a signal peptide (aa 1-21),  a mucin (aa 316-487) domain,  a 
transmembrane (aa 488-510) domain and a short cytoplasmic tail (aa 511-545) 
without any significant peptide motif. Interestingly, chTim4L has two almost 
identical IgV domains (aa 22-130 and 208-316) linked by a short polypeptide chain 
(aa 131-207). Alignment of the putative aa sequences of chTim4L and chTim4S 
indicated that chTim4L and chTim4S share identical signal peptide, mucin and 
cytoplasmic domains, but there are aa differences between them in the IgV and 
transmembrane domains (Figure 3.6). For example, T23, T97, A128 in the IgV 
domain and L509 in the mucin domain of chTim4L correspond to A23, I97, V128 (in 







             signal peptide         ♦ IgV domain →                   
chTimD4L  MSHFVLFHWIVIQTFIVHTMSETVVQGVIGQPVTLPCSYRVAREKDISDM  50 
chTimD4S  MSHFVLFHWIVIQTFIVHTMSEAVVQGVIGQPVTLPCSYRVAREKDISDM  50 
                                                                
chTimD4L  CWGRGPCPNSKCNGKLLHTTGNRVTFRTSQRYNLQGYISYGDVSLTTQEV 100 
chTimD4S  CWGRGPCPNSKCNGKLLHTTGNRVTFRTSQRYNLQGYISYGDVSLTIQEV 100 
                                        ♦ hinge →                       
chTimD4L  KAEDAGTYCCRVEIPGWFNDIKKNIQLAVLEVFDETASGTYLEKMVSTSA 150 
chTimD4S  KAEDAGTYCCRVEIPGWFNDIKKNIQLVVL-------------------- 130 
 
chTimD4L  LQEFSSSFQAADMRTEGDGFFYSTELIPLPEATALPEPTTLQTPKLTLGP 200 
chTimD4S  -------------------------------------------------- 130 
                 ♦ IgV domain →                                                
chTimD4L  SAMHTASETVVRGVIGQPVTLPCSYQVAQEKDISDMCWGRGPCPHSKCNG 250 
chTimD4S  -------------------------------------------------- 130 
                                                                 
chTimD4L  KLLHTTGSEVTFRTSQRYNLQGYISYGDVSLTIQEVKAEDAGTYCCRVEI 300 
chTimD4S  -------------------------------------------------- 130 
                          ♦ mucin domain →                                       
chTimD4L  PGWFNDIKKNIQLVVLEAPPLMTTTTGKALTSPNHFRTTTFALQETSDLQ 350 
chTimD4S  ----------------EAPPLMTTTTGKALTSPNHFRTTTFALQETSDLQ 164 
                                                                 
chTimD4L  ATTWAAVPTVAPTTTGSPPTFDETTSDNVMEEVMTISALPDFSTNFETSD 400 
chTimD4S  ATTWAAVPTVAPTTTGSPPTFDETTSDNVMEEVMTISALPDFSTNFETSD 214 
                                                                 
chTimD4L  AWIEGEPVFCATQPEVTTEFPSILLTTDRTEEANSSLLADDVPTVATALP 450 
chTimD4S  AWIEGEPVFCATQPEVTTEFPSILLTTDRTEEANSSLLADDVPTVATALP 264                                                              
                                               ♦ TM domain →                  
chTimD4L  EPTTLQTPKLTLGPSETSVSSDSNTEKTGMKLSFPISTILTVSLIGISII 500 
chTimD4S  EPTTLQTPKLTLGPSETSVSSDSNTEKTGMKLSFPISTILTVSLIGISII 314 
                    ♦ cytoplasmic →                                             
chTimD4L  LMLIVLSLLWKRRHTRKFILKSLRPAEDLEKVFSGSEGENNLFVL 545 
chTimD4S  LMLIVLSLPWKRRHTRKFILKSLRPAEDLEKVFSGSEGENNLFVL 359 
                                                                 
 
Figure 3.6. Alignment of chTim4S and chTim4L. Both of their cDNAs were 
amplified from splenic cDNA from a line72 bird. Filled diamonds label the start-
points of each domain.  The domains are labelled above sequences. Identical residues 






3.3.6 Polymorphisms in chTim4S and chTim4L  
To determine if similar patterns of polymorphisms of chTim4S and chTim4L 
are consistent in other chicken strains, their cDNAs were amplified again from a 6-
week-old J line bird. Total RNA was isolated from: 1) spleen, 2) rchCD40L-
stimulated adherent splenocytes and 3) rchCD40L-stimulated suspension 
splenocytes, to determine if chTim4S and chTim4L have different expression 
patterns in different cell populations. The rchCD40L-stimulated splenocytes were 
prepared as follows:  splenocytes were isolated from the rest of spleen tissue (section 
2.3.5.1) and cultured with rchCD40L fusion protein for 72 h (section 2.3.5.4); the 
resulting adherent and the suspension splenocytes were harvested separately for 
isolation of total RNA (section 2.4). After reverse transcription of total RNA into 
cDNA (section 2.5.1) as PCR templates, chTim4S and chTim4L cDNAs were 
amplified from them with the primer pair Tim4-F1/R1, as described in section 3.2.1. 
As shown in Figure 3.7A, a bright band of 1.1 kb was amplified from the 
cDNA from spleen tissue. Interestingly, amplification from cDNA from the 
rchCD40L-stimulated adherent and suspension cells both resulted in two different 
sizes of bands. The former had two larger bands (which will be further described in 
section 3.3.7), whereas the latter had two bands of different intensity and obviously 
different molecular size (Figure 3.7A). A nested PCR with the primer pair Tim4-
F2/R2 (section 3.2.1) was also used to determine if the two bands from the cDNA 
from rchCD40L-stimulated suspension cells are chTim4 cDNAs. As shown in Figure 
3.7B, each nested PCR reaction resulted in a clear bright band of a similar size to 
their templates. The PCR products, including the bright band amplified from the 









Figure 3.7. Amplification of chTim4 cDNA from a J line bird. (A). cDNAs from 
rchCD40L-stimulated adherent splenic cells (lane 1), spleen tissue (lane 2) and 
rchCD40L-stimulated suspension splenocytes (lane 3) were used as PCR templates 
with primer pair Tim4-F1/R1. (B). Nested-PCR products in lane L and S were 
amplified using the large (L) and small (S) bands in lane 3 in (A) as templates, with 
primer pair Tim4-F2/R2. M = TrackIt™ 1 Kb Plus DNA Ladder (Invitrogen). 
pGEM-T Easy for sequencing. The sequencing results indicated that the PCR 
products from spleen tissue and the small band from the nested PCR were chTim4S, 
whereas the large band from the nested PCR was chTim4L.  
The putative aa sequences of chTim4L and chTim4S isolated from the J line 
bird were compared with those sequences cloned from the original line 72 bird, as 
shown in Figure 3.8A. There were six aa differences in the chTim4L molecules 
between two line (T97I, H204N, A291V, A355T, L423R and A438T), and seven in 
chTim4S (A23T, N24S, R25E, V127A, A135T, A252T and P323L). It remains to be 
determined if these aa changes would affect their biological functions, but none of 
these polymorphisms occur in known important aa residues, such as the cysteines 














M L S 
99 
 
            signal peptide        ♦ IgV domain → 
7_Tim4L  MSHFVLFHWIVIQTFIVHTMSETVVQGVIGQPVTLPCSYRVAREKDISDM :  50 
7_Tim4S  MSHFVLFHWIVIQTFIVHTMSEAVVQGVIGQPVTLPCSYRVAREKDISDM :  50 
J_Tim4S  MSHFVLFHWIVIQTFIVHTMSETVVQGVIGQPVTLPCSYRVAREKDISDM :  50 
J_Tim4L  MSHFVLFHWIVIQTFIVHTMSETVVQGVIGQPVTLPCSYRVAREKDISDM :  50 
                                                                    
7_Tim4L  CWGRGPCPNSKCNGKLLHTTGNRVTFRTSQRYNLQGYISYGDVSLTTQEV : 100 
7_Tim4S  CWGRGPCPNSKCNGKLLHTTGNRVTFRTSQRYNLQGYISYGDVSLTIQEV : 100 
J_Tim4S  CWGRGPCPNSKCNGKLLHTTGSEVTFRTSQRYNLQGYISYGDVSLTIQEV : 100 
J_Tim4L  CWGRGPCPNSKCNGKLLHTTGNRVTFRTSQRYNLQGYISYGDVSLTIQEV : 100 
                                       ♦ hinge →                      
7_Tim4L  KAEDAGTYCCRVEIPGWFNDIKKNIQLAVLEVFDETASGTYLEKMVSTSA : 150 
7_Tim4S  KAEDAGTYCCRVEIPGWFNDIKKNIQLVVL-------------------- : 130 
J_Tim4S  KAEDAGTYCCRVEIPGWFNDIKKNIQLAVL-------------------- : 130 
J_Tim4L  KAEDAGTYCCRVEIPGWFNDIKKNIQLAVLEVFDETASGTYLEKMVSTSA : 150 
                                                                    
7_Tim4L  LQEFSSSFQAADMRTEGDGFFYSTELIPLPEATALPEPTTLQTPKLTLGP : 200 
7_Tim4S  -------------------------------------------------- : 130 
J_Tim4S  -------------------------------------------------- : 130 
J_Tim4L  LQEFSSSFQAADMRTEGDGFFYSTELIPLPEATALPEPTTLQTPKLTLGP : 200 
                ♦ IgV domain →                                                  
7_Tim4L  SAMHTASETVVRGVIGQPVTLPCSYQVAQEKDISDMCWGRGPCPHSKCNG : 250 
7_Tim4S  -------------------------------------------------- : 130 
J_Tim4S  -------------------------------------------------- : 130 
J_Tim4L  SAMNTASETVVRGVIGQPVTLPCSYQVAQEKDISDMCWGRGPCPHSKCNG : 250 
                                                                    
7_Tim4L  KLLHTTGSEVTFRTSQRYNLQGYISYGDVSLTIQEVKAEDAGTYCCRVEI : 300 
7_Tim4S  -------------------------------------------------- : 130 
J_Tim4S  -------------------------------------------------- : 130 
J_Tim4L  KLLHTTGSEVTFRTSQRYNLQGYISYGDVSLTIQEVKAEDVGTYCCRVEI : 300 
                         ♦ mucin domain →                                      
7_Tim4L  PGWFNDIKKNIQLVVLEAPPLMTTTTGKALTSPNHFRTTTFALQETSDLQ : 350 
7_Tim4S  ----------------EAPPLMTTTTGKALTSPNHFRTTTFALQETSDLQ : 164 
J_Tim4S  ----------------EAPPLMTTTTGKALTSPNHFRTTTFALQETSDLQ : 164 
J_Tim4L  PGWFNDIKKNIQLVVLEAPPLMTTTTGKALTSPNHFRTTTFALQETSDLQ : 350 
                                                                    
7_Tim4L  ATTWAAVPTVAPTTTGSPPTFDETTSDNVMEEVMTISALPDFSTNFETSD : 400 
7_Tim4S  ATTWAAVPTVAPTTTGSPPTFDETTSDNVMEEVMTISALPDFSTNFETSD : 214 
J_Tim4S  ATTWTAVPTVAPTTTGSPPTFDETTSDNVMEEVMTISALPDFSTNFETSD : 214 
J_Tim4L  ATTWTAVPTVAPTTTGSPPTFDETTSDNVMEEVMTISALPDFSTNFETSD : 400 
                                                                    
7_Tim4L  AWIEGEPVFCATQPEVTTEFPSILLTTDRTEEANSSLLADDVPTVATALP : 450 
7_Tim4S  AWIEGEPVFCATQPEVTTEFPSILLTTDRTEEANSSLLADDVPTVATALP : 264 
J_Tim4S  AWIEGEPVFCATQPEVTTEFPSILLTTDRTEEANSSLLTDDVPTVATALP : 264 
J_Tim4L  AWIEGEPVFCATQPEVTTEFPSIRLTTDRTEEANSSLLTDDVPTVATALP : 450 
                                              ♦ TM domain →              
7_Tim4L  EPTTLQTPKLTLGPSETSVSSDSNTEKTGMKLSFPISTILTVSLIGISII : 500 
7_Tim4S  EPTTLQTPKLTLGPSETSVSSDSNTEKTGMKLSFPISTILTVSLIGISII : 314 
J_Tim4S  EPTTLQTPKLTLGPSETSVSSDSNTEKTGMKLSFPISTILTVSLIGISII : 314 
J_Tim4L  EPTTLQTPKLTLGPSETSVSSDSNTEKTGMKLSFPISTILTVSLIGISII : 500 
                   ♦ cytoplasmic →                                    
7_Tim4L  LMLIVLSLLWKRRHTRKFILKSLRPAEDLEKVFSGSEGENNLFVL : 545 
7_Tim4S  LMLIVLSLPWKRRHTRKFILKSLRPAEDLEKVFSGSEGENNLFVL : 359 
J_Tim4S  LMLIVLSLLWKRRHTRKFILKSLRPAEDLEKVFSGSEGENNLFVL : 359 






            ▼             ▼  ▼               ▼            ▼▼ 
7_IgV0  EAVVQGVIGQPVTLPCSYRVAREKDISDMCWGRGPCPNSKCNGKLLHTTGNRVTF :  55 
7_IgV1  ETVVQGVIGQPVTLPCSYRVAREKDISDMCWGRGPCPNSKCNGKLLHTTGNRVTF :  55 
7_IgV2  ETVVRGVIGQPVTLPCSYQVAQEKDISDMCWGRGPCPHSKCNGKLLHTTGSEVTF :  55 
J_IgV0  ETVVQGVIGQPVTLPCSYRVAREKDISDMCWGRGPCPNSKCNGKLLHTTGSEVTF :  55 
J_IgV1  ETVVQGVIGQPVTLPCSYRVAREKDISDMCWGRGPCPNSKCNGKLLHTTGNRVTF :  55 
J_IgV2  ETVVRGVIGQPVTLPCSYQVAQEKDISDMCWGRGPCPHSKCNGKLLHTTGSEVTF :  55 
 
                                                           ▼           
7_IgV0  RTSQRYNLQGYISYGDVSLTIQEVKAEDAGTYCCRVEIPGWFNDIKKNIQLVVL : 109 
7_IgV1  RTSQRYNLQGYISYGDVSLTTQEVKAEDAGTYCCRVEIPGWFNDIKKNIQLAVL : 109 
7_IgV2  RTSQRYNLQGYISYGDVSLTIQEVKAEDAGTYCCRVEIPGWFNDIKKNIQLVVL : 109 
J_IgV0  RTSQRYNLQGYISYGDVSLTIQEVKAEDAGTYCCRVEIPGWFNDIKKNIQLAVL : 109 
J_IgV1  RTSQRYNLQGYISYGDVSLTIQEVKAEDAGTYCCRVEIPGWFNDIKKNIQLAVL : 109 
J_IgV2  RTSQRYNLQGYISYGDVSLTIQEVKAEDVGTYCCRVEIPGWFNDIKKNIQLVVL : 109 
 
 
Figure 3.8. ChTim4S and chTim4L polymorphisms. (A). Alignments of chTim4S 
and chTim4L aa sequences from a J line and a line 72 bird. Filled diamonds label 
start-points of domains.  The domains are labelled above sequences. (B). Alignment 
of IgV domain aa sequence; the two chTim4L IgV domains, named IgV1 and IgV2, 
were compared with the IgV domain of chTim4S. Identical residues are shown in 
black, less homologous residues in grey. Dashes show gaps. Filled triangles indicate 
the persistent aa variants between the IgV domains of chTim4S and chTim4L. 
The aa sequences of the IgV domains in chTim4S and chTim4L from both 
lines of chickens were compared, as shown in Figure 3.8B. There were aa in the 
chTim4S IgV domain that were persistently different to those in either IgV domain 
of chTim4L. For example, in the line 72 bird, N72, R73 and A128 of chTim4S are 
identical to corresponding aa in IgV1 of chTim4L, but vary (S258, E259 and V314) 
in IgV2 of chTim4L. However, in the J line, S72, E73 and V128 in the IgV of 
chTim4S are different to N72, R73 and A128 in IgV1 of chTim4L, identical to S258 
and E259 in IgV2 of chTim4L, but different to V314 (Figure 3.8B).  
The polymorphisms between chTim4S and chTim4L are consistent in both 




are common events in different lines of bird and chTim4S and chTim4L mRNAs 
may be randomly transcribed from different parental alleles. 
3.3.7 Identification of a new longer chTim4 isoform  
 As shown in Figure 3.7A, amplification of chTim4 from cDNA from 
rchCD40L-stimulated adherent splenocytes resulted in two large bands. Both of them 
(together) were then purified and subcloned in pGEM-T Easy. Eight cloned plasmids 
were sequenced. Seven of them contained chTim4L cDNA, but one plasmid 
contained cDNA even longer than that of chTim4L, as shown in Figure 3.9. This 
product was named chTim4-extra-long isoform (chTim4eL). 
The chTim4eL cDNA has an open reading frame (ORF) of 1836 base-pairs 
(Figure 3.9). Sequence alignment of chTim4eL and chTim4L (Figure 3.9) indicated 
that chTim4eL is 198 bp longer than chTim4L in the hinge domain, and almost 
identical over the rest of the molecules. However, single nucleotide polymorphisms 
(SNPs) are also present between them (Figure 3.9). 
3.3.8 Identification of a new shorter isoform of chTim4 
  Intensive analysis of the chTim4L cDNA sequences indicated that, as well as 
the sequences encoding the two repeated IgV domains, another two regions (545-605 
bp and 738-798 bp) were also highly homologous. Further genomic analysis of these 
two regions indicated that they correspond to two different exons, exons 4 and 8 (the 
chTim4 gene structure will be further described below); interestingly, intronic 
sequences proximal to the 5’ and 3’ end of exons 4 and 8 also had high similarity. As 
shown in Figure 3.10, intron 3 (upstream of exon 4) is homologous to intron 7  
102 
 
                       signal peptide            ♦ IgV domain →                                                                     
Tim4eL ATGTCCCACTTTGTGTTGTTTCACTGGATTGTCATACAGACCTTCATAGTGCACACCATG :   60 
Tim4L0 ATGTCCCACTTTGTGTTGTTTCACTGGATTGTCATACAGACCTTCATAGTGCACACCATG :   60 
 
Tim4eL TCAGAAACTGTTGTTCAAGGAGTGATAGGACAACCTGTCACATTGCCTTGCTCCTACCGG :  120 
Tim4L0 TCAGAAACTGTTGTTCAAGGAGTGATAGGACAACCTGTCACATTGCCTTGCTCCTACCGG :  120 
 
Tim4eL GTAGCACGAGAGAAGGACATCTCCGATATGTGCTGGGGCAGAGGCCCGTGCCCAAACTCC :  180 
Tim4L0 GTAGCACGAGAGAAGGACATCTCCGATATGTGCTGGGGCAGAGGCCCGTGCCCAAACTCC :  180 
 
Tim4eL AAGTGCAATGGCAAACTTTTGCACACCACTGGGAACAGGGTGACGTTCAGAACATCACAG :  240 
Tim4L0 AAGTGCAATGGCAAACTTTTGCACACCACTGGGAACAGGGTGACGTTCAGAACATCACAG :  240 
 
Tim4eL CGGTACAACCTGCAGGGCTACATTTCCTACGGAGATGTGTCTCTGACCATTCAGGAGGTG :  300 
Tim4L0 CGGTACAACCTGCAGGGCTACATTTCCTACGGAGATGTGTCTCTGACCATTCAGGAGGTG :  300 
 
Tim4eL AAGGCAGAAGATGCGGGCACATACTGCTGCCGCGTGGAGATCCCAGGCTGGTTCAATGAC :  360 
Tim4L0 AAGGCAGAAGATGCGGGCACATACTGCTGCCGCGTGGAGATCCCAGGCTGGTTCAATGAC :  360 
                                         ♦  hinge → 
Tim4eL ATCAAGAAGAACATTCAGCTGGCGGTGCTCGAAGCACCCTCTGTGAAGAAAAAGCCTAAG :  420 
Tim4L0 ATCAAGAAGAACATTCAGCTGGCGGTGCTCGAAG-------------------------- :  394 
 
Tim4eL AAAAATGATTCCAAAACCACAAAACTTCCCATAAAAACAACTTTTGCACCCCAAACAACT :  480 
Tim4L0 ------------------------------------------------------------ :  394 
 
Tim4eL TCTGGTCTTCAAGGAACAGTGCGGACTGCTGTCTTCCTGACAACCACTGTCCCCACAGCA :  540 
Tim4L0 ------------------------------------------------------------ :  394 
 
Tim4eL GCTCCTGCAACCACTGAGTCTCCGAGGGTAACAACTGTTTATTTTCCCCCAGTATTTGAT :  600 
Tim4L0 ----------------------------------------------------TATTTGAT :  402 
 
Tim4eL GAGACAGCAAGTGGCACTTATCTAGAAAAAATGGTGTCAACCAGTGCTCTCCAAGAATTT :  660 
Tim4L0 GAGACAGCAAGTGGCACTTATCTAGAAAAAATGGTGTCAACCAGTGCTCTCCAAGAATTT :  462 
 
Tim4eL TCATCCAGTTTTCAAGCAGCTGATATGAGGACTGAAGGTGATGGCTTCTTCTACTCAACA :  720 
Tim4L0 TCATCCAGTTTTCAAGCAGCTGATATGAGGACTGAAGGTGATGGCTTCTTCTACTCAACA :  522 
                              
Tim4eL GAGTTAATCCCTCTTCCTGAAGCAACAGCCCTGCCAGAGCCAACCACACTTCAGACACCG :  780 
Tim4L0 GAGTTAATCCCTCTTCCTGAAGCAACAGCCCTGCCAGAGCCAACCACACTTCAGACACCG :  582 
                             ♦  IgV domain → 
Tim4eL AAGTTAACCCTTGGTCCCTCAGCAATGAACACTGCATCAGAAACTGTTGTTCGAGGAGTG :  840 
Tim4L0 AAGTTAACCCTTGGTCCCTCAGCAATGAACACTGCATCAGAAACTGTTGTTCGAGGAGTG :  642 
 
Tim4eL ATAGGACAACCTGTCACATTGCCTTGCTCCTACCAGGTGGCACAAGAGAAGGACATCTCC :  900 
Tim4L0 ATAGGACAACCTGTCACATTGCCTTGCTCCTACCAGGTGGCACAAGAGAAGGACATCTCC :  702 
 
Tim4eL GATATGTGCTGGGGCAGAGGCCCGTGCCCACACTCCAAGTGCAATGGCAAACTTTTGCAC :  960 
Tim4L0 GATATGTGCTGGGGCAGAGGCCCGTGCCCACACTCCAAGTGCAATGGCAAACTTTTGCAC :  762 
 
Tim4eL ACCACTGGGAGCGAGGTGACATTCAGAACATCACAGCGGTACAACCTGCAGGGCTACATT : 1020 
Tim4L0 ACCACTGGGAGCGAGGTGACATTCAGAACATCACAGCGGTACAACCTGCAGGGCTACATT :  822 
 
Tim4eL TCCTACGGAGATGTGTCTCTGACCACTCAGGAGGTGAAGGCAGAAGATGTGGGCACATAC : 1080 
Tim4L0 TCCTACGGAGATGTGTCTCTGACCATTCAGGAGGTGAAGGCAGAAGATGTGGGCACATAC :  882 
                                                                              
Tim4eL TGCTGCCGCGTGGAGATCCCAGGCTGGTTCAATGACATCAAGAAGAACATTCAGCTGGTG : 1140 
Tim4L0 TGCTGCCGCGTGGAGATCCCAGGCTGGTTCAATGACATCAAGAAGAACATTCAGCTGGTG :  942 
                 ♦ mucin domain →  
Tim4eL GTGCTCGAAGCACCTCCATTGATGATAACAACCACGGGAAAAGCTCTCACTTCCCCCAAC : 1200 
Tim4L0 GTGCTCGAAGCACCTCCATTGATGACAACAACCACGGGAAAAGCTCTCACTTCCCCCAAC : 1002 
Tim4eL CATTTTAGAACAACGACTTTTGCTCTCCAAGAAACCTCTGATCTTCAAGCAACCACATGG : 1260 





Tim4eL ACTGCTGTCCCCACAGTGGCACCTACAACCACTGGGTCTCCCCCAACGTTTGATGAGACA : 1320 
Tim4L0 ACTGCTGTCCCCACAGTAGCACCTACAACCACTGGGTCTCCCCCAACGTTTGATGAGACA : 1122 
 
Tim4eL ACAAGTGATAACGTTATGGAAGAAGTGATGACTATCAGTGCTCTCCCAGATTTTTCAACC : 1380 
Tim4L0 ACAAGTGATAACGTTATGGAAGAAGTGATGACTATCAGTGCTCTCCCAGATTTTTCAACC : 1182 
 
Tim4eL AATTTCGAAACAAGTGATGCATGGATTGAAGGTGAACCTGTGTTCTGCGCAGCACAGCCC : 1440 
Tim4L0 AATTTCGAAACAAGTGATGCATGGATTGAAGGTGAACCTGTGTTCTGCGCAACACAGCCC : 1242 
            
Tim4eL GAAGTGACTACTGAATTCCCAAGTATACGTTTGACTACAGACAGAACTGAAGAGGCCAAC : 1500 
Tim4L0 GAAGTGACTACTGAATTCCCAAGTATACGTTTGACTACAGACAGAACTGAAGAGGCCAAC : 1302 
                                          
Tim4eL AGTTCTCTCTTGACAGATGATGTGCCAACTGTAGCAACAGCACTGCCAGAGCCAACCACA : 1560 
Tim4L0 AGTTCTCTCTTGACAGATGATGTGCCAACTGTAGCAACAGCACTGCCAGAGCCAACCACA : 1362 
                                          
Tim4eL CTTCAGACACCGAAGTTAACCCTTGGTCCCTCAGAGACTTCAGTGAGTTCAGACAGCAAT : 1620 
Tim4L0 CTTCAGACACCGAAGTTAACCCTTGGTCCCTCAGAGACTTCAGTGAGTTCAGACAGCAAT : 1422 
                                  ♦ TM domain →  
Tim4eL ACAGAGAAAACTGGGATGAAACTTTCCTTTCCCATCTCCACCATTCTCACCGTATCTCTC : 1680 
Tim4L0 ACAGAGAAAACTGGGATGAAACTTTCCTTTCCCATCTCCACCATTCTCACCGTATCTCTC : 1482 
                                                           ♦ cytoplasmic →  
Tim4eL ATAGGGATATCCATTATTTTAATGTTGATAGTCTTATCGTTGCTTTGGAAACGAAGACAC : 1740 
Tim4L0 ATAGGGATATCCATTATTTTAATGTTGATAGTCTTATCGTTGCTTTGGAAACGAAGACAC : 1542 
            
Tim4eL ACAAGGAAATTTATTTTAAAAAGCCTTAGACCAGCTGAAGACCTTGAAAAAGTTTTCAGT : 1800 
Tim4L0 ACAAGGAAATTTATTTTAAAAAGCCTTAGACCAGCTGAAGACCTTGAAAAAGTTTTCAGT : 1602 
 
Tim4eL GGCTCTGAAGGAGAAAACAACCTTTTTGTGCTGTGA : 1836 
Tim4L0 GGCTCTGAAGGAGAAAACAACCTTTTTGTGCTGTGA : 1638 
                                                     
Figure 3.9. Alignment of chTim4L and chTim4eL sequences. Both chTim4L and 
chTim4eL were amplified from cDNA from the same J line bird. The start-points of 
domains are highlighted in red-coloured nucleotide residues and indicated by filled 
diamonds. The domains are labelled above the sequences. Identical residues are 









exon8 AGCCAAGTCCAGGCAGAACCTCGTCTGTTTTTTTTTAGTTAATTTCTCACAAGCGTTTGC  
 
exon4 CAGACAGATTGGGTTAGCTGGGTGTTTGGTTCCTGCTGAGCAGGCTCTCATTTAGTTTCT  
exon8 CAGACAGATTGGGTTAGCTGGGTGTTTGGTTCCTGCTGAGCAGGCTCTCATTTAGTTTCT  
 
exon4 CTTCTGTCTTTGCCTGATTTTCTCCAGCAACAGCCCTGCCAGAGCCAACCACACTTCAGA  
exon8 CTTCTGTCTTTGCCTGATTT-CCCCAGCAACAGCACTGCCAGAGCCAACCACACTTCAGA  
 
exon4 CACCGAAGTTAACCCTTGGTCCCTCAGGTACGGAGAGGAGGCACCAATAGTTGCTCCACC  
exon8 CACCGAAGTTAACCCTTGGTCCCTCAGGTACGGAGAGGAGGCACCAATAGTTGCTCCACC  
 
exon4 AAGCGGGCTGTGGGTTGCTGCCAGAAAGTCTAATTTTGACCCATGGGACATGTGTGCTGG  
exon8 AAGCGGGCTGTGGGTTGCTGCCAGAAAGTCTAATTTTGACCCATGGGACATGTGTGCCAG  
 
exon4 AGTGAGATATGCACTTTGTGTACTTGT : 326 
exon8 AGTGAGATATGCTGTATTTGTTACTCA : 326 
Figure 3.10. Alignments of exons 4 and 8 and intronic sequences proximal to them. 
Yellow-shaded nucleotides show exons 4 and 8 and red-coloured nucleotides show 
the variant. Black-shaded nucleotides are identical nucleotides in relevant intronic 
regions and grey-shaded nucleotides show differences. Dashes show gaps. 
(upstream of exon 8) at their 3’ ends; intron 4 (downstream of exon 4) is also 
homologous to intron 8 (downstream of exon 8) at their 5’ ends, implying exons 4 
and 8 may share an equal chance to be spliced during pre-mRNA splicing, because 
crucial factors for splicing are normally present in intronic regions proximal to a 
exon to be spliced, such as 5’ splice donor sites in the downstream intron and 3’ 
splice acceptor sites in upstream intron. The upstream intron also contains a branch 
sequence, the binding site for deposition of the spliceosome (a complex of snRNA 
and protein subunits) that removes introns from transcribed pre-mRNAs (Reed and 
Maniatis, 1988). 
An attempt was then made to amplify this new potential variant of chTim4 by 
RT-PCR, as described in section 3.2.1. A cDNA template derived from the spleen of 
a 6-week-old J line bird was used as template in PCR amplification with the primer 









Figure 3.11. Amplification of an extra-short isoform of chTim4 by RT-PCR. (A). 
Splenic cDNA from a J line bird was used as template with primers chTim4F1/R1. 
(B). Nested PCR product amplified using the small band in (A, arrowed) as template 
with primers chTim4-F2/R2. M = 100 bp DNA ladder (Promega). 
and a faint 800 bp band. The former had a similar molecular size to chTim4S, 
whereas the latter had never been seen before. The small band (800 bp) was then 
purified and used as template in a nested PCR with the primer pair chTim4-F2/R2 
(section 3.2.1). As shown in Figure 3.11B, the nested PCR resulted in a bright band 
of similar molecular size to its template. This nested PCR product was then 
subcloned into pGEM-T Easy for sequencing. The sequencing results indicated that a 
new 846 bp cDNA was highly homologous to chTim4, and was therefore named 
chTim4-extra-short (chTim4eS) isoform.  Sequence alignment of chTim4eS and 
chTim4L, as shown in Figure 3.12, indicated that both of them are almost identical in 
the signal peptide, IgV and transmembrane domains and cytoplasmic tails. However, 
chTim4eS has a very short mucin domain, but maintains a similar hinge region to 























                              
                              signal peptide        ♦ IgV domain →                                                
Tim4L0 ATGTCCCACTTTGTGTTGTTTCACTGGATTGTCATACAGACCTTCATAGTGCACACCATG :   60 
Tim4eS ATGTCCCACTTTGTGTTGTTTCACTGGATTGTCATACAGACCTTCATAGTGCACACCATG :   60 
 
Tim4L00TCAGAAACTGTTGTTCAAGGAGTGATAGGACAACCTGTCACATTGCCTTGCTCCTACCGG :  120 
Tim4eS TCAGAAACTGTTGTTCAAGGAGTGATAGGACAACCTGTCACATTGCCTTGCTCCTACCGG :  120 
 
Tim4L0 GTAGCACGAGAGAAGGACATCTCCGATATGTGCTGGGGCAGAGGCCCGTGCCCAAACTCC :  180 
Tim4eS GTAGCACGAGAGAAGGACATCTCCGATATGTGCTGGGGCAGAGGCCCGTGCCCAAACTCC :  180 
 
Tim4L0 AAGTGCAATGGCAAACTTTTGCACACCACTGGGAACAGGGTGACGTTCAGAACATCACAG :  240 
Tim4eS AAGTGCAATGGCAAACTTTTGCACACCACTGGGAACAGGGTGACGTTCAGAACATCACAG :  240 
 
Tim4L0 CGGTACAACCTGCAGGGCTACATTTCCTACGGAGATGTGTCTCTGACCATTCAGGAGGTG :  300 
Tim4eS CGGTACAACCTGCAGGGCTACATTTCCTACGGAGATGTGTCCCTGACCATTCAGGAGGTG :  300 
 
Tim4L0 AAGGCAGAAGATGCGGGCACATACTGCTGCCGCGTGGAGATCCCAGGCTGGTTCAATGAC :  360 
Tim4eS AAGGCAGAAGATGCGGGCACATACTGCTGCCGCGTGGAGATCCCAGGCTGGTTCAATGAC :  360 
                                         ♦ hinge → 
Tim4L0 ATCAAGAAGAACATTCAGCTGGCGGTGCTCGAAGTATTTGATGAGACAGCAAGTGGCACT :  420 
Tim4eS ATCAAGAAGAACATTCAGCTGGCGGTGCTCGAAGTATTTGATGAGACAGCAAGTGGCACT :  420 
 
Tim4L0 TATCTAGAAAAAATGGTGTCAACCAGTGCTCTCCAAGAATTTTCATCCAGTTTTCAAGCA :  480 
Tim4eS TATCTAGAAAAAATGGTGTCAACCAGTGCTCTCCAAGAATTTTCATCCAGTTTTCAAGCA :  480 
 
Tim4L0 GCTGATATGAGGACTGAAGGTGATGGCTTCTTCTACTCAACAGAGTTAATCCCTCTTCCT :  540 
Tim4eS GCTGATATGAGGACTGAAGGTGATGGCTTCTTCTACTCAACAGAGTTAATCCCTCTTCCT :  540 
            
Tim4L0 GAAGCAACAGCCCTGCCAGAGCCAACCACACTTCAGACACCGAAGTTAACCCTTGGTCCC :  600 
Tim4eS GAAGCAACAGCCCTGCCAGAGCCAACCACACTTCAGACACCGAAGTTAACCCTTGGTCCC :  600 
           ♦ IgV domain →  
Tim4L0 TCAGCAATGAACACTGCATCAGAAACTGTTGTTCGAGGAGTGATAGGACAACCTGTCACA :  660 
Tim4eS TCAG-------------------------------------------------------- :  604 
 
Tim4L0 TTGCCTTGCTCCTACCAGGTGGCACAAGAGAAGGACATCTCCGATATGTGCTGGGGCAGA :  720 
Tim4eS ------------------------------------------------------------ :  604 
 
Tim4L0 GGCCCGTGCCCACACTCCAAGTGCAATGGCAAACTTTTGCACACCACTGGGAGCGAGGTG :  780 
Tim4eS ------------------------------------------------------------ :  604 
 
Tim4L0 ACATTCAGAACATCACAGCGGTACAACCTGCAGGGCTACATTTCCTACGGAGATGTGTCT :  840 
Tim4eS ------------------------------------------------------------ :  604 
 
Tim4L0 CTGACCATTCAGGAGGTGAAGGCAGAAGATGTGGGCACATACTGCTGCCGCGTGGAGATC :  900 
Tim4eS ------------------------------------------------------------ :  604                                                                                                                                                           
                                                           ♦ mucin domain →  
Tim4L0 CCAGGCTGGTTCAATGACATCAAGAAGAACATTCAGCTGGTGGTGCTCGAAGCACCTCCA :  960 
Tim4eS ------------------------------------------------------------ :  604 
 
Tim4L0 TTGATGACAACAACCACGGGAAAAGCTCTCACTTCCCCCAACCATTTCAGAACAACGACT : 1020 
Tim4eS ------------------------------------------------------------ :  604 
 
Tim4L0 TTTGCTCTCCAAGAAACTTCTGATCTTCAAGCAACCACATGGACTGCTGTCCCCACAGTA : 1080 
Tim4eS ------------------------------------------------------------ :  604 
 
Tim4L0 GCACCTACAACCACTGGGTCTCCCCCAACGTTTGATGAGACAACAAGTGATAACGTTATG : 1140 
Tim4eS ------------------------------------------------------------ :  604 
 
Tim4L0 GAAGAAGTGATGACTATCAGTGCTCTCCCAGATTTTTCAACCAATTTCGAAACAAGTGAT : 1200 
Tim4eS ------------------------------------------------------------ :  604                                                                           
                                                      
Tim4L0 GCATGGATTGAAGGTGAACCTGTGTTCTGCGCAACACAGCCCGAAGTGACTACTGAATTC : 1260 




Tim4L0 CCAAGTATACGTTTGACTACAGACAGAACTGAAGAGGCCAACAGTTCTCTCTTGACAGAT : 1320 
Tim4eS ------------------------------------------------------------ :  604 
                        
Tim4L0 GATGTGCCAACTGTAGCAACAGCACTGCCAGAGCCAACCACACTTCAGACACCGAAGTTA : 1380 
Tim4eS ------------------------------------------------------------ :  604 
                        
Tim4L0 ACCCTTGGTCCCTCAGAGACTTCAGTGAGTTCAGACAGCAATACAGAGAAAACTGGGATG : 1440 
Tim4eS ----------------AGACTTCAGTGAGTTCAGACAGCAATACAGAGAAAACTGGGATG :  648 
                ♦ TM domain →  
Tim4L0 AAACTTTCCTTTCCCATCTCCACCATTCTCACCGTATCTCTCATAGGGATATCCATTATT : 1500 
Tim4eS AAACTTTCCTTTCCCATCTCCACCATTCTCACCGTATCTCTCATAGGGATATCCATTATT :  708 
                                         ♦ Cytoplasmic →  
Tim4L0 TTAATGTTGATAGTCTTATCGTTGCTTTGGAAACGAAGACACACAAGGAAATTTATTTTA : 1560 
Tim4eS TTAATGTTGATAGTCTTATCGTTGCTTTGGAAACGAAGACACACAAGGAAATTTATTTTA :  768 
             
Tim4L0 AAAAGCCTTAGACCAGCTGAAGACCTTGAAAAAGTTTTCAGTGGCTCTGAAGGAGAAAAC : 1620 
Tim4eS AAAAGCCTTAGACCAGCTGAAGACCTTGAAAAAGTTTTCAGTGGCTCTGAAGGAGAAAAC :  828 
 
Tim4L0 AACCTTTTTGTGCTGTGA : 1638 
Tim4eS AACCTTTTTGTGCTGTGA :  846 
                                     
 
Figure 3.12. Alignment of Tim4L and Tim4eS. Both cDNAs were amplified from the 
same J line bird. Filled diamonds label the start-points of domains.  The domains are 
labelled above the sequences. Identical residues are shown in black, less homologous 
residues in grey. Dashes show gaps. 
3.3.9 Gene structure of chTim4 isoforms 
The four chTim4 isoform cDNA sequences were compared with the chicken 
genome sequence in ENSEMBL to determine their gene structures. As shown in 
Figure 3.13, all four chTim4 isoforms are encoded by a single gene, which lies 
between nucleotides 11,536,376 and 11,551,073 on chromosome 13. The chTim4eL 
cDNA is derived from 12 exons with a long exon 3. ChTim4L is also encoded by 12 
exons, but its exon 3 is 198 bp shorter than that of chTim4eL at the 5’ end. ChTim4S 
is encoded by 9 exons, lacking exons 3, 4 and 5 of the chTim4L isoform. ChTim4eS 
is encoded by 8 exons with the same short exon 3 as chTim4L, but lacks exons 5, 6, 
7 and 8 of the chTim4L isoform.  
The exons encoding substructure of chTim4 proteins were also analysed, as 












Figure 3.13. Exon usage of the four chTim4 isoforms. Boxes represent exons and are 
linked by introns, shown as dotted lines. The number above the box shows the length 
of each exon in base-pairs and that beneath the box indicates each exon. The sub-
structures of the chTim4 proteins encoded by the exons are labelled on the top of 
exons, where SP = signal peptide, TM = transmembrane domain and CT = 
cytoplasmic tail. 
the two repeated IgV domains, exons 3 and 4 the polypeptide hinge between the two 
IgV domains , exons 6-9 the mucin domain, exon 10 the transmembrane domain and 
exons 11 and 12 the cytoplasmic tail. Therefore, both chTim4eL and chTim4L 
proteins have two repeated IgV domains, but the former has a longer hinge than the 
latter. By contrast, both chTim4S and chTimeS only have one IgV domain; the 
former has a longer mucin domain, identical to those of chTim4eL and chTim4L, 
whereas the latter has a very short mucin domain, but maintains the same hinge as 
chTim4L. 
3.3.10 Expression of recombinant chTim family proteins 
Recombinant proteins were expressed in the supernatants of COS-7 cells 




section 2.7.1. The presence of recombinant protein in the COS-7 cell supernatants 
was tested by ELISA as described in section 2.6.2. 
The chTim1 extracellular domain Ig fusion protein was expressed at higher 
levels than those of the chTim4S extracellular domain Ig fusion protein, even though 
all transfection procedures were as similar as possible. However, the expression 
levels of the chTim4L-2IgV and chTim4L-extracellular domains were very low or 
not detectable in the capture ELISA assay (Figure 3.14). When comparing yields of 
the different subunit chTim molecules, as shown in Figure 3.15, the recombinant 
mucin domain protein had the highest expression levels. The IgV domain protein had 
similar levels of expression to those of the extracellular domain proteins. The 
variation in levels of fusion protein expression may be a consequence of PS binding 
sites in the IgV domain, by means of which the fusion protein could partially bind to 
PS on the membrane of the intracellular cell apparatus or the inner layer of the cell 
membrane during expression, eventually impacting on secretion levels of the protein 
in the supernatants.  
To determine if the chTim4L-Ig fusion protein does not express at all, the 
plasmids were electroporated into COS-7 cells, as described in section 2.7.2. The 
transfected cells were then fixed and probed with an anti-human IgG antibody and 
anti-PDI (which stains the ER apparatus) or anti-GM130 (for Golgi apparatus) 
antibodies, followed by fluorescently labelled secondary antibodies, as described in 
section 2.8. The stained cells were analysed by confocal microscopy. The protein 















Figure 3.14. Detection of expression of chTim family proteins by a capture ELISA. 
The Ig fusion proteins in transfected COS-7 supernatants, containing extracellular 
domains of chTim1 (blue line), chTim4S (pink line), chTim4L (red line) or the IgV 
domains of chTim4L (2IgVs, light blue line), were captured on ELISA plates, pre-
coated with unlabelled goat anti-human IgG antibody. The bound fusion proteins 
were then probed with an HRP-conjugated goat anti-human IgG antibody. The HRP 
activities were detected by the substrate OPD and read at OD 490 nm. Negative 




















       
 
     
 
Figure 3.15.  COS-7 cell transient expression of recombinant chTim domain proteins 
analysed by capture ELISA. The top graph shows Ig-fused Tim1 domains, with Ig-
fused Tim4S domains in the bottom graph. The IgV domains are shown as blue lines, 
the mucin domains as solid red lines, the extracellular domains as green lines. A 
purified Ig-fused chicken CD86 protein at concentration of 0.5 (triangle), 1.0 
(diamond) and 2.0 (dot) µg/ml was used as positive control (P Ctl, red dashed lines). 




























Figure 3.16. Confocal microscopy of co-localisation of chTim4L-extracellular-Ig 
fusion protein in COS-7 cells. Transfected cells were co-stained with a biotinylated 
goat anti-human IgG Ab, followed by an Alexa-fluor 568-conjugated streptavidin in 
red, and either (A) a mouse anti-PDI (for ER apparatus) or (B) a mouse anti-GM130 
(for Golgi apparatus), followed by detection using an Alexa fluor 488 conjugated 
goat anti-mouse Ab in green. Nuclei were stained with DAPI in blue. Therefore, 
negatively-transfected cells are in green and blue; positively-transfected cells are in 





3.3.11 Large-scale protein expression from stably transfected CHO cells 
Three Ig-tagged fusion plasmids, including the chTim1-, chTim4S-
extracellular and the chTim4L hinge domains, and two His6-tagged plasmids 
containing extracellular domain of either chTim1 or chTim4S were transfected into 
CHO-K1 cells to establish stable transfectants (for details see Table 3.3). Single 
colonies were screened by capture ELISA, as described in section 2.6.2, for Ig-fusion 
protein-producing colonies. 
In each transfection, 960 colonies (ten 96-well plates) were screened. 48 
colonies with the highest ELISA optimal density (OD) readings were then selected 
and grown up in 24-well plates. After further screening, 12 colonies were chosen and 
grown up in 6-well plates. After a third round of screening, 6 colonies were chosen to 
grow up in T75 tissue culture flasks and one colony, finally, which consistently 
scored highly in all rounds of screening, was chosen to express recombinant protein 
at a large scale by miniPERM culture (section 3.2.4). For the His6-tagged fusion 
proteins, in each transfection, ten 96-well plates were seeded for growing up single 
colonies. After counting the colony numbers in each well under the microscope, the 
supernatants from the wells, with only one colony per well, were chosen and dotted 
into nitrocellulose membranes. Dot-blotting assays were performed as described in 
section 2.6.3. Figures 3.17 (A, B) and 3.18 (A, B) show the selection of colonies 
secreting His6-tagged proteins by dot-blot. 17 chTim1-His6- and 5 chTim4S-His6- 
expressing colonies were chosen to grow up in 24-well plates. The supernatants were 
further tested by slot-blotting, as shown in Figures 3.17 (C) and 3.18 (C). Stably 
transfected colonies 1 (expressing chTim1) and 5 (expressing chTim4S) were 

















Figure 3.17. Selection of stably transfected CHO colonies expressing high levels of 
chTim1-His6 protein by dot- (A, B) or slot- (C) blotting. (A) and (B) show results of 
screening single colonies grown on 96-well plates. (C) shows a further screen of the 
colonies grown on 24-well plates. The numbers above the slots and dots correspond 
to the same colonies. Negative controls (N) were Ham’s F12 medium, and the 
positive control (P) was 500 ng of purified His6-tagged protein (chCD86-His6). 
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Figure 3.18. Selection of stably transfected CHO colonies expressing high levels of 
chTim4S-His6 protein by dot- (A, B) or slot- (C) blotting. (A) and (B) show results 
of screening single colonies grown on 96-well plates. (C) shows a further screen of 
the colonies grown on 24-well plates. The numbers above the slots and dots 
correspond to the same colonies. Negative control (N) was Ham’s F12 medium, and 
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The supernatants from the miniPERM culture were further tested by slot-blotting, as 
shown in Figure 3.19. 
3.3.12 Characterisation of purified recombinant chTim fusion proteins 
Recombinant proteins from the miniPERM supernatants were purified on a 
protein G column for the Ig-tagged proteins (section 2.9) or by Ni-NTA slurry for the 
His6-tagged proteins (section 3.2.6). The purified proteins were then electrophoresed 
on an SDS-PAGE gel, followed by Coomassie blue staining (section 2.6.5) to 
monitor protein purity or western blot (section 2.6.6) to estimate the approximate 
molecular weight. The 231 aa of the monomerised IgG1 Fc tag have a calculated 
molecular mass of 26.4 kDa and two N-linked glycosylation sites, resulting in the 
protein migrating as 30-35 kDa in an SDS-PAGE gel. This Ig-tag was fused to the 
chTim1- or chTim4S-extracellular domains or the chTim4L-hinge domain, with 
molecular masses of 46.5, 56.4 and 34.6 kDa, respectively, predicted with Protparam 
software (http://web.expasy.org/protparam).  
As a result of O-linked or N-linked glycosylation (or both), the Ig-tagged 
chTim1- and chTim4S-extracellular domain fusion proteins migrated at 
approximately 72 kDa and 95 kDa respectively under reducing or non-reducing 
conditions (Figures 3.20A, 3.21A and B). The chTim4L-hinge-Ig protein migrated at 
55 kDa under reducing conditions (Figures 3.20B and 3.21C). His6-tagged chTim1- 
and chTim4S-extracellular domain fusion proteins migrated at approximately 46 and 
66 kDa respectively (Figures 3.22A and B). To avoid bovine Ig contamination, Ig-
depleted Foetal bovine serum (FBS) was used in the cell cultures instead of normal 













Figure 3.19. Expression of chTim-His6 fusion proteins with miniPERM cultures. 
Stable CHO transfectants were cultured with miniPERM bioreactors for massive 
protein expression, followed by analysis of protein in their supernatants with slot-
blotting. The diluted or undiluted supernatant was dotted onto a nitrocellulose 
membrane and probed with a Penta-his antibody. Neat = undiluted, 10× = ten times 
dilution, 20× = twenty times dilution, N = negative control (supernatant from 





















Figure 3.20. Coomassie blue staining of purified chTim-Ig fusion proteins. The 
chTim-Ig fusion proteins were expressed by stably transfected CHO cells cultured in 
a miniPERM bioreactor. The purified proteins were resolved on 4-12% SDS-PAGE 
gels under reducing conditions. (A). ChTim1- and chTim4S-extracellular domain Ig 
fusion proteins, M = Pageruler prestained protein ladder (Fermentas). (B). ChTim4-
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Figure 3.21. Western blot analysis of purified chTim-Ig fusion proteins. Purified 
chTim1- and chTim4S-extracelluar domain Ig fusion proteins were resolved on SDS-
PAGE (A) under non-reducing conditions, or (B) under reducing conditions; (C) 
chTim4L-hinge-Ig protein resolved under reducing conditions. Proteins were then 
probed by HRP-conjugated goat anti-human IgG antibody, followed by ECL 
detection. Ig = human IgG1 (Pro100-Lys330) (R&D Systems). M = Full-range 
rainbow protein ladder (A, B) (Invitrogen) or Precision Plus protein standard (all 
blue) (C). Chemiluminescence was exposed on X-ray films (A, B) or directly 
















































Figure 3.22. Purified chTim1- and chTim4S-extracellular domain His6 fusion 
proteins. The Ni-NTA affinity-purified chTim-His6 fusion proteins were 
electrophoresed on 4-12% SDS-PAGE gels under reducing conditions, followed by 
(A) Coomassie blue staining or (B) western blotting.  A Penta-his antibody was used 
to probe the chTim-His6 proteins in western blot, followed by HRP-conjugated goat 
anti-mouse IgG antibody. ECL was used to detect HRP activity. M = Pageruler 








purification on a protein G column (Figure 3.20A and B). Affinity purified His6-
tagged proteins using Ni–NTA resin were less pure (Figure 3.22A).   
3.4 Discussion 
As described previously, the murine Tim family lies on chromosome 11, 
which is homologous to the human chromosomal region 5q23-35, which contains the 
human Tim family genes. Both regions are linked to atopy and asthma (Loots et al., 
2000; Yokouchi et al., 2000; Walley et al., 2001). The human 5q region contains a 
large number of cytokine genes, including IL-9, IL-12 p40 and the Th2 cytokine 
cluster, which contains the genes that encode IL-4, -5 and -13, as well as 
granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-3 (Loots et al., 
2000; Kelly et al., 2000). Chromosome 13 is the syntenic chicken chromosome 
encoding IL-9, IL-12 p40, the Th2 cytokine cluster (IL-4, -5 and -13), GM-CSF and 
IL-3 (Kaiser et al., 2005; Avery et al., 2004; Balu et al., 2003; 2011). The chicken 
Tim locus maps to a syntenically conserved region on chromosome 13.  
The number of Tim family members is different in human and mouse species. 
Orthology of Tim genes between them has been studied by phylogenetic analysis of 
IgV domain. Murine Tim4-8 genes together were evolved independently; murine 
Tim3, a homology of human Tim3, is also an ancient Tim gene lineage. However, 
murine Tim1 and Tim4, homologous to human Tim1 and Tim4 respectively, are 
closely related and cluster in a different branch, suggesting they may be a 
consequence of paralogous duplication to each other in early evolutionary stage in 
both species. Later on, a paralogous duplication of murine Tim1 resulted in a novel 
murine Tim2 (Shakhov et al., 2004; Kuchroo et al., 2003). However, a phylogenetic 
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tree of full-length Tims (Figure 3.2B) showed that Tim1 and Tim3 in both human 
and mouse are more closely related to each other and equally related to human and 
mouse Tim4. This cluster pattern of Tim molecules is consistent with evolution of 
their biological functions. Because the role of mucin domains in Tims is to help IgV 
domains properly interacting with their ligands, therefore, they co-evolved; Tim1 and 
Tim3 have functional similarities with expressing on the surface of CD4
+
 T cells and 
regulating immune response of these cells, consistently to their evolutionary 
relationship. Chicken evolutionarily lost functional Tim3, but has Tim1 and Tim4, 
which are homologous to their counterparts in human and mouse. 
Polymorphisms are present in mammalian Tim molecules and are associated 
with susceptibility to disease. The mucin domain in Tim1 is longer in BALB/c mice, 
which are more susceptible to Th2-driven airway hypersensitivity, than in DBA/2 
and C57BL/6 mice, which develop less airway reactivity following antigen challenge 
(McIntire et al., 2001). Like mice, an insertion of six aa forming a long human Tim1 
mucin domain (157insMTTTVP) resulted in protection against asthma and allergy in 
subjects previously exposed to HAV (McIntire et al., 2003). Unlike Tim1, murine 
Tim3 has two splice variants, a full-length Tim3 (encoding a membrane protein) and 
a short soluble Tim3 (encoding a soluble Tim3), lacking the mucin and 
transmembrane domains of full-length Tim3. This soluble Tim3 binds with high 
affinity and avidity to its receptors and serves to inhibit effector Th1 cell responses, 
which are crucial for the induction of peripheral tolerance (Sabatos et al., 2003). 
Chicken Tim1 insertion/deletion variants have yet to be identified. However, chicken 
Tim4 was originally identified in these studies as two novel splice variants, a short 
and a long isoform; the latter has an extra IgV domain when compared to the former. 
123 
 
They are both encoded by the same gene (Figure 3.13). ChTim4L is encoded by 12 
exons. Among them, exons 2 and 5 are highly homologous, encoding two IgV 
domains of chTim4L protein. They are linked by polypeptides encoded by exon 3 
and 4 (Figure 3.13). However, chTim4S is encoded by 9 exons, lacking exons 3, 4 
and 5 of the chTim4L.  
Comparison of the putative aa sequences of chTim4S and chTim4L indicated 
that they have identical sequences in their signal peptide, mucin and cytoplasmic 
domains. However, a single aa difference is present in the transmembrane domain 
and there are more differences in the IgV domains; the IgV domain of chTim4S is 
not entirely identical to either IgV domain of chTim4L (Figures 3.6 and 3.8B). To 
determine if aa variations between chTim4S and chTim4L are also present in 
different genetic backgrounds, chTim4S and chTim4L cDNAs were amplified again 
from an outbred J line bird. Similarly to the cDNA clones from the line 72 bird, aa 
variations, this time in the mucin and IgV domains were also present between 
chTim4S and chTim4L from the J line bird (Figure 3.8A). Several aa residues were 
persistently variable between the IgV domain of chTim4S and either of the IgV 
domains of chTim4L in both lines (Figure 3.8B). A possible explanation for these 
differences is that chTim4S and chTim4L are splice variants of the same gene but 
that they are transcribed from different parent alleles, which are heterozygous at the 
chTim4 locus.  
It is notable that exons 4 and 8 of chTim4L and the intronic sequences around 
them are highly homologous (Figure 3.10). As mentioned previously, the elements 
associated with regulation of RNA splicing are normally located close to an exon to 
be spliced at the 5′ and 3′ ends of introns, such as the branch site and splice sites. 
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Therefore, the sequence similarity implies that exons 4 and 8 may have equal chance 
of being spliced during RNA splicing, probably resulting in the different alternative 
splice variants to chTim4S and chTim4L. An attempt was made to clone this 
predicted chTim4 splice variant by RT-PCR.  Eventually, a shorter version of 
chTim4 cDNA was cloned from splenic RNA from a J line bird (Figure 3.11). This 
new chTim4 isoform was even shorter than chTim4S and thus named chTim4eS. It 
was encoded by 8 exons. As predicted, the chTim4eS mRNA excludes exons 5, 6, 7 
and 8 of chTim4L. There is only a single nucleotide polymorphism between exons 4 
and 8 (Figure 3.10). The chTim4eS mRNA includes exon 4 but excluded exon 8, as 
it has the same nucleotide residue as that in exon 4. 
 An extra longer isoform of chTim4 (chTim4eL) was also identified with a 
longer exon 3 than that of chTim4L but almost identical to chTim4L in the remainder 
of the molecule. It was not detected when chTim4S and chTim4L were first 
amplified, probably due to low abundance in the RNA sample. Adherent splenocytes 
stimulated with rchCD40L seem to express high levels of chTim4eL (Figure 3.13A), 
although it is yet to be determined if the high expression levels of chTim4eL were a 
consequence of rchCD40L stimulation or if chTim4eL-expressing cells were 
enriched in adherent splenocytes. ChTim4 has 12 constitutive exons and a longer 
constitutive exon 3 is present in chTim4eL, whereas the other chTim4 variants have 
a shorter alternatively splicing exon 3. RT-PCR results indicated that chTim4eL is 
not abundantly expressed in normal spleen tissue (Figure 3.7A), although it contains 
all of the constitutive exons; chTim4S and chTim4L are the most abundant forms 
present in spleen tissue and rchCD40L-stimulated suspension splenocytes 
respectively (Figure 3.7A). There may be regulatory elements in exon 3, such as an 
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exonic splicing enhancer (ESE)/silencer (ESS), or in the intronic region flanking 
exon 3, such as an intronic splicing enhancer (ISE)/silencer (ISS), that may control 
splicing to give a shorter form of exon 3.  
HAV infection studies indicated that both murine Tim1-IgV and -mucin 
domains are involved in virus invasion, but play different roles. A fusion protein 
containing only the IgV domain could block the binding of HAV to cells, but a 
similar fusion protein containing only the mucin domain did not. However, a fusion 
protein consisting of both IgV and mucin domains of Tim1 blocked ten-fold more 
infection than the IgV domain alone and efficiently triggered viral uncoating, a 
necessary event for viral entry, suggesting the IgV domain of Tim1 has a binding site 
for HAV and the mucin domain may enhance this interaction (Silberstein et al., 
2001; 2003). In addition, mucosal addression cell adhesion molecule (MAdCAM)-1, 
which has a similar structure to that of the Tim family, has two distinct ligands, one 
for its Ig domains and one for its mucin domain, and each ligand has a separate 
function (Berg et al., 1993; Shaw and Brenner, 1995). As described before (Chapter 
1), each mammalian Tim molecule has multiple ligands and their binding sites are 
mapped to their IgV domains; Tim1 ligands include PS, IgA, LMIR5, Tim4 and 
Tim1 itself as well as HAV virus; Tim2 ligands include H-ferritin and Sema4A; 
Tim3 ligands include PS and galectin-9 and Tim4 ligands include PS and LMIR5. 
Through interaction with multiple ligands, these Tim proteins play complex roles 
(Freeman et al., 2010; Kane, 2010). To determine if different domains of the chicken 
Tim family proteins play differential roles, fusion proteins containing different 
chTim domains were expressed. Chicken Tim molecules have potential multiple N- 
and O- linked glycosylation sites, suggesting they may be highly glycosylated 
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proteins. Therefore, mammalian expression systems were used to express these 
recombinant chTim fusion proteins to allow post-translation modifications and 
hopefully generation of functional proteins. The resulting chTim fusion proteins will 
be used to investigate their biological and immunological roles; for example, do they 
act as PS receptors to mediate dead cell clearance and as costimulatory molecules to 
stimulate immune cell proliferation in Chapter 4. The chTim fusion proteins will also 
be used to generate anti-chTim mAbs to investigate chTim molecule expression on 
chicken immune cells in Chapter 5. 
However, recombinant chTim4L fusion proteins, containing IgV (two IgVs) 
and entire extracellular domains, proved difficult to detect in the supernatants of 
transfected mammalian cells (Figure 3.14), although they were expressed by these 
cells (Figure 3.16). A possible explanation is that the double PS-binding sites in the 
chTim4L protein may result in the protein binding tightly to PS, either on the 
membrane of the ER apparatus to prevent intracellular transportation of the fusion 
protein, or on the inner layer of the transfected cell membrane to limit the ability of 
soluble protein to be secreted into the supernatant. The unique hinge between the two 
IgV domains of chTim4L was fused to an Ig tag for protein expression and used to 











Chapter 4.    Characterisation of the chicken Tim family 
molecules. 
4.1 Introduction 
The first member of the Tim family molecules to be discovered was Tim1, 
originally identified as a receptor of hepatitis A virus (HAV) in African green 
monkey and named HAVCR-1 (Kaplan et al., 1996). It has a structure similar to that 
of mucosal addressin cell adhesion molecule 1 (MAdCAM-1). Its extracellular 
region consists of an IgV domain and a mucin domain (Ichimura et al., 1998). The 
IgV domain has an HAV binding site, while the mucin domain enhances binding, 
which results in 10 times more HAV neutralisation from the entire extracellular 
domain than from the IgV domain alone (Silberstein et al., 2001; 2003). Murine 
Tim1 is expressed on activated but not naïve CD4
+
 T cells, especially on 
differentiated Th2 cells. Th1 and Th17 cells express little or no Tim1 (McIntire et al., 
2001; Umetsu et al., 2005; Meyer et al., 2005a; Nakae et al., 2007b). Other cell 
types, such as mast cells, B cells and tubular epithelials cells post-kidney injury, also 
express variable levels of Tim1. Tim1 mRNA can be detected in invariant natural 
killer T cells (Khademi et al., 2004). Tim1, as a costimulatory molecule, plays a role 
in regulation of Th2 immune responses and cytokine production (Umetsu et al., 
2005). In vivo administration of an agonist Tim1 mAb together with antigen also 
enhances antigen-specific T cell responses (Umetsu et al., 2005). Interestingly, Tim1 
mAbs also show profoundly different effects on airway inflammation. A murine 
Tim1 mAb which recognises an epitope in the mucin domain can exacerbate airway 
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inflammation in a mouse model of asthma, but a murine Tim1 mAb mapping to the 
IgV domain can block inflammation in the same model (Sizing et al., 2007).  
In mammals, Tim4 is a natural ligand of Tim1. It is preferentially expressed 
on antigen presenting cells and plays a role in costimulation of activated T cells to 
proliferate through Tim1-Tim4 interaction (Meyer et al., 2005a). The crystal 
structure of the Tim4 IgV domain revealed a metal ion-dependent ligand binding site 
where phosphatidylserine (PS) binds (Santiago et al., 2007a). PS exposure is a 
marker for apoptotic cells. As a receptor for PS, Tim4 mediates the phagocytosis of 
apoptotic cells by macrophages or DCs to maintain the body’s homeostasis 
(Kobayashi et al., 2007). Tim4 also plays an important role in vivo as a mediator of 
tolerance. In vivo administration of Tim4 mAb, post-dexamethasone-induced 
apoptosis in the murine thymus, blocks binding of PS and results in the development 
of autoantibodies (Miyanishi et al., 2007). 
In this Chapter, the expression patterns of the chicken Tim mRNAs in various 
tissues and cell types will be studied using quantitative real-time RT-PCR (qRT-
PCR) to address if they are immune-related molecules and which cells express which 
molecules. The chTim fusion proteins generated and described in Chapter 3 will also 
be used to investigate chTim ligands and to study their potential roles in the 
phagocytosis of dead cells and costimulatory activity, as described for their 
mammalian counterparts.  
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4.2 Materials and Methods 
4.2.1 Measurement of chTim expression on tissue panel by qRT-PCR 
Primers and probes for qRT-PCR (Table 4.1) were designed using 
PrimerExpress software (Applied Biosystems). All probes were labelled with the 
fluorescent report dye 5-carboxyfluorescein (FAM) at the 5’ end and the quencher 
N,N,N,N’-tetramethyl-6-carboxyrhodamine (TAMRA) at the 3’ end. The primers 
were obtained from Sigma and the probes from Eurogentec. One-step Taqman assays 
were performed using the Reverse Transcriptase qPCR Master Mix kit (Eurogentec) 
according to the manufacturer’s instructions, except that 10 µl reactions were used. 
The specific products were amplified and detected using the ABI PRISM7700 
Sequence Detection System (Applied Biosystems) with the following thermal 
cycling profile: 48°C for 30 s, 95°C for 20 s, and then 40 cycles of 95°C for 3 s 
followed by 60°C for 30 s. Tissues were taken from a 6-week-old line 72 bird and 
total mRNA prepared with RNeasy mini kits (QIAGEN) including on-column 
digestion with DNase (QIAGEN). Each assay was performed in triplicate. The 
results are expressed in terms of the threshold cycle value (Ct), the cycle at which the 
change in the reporter dye passes a significance threshold (∆Rn). For variation 
caused by sampling and RNA preparation, the Ct value of 28S rRNA product from 
each individual RNA sample assay was used to standardise the Ct value of the target 
gene in the same RNA sample. To normalise the RNA levels between samples within 
an experiment, the mean Ct value of 28S product was calculated by pooling values 
from all samples in the same experiment. For standard curves, RNA isolated from 
HD11 cells stimulated by LPS, or COS-7 cells transfected with the cloned full-length 
cDNA in pCI-neo, was used as template for amplification. The threshold level was  
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Table 4.1. Primers and probes for qRT-PCR. 
set to the same value for each plate where a given gene was assayed. The following 
equation was used to calculate the adjusted Ct value (Nt): Nt = Ct + (S/S’) (Nt’-Ct’), 
where Nt is the adjusted value, S and S’ are the slopes of the standard curve semilog 
plots of Ct against loge (initial amount of RNA) for the chTim RNAs and 28S RNA, 
and Ct and Ct’ are respectively the Ct measurement for the chTim RNAs and 28S 
RNA in the samples. 
4.2.2 Binding of Tim protein to PS detected by dot-blot 
L-α-phosphatidylcholine (PC) from egg yolk, 3-sn-phosphatidylethanolamine 
(PE) from bovine brain, L-α-phosphatidylinositol (PI) ammonium salt solution from 
bovine liver and 3-sn-phosphatidyl-L-serine (PS) sodium salt from bovine brain were 





 Probe (FAM)-AGGACCGCTACGGACCTCCACCA-(TAMRA) 
 Forward primer  GGCGAAGCCAGAGGAAACT 




 Probe (FAM)-TGGCTTACAGGCCCCACAGTGTCG-(TAMRA) 
 Forward primer    TCCTGGACTGGATCCTTCTGA 





 Probe (FAM)-ACTGTAGCAACAGCACTGCCAGAGCCA-(TAMRA) 
 Forward primer    AGTTCTCTCTTGGCAGATGATGTG 





 Probe (FAM)-CCTGCCAGAGCCAACCACACTTCA-(TAMRA) 
 Forward primer    TCCCTCTTCCTGAAGCAACAG 





purchased from Sigma-Aldrich and dissolved in chloroform. Phospholipid binding 
assays on a nitrocellulose membrane were performed as previously described 
(Miyanishi et al., 2007). Each phospholipid solution (2 µg) was dotted onto the 
membrane strips, with PBS as a blank control, and air-dried at room temperature. 
After blocking the membrane with 1% casein/PBA for 1 h, the membranes were 
incubated for 1 h with COS-7 cell supernatants containing 1 µg/ml of chTim1-Ig or 
chTim4S-Ig fusion protein. The membranes were washed with PBST. Binding 
proteins were detected with HRP-conjugated goat anti-human IgG Ab (Southern 
Biotech) and developed with an ECL kit (GE Healthcare) as described in section 
2.6.3.  
4.2.3 Binding of Tim protein to PS detected by ELISA 
A solid-phase ELISA assay to test interactions between chTim proteins and 
phospholipids was carried out as previously described (Miyanishi et al., 2007). Each 
phospholipid stock solution was diluted in ethanol to a concentration of 2 µg/ml, and 
added to each well of a 96-well ELISA plate, 50 µl per well, and air-dried. The plate 
was blocked with 3% BSA/PBS (w/v) at 4°C overnight. The purified chTim1- or 
chTim4-Ig fusion protein was two-fold serially diluted in 1% BSA/PBS on the lipid-
coated plate. Each dilution was performed in triplicate wells, and incubated for 1 h at 
room temperature. The plate was washed with PBST, the bound protein was detected 
by adding 1 µg/ml of goat anti-human IgG Ab conjugated to HRP and peroxidase 
activity was detected with the substrate OPD, as described in section 2.6.1. 
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4.2.4 Phagocytosis assay 
Full-length chTim1 cDNAs, cloned in expression vector pcIneo, were 
transfected into NIH-3T3 cells using the Gene Pulser Xcell electrophoration system 
(Bio-Rad) with the pre-set programme for 3T3 cells, as described in section 2.7.2. 
Transfected cells, or untransfected cells as a control, were seeded at 1×10
3
 cells per 
well on a 4-well chamber slide (Sigma-Aldrich) and cultured for 48 h. Apoptotic 
cells were prepared by culturing chicken splenocytes with 50 µg/ml ConA for 6 h, 
and then mixing with with 4',6-diamidino-2-phenylindole (DAPI) solution (300 nM 
in PBS) for 5 min to label cell nuclei, following which labelled cells were washed 
twice with PBS. Apoptotic cells, 1×10
6
 cells per well, were added to 3T3 cells in the 
chamber slides and incubated for 30 min at 37ºC, 5% CO2. To remove non-
phagocytosed cells, the 3T3 cell layers were vigorously washed with PBS five times, 
and cells phagocytosed by the 3T3 cells were visualized with an ultraviolet 
microscope (Leica). 
4.2.5 Labelling the Ig fusion protein with fluorescent dye 
A fluorescent dye, Alexa fluor 647, was conjugated to recombinant Ig 
proteins using a Zenon Human IgG Labeling Kit (Invitrogen), according to the 
manufacturer’s instructions. Purified Ig protein solution (1 µg) was mixed with 5 µl 
labelling reagent, incubated for 5 min, and the reaction terminated by adding 5 µl 




4.2.6 PS inhibition of chTim4S protein binding to stimulated 
splenocytes 
Chicken splenocytes were isolated as described in section 2.3.5.1 and 
cultured in complete RPMI1640 medium supplemented with or without 3 µg/ml 
rchCD40L protein or 3 µg/ml ConA (Sigma-Aldrich) for 48 h as described in section 
2.3.5.4. PS was diluted in PBS and sonicated in an ultrasonic liquid processor 
(Misonix) at full power for 5 min to make up a 1.2 mg/ml (1.5 M) solution. The PS 
solution was then mixed with chTim4S-Ig at a ratio of 150 nmoles (0.12 µg) PS per 
µg protein in PBS containing 10% FCS, 2.5 mM CaCl2 for 1 h at room temperature 
to block the PS binding site. A chCTLA4-Ig fusion protein was included as a PS-
blocking control or an irrelevant Ig protein (human IgG Fc, R&D Systems) as a 
negative control. The blocked and unblocked recombinant proteins were then 
adjusted to 10 µg/ml with PBS containing 10% FCS, 2.5 mM CaCl2. These protein 
solutions were used to immunostain cultured splenocytes for flow cytometric 
analysis as described in section 2.10. A FTIC-conjugated goat anti-human IgG 
antibody (SouthernBiotech) was used to detect the bound protein on cells.  
4.2.7 Splenocyte costimulation assay  
Anti-chicken CD3 and CD28 antibodies (SouthernBiotech) were immobilized 
on a flat-bottomed 96-well tissue culture plate as described previously (Meyers et al., 
2005a). Briefly, CD3 and/or CD28 antibodies were diluted to 1.0 µg/ml in sterile 
PBS. The antibody solution, or PBS as controls, 50 µl per well, was added onto the 
plate and incubated for 3 h at 37ºC; the plate was then vigorously washed three times 
with sterile PBS to remove any unbound antibodies.  
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Chicken splenocytes were isolated as described in section 2.3.5.1 and 
adjusted to a density of 2.0×10
6
 cells/ml. The cell suspension (100 µl/well) was 
added to the antibody-coated plate with or without the addition of chTim4S-Ig fusion 
protein in different concentrations, with an irrelevant Ig protein (chBAFFR-Ig, a gift 
from Dr John Young, IAH, Compton, UK) as control. The cells were cultured at 
41ºC, 5% CO2. At 48 h of culture, the cells were pulsed with 1 μCi of [
3
H] thymidine 
per well for 16 h. Incorporation of [
3
H] thymidine [corrected counts per minute 
(c.c.p.m.)] was measured in a β-scintillation counter (Perkin Elmer). 
4.2.8 Sorting chicken splenocyte subsets with MACs cell sorter 
Spleens were taken from 6-week-old 72 line birds for isolation of splenocytes 
(section 2.3.5.1). The cells were sorted into different subsets using an autoMACS 
Separator (Miltenyi Biotec). As per manufacturer’s instructions, cells were labelled 
with magnetic microbeads (Miltenyi Biotec) prior to cell sorting. Briefly, for each 
magnetic labelling, 2×10
7
 cells were resuspended in 200 µl 1% BSA/PBS and 1 µg 
antibody added (mouse anti-chicken cell surface marker, SouthernBiotech), mixed 
thoroughly and incubated on ice for 20 min. The cells were washed three times with 
1 ml of PBS, pelleted and resuspended in 160 µl of running buffer (PBS containing 
0.5% BSA (w/v), 2 mM EDTA, 0.09% azide).  Magnetic microbeads (40 µl), 
coupled with goat anti-mouse IgG antibody, were then added to the cell suspension 
and mixed thoroughly. The cells were incubated on ice for 15 min to allow the beads 
to bind to the cells. After washing three times as before to remove unbound beads, 
the cells were then resuspended in 500 µl running buffer and transferred to a 15 ml 
Falcon tube for cell sorting on an autoMACS Separator with a positive separation 
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programme. The sorted cells were then pelleted again for total RNA preparation, as 
described in section 2.4. 
4.2.9 rchCD40L-stimulated adherent and suspension splenocytes  
Splenocytes were isolated a 6-week-old line72 bird, as described in section 
2..3.5.1, and incubated in complete RPMI 1640 medium at 37ºC, 5% CO2 for 3 h, as 
described in section 2.3.5.4. Resulted suspension cells were then transferred to new 
tissue culture flasks and cultured with or without the addition of 2 µg/ml rchCD40L 
for 72 h at 41ºC, 5% CO2; the adherent cells were also cultured in complete RPMI 
1640 medium (section 2.3.5.4) with or without the addition of 2 µg/ml rchCD40L for 
72 h at 41ºC, 5% CO2. 
4.3 Results 
4.3.1 Tissue mRNA expression patterns of chTim1 and chTim4  
The mRNA expression levels of chTim1 and chTim4 were measured in 
various tissue RNA samples by one-step qRT-PCR, as described in section 4.2.1. As 
shown in Figure 4.1A, chTim1 mRNA was present in high abundance in all the 
immune and non-immune organs tested, except for muscle. To detect chTim4, two 
sets of primers and probes were designed: one set, across exons 7 and 8, should 
detect all the chTim4 isoforms except for chTim4eS; another set, across exons 3, 4 
and 5, should detect chTim4eL, chTim4L and chTim4eS. As shown in Figure 4.1B, 
analysis with the first set of qRT-PCR reagent indicated that chTim4 is abundantly 
expressed in all immune and non-immune tissues tested, except for muscle. In 




















Figure 4.1.  Quantification of chTim mRNA in various tissues, as measured by real-
time RT-PCR, with results expressed as corrected 40-Ct. (A) chTim1, (B) chTim4S 







spleen, bursa of Fabricius and the thymus at low levels (Figure 4.1C), suggesting the 
chTim4 isoforms containing exons 3 and 4 (chTim4eL, chTim4L and chTim4eS) are 
either not expressed or expressed at levels below the sensitivity of the assay in most 
tissues. By contrast, qRT-PCR across exons 7 and 8 detected high levels of chTim4 
expression in these tissues, suggesting abundant chTim4S expression in these tissues.  
4.3.2 mRNA expression patterns of chTim1 and chTim4 in immune 
cells 
qRT-PCR analysis of various chicken tissues revealed chTim mRNAs were 
highly expressed in the spleen (Figure 4.1). To determine which cell subsets in the 
spleen express chicken Tim mRNAs, a set of RNAs (kind gifts from Dr Zhiguang 












 cells, isolated by 
positive selection from the spleens of 6-week-old inbred line 72 chickens, were 
examined by qRT-PCR. A set of RNAs from APCs (a kind gift from Dr Zhiguang 
Wu) was also analysed for chTim expression, including bone marrow-derived DCs, 
peripheral blood-derived macrophages, LPS- or rchCD40L-stimulated DCs or 
macrophages (for 24 h) prepared as described before (Wu et al., 2010a). In splenic 




 cells express chTim mRNAs at 




 cells and no 




 cells. APCs also express all chTims, but 
there was no detectable expression of those chTim4 isoforms containing exons 3 and 
4 (chTim4eL, chTim4L and chTim4eS) in peripheral blood derived-macrophages 



















Figure 4.2.  Quantification of chTim mRNA in various immune cell subsets, as 
measured by qRT-PCR, with results expressed as corrected 40-Ct. (A) chTim1, (B) 
chTim4S and (C) chTim4L. Dashed lines show the chTim expression levels in CD4
+
 







To confirm the qRT-PCR findings and to attempt to distinguish expression of 
the different isoforms, chTim4 mRNA expression was reanalysed by RT-PCR using 
a new panel of RNAs, which were prepared from various splenocyte subsets from 6-







CD8β+, TCR1+, TCR2+, Bu-1+ and KUL01+ cells. RNAs from rchCD40L-stimulated 
adherent and suspension splenocytes (section 4.2.9) were also included to see if 
stimulation varied expression of chTim4 isoforms. All RNAs, 1µg per sample, were 
then reversely transcribed into cDNAs (section 2.5.1) which were then used as 
templates to amplify full-length chTim4 cDNAs with the primers Tim4-F1/R1, as 
described in section 3.2.1. As shown in Figure 4.3, T cells (CD3
+

















 cells express low or undetectable levels of chTim4 
mRNA. These results are consistent with the previous qRT-PCR analysis of the cell 
panel (Figure 4.2), and suggest that chTim4S is the constitutive isoform expressed by 
immune cells. By contrast, all cultured adherent and suspension splenocytes 
preferentially expressed chTim4L mRNA (Figure 4.3).  
4.3.3 Distribution of chicken Tim ligands on splenocytes 
To investigate the contribution of different parts of the chicken Tim molecule 
in binding to potential receptors, recombinant fusion proteins, containing only the 
IgV domain, only the mucin domain or the entire extracellular domain of chTim1 or 
chTim4S, with a human IgG Fc tag, were expressed from transiently transfected 








                             
 
Figure 4.3.  RT-PCR analysis of chTim4 expression in various splenic cell types. 
Total RNA was extracted from sorted splenocyte subsets, as well as stimulated or 
unstimulated adherent and suspension splenocytes. Full length chTim4 cDNAs were 
amplified by RT-PCR with the primers Tim4-F1/R1. 1 = TCR1
+
, 2 = TCR2
+
, 3 = 
rchCD40L-stimulated adherent cells, 4 = non-stimulated adherent cells, 5 = non-





, 9 = CD8α
+
, 10 = CD8β+, 11 = Bu-1+, 12 = KUL01+. M = TrackIt™ 1 Kb 
Plus DNA Ladder (Invitrogen). 
 
shown in Figure 4.4A, flow cytometric analysis indicated that the Tim1-IgV and -
mucin fusion proteins have no detectable staining on splenocytes, while the chTim1-
extracellular-Ig fusion protein had a slight, but increased binding when compared to 
controls (human IgG Fc, R&D Systems). This suggests that the splenic cell 
population expressing the chTim1 receptor is small in number. Similarly, the 
chTim4S-mucin domain fusion protein did not bind to splenocytes (Figure 4.4B). By 
contrast, the chTim4S-IgV-Ig fusion protein positively stained a population of 
splenocytes. A larger population was stained by the entire Tim4S-extracellular-Ig 
fusion protein (Figure 4.4B). These binding patterns are consistent with those of 
mammalian Tim4, where the IgV domain possesses the ligand binding site and high 
affinity binding requires both the IgV and mucin domains (Silberstein et al., 2001; 
2003; Meyers et al., 2005a; Santiago et al., 2007a; 2007b). 
 






















Figure 4.4. Splenocytes were stained with recombinant fusion proteins of chTim1 or 
chTim4S. (A) Splenocytes were stained with human IgG1 Fc (filled histogram), 
chTim1-IgV domain (dashed line), chTim1-mucin domain (dotted line) and chTim1 
entire extracellular domain (solid line). (B) Splenocytes were stained with human 
IgG Fc (filled histogram), chTim4S-IgV domain (dashed line), chTim4S-mucin 
domain (dotted line) or chTim4S entire extracellular domain (solid line). The 
detecting Ab was a goat anti-human IgG-FITC. The flow cytometric results here 





4.3.4 Upregulation of chTim4S ligand expression on stimulated 
splenocytes  
Ligands of the chTim molecules, presumably chTim1, chTim4 and/or PS, are 
expressed on splenocytes, as shown by flow cytometric analysis using the 
recombinant chTim fusion proteins (Figure 4.4). To address if these ligands are 
regulatively or constitutively expressed on splenocytes, splenocytes were stimulated 
with rchCD40L for B cell, or ConA for T cell, proliferation. The expression levels of 
the chTim4S ligand(s) were measured by flow cytometric analysis, immunostaining 
the cells with recombinant chTim4S-Ig fusion protein and anti-chicken Bu-1 or CD3 
antibodies. As shown in Figure 4.5A, stimulation with rchCD40L resulted in a higher 
frequency of Bu-1
+
 splenocytes when compared with non-stimulated splenocytes, 
suggesting rchCD40L stimulation successfully enhanced B cell activation and 
proliferation.  




 cells was also increased when 
compared with non-stimulated splenocytes, suggesting rchCD40L-stimulated B cells 
upregulated expression levels of the chTim4S ligand(s). Similarly to rchCD40L 





 cells when compared with non-stimulated splenocytes, as shown in 
Figure 4.5B, suggesting ConA stimulation could also induce upregulated expression 
levels of the chTim4S ligand(s) on activated T cells. 
4.3.5 PS is a ligand of the chTim proteins, as analysed by dot-blot and 
ELISA 




















Figure 4.5. The ligands of Tim4S were upregulated after stimulation, as measured by 
flow cytometry. Splenocytes were cultured with or without (A) rchCD40L or (B) 
ConA for 48 h. The cells were stained with Tim4S-Ig fusion protein, or human IgG1 
Fc as negative control, conjugated to Alexa fluor 647, and either anti-Bu-1-FITC (A) 
or anti-CD3-FITC (B) mAbs. The flow cytometric results here represent one 
































predicted aa sequences of chTim1 and chTim4S contain a conserved PS-binding site 
(Santiago et al., 2007a; 2007b; Kobayashi et al., 2007). To test whether this predicted 
site in the chicken is functional, the interaction of chTim1 or chTim4S with PS was 
examined by a protein-phospholipid overlay assay as described in section 4.2.2. 
Various phospholipids were dotted on nitrocellulose membranes and the chTim 
fusion proteins were used to probe them. As shown in Figure 4.6, the chTim1-Ig and 
chTim4-Ig fusion proteins specifically bind to PS but not to the other phospholipids, 
except for slight binding to PE by chTim4S.  
To confirm if PS is a ligand of chTim4S and chTim1, solid-phase ELISA was 
performed on phospholipid-coated plates as described in section 4.2.3. As the results 
show in Figure 4.7, the chTim1- and chTim4-Ig fusion proteins displayed dose-
dependent binding to PS with only background levels to the other phospholipids 
tested.  
4.3.6 ChTim4S-Ig recognises PS exposed on the surface of apoptotic 
chicken cells 
The protein-phospholipid overlay studies demonstrated that chTim1 and 
chTim4 specifically bind to PS and not to other phospholipids (Figures 4.6-4.7). 
Stimulation of chicken splenocytes also revealed that ConA and rchCD40L could 
upregulate the expression levels of chTim4S ligands on the cell surface (Figure 4.5). 
It seems a reasonable hypothesis that cell death is inevitable during culture, leading 
to PS exposure on the cell surface. To investigate this, splenocytes were cultured 
with a high dose of ConA (50 µg/ml) for 6 h to mimic activation-induced cell death 













Figure 4.6. Dot-blot analysis of interaction of chTim1-Ig and chTim4S-Ig fusion 
proteins with phospholipids. Each phospholipid was dotted onto nitrocellulose 
membrane strips, with PBS as negative control. COS-7 cell supernatants containing 
either chTim1-Ig or chTim4S-Ig fusion proteins were incubated with the membranes. 
Binding of fusion protein was detected with an HRP-conjugated goat anti-human IgG 
antibody. The HRP activity was detected with an ECL kit. PC = Phosphatidylcholine, 





















Figure 4.7. Solid phase ELISA assays of interactions of chTim1-Ig and chTim4S-Ig 
with PS. Phospholipids tested were coated on ELISA plates and purified recombinant 
(A) chTim1- and (B) chTim4S-extracellular-Ig fusion proteins were 2-fold serially 
titrated on the plates. The bound Ig fusion proteins were probed with an HRP-
conjugated goat anti-human IgG antibody. An OPD substrate was used to detect HRP 
activity. Error bar represents the standard error in triplicate wells of each dilution. PC 
= Phosphatidylcholine, PE = phosphatidylethanolamine, PI = phosphatidylinositol, 











































cells or FITC-conjugated annexin V, a receptor of PS, which is normally used to 
detect PS exposure on dying and dead cells (Kobayashi et al., 2007). The resultant 
staining was then analysed by flow cytometry, as shown in Figure 4.8. PI staining of 
ConA-stimulated splenocytes clusters into two clear populations with bright and less 
bight staining, the former indicating dead cells and latter live cells (Figure 4.8A). PI 
staining was consistent with analysis of the forward scatter (FSC) versus side scatter 
(SSC) plot (Figure 4.8B), which is normally used to analyse dead cells in the whole 
population because condensation of dead cells during apoptosis results in reduced 
distribution of them in forward scatter and thereby live and dead cells cluster 
separately in forward and side scatter respectively. The result of annexin V staining 
was also consistent with PI staining, where an even larger population of ConA-
stimulated cells were positively stained by annexin V than that of PI staining, 
because early apoptotic cells are annexin V positive but PI negative (Kobayashi et 
al., 2007). The analysis of ConA-stimulated splenocytes suggested that in vitro 
stimulation of chicken splenocytes could induce the cell death. 
Therefore, to analyse other potential ligands of Tim4S on the cell surface but 
avoid any effects of PS, the chTim4S-Ig fusion protein was pre-blocked with PS. PS-
blocked chTim4S-Ig was then used to determine if it could bind another ligand on 
ConA- or rchCD40L-stimulated splenocytes. A rchCTLA4-Ig fusion protein, which 
binds to its ligands CD80 and CD86 on activated splenocytes, was used as PS- 
blocking control. The resultant interactions between chTim4 and its ligand(s) were 
analysed by flow cytometry. As shown in Figure 4.9, the cells were gated into 
different populations, including dead and live cells, in forward versus side scatter 














Figure 4.8. PS exposure on apoptotic chicken splenocytes. Splenocytes were cultured 
with high-dose ConA for 6 h, followed by PI staining. (A) dead cells with bright PI 
staining and live cells with no PI staining were gated and their percentages 
calculated; (B) The previously gated dead cells (in red) and live cells (in blue) were 
analysed by FSC vs SSC plot again, indicating that dead and live cells are separately 
clustered along SSC or FSC. (C) FITC-labelled annexin V staining of ConA-
stimulated splenocytes show in blue, unstained cells as control in dotted line.  Marker 
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Figure 4.9. ChTim4S recognises PS exposed on apoptotic splenocytes. Splenocytes 
were cultured alone (A) or with ConA (B) or rchCD40L (C) for 48 h. In the left-most 
panels, red represents unstained cells, blue shows annexin V-FITC staining and green 
shows chTim4S-extracellular-domain IgFc fusion protein staining. The cells were 
then stained (left column of histograms) with Tim4S-extracellular-domain IgFc 
fusion protein (black lines), the same protein pre-incubated with PS for 1 h (orange 
lines) or IgFc fusion protein alone as a negative control (filled histogram). Cells were 
also stained similarly, but with rchCTLA4-extracellular-domain IgFc fusion protein, 
as another negative control (right column of histograms). Binding was detected with 
a rabbit anti-human IgG-FITC polyclonal antibody. Different cell populations were 
gated by side and forward scatters. For each treatment, the top panel of histograms 
show dead cells. The middle and bottom panels are live cells; the former were highly 
stimulated and latter were less stimulated. The flow cytometric results here represent 
one experiment of four repeats. 
compared, plotting overlaid histograms (Figure 4.9). 
 With unstimulated splenocytes (Figure 4.9A), live cells did not stain with 
chTim4S (and therefore pre-incubation of chTim4S with PS had no discernible 
effect). Dead cells, on the other hand, stained strongly with chTim4S and this 
staining was largely ablated following pre-incubation of chTim4S with PS. For 
ConA-stimulated cells (Figure 4.9B), both live and dead cells stained with chTim4S 
(with dead cells staining more strongly) and again, pre-incubation of chTim4S with 
PS largely ablated this staining. A similar pattern of staining was seen following 
chCD40L stimulation (Figure 4.9C), in all three populations of cells (dead, live and 
early apopototic). 
 Staining with chCTLA4 or chCTLA4 pre-incubated with PS gave essentially 
identical patterns. For dead cells, in all cases, and unstimulated live cells, these 
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patterns were the same as those with the negative control IgFc fusion protein. In the 
live cells following ConA and chCD40L stimulation, staining with chCTLA4 
identified a positive population of splenocytes, as would be expected 48 h post- 
stimulation, but these patterns were not altered by pre-incubation of chCTLA4 with 
PS. 
4.3.7 Phagocytotic activity mediated by chicken Tim molecules 
 The mammalian Tim molecules enhance phagocytotic activity through 
recognition of PS exposed on the surface of dead cells (Kobayashi et al., 2007; 
Miyanishi et al., 2007; Santiago et al., 2007a; 2007b). To investigate if the chicken 
Tim molecules have the same phagocytotic function, full-length chTim cDNAs in 
expression vectors were transfected into NIH-3T3 cells to allow the proteins to be 
overexpressed on the surface of these cells. ConA-induced apoptotic cells, labelled 
by DAPI, were then mixed with the transfected 3T3 cells to detect chTim-mediated 
phagocytosis, as described in section 4.2.4. The ultra-violet microscopy results, as 
shown in Figure 4.10, indicate that 3T3 cells transfected with full-length chTim1, 
chTim4S and chTim4L phagocytosed more dead cells, with more blue fluorescent 
dots on the 3T3 cell background imaged with differential interference contrast (DIC), 
than untransfected 3T3 cells that only had very rare dead cells. 
4.3.8 Chicken Tim4S has costimulatory activity on T cells 
 Murine Tim4 costimulate T cell proliferation mediated by anti-CD3 and -
CD28 antibodies in vitro (Meyers et al, 2005a). To determine if chicken Tim4S 
shows similar costimulatory activity, chicken splenocytes were cultured on plates 















Figure 4.10. Chicken Tim molecules mediate phagocytosis of dead cells. NIH-3T3 
cells were transfected with or without full-length chTim1, chTim4S and chTim4L 
cDNAs. 48 h post-transfection, the high-dose ConA-induced apoptotic cells, labelled 
by DAPI, were incubated with transfected 3T3 cells for 30 min, and then non-
attached cells were washed off. The images were taken through a UV microscope. 
The bright blue fluorescent dots, shown by arrowheads, show apoptotic cells taken 







chTim4S-Ig fusion protein in the growth medium. The cells were then pulsed with 
[
3
H] thymidine after 48 h, as described in section 4.2.7. As shown in Figure 4.11, the 
chTim4S-Ig fusion protein or anti-CD3 or -CD28 antibodies alone have no effect on 
cell proliferation. As expected, anti-CD3 and anti-CD28 stimulated proliferation of 
splenocytes. The addition of chTim4S-Ig fusion protein stimulated further 
proliferation. 
 To prove that costimulation was due to chTim4S and not the Ig tag, an 
irrelevant Ig fusion protein (human IgG1 Fc) was used as a control in a similar 
proliferation assay. As shown in Figure 4.12, chTim4S-Ig induced cell proliferation, 
while the Ig controls had no effect. 
4.4 Discussion 
 The qRT-PCR results revealed that the transcription patterns of the chicken 
Tim mRNAs are different from those of their mammalian counterparts in the tissues 
tested. Mammalian Tim1 and Tim4 are described as immune-related molecules, 
highly expressed in lymphoid organs, but with no detectable expression in non-
lymphoid tissues, except for high Tim1 expression in the kidney (Umetsu et al., 
2005). Chicken non-immune tissues, on the other hand, also highly express chTim1 
and chTim4S. In part, this may be explained by the fact that the chicken immune 
system does not have lymph nodes. Instead, the chicken develops diffuse lymphoid 
aggregates in organs (Michael et al., 1974). The chicken spleen contains 
heterogeneous cell subsets, predominantly resting T and B cells, but also a low 
number of macrophages and DCs. The chicken thymus mainly contains naïve T cells, 





Figure 4.11. Chicken Tim4S-Ig protein costimulates splenocyte proliferation, as 
measured by [
3
H] thymidine incorporation. Chicken splenocytes from line 72 birds 
were cultured with or without the addition of Tim4S-Ig fusion protein for 48 h on 
plates pre-coated with or without anti-chicken CD3 and/or CD28 antibodies. 1, cells 
only; 2, CD3; 3, CD28; 4, 1 µg/ml protein, 5, 2.5 µg/ml protein; 6, 5 µg/ml protein; 
7, CD3+CD28; 8, CD3+CD28+1 µg/ml protein; 9, CD3+CD28+2.5 µg/ml protein; 
10, CD3+CD28+5 µg/ml protein. Figure shows means and standard errors in 
triplicate wells of each treatment. Pairwise comparison analyses, as linked by lines, 
were carried out by student t test and the P values labelled above lines. CD3+CD28 
treatment (7) were compared with cells alone (1), or CD3 (2), CD28 (3) alone or 
different concentration of fusion protein (4-6) with all p values less than 0.05. The 





Figure 4.12. Re-analysis of chTim4S-Ig protein bioactivity in costimulation of 
splenocyte proliferation as measured by [
3
H] thymidine incorporation. Chicken 
splenocytes were cultured with or without addition of Tim4S-Ig fusion protein for 48 
h, with an irrelevant Ig protein (human IgG Fc) as negative control, on plates pre-
coated with anti-chicken CD3 and CD28 antibodies. Figure shows the means and 
standard errors in triplicate wells of each treatment. Pairwise comparison analyses, as 
linked by lines, were carried out by student t test and P values labelled above lines. 







cells. The mRNA of exons 3 and 4-containing chTim4 isoforms (chTim4eL, 
chTim4L and chTim4eS) can be detected in thymus (Figure 4.1), suggesting that 
they are expressed by naive T cells but at very low level. Their mRNAs were also 
measured at similar expression levels in the bursa of Fabricius and spleen (Figure 





 T cells and DCs expressed low levels of the chTim mRNAs, 
but they were abundantly present in TCR1
+
 T cells, B cells and macrophages (Figure 
4.2). The mRNA expression patterns of chTim1 on immune cells is consistent with 





 T cells (Mesri et al., 2006; Khademi et al., 2004), but constitutively 
expressed in splenic B cells (Sizing et al., 2007) and DCs (Xiao et al., 2011). By 
contrast, chTim1 is expressed at highest levels in chicken TCR1
+
 T and Bu-1
+
 B 
cells, suggesting it may have more important roles in these cell subsets than in other 
cells. Blood monocyte-derived chicken macrophages also expressed chTim1 mRNA 
at high levels. Whether this expression pattern reflects a role of chTim1 on 
macrophages to mediate phagocytosis of dead cells requires further elucidation. 





), at low level in splenic B cells (B220
+
), but 
has very low or undetectable expression in murine T cells (CD3
+
) (Meyers et al., 
2005a). Murine Tim4 mRNA is also expressed in peritoneal macrophages and LPS-
matured murine DC generated from bone marrow with Flt3L, but not in immature 
DC (Miyanishi et al, 2007; Meyers et al., 2005a). Chicken Tim4 (predominant 
chTim4S) has a similar mRNA expression pattern to that of mammalian Tim4 - low 




 T cells, but high expression levels in 
157 
 
macrophages (Figure 4.2B). Immature bone marrow-derived DCs induced with 
rchGM-CSF and rchIL-4 also expressed chTim4 mRNA, but at low levels, and there 
was no obvious variation in chTim4 mRNA expression between immature and 
mature DCs (Figure 4.2B, C), different to what was seen in mice, possibly reflecting 
the different culture methods. Consistent with qRT-PCR analysis in the tissue panel 
(Figure 4.1C), chTim4 mRNA isoforms containing exons 3 and 4 (chTim4eL, 
chTim4L and chTim4eS) were also expressed by different chicken immune cells 
from the spleen at low levels (Figure 4.2C). Interestingly, these chTim4 isoforms 
were not expressed by blood monocyte-derived macrophages under any conditions; 
by contrast, chTim4S was expressed at high levels in these cells and expression 
levels varied with different stimulation, such as downregulation with LPS 
stimulation, but upregulation with rchCD40L stimulation (Figure 4.2B), suggesting 
chTim4S is the predominant isoform present in blood monocytes or monocyte-
derived macrophages.  Splenic Bu-1
+
 cells had the highest levels of chTim4 
expression, suggesting that chTim4 may have a more important role in B cells than in 
other APCs.  The expression of chTim4 at the protein level in chicken APCs will be 
further studied using mAb immunostaining in Chapter 6. 
It is not clear why splenic TCR1
+
 cells also express chTim4 and chTim1 
mRNA at high levels (Figure 4.2). Chicken splenic TCR1
+
 cells are γδ T cells which 





. When they migrate into the spleen and intestine, two thirds of 





 T cells are abundantly present among splenocytes, the splenic CD8
+
 T 
cells had low levels expression of chTim1 and chTim4 (Figure 4.2), suggesting that 
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splenocytes are αβ T cells, but expression of chTim1 and chTim4 mRNAs could not 
be detected in these T cells (Figure 4.2), suggesting they may not be involved in 
chTim4-associated functions, at least in naïve or resting stages.  
Splenic TCR2
+
 T cells did not express chTim4 mRNA, which was also 
demonstrated by RT-PCR in a new panel of sorted splenic subsets (Figure 4.3). 
Consistently, CD4
+





), B cells (Bu-1
+
) and macrophages (KUL01
+
) in the spleen 
expressed high levels of chTim4S (Figure 4.3). By contrast, chTim4L was expressed 
only by cultured and activated splenic splenocytes (Figure 4.3). Both qRT-PCR and 
RT-PCR analysis consistently indicated that chTim4S is predominantly expressed in 
normal immune tissues and cells (Figures 4.2-4.3), suggesting chTim4S is a 
constitutive form of chTim4 and may be homologous to mammalian Tim4.  
Chicken Tim ligands expressed on splenocytes were detected with chTim-Ig 
fusion proteins (Figure 4.4). The chTim1- or chTim4S-IgV domains contain the 
ligand binding sites as they bound but the mucin domains have no detectable binding 
sites, as they did not bind. However,  IgV + mucin domain bound more strongly than 
the IgV domains alone, suggesting that the chTim IgV domains play critical roles in 
binding to the receptor(s), whereas the mucin domains have no specific ligand but act 
to enhance the binding affinity.  
The chTim4S-Ig fusion protein was also used to study expression of its ligand 
on chicken splenocytes after stimulation.  Flow cytometric analysis (Figure 4.5) 
revealed dramatic upregulation of chTim4S ligands on ConA- or rchCD40L-
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stimulated splenocytes. Similar results were also seen for murine Tim4, where Tim4 
ligand expression on activated splenic cells led to the hypothesis that Tim1 is a 
natural ligand of Tim4, which was eventually demonstrated with studies showing 
that Tim4-Ig fusion protein bound to full-length Tim1-transfected CHO cells and that 
the Tim4-Tim1 interaction can be blocked with an anti-Tim1 mAb (Meyers et al., 
2005a). 
  Phosphatidylserine (PS) was also found to be a ligand of murine Tim4. The 
crystal structure of the murine Tim4-IgV domain identified a metal-ion-dependent 
ligand binding site (MILIBS). PS penetrates into the MILIBS and co-ordinates with 
the metal ion (Santiago et al., 2007a). Tim4 bound to PS mediated uptake of 
apoptotic cells, but mutations in this site eliminated PS binding and phagocytosis 
(Kobyashi et al., 2007). The chicken Tim1 and Tim4 molecules also contain this 
conserved PS binding site, which suggests that the chicken Tim molecules may play 
roles in the phagocytosis of dead cells. To test this hypothesis, the chTim1- and 
chTim4S-Ig fusion proteins were used to hybridise with different phospholipids on a 
solid phase. The protein-phospholipid overlay assays (Figures 4.6 and 4.7) 
demonstrated that chTim fusion proteins specifically bind to PS, but not to other 
phospholipids. In quiescent cells, PS is restricted to the inner plasma-membrane 
leaflet. But apoptotic, injured, infected, senescent or necrotic factors can cause PS 
externalisation to the outer leaflet. Activation stimuli can  also induce PS exposure 
on different immune cells, such as stimulated B cells after anti-IgM cross-linking 
(Dillon et al., 2000), T cells stimulated with protein melan-A, known as melanoma 
antigen recognized by T cells (Fischer et al., 2006) and mitogen-activated master 
cells (Smrz et al., 2007). PS exposure strongly depends on the amount of presented 
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antigen. This raised the question, which ligand is upregulated on stimulated chicken 
splenocytes, chTim1, PS or both? To identify the potential ligand but avoid the PS 
effect, chTim4S-Ig fusion protein was pre-incubated with PS and then added to 
stimulate chicken splenocytes for flow cytometric analysis again. As per the previous 
observations, the chTim4S-Ig protein bound to most dead and activated cells. After 
PS blocking there was no detectable binding of chTim4S-Ig to cells, suggesting PS is 
predominantly exposed on activated splenic cell surfaces, whereas any other 
potential ligand may be expressed at very low levels, or PS blocking binding, or PS 
causes conformational change. 
Hoffmann et al. (2001) proposed a two-step model of phagocytosis, where in 
first step apoptotic cells and phagocytes are bridged through interaction between PS 
and its receptors; for example, Tim4 catches apoptotic cells by recognizing PS. A 
putative co-receptor (for signal transduction) is coupled to Tim4 to activate the 
integrin αvβ3 complex to initiate uptake, in which milk fat globule epidermal growth 
factor VIII (MFG-E8) binds to PS on apoptotic cells and to the activated integrin 
αvβ3 complex on the phagocytes. The signal from the integrin αvβ3 complex then 
activates the macrophages’ internalisation of apoptotic cells into lysosomes. This 
final step is mediated by Rac1, Rab5, and other, as-yet-unidentified molecules. 
  To determine if this model applies in the chicken, it is essential to address if 
the interaction between chicken Tim molecules and PS enhances phagocytosis. An in 
vitro phagocytosis model (well-studied in mammalian Tim molecules), NIH-3T3 
cells overexpressing chTim protein as phagocytes, was used to detect chTim 
molecule-mediated phagocytosis.  As analysed by flow cytometry after annexin V 
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and PI staining (Figure 4.8), the apoptotic chicken splenocytes exposed PS on their 
cell surface after high-dose ConA stimulation. When these apoptotic cells were 
mixed with 3T3 cells transfected with full-length cDNAs of chTim1, chTim4S and 
chTim4L (Figure 4.10), the transfected 3T3 cells phagocytosed more apoptotic cells 
than untransfected cells. Although it is not known to what extent the previous qRT-
PCR data for different chicken cells reflects their expression at the protein level, the 
binding of chTim1 and chTim4S to PS suggests they play crucial roles in the 
phagocytosis of dead cells by macrophages and DCs. qRT-PCR indicated that the 
chTim mRNAs were highly expressed by γδ T cells (TCR1
+
). The biological 
function of these cells is unclear, but they are clearly capable of cytotoxic activity in 
vitro (Chen et al., 1994). The expression of chTim molecules on chicken γδ T cells 
may help capture apoptotic or infected cells through recognition of PS, and facilitate 
cytotoxic activity. 
Administration of murine Tim4-Ig fusion protein in vivo with antigen 
produces increased basal T cell proliferation and enhanced production of IL-2 and 
IFN-γ (Meyers et al., 2005a). Several in vitro studies also indicate that Tim4-Ig can 
play bilateral roles in T cell proliferation. In the presence of anti-CD3 and -CD28 
antibodies for pre-activation of naïve T cells, Tim4-Ig induced dramatically higher 
levels of proliferation and cytokine production than those stimulated with a control 
protein, as well as an increased phosphorylation of Tim1. Tim4 was therefore 
defined as a costimulatory molecule that promotes T cell expansion and survival by 
cross-linking Tim1 on activated T cells (Meyers et al., 2005a, Rodriguez-Manzanet 
et al., 2008). By contrast, murine Tim4-Ig inhibited the proliferation of naïve T cells, 
on which there is very low or no Tim1 expression. It was supposed that Tim4-Ig 
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suppressed the naïve T cell proliferation by binding to an unknown ligand (Mizui et 
al., 2008). The chicken Tim4S-Ig fusion protein induced splenocyte proliferation in 
the presence of anti-chicken CD3 and CD28 antibodies (Figures 4.11 and 4.12). 
Although it is not determined which T cell subset(s) proliferated, this result suggests 
that the chicken Tim4S molecule has a function in the regulation of T cell immune 
responses. 
It has been demonstrated in this Chapter that chTim molecules have a potent 
physiological role in the phagocytosis of apoptotic cells by their interaction with PS. 
The chTim4S-Ig fusion protein also showed costimulatory activity in enhancement 
of splenocyte proliferation. To determine in more detail how these roles are fulfilled, 
it is essential to know the expression patterns of the chTim molecules on chicken 
primary cells. Therefore, anti-chTim mAbs will be generated and characterised in 
Chapter 5, and specific expression of chTim proteins on chicken immune cells will 

















Chapter 5.    Generation and characterisation of anti-chicken 
Tim antibodies. 
5.1 Introduction 
In mammals, Tim1 has a wide variety of physiological and pathological 
functions, such as being a marker of acute kidney injury (Kim-1) reflecting ischemic 
kidney injury (Ichimura et al., 1998), and a receptor for the hepatitis A virus 
(HAVCR-1) associated with its invasion (Silberstein et al., 2003). Allergy, atopic 
and autoimmune diseases also have a strong association between expression levels of 
Tim1 and disease development (Meyers et al., 2005b). Tim1 is preferentially 
expressed on activated Th2 T cells, but not on naïve T cells, acting as a positive 
regulator in Th2 cell immune responses (Umetsu et al., 2005; de Souza et al., 2005). 
Cross-linking Tim1 using an agonistic anti-Tim1 antibody (3B3) can costimulate 
Th2 cells to proliferate and increase IL-4 production in the presence of anti-CD3 and 
-CD28 antibodies (Umetsu et al., 2005). The costimulatory effects of Tim1 on T cells 
suggest the possibility of targeting Tim1 to develop novel prophylactic and/or 
therapeutic vaccination strategies. An anti-Tim1 mAb used as an adjuvant with an 
influenza vaccine enhanced antigen-specific lymphocyte proliferation, IFN-γ 
production and cross-virus strain reactivity (Soo Hoo et al., 2006). However, cross-
linking of Tim1 can also have inhibitory activities. Another Tim1-specific mAb 
(RMT1-10), sharing an overlapping epitope in the IgV domain with 3B3 but with 
low avidity, decreased antigen-specific CD4
+
 T cell expansion and production of 
IFN-γ and IL-17 by these cells (Xiao et al., 2007). In treatment of experimental 
autoimmune encephalomyelitis (EAE), a mouse model of human multiple sclerosis 
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(MS), administration of RMT1-10 ameliorated antigen-induced EAE, suggesting an 
antagonistic anti-Tim1 antibody may have beneficial effects against human MS. 
However, in the same experiment, the previously agonistic mAb 3B3 exacerbated 
EAE, suggesting the epitope and strength of antibody should be carefully considered 
if anti-Tim1 antibodies are to be used for immunotherapy (Xiao et al., 2007). 
Activating/blocking activities of anti-Tim1 mAbs were also independently 
demonstrated by another group in a study of antigen-induced asthma (Sizing et al., 
2007). Two anti-Tim1 antibodies, against different epitopes in the IgV (4A2.2) and 
mucin domains (3A2.5), had inhibitory activity on antigen-induced lung 
inflammation and caused a large reduction in Th2 cytokine production (Seizing et al., 
2007). However, in the same experiment, in vivo administration of another two anti-
Tim1 antibodies (5D1.1 and 1H8.2), both which recognise epitopes which mapped to 
the mucin domain, significantly enhanced lung responses to antigens and increased 
expression of Th2 cytokines in ex vivo re-stimulation (Seizing et al., 2007). All this 
evidence suggests that Tim1 plays reciprocal roles in the regulation of Th2 immune 
responses.  
In attempts to identify a Th1-specific cell surface protein, Th1 cell clones and 
lines were used to immunise mice. Two mAbs from 20,000 tested selectively stained 
Th1 but not Th2 cells. A target antigen, Tim3, was eventually identified as being 
specifically expressed on the surface of Th1 cells (Monney et al., 2002). Tim3 plays 
a negative role in the regulation of Th1 cell responses. In vitro addition of a Tim3 
ligand, galectin-9, induced Tim3-dependent Th1 cell death but not that of Th2 cells 
(Zhu et al., 2005). In vivo administration of galectin-9 also downregulated Th1 
immune responses (Zhu et al., 2005). Tim3 is also expressed on DCs and 
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macrophages and synergises with TLRs to regulate innate immunity (Anderson et al., 
2007).  Chronic HIV and HCV co-infections impaired Th1 and cytotoxic CD8
+
 T 
cell immune responses with high level expression of Tim3 and programmed cell 
death 1 (PD-1) on the cell surface. However, ex vivo addition of an anti-Tim3 mAb, 
which functionally blocks the interaction between Tim3 and its ligand, to PBMC 
cells isolated from these infected patients, rescued Th1 and cytotoxic CD8
+
 T cell 
immune responses and IFN-γ production (Vali et al., 2010).  
In a library of hamster mAbs generated against mouse peritoneal 
macrophages, a single mAb strongly inhibited the PS-dependent engulfment of 
apoptotic cells, and this antigen was eventually identified as the murine Tim4 
molecule. It has been well-documented that Tim4 is a receptor for PS and plays a 
role in the enhancement of dead cell clearance (Miyanishi et al., 2007). Tim4 is also 
a natural ligand of Tim1. Ex vivo administration of a Tim4-Ig fusion protein in the 
presence of anti-CD3 and -CD28 mAbs can stimulate T cell proliferation, suggesting 
a costimulatory activity derived from the Tim4-Tim1 interaction (Meyers et al., 
2005a). However, Tim4-Ig fusion proteins can also bind to naïve T cells, which do 
not express Tim1, and inhibit activation of these cells, suggesting an unkown ligand 
of Tim4 may exist on naïve T cells. On pre-activated T cells, this Tim4-Ig inhibitory 
activity disappears (Mizui et al., 2008; Cao et al., 2011). 
In an attempt to generate anti-chicken Tim mAbs, mice were immunised with 
Ig-tagged chTim fusion proteins; the splenocytes were subsequently isolated and 
fused with a partner cell line to generate immortal hybridomas for producing antigen-
specific antibodies. The specificity of the anti-chTim mAbs was then intensively 
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examined with different methods, including ELISA, immunostaining of transfected 
COS-7 and CHO cells, western blot, etc.  
5.2 Materials and Methods 
5.2.1 Immunization of mice 
Two Biozzi strain mice were immunized with a chTim1-extracellular-Ig 
fusion protein for generation of anti-Tim1 antibodies and three BALB/C strain mice 
with a chTim4S-extracellular-Ig fusion protein for anti-Tim4 antibodies. Two Biozzi 
strain mice were also immunised with a chTim4L-hinge-Ig fusion protein to generate 
mAbs against novel Tim4 isoforms, including potentially chTim4eL, chTim4L and 
chTim4eS. All mice were pre-bled on day 0 from the tail vein by cutting a small nick 
and collecting blood for serum. On day 1, each mouse was primarily immunised by 
subcutaneous injection of 50 μg purified Ig fusion protein which was emulsified with 
adjuvant, TiterMax gold (Invitrogen). A first boost was given on day 21 by the same 
procedure as the primary immunisation. On day 28, the mice were bled from the tail 
vein for serum. A second boost was given on day 35. One week later (on day 42), the 
mice were bled from the tail vein again for serum. A final boost was performed on 
day 50 by intraperitoneal (ip) injection of 50 μg purified Ig protein without any 
adjuvant. 
5.2.2 Evaluation of immune response by ELISA  
The immune responses of the immunised mice against the chTim1 and 
chTim4S Ig fusion proteins were tested by a standard indirect ELISA. Briefly, 
purified chTim1- and chTim4S-His6 proteins (mutually as controls) were coated on 
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ELISA plates (section 2.6.1). After blocking the plates with 1% casein/PBS, the sera, 
including pre-immunisation and immunization sera, were serially titrated on the 
plates, followed by probing with HRP-conjugated goat anti-mouse IgG. The HRP 
activity was detected with OPD substrate.  
A capture ELISA assay was applied to analyse immune responses against the 
chTim4L-hinge-Ig fusion protein, as described in section 2.6.1. As shown in Figure 
5.1, to eliminate any background caused by anti-Ig antibodies in the anti-chTim4L-
hinge-Ig sera, a competitive ELISA assay was also used to evaluate immune 
responses. An ELISA plate was coated with chTim4L-hinge-Ig fusion protein or 
irrelevant Ig protein (rchCD86-Ig) as negative control. The sera from day 42 were 
diluted at 1:150 in PBS.  The serum solution (100 μl) was then mixed with 10 μg 
irrelevant Ig fusion protein (rchCD86-Ig) or PBS and incubated at room temperature 
for 1 h to allow blockade of anti-Ig responses. The sera were then serially titrated on 
plates. The rest of the ELISA procedure was as described previously. 
5.2.3 Fusion of immunized mouse spleen cells with partner cells, SP2/0 
 Two days before fusion, mouse peritoneal macrophages as feeder cells were 
grown on flat-bottomed 96-well plates in complete RPMI 1640 medium plus 1× 
HAT reagent (hypoxanthine/aminopterin/thymidine, Life Technologies) at 37ºC, 5% 
CO2. One day before fusion, cultured SP2/0 cells were split to ensure that cells were 
in the exponential phase of growth at the time of fusion. On fusion day, the SP2/0 
cells were split, pelleted and resuspended in serum-free RPMI 1640. 
The spleens from the immunised mice were collected and single cells were 
flushed out with a 10 ml syringe filled with serum-free RPMI 1640 and with a 26G 
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Figure 5.1.  Competitive ELISA assay. Ig fusion protein (a, b) or Ig control protein 
(c, d) were coated on solid phase in step one. Sera (a, c) or Ig pre-blocking sera, 
rchCD86-Ig (b, d) were added onto the plate in step 2, follow by HRP-labelled 
secondary antibody in step 3. Finally, the HRP activity was detected by an OPD 
substrate.    





needle attached. The flushing was repeated at various points along the spleen until 
the bulk of the contents were removed. The cell suspension was transferred to a new 
Universal and centrifuged at 1,100 g for 5 min. The cell pellet was resuspended in 5 
ml serum-free RPMI 1640. Prior to counting the cells, cell suspension (100 µl) was 
mixed with 4.9 ml 0.85% NH4Cl and incubated for 2 min at room temperature to 
swell B cells and lyse red blood cells. SP2/0 cells were then mixed with the spleen 
cells in a new Universal at a ratio of 1:5. The combined cells were pelleted as before 
and the supernatant discarded. To fuse the cells, 1 ml pre-warmed polyethylene 
glycol (PEG) (Roche) was slowly added to the cells, followed by the addition of 10 
ml pre-warmed serum-free RPMI 1640 to dilute the PEG. The fused cells were 
pelleted again as before and resuspended in HAT selective medium (complete RPMI 
1640 growth medium plus 1× HAT). The cell density was adjusted to 1×10
6
 cells/ml 
and the cell suspension (100 µl/well), including unfused spleen cells as a control, 
was then dispensed into the above prepared macrophage plates and returned to the 
37ºC, 5% CO2 incubator. 
5.2.4 Positive hybridoma selection 
Control wells were tested for background activity after 5 days growth in 96-
well plates. The cells were then refed by replacing 0.1 ml medium from each well 
with 0.2 ml HAT selective medium.  
The main screenings for positive clones were carried out on day 10. 
ChTim4L-hinge-Ig fusion protein was used in an indirect ELISA to screen 
hybridomas for anti-chTim4L-hinge antibodies as described in section 2.6.1. To 
diminish the effect of Ig responses, the positive wells were re-screened by a 
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competitive ELISA (section 5.2.2). The hybridoma supernatant, 10 μl per sample, 
was diluted in 90 μl 1% casein/PBS, and then blocked with 1 μg (10 μl) irrelevant Ig 
fusion protein (rchCD86-Ig) for 1 h at room temperature. The supernatants (50 µl) 
were then added to test and control wells on the plates for ELISA assays.  
Hybridomas which produced anti-chTim1 or -chTim4S antibodies were 
screened using an indirect ELISA (section 5.2.2), in which His6-tagged chTim1 or 
chTim4S proteins were used as specific antigens in the corresponding assays. 
5.2.5 Subcloning monoclonal hybridoma 
The positive hybridomas were split from 96-well plates and grown up in 24-
well plates with pre-grown mouse peritoneal macrophages. After 3-5 days growth, 
when the cells were 60-70% confluent, the supernatants were collected for further 
testing as before. The hybridomas were then ranked in order depending on the test 
results and several of the best hybridomas were chosen for subcloning using a 
limiting dilution method. In brief, the cells were split, counted and diluted at 2×10
3
 
cells/ml in 10 ml HT medium, complete RPMI 1640 medium plus 1× HT reagent 
(hypoxanthine/thymidine, Sigma-Aldrich), in a Universal. This cell suspension (1 
ml) was further diluted in 9 ml HT medium, from which 3 ml of cell suspension were 
further diluted in 7 ml HT medium. On a 96-well plate with pre-grown mouse 
peritoneal macrophages, cell suspension from the first dilution was plated out on half 
of a plate at 100 µl/well, and 100 µl per well of cell suspension from the second 
dilution on the other half of the plate. The cell suspension from the third dilution was 
dispensed on a new macrophage plate at 100 µl/well. The cells were cultured at 
37ºC, 5% CO2 for 5-7 days. The clones in each well were scored under a microscope 
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and the wells containing a single clone identified. Two days later, the hybridamas 
were screened by ELISA. Several wells with the highest ELISA readings containing 
single clones were split and grown up in 24-well plates. After a further ELISA, the 
best hybridomas were chosen for a second round of subcloning.   
5.2.6 Labelling of monoclonal antibodies 
After double subclonings, the monoclonal hybridomas were grown up at a 
large scale, the tissue culture supernatants harvested and the mAbs purified as 
described in section 2.9.  
The purified mAbs were biotinylated using Sulfo-NHS-LC-Biotin reagent 
(Thermo Scientific) according to the manufacturer’s instructions. Briefly, the mAbs 
were adjusted to 2 mg/ml by either concentration with 100 kDa Amicon Ultra 
centrifugal filter units (Sigma-Aldrich) or dilution with PBS. Immediately before 
use, 2.3 mg Sulfo-NHS-LC-biotin reagent were dissolved in 500 µl DMSO to make a 
10 mM biotin solution. For each labelling reaction, biotin solution (27 µl) was added 
to 1 ml (2 mg/ml) mAb solution, mixed well and incubated at room temperature for 
30 min. The labelled mAbs were then dialysed in Slide-A-lyzer dialysis cassettes (30 
kDa molecular weight cut-off, Thermo Scientific) against PBS to remove uncoupled 
biotin reagent and DMSO. Finally, the biotinylated mAbs were filtered through a 
syringe filter with 0.2 µm pore size. 
The purified mAbs were also coupled with a fluorescent dye using an Alexa 
fluor 647 monoclonal antibody labelling kit (Invitrogen) as per the manufacturer’s 
instructions. Briefly, 10 µl 1 M sodium bicarbonate were added to 100 µl antibody 
solution (100 µg) This mix (100 µl) was added to a reactive dye, mixed well and 
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incubated for 1 h at room temperature to label the antibody. A spin column was 
prepared by filling it with 1.5 ml resin and excessive liquid removed by 
centrifugation at 1,100 g for 3 min. To remove unlabelled dye from labelled 
antibody, the antibody/dye mixture was loaded onto the column and centrifuged at 
1,100 g for 3 min. Flowthough was collected containing the successfully labelled 
antibody and stored at 4ºC. 
5.2.7 Antibody epitope mapping 
The epitopes recognised by the anti-chTim mAbs were mapped to different 
domains using capture ELISA assays as described in section 2.6.1. Briefly, chTim-
IgV, -mucin or -extracellular domain Ig fusion proteins, transiently expressed by 
COS-7 cells, were captured on ELISA plates pre-coated with unlabelled goat anti-
human IgG antibody. The primary mAbs against chTim1 or chTim4S were then 
serially titrated on the plates. A goat anti-mouse IgG-HRP antibody was used to 
detect the bound primary antibody and the HRP activity was detected with an OPD 
substrate. 
The binding sites of anti-Tim1 mAbs were also tested by a competitive 
ELISA. Briefly, the ELISA plate was coated with chTim1-His6 protein (section 
2.6.1) and blocked with 1% casein/PBS as before. Unlabelled anti-chTim1 antibodies 
or PBS as control were added to the plate and incubated for 1 h. After washing the 
plate, biotinylated anti-chTim1 mAbs or a biotinylated isotype control mAb (ILA12), 
1 µg/ml, 50 µl/well, were then added to the plate. HRP-conjugated streptavidin 
(1:1000 dilution) was used to detect the bound biotinylated mAbs. OPD substrate 
was used to detect the HRP activity. 
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5.2.8 Transfected COS-7 cell lysates 
 COS-7 cells were transfected with full-length chTim1, chTim4S and 
chTim4L cDNAs cloned in pCIneo using a Gene Pulser Xcell electrophoration 
system (Bio-Rad), as described in section 2.7.2. Viable transfected cells (10
6
) were 
seeded in a T75 tissue culture flask and cultured for 48 h. The cells were removed 
from the flasks with cell scrapers (Sigma-Aldrich). The cells were pelleted and 
washed twice with cold PBS. To lyse the cells, 2×10
6
 cells were resuspened in 100 µl 
PBS and mixed thoroughly with an equal volume of 2× SDS-PAGE reducing sample 
buffer. The cell lysates were then immediately heated at 95ºC for 5 min and stored at 
-20ºC.  
5.2.9 Whole cell ELISA 
Full-length chTim1, chTim4S and chTim4L cDNAs were stably transfected 
into CHO cells and single cell clones were grown up in 96-well plates as described in 
section 3.2.3. The single cell clones were then split and equally reseeded into two 
new 96-well plates, one clone/well/plate. When the cells were fully confluent, the 
clones with high-level protein expression were screened with a whole cell ELISA 
assay. Briefly, supernatant was removed from the plates and the cell layers washed 
twice with PBS, 200 µl/well. To fix the cells, 100% ethanol was added to the cells, 
100 µl/well, and incubated for 10 min at room temperature. The plate was washed 
twice with PBS and then blocked with 1% casein/PBS (100 µl/well) for 1 h. The 
primary mAbs, GG9 (anti-chTim1), JH9 (anti-chTim4S) and IE12 (anti-chTim4L-
hinge), were added to the corresponding plates. The bound primary antibodies were 
detected by biotinylated goat anti-mouse IgG antibody (Amersham Bioscience). The 
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biotin was then detected using an ABC kit (GE Healthcare) as per the manufacturer’s 
instructions. One drop of solution A was diluted in 10 ml of PBS and then mixed 
with one drop of solution B, incubating for 30 min to form the biotin-avidin complex 
(avidin is conjugated with HRP). This complex, 50 µl/well, was added to plates and 
incubated for 30 min. OPD substrate solution was used to test the HRP bioactivity. 
The optical density was read at a wavelength of 490 nm. Six positive clones from 
each transfection were chosen to grow up in 24-well plates and retested again by the 
whole cell ELISA assay. The best clone from each transfection was then grown up 
for testing anti-chTim mAbs in flow cytometric analysis. 
5.3 Results 
5.3.1 Mice immune responses post-immunisation with chTim-Ig 
proteins 
To generate monoclonal antibodies against chTim1 or chTim4, purified Ig-
fusion proteins, containing the whole extracellular domains of chTim1 or chTim4S, 
were used to immunise mice. To generate antibodies that would distinguish novel 
chTim4 isoforms (chTim4eL, chTim4L and chTim4eS) from chTim4S, an Ig-tagged 
fusion protein containing the hinge (encoded by exons 3 and 4) between the two IgV 
domains of chTim4L (chTim4L-hinge-Ig) was generated and used to immunise mice. 
The mouse sera were sampled before and between immunisations. ELISA assays 
were used to analyse the serological immune responses against the corresponding 
antigens.  
  A His6-tagged chTim1 protein was used as antigen to detect chTim1-specific 















Figure 5.2.  Measurement of chTim1-specific serological responses in immunised 
mice. Immune responses of (A) mouse 1 and (B) mouse 2 were analysed by indirect 
ELISA, measuring the presence of chTim1-specific antibody in immunised sera, bled 
on day 28 and 42 post-initial immunisation with pre-immunised sera, bled on day 0, 
as negative controls. Recombinant chTim1-His6 protein was used as antigen pre-
coated on ELISA plates. All sera were 2-fold titrated on plates after an original 1:300 
dilution. The secondary Ab is HRP-conjugated goat anti-mouse IgG, followed by a 




















































































after two immunisations, mouse 2 produced a strong immune response, whereas 
mouse 1 had just started to respond to antigen, compared with pre-immunised sera. 
After a third immunisation, the response of mouse 1 increased further, but the 
response of mouse 2 dropped from previous levels. 
A His6-tagged chTim4S protein was also used as antigen to detect chTim4-
specific antibodies in sera with an indirect ELISA (section 5.2.2). As showed in 
Figure 5.3, all three mice generated high immune responses against chTim4S-His6 
protein after the first two immunisations in comparison with the pre-immunised sera. 
A third boost stimulated even higher responses in all mice than the previous 
immunisations.  
The chTim4L-hinge-Ig fusion protein was used as antigen in a capture ELISA 
assay to detect serological immune responses post-immunisation (section 2.6.1). As 
shown in Figure 5.4A, mouse 1 produced a very strong response after two 
immunisations, and a third immunisation also increased the response to a higher 
level. Mouse 2 (Figure 5.4C) had no immune response to antigen after the primary 
and first booster immunisation, although a third immunisation increased the 
response. It is therefore difficult to decide if the immune response was fully 
established. However, ELISA also indicated that all sera positive to the test antigen 
also had very strong reactive signals to irrelevant Ig fusion protein (rchCD86-Ig) on 
control plates (Figure 5.4B and D), resulting in no obvious differences of serological 
reactions between the test and control plates. 
  To determine specific immune responses against the hinge part of the 

















Figure 5.3.  Measurement of chTim4S-specific serological immune responses in 
immunised mice. The responses of (A) mouse 1, (B) mouse 2  and (C) mouse 3 in 
immunised sera, bled on day 28 and day 42 post-initial immunisation with pre-
immunised sera bled on day 0, as negative control, were measured by indirect ELISA 
assays with chTim4S-His6 protein pre-coated on plates. All sera were 3-fold titrated 
on plates after an original 1:60 dilution. The secondary Ab is HRP-conjugated goat 
















































































































































Figure 5.4.  Capture ELISA analysis of serological responses against chTim4L-
hinge-Ig fusion protein in immunised mice. Recombinant chTim4L-hinge-Ig fusion 
protein (A, C) and irrelevant Ig fusion protein (rchCD86-Ig) as negative antigen 
controls (B, D) were captured by pre-coated goat anti-human IgG antibody onto 
ELISA plates. The responses of mouse 1 (A, B) and mouse 2 (C, D) were analysed 
by measuring the presence of antibody in immunised sera, bled on day 28 and 42 
post-primary immunisation, with pre-immunised sera, bled on day 0, as negative 
serum controls. All sera were 2-fold titrated on plates after an original 1:300 dilution. 
The secondary Ab is HRP-conjugated goat anti-mouse IgG. The HRP activity was 










were incubated with excessive irrelevant Ig fusion protein (rchCD86-Ig), prior to 
adding to the plate in a competitive ELISA, as described in section 5.2.2. The sera 
tested were bled after a third immunisation. As shown in Figure 5.5, sera only still 
strongly reacted with Ig antigen control on the ELISA plate, whereas pre-blocked 
sera did not interact with it, suggesting blocking with irrelevant Ig completely 
abolished serological reaction of the anti-Ig antibody.  However, as expected, these 
pre-blocked sera still strongly and dose-dependently bound to the chTim4L-hinge-Ig 
fusion protein, suggesting that strong immune responses specifically against the 
hinge part of the chTim4L fusion protein have been successfully established in 
immunised mice, especially in mouse 1.  
5.3.2 Fusions and positive selections of hybridomas  
The serological results showed that mouse 1 in both the chTim1-Ig and 
chTim4L-hinge-Ig immunisations, and mouse 1 and 2 in the chTim4S-Ig 
immunisation, had established very good immune responses against the respective 
antigens. Therefore, the spleens were taken after a fourth immunisation and 
splenocytes isolated from all of these mice for fusions with the partner cells, SP2/0, 
as described in section 5.2.3.  
A single fusion was carried out to generate anti-chTim4L-hinge-Ig 
monoclonal antibodies and a total of 768 polyclonal hybridomas (eight 96-well 
plates) were screened by capture ELISA (section 2.6.1). A resultant 143 positive 
hybidomas produced antibodies against chTim4L-hinge-Ig fusion protein but also 
reacted with the irrelevant Ig control protein. To distinguish chTim4L-hinge-specific 




Figure 5.5.  Competitive ELISA analysis of specific immune responses against 
chTim4L-hinge domain. Prior to titration on ELISA plates which pre-coated with 
chTim4L-hinge-Ig fusion protein and an Ig control antigen (rchCD86-Ig) as control 
antigen, sera from mice with three immunisations were pre-incubated with or without 
excessive irrelevant Ig fusion protein (rchCD86-Ig) to remove the detection of anti-Ig 
Ab. All sera were 2-fold titrated on plates after an original 1:300 dilution. The bound 
primary Ab was detected by an HRP-conjugated goat anti-mouse IgG Ab, followed 
by colourisation of OPD substrate. Serum/Ig in pink = untreated sera reaction with 
immobilised Ig control on the plate; Serum+Ig/Tim4-h-Ig in green = Ig-blocked sera 
reaction with chTim4L-hinge-Ig; Serum+Ig/Ig in blue = Ig-blocked sera reaction 
with Ig control. (A) mouse 1 and (B) mouse 2.  
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re-screen these positive antibodies, in which an irrelevant Ig-fusion protein 
(rchCD86-Ig) was used to block the supernatants prior to adding to antigens on 
plates, as described in section 5.2.2. Eventually, 13 hybridomas were identified 
positively secreting antibodies specifically against the hinge part of the chTim4L 
fusion protein but not the Ig domain. After two rounds of subcloning of all these 
polyclonal hybrydomas, five monoclonal hybridomas, as listed in Table 5.1, were 
eventually obtained to produce specific mAbs against the hinge part of chTim4L. 
A single fusion was also carried out to generate anti-chTim1 monoclonal 
antibodies and a total of 768 polyclonal hybridomas (eight 96-well plates) were 
screened by indirect ELISA (section 5.2.2). 102 positive hybridomas were identified 
and then grown up in 24-well plates. 56 hybridomas survived and were expanded. 
Only 8 of these secreted chTim1-specific antibodies. After two rounds of subcloning 
of these hybridomas, finally, 3 monoclonal hybridomas, as listed in Table 5.1, were 
established to sustainably produce anti-chTim1 mAbs. 
Two fusions were performed individually with the splenocytes isolated from 
mouse 1 and 2 respectively immunised with the chTim4S-Ig fusion protein. 
Approximately 2,000 hybridomas (twenty 96-well plates) were screened by indirect 
ELISA (section 5.2.2) and 256 positive hybridomas were obtained. They were then 
expanded on 24-well plates and 154 hybridomas survived, among which 47 produced 
chTim4S-specific antibodies. These hybridomas were ranked by ELISA analysis and 
9 hybridomas were chosen to perform subcloning. Eventually, 5 monoclonal 




  Table 5.1. List of mAbs against chTim molecules. 
5.3.3 Anti-chTim1 antibody specificity and epitopes recognised, as 
determined by ELISA analysis 
The established monoclonal hybridomas were cultured in large scale and the 
supernatants harvested. The mAbs were then purified with protein G columns,as 
described in section 2.9. The purified mAbs were analysed for their antigen 
specificity by ELISA. 
To characterise the specificity of the anti-chTim1 mAbs, they were titrated on 
chTim1-His6-coated ELISA plates, along with anti-chTim4L-hinge and isotype 
control mAbs. The bound antibodies were measured by colorimetric assay, as shown 
in Figure 5.6. Anti-chTim1 mAbs specifically recognise the chTim1-His6 protein, as  






























Figure 5.6. Indirect ELISA analysis of specificity of anti-chTim1 mAbs. ChTim1-
His6 protein was used as antigen pre-coated on ELISA plates. Anti-chTim1 mAbs 
(CF3, GG9 and EG7), anti-chTim4L-hinge mAbs (AE3, AE7, BE6, IE12 and DD9) 
and isotype control mAbs, ILA12 (IgG2a) and Gri 3.1(IgG1) were titrated on the 
plates. A HRP-conjugated goat anti-mouse-IgG Ab was used to detect bound primary 
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compared to isotype control mAbs. As expected, anti-chTim4L-hinge mAbs did not 
cross-react with the chTim1-His6 antigen, only producing background interactions, 
similar to those of the isotype mAb controls.  
To further determine the binding sites of the anti-chTim1 mAbs, a capture 
ELISA (section 2.6.1) was used to determine if they bound to different domains of 
the chTim1 protein, including the chTim1-IgV-Ig and chTim1-mucin-Ig fusion 
proteins as targets, as shown in Figure 5.7. The three anti-chTim1 mAbs all dose-
dependently bound to the mucin domain of the chTim1 molecule. By contrast, only 
background binding to the IgV domain of chTim1 was seen, suggesting these anti-
chTim1 mAbs recognise epitopes mapping to the mucin domain of chTim1 but not to 
the IgV domain.  
To determine if the epitopes recognised by the three anti-chTim1 mAbs were 
closely located, a competitive ELISA (section 5.2.7) was used. Unlabelled anti-
chTim1 mAbs were used to block the binding sites on chTim1-His6 pre-coated on 
ELISA plates, prior to the addition of biotinylated anti-chTim1 mAbs. The bound 
biotinylated mAbs were detected by HRP-conjugated streptavidin, as shown in 
Figure 5.8. The pre-incubation of any of the anti-chTim1 mAbs dramatically reduced 
the binding of the other two anti-chTim1 mAbs to the chTim1 antigen, suggesting 
that the epitopes of the three anti-chTim1 mAbs may be closely associated. However, 
the binding efficiency of the three anti-Tim1 mAbs to their antigen shows variation 
















Figure 5.7. Epitope mapping of anti-chTim1 mAbs, as detected by a capture ELISA. 
Recombinant chTim1-IgV-Ig (IgV) and chTim1-mucin-Ig (mucin) fusion proteins, as 
antigens, were captured onto ELISA plates by pre-coated goat anti-human IgG 
antibody, and anti-chTim1 mAbs, including CF3, GG9 and EG7, were titrated on this 
plate. An HRP-conjugated goat anti-mouse IgG antibody was used to detect bound 






















Figure 5.8. Analysis of the epitopes bound by the anti-Tim1 mAbs by a competitive 
ELISA. ChTim1-His6, as an antigen pre-coated on the plate, was incubated with 
unlabelled anti-chTim1 mAbs, EG7 (2), CF3 (3), GG9 (4) and PBS (1, 5). After 
washing the plate, biotinylated anti-chTim1 mAbs were added to 1, 2, 3 and 4, and a 
biotinylated control mAb (ILA12) to 5, to compete for binding to the antigen. Bound 
biotinylated Abs were detected by HRP-conjugated streptavidin, followed by 
colorimetric assay with an OPD substrate. (A) biotinylated CF3, (B) biotinylated 










5.3.4 Anti-chTim4 antibody specificity and epitopes recognised, as 
detected by ELISA analysis 
To characterise the specificity of the anti-chTim4S mAbs, an indirect ELISA 
(section 5.2.2) was used with chTim4S-His6 protein as the target antigen, and 
chTim1-His6 protein as a negative control, as shown in Figure 5.9. Anti-chTim4S 
mAbs specifically recognised chTim4S-His6 protein, but did not cross-react with the 
control antigen. 
To determine the location of the epitopes recognised by the anti-chTim4S 
mAbs, a capture ELISA (section 2.6.1) was used with chTim4S-IgV-Ig and 
chTim4S-mucin-Ig fusion proteins as antigens, along with an irrelevant Ig negative 
control, rchCD86-Ig fusion protein, as shown in Figure 5.10A. Four anti-chTim4S 
mAbs, including FA1, JH9, JF1 and BC8, strongly and dose-dependently bound to 
the chTim4S-IgV-Ig fusion protein compared to their binding to the negative Ig 
control; by contrast, these mAbs did not bind to the chTim4S-mucin-Ig protein, 
suggesting the epitopes recognised by them are on the IgV domain of chTim4S. One 
anti-chTim4S mAb, AA12, had only background binding to either antigen when 
compared with the negative Ig control (Figure 5.10A), suggesting its epitope is 
neither on the IgV nor the mucin domain of chTim4S. However, AA12 was 
previously shown to bind to the chTim4S-His6 protein (Figure 5.9), suggesting 
AA12 recognises an epitope comprising elements of both the IgV and mucin 
domains of chTim4S. To confirm this prediction, a capture ELISA was used to re-
map the epitope recognised by AA12, where IgV, mucin and whole extracellular 
(IgV+mucin) domain chTim4S fusion proteins were captured by their fused-Ig tag, 














Figure 5.9.  Specificity of anti-chTim4S mAbs analysed by an indirect ELISA. 
Recombinant chTim4S-His6 and chTim1-His6 proteins, as antigens, were coated 
onto ELISA plates. Anti-chTim4S mAbs, including FA1, JH9, JF1, BC8 and AA12, 
were then 3-fold titrated on this plate. Bound primary mAbs were detected by an 
HRP-conjugated goat anti-mouse IgG antibody, followed by colorimetric assay with 
an OPD substrate. N Ctl = negative controls, wells containing no coating antigen, nor 
adding a primary antibody. Solid lines represent interactions of the antibodies with 
chTim4S, and dashed black lines interactions with chTim1. 
 
 















Figure 5.10. Epitopes of anti-chTim4S mAbs analysed by capture ELISA. (A). 
ChTim4S-IgV-Ig and chTim4S-mucin-Ig fusion proteins were captured on ELISA 
plates pre-coated with goat anti-human IgG antibody, and anti-chTim4S mAbs, 
including FA1, JF1, JH9, BC8 and AA12, were then 3-fold titrated on the plate. 
Solid colour lines represent interaction of the mAbs with the chTim4S-IgV-Ig protein 
and dotted black lines are interaction with the chTim4S-mucin-Ig protein. N Ctl = 
negative control, where wells are neither coated with antigen, nor a primary antibody 
added. (B). ChTim4S-IgV-, -mucin- and -extracellular-Ig fusion proteins and an 
irrelevant Ig (rchCD86-Ig) as negative control, were captured by pre-coated goat 
anti-human IgG antibody in triplicate wells on plate, followed by the addition of the 
mAb AA12. Bound AA12 was detected by an HRP-conjugated goat anti-mouse IgG 

























Consistently, AA12 specifically bound to the whole extracellular domain chTim4S 
fusion protein in comparison with the negative Ig control, but not to the IgV or 
mucin domain chTim4S fusion proteins. 
To characterise the specificity of the anti-chTim4L-hinge mAbs, chTim4L-
hinge-Ig fusion protein was used as antigen in a capture ELISA (section 2.6.1), 
which also included isotype control mAbs, ILA12 and GRi3.1, as shown in Figure 
5.11.  The anti-chTim4L-hinge mAbs specifically recognised chTim4L-hinge-Ig 
fusion protein when compared with the isotype control mAbs. However, the binding 
efficiency of the antibodies for the antigen appeared to be variable. Three anti-
chTim4L-hinge mAbs, including EA3, AE7 and IE12, bound with high amount, but 
DD9 and BE6 appeared to be low and very low, respectively.  
To further characterise the ability of the mAbs to recognise full-length 
chTim4L protein, plasmid encoding full-length chTim4L cDNA was transfected into 
COS-7 cells (section 2.7.2), followed by immunostaining with anti-chTim4L-hinge 
mAbs, including EA3, AE7, IE12 and DD9 (section 2.8). The staining results were 
analysed by confocal microscopy, as shown in Figure 5.12. Antibodies EA3, IE12 
and DD9 positively stained some, but not all of the transfected COS-7 cells in the 
same observed field, suggesting these antibodies stain the positively transfected 
COS-7 cells expressing chTim4L protein. However, the staining was mostly 
concentrated around nuclei, suggesting that the expressed chTim4L proteins are 
located in that area, an observation consistent with the expression of chTim4L 
soluble protein, which was previously shown to be intracellularly expressed in the 
ER in transfected COS-7 cells (Figures 3.14 and 3.16). Surprisingly, mAb AE7 














Figure 5.11. Specificity of anti-chTim4L-hinge mAbs analysed by an indirect 
ELISA. ChTim4L-hinge-Ig fusion protein was used as an antigen pre-coated on 
ELISA plates. The anti-chTim4L-hinge mAbs, including AE3, AE7, BE6, IE12 and 
DD9, and isotype control mAbs, ILA12 (IgG2a) and Gri 3.1 (IgG1), were then 3-fold 
titrated on the plates. Bound primary mAbs were detected by an HRP-conjugated 




















Figure 5.12. Confocal microscopy of anti-chTim4L-hinge mAbs immunostaining 
transfected COS-7 cells. Vectors expressing full-length chTim4L cDNAs were 
transiently transfected into COS-7 cells, followed by immunostaining the cells with 
the anti-chTim4L-hinge mAbs, AE7, DD9, IE12 and EA3. Bound primary mAbs 
were detected by Alex Fluor 586-conjugated goat anti-mouse IgG antibody in red 









cross-react with an unknown nuclear antigen in those cells. 
5.3.5 Specificity of anti-chTim mAbs characterised with transiently   
transfected COS-7 cells 
To determine if the anti-chTim mAbs recognise their cognate antigen 
expressed in transfected cells, the full-length respective chTim cDNAs in expression 
vectors were transiently transfected into COS-7 cells (section 2.7.2). The transfected 
COS-7 cells were fixed by paraformaldehyde and then immunostained with the anti-
chTim mAbs (section 2.8). Consistent with the previous ELISA results, the anti-
chTim1 mAbs (Figure 5.13), including CF3, EG7 and GG9, specifically recognised 
chTim1-transfected COS-7 cells in comparison with the control isotype mAb 
(ILA12) staining. They did not cross-react with chTim4S- and chTim4L-transfected 
COS-7 cells.  
Although the anti-chTim4L-hinge mAbs (Figure 5.14), including AE7, IE12 
and EA3, specifically recognised the chTim4L antigen expressed by transfected 
COS-7 cells in comparison with the isotype control mAbs GRi3.1 and ILA12, the 
strength of interaction between antibody and antigen was variable.  IE12 and EA3 
strongly bound to chTim4L-transfected cells, but EA3 bound slightly less than IE12. 
Similar to the previous confocal results (Figure 5.12), AE7 mAb bound to transfected 
cells, but the binding seemed to be condensed to nuclei. DD9 had very low or 
undetectable staining of chTim4L-transfected COS-7 cells. These results are 
consistent with the previous observations with ELISA (Figure 5.11) and confocal 
analysis (Figure 5.12). As expected, the anti-chTim4L-hinge mAbs did not cross-















Figure 5.13. Immunostaining of COS-7 transfectants with anti-chTim1 mAbs. 
Vectors expressing full-length cDNAs of chTim1 (left panel), chTim4S (middle 
panel) or chTim4L (right panel) were transiently transefected into COS-7 cells, 
followed by immnostaining the cells with anti-chTim1 (EG7, CF3 and GG9) and 
isotype controls ILA12 (IgG2a) mAbs. The secondary antibody was biotinylated goat 
anti-mouse IgG, followed by HRP-labelled straptavidin. AEC chromogen was used 
to detect HRP bioactivity, shown as red. The nuclei were counter-stained by 
hematoxylin, shown as purple. The positive staining showed cells were in dark red 
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Figure 5.14. Immunostaining of COS-7 transfectants with anti-chTim4L-hinge 
mAbs. Vectors expressing full-length cDNAs of chTim1 (left panel), chTim4S 
(middle panel) or chTim4L (right panel) were transiently transefected into COS-7 
cells, followed by immnostaining the cells with anti-chTim4L-hinge (EA3, AE7, 
IE12 and DD9) mAbs. GRi3.1 (IgG1) and ILA12 (IgG2a) are isotype controls. The 
secondary antibody was biotinylated goat anti-mouse IgG, followed by HRP-labelled 
straptavidin. AEC chromogen was used to detect HRP bioactivity, shown as red. The 
nuclei were counter-stained by hematoxylin, shown as purple. The positive staining 
showed cells were in dark red when compared with negative staining. 
As predicted, the anti-chTim4S mAbs (Figure 5.15), AA12, BC8, JF1, JH9 
and FA1, recognised not only chTim4S, which is consistent to previous results by 
ELISA analysis (Figure 5.9), but also chTim4L antigens expressed by transfected 
COS-7 cells, when compared with the isotype control mAb, GRi3.1. However, all 
five antibodies did not cross-react with chTim1- transfected cells. One anti-chTim4S 
mAb, JF1, appeared to have a different staining pattern on chTim4S- and chTim4L-
transfected COS-7 cells, strongly binding to the former but less strongly to the latter 
(Figure 5.15).   
5.3.6 Characterisation of anti-chTim mAbs by western blot analysis 
To further characterise the anti-Tim4S mAbs and determine molecular 
weights of the full-length chTim4S and chTim4L proteins, cell lysates, obtained from 
previously transfected COS-7 cells (section 5.2.8), were used for western blot 
analysis, as shown in Figure 5.16. MAbs FA1 and JF1 strongly bound to bands at 
approximately 33 kD in chTim4S- and chTim4L-transfected cell lysates, but very 
weakly to a similar size band in chTim1-transfected cell lysate. JH9 and AA12 mAbs 
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Figure 5.15. Immunostaining of COS-7 transfectants with anti-chTim4S mAbs. 
Vectors expressing full-length cDNAs of chTim1 (left panel), chTim4S (middle 
panel) or chTim4L (right panel) were transiently transefected into COS-7 cells, 
followed by immnostaining the cells with anti-chTim4S (AA12, BC8, JF1, JH9 and 
FA1) and isotype controls Gri3.1 (IgG1) mAbs. The secondary antibody was 
biotinylated goat anti-mouse IgG, followed by HRP-labelled straptavidin. AEC 
chromogen was used to detect HRP bioactivity, shown as red. The nuclei were 
counter-stained by hematoxylin, shown as purple. The positive staining showed cells 
































Figure 5.16. Characterisation of chTim4S mAbs by western blot. Transfected COS-7 
cell lysates, containing full-length chTim proteins, were used for western blots. The 
anti-chTim4S mAbs, as labelled beneath each picture, were used to probe the blots, 
followed by an HRP-conjugated goat anti-mouse IgG Ab for detection of bound 
primary mAbs. ECL reagent was used to detect HRP bioactivity. Tim1 = Tim1-
transfected COS-7 cell lysate, Tim4S = Tim4S-transfected COS-7 cell lysate, Tim4L 
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cell lysate and a 95 kDa band in the chTim4L-transfected cell lysate. BC8 detected 
even more bands, 75, 70 and 33 kDa bands in cell lysate containing chTim4S, and 
250, 95 and 33 kDa bands in cell lysate containing chTim4L, but bound most 
strongly to the 75 kDa and 95 kDa bands. The major 75 and 95 kDa bands in the 
respective chTim4S- and chTim4L-transfected cell lysates are bigger than the 
molecular mass of 36.9 kDa of full length chTim4S and 57.3 kDa of full-length 
chTim4L, as predicted using the Protparam programme (http://web.expasy. org/cgi-
bin/protparam/protparam). This suggests that chTim4S and chTim4L protein may be 
highly glycosylated, and they do possess multiple N- and O-linked glycosylation 
sites. However, it is not clear why all the anti-chTim4S mAbs recognised a 33 kDa 
band in the chTim4S- and chTim4L-transfected cell lysates.  
The expression of ChTim1 and chTim4L by transfected COS-7 cells was also 
determined by western blot, where GG9 (anti-chTim1) and IE12 (anti-chTim4L-
hinge) mAbs were used to detect the presence of expressed proteins, as shown in 
Figure 5.17. IE12 specifically bound to a band of 95 kDa in the chTim4L-transfected 
COS-7 cell lysate and did not cross-react with chTim1- and chTim4S-transfected 
COS-7 cell lysates (Figure 5.17A). GG9 did not cross-react with chTim4S- and 
chTim4L-transfected COS-7 cell lysates, but it bound to two different bands of 50 
and130 kDa in the chTim1-transfected cell lysate (Figure 5.17A), which are both 
bigger than the predicted size of 28 kDa. 
An AEC substrate was also used in western blot analysis to determine protein 
products in each chTim-transfected COS-7 cell lysate, as shown in Figure 5.17B. 
Differently to previous observations, anti-chTim1 mAb GG9 specifically recognised 
















Figure 5.17. Expression of full length chTim molecules by transfected COS-7 cells, 
as detected by western blot. COS-7 cell lysates containing full length chTim1, 
chTim4S or chTim4L proteins were blotted onto nitrocellulose membranes and 
probed with mAbs GG9, IE12 and JH9, as labelled beneath each picture. ECL kit (A) 
and AEC substrate (B) were used to detect bound antibodies. Tim1 = chTim1-
transfected cell lysate, Tim4S = chTim4S-transfected cell lysate, Tim4L = chTim4L-
transfected cell lysate, M = Pageruler prestained protein ladder (Fermentas, A) and 
Precision Plus protein standard (all blue, BioRad, B). 
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mAb JH9. A major 95 kDa band for chTim4L protein was detected by both anti-
chTim4L-hinge (IE12) and anti-chTim4S (JH9) mAbs. 
5.3.7 Specificity of anti-chTim mAbs characterised with stably 
transfected CHO cells 
To determine the ability of anti-chTim mAbs to recognise native proteins 
constitutively expressed on the cell surface, CHO cells were stably transfected with 
vectors expressing full-length chTim cDNAs, as described in section 5.2.9. 
Monoclonal cultures of stably transfected CHO cells were then immunostained with 
anti-chTim mAbs, followed by flow cytometric analysis, as shown in Figure 5.18.  
The anti-chTim1 mAbs, GG9, CF3 and EG7, specifically bound to chTim1-
transfected CHO cells, but not to chTim4S- and chTim4L-transfected cells, 
compared with negative controls, which included cell controls, and isotype-matched 
control mAbs, ILA12 or GRi3.1. The anti-chTim4L-hinge mAbs, IE12, EA3, DD9 
and AE7, specifically recognised chTim4L-transfected CHO cells, but did not cross-
react with chTim4S- and chTim1-transfected cells. However, one anti-chTim4L-
hinge mAb, BE6, weakly bound to both chTim4L- and chTim4S-transfected CHO 
cells. Anti-chTim4S mAbs recognised both chTim4S- and chTim4L-transfected 
CHO cells, but did not cross-react with chTim1-transfected cells. However, staining 
of chTim4S-transfected CHO cells with anti-chTim4S mAbs showed a broad 
distribution of fluorescence intensity, suggesting that the chTim4S protein is not 
homogeneously expressed by each cell, which may be caused by a heterogeneous 
cell culture. Consistent with previous results, JF1 showed different patterns in 
immunostaining chTim4S- and chTim4L-transfected cells, strongly to the former, but 
















Figure 5.18. Immunostaining of stably transfected CHO cells. CHO cells were stably 
transfected with full-length cDNAs of chTim1 (red), chTim4S (blue) or chTim4L 
(green), followed by immnostaining with anti-chTim1 (GG9, CF3 and EG7), anti-
chTim4L-hinge (IE12, EA3, DD9, AE7 and BE6) or anti-chTim4S (JH9, BC8, 
AA12, FA1 and JF1) mAbs. Dotted black lines represent negative controls, which 
are corresponding isotype mAbs, ILA12 (IgG2a) or GRi3.1 (IgG1). The bound 
primary antibody was detected by an Alexa fluor 647-labelled goat anti-mouse IgG 
Ab (1:1,000 dilution), shown as FL4 in x-axis. All primary mAbs were diluted at 1 
µg/ml, 50 µl of them for immunestaining. 
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recognised their own antigens in their native form expressed on the cell surface. 
To determine the strength of recognition by the anti-chTim mAbs of their 
own antigens, the previous immunostaining results of transfected CHO were 
compared, as shown in Figure 5.19. The shift in distance of the fluorescence intensity 
peaks illustrates the binding efficiency of the mAb. Among the anti-chTim1 mAbs, 
GG9 and CF3 are higher than EG7 (Figure 5.19A). For the anti-chTim4L-hinge 
mAbs, the descending order is IE12 > EA3 > AE7 > DD9 > BE6 (Figure 5.19B). The 
anti-chTim4S mAbs appear to have different binding patterns to the chTim4S and 
chTim4L antigens. JH9, AA12 and FA1 strongly bind to both chTim4L- and 
chTim4S-tranfected CHO cells (Figures 5.17C and D); but compared to them, BC8 
and JF1 bind chTim4L-tranfected CHO cells more weakly. BC8 is slightly weaker 
than the other anti-chTim4S mAbs in immunostaing chTim4S-tranfected CHO cells.  
5.4 Discussion 
The immune response is more potent when the phylogenetic distance between 
the antigen source and the immune system involved increases. Therefore, it is an 
advantage to choose the mouse to generate anti-chTim antibodies, because the 
chicken is evolutionarily distant from the mouse and the chTim molecules also share 
very low homology with their murine equivalents (discussed in Chapter 3). The 
molecular size of the antigen also influences its immunogenicity. Therefore, a 
strategy of fusing a human Ig Fc tag of large molecular weight to the chTim proteins 
not only facilitates the purification of recombinant fusion proteins, but also increases 
the immunogenicity of the chTim molecule. As expected, the immunisation of mice 
















Figure 5.19. Characterisation of anti-chTim mAbs with immunostaining of stably 
transfected CHO cells. (A). Immunostaining of chTim1-transfected CHO cells with 
anti-chTim1. (B). Immunostaining of chTim4L-transfected CHO cells with anti-
chTim4L-hinge. (C). Immunostaining of chTim4L-transfected CHO cells with anti-
chTim4S. (D). Immunostaining of chTim4S-transfected CHO cells with anti-
chTim4S. The mAbs and corresponding coloured lines are listed in the legends. 
Negative controls are isotype mAbs, ILA12 (IgG2a) or GRi3.1 (IgG1), as shown in 
dotted black lines. The bound primary Ab was detected by an Alexa fluor 647-
labelled goat anti-mouse Ig Ab (1:1,000 dilution), shown as FL4 in x-axis. All 












responses in the majority of mice. However, a big drawback of immunisation with Ig 
fusion protein is a concurrent anti-Ig response which produces high background 
effects during hybridoma screening. To diminish detection of Ig responses, modified 
methods were used, such as competitive ELISA or the use of His6-tagged proteins in 
indirect ELISA, and these efficiently improved the accuracy of the screening results. 
The anti-chTim antibodies specifically recognised their own antigen in 
ELISA assays, but the chTim4L-extracellular-Ig fusion protein was excluded, 
because the soluble protein was not available (discussed in Chapter 3). To 
characterise the ability of anti-chTim4L-hinge mAbs to recognise full-length 
chTim4L proteins, COS-7 cells were transfected with vector expressing full-length 
chTim4L cDNA. The transfected cells were fixed and permeablised prior to staining 
with antibodies. The confocal results (Figure 5.12) revealed that anti-chTim4L-hinge 
mAbs can recognise chTim4L protein, but the staining was condensed around the 
nucleus. A consistent result was observed for soluble chTim4L-Ig fusion protein 
(Chapter 3), where the protein was trapped in the ER instead of being secreted into 
the supernatant.  
Anti-chTim mAbs were also used to immunostain COS-7 cells transfected 
with vector expressing full-length chTim1, chTim4S and chTim4L cDNAs (Figures 
5.13-5.15). Anti-chTim1 and -chTim4S mAbs recognised the antigens expressed by 
transfected COS-7 cells and the positively-stained cells, like scrambled eggs, showed 
the colour homogeneously spread across the entire cell. However, in the cells 
positively stained by the anti-chTim4L-hinge mAbs, the peripheral colour was 
weaker than the areas surrounding the nucleus, which are consistent with the 
previous confocal results, suggesting the protein is concentrated in the central region. 
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Murine Tim proteins are expressed in intracellular vesicles of transfected cell lines 
(Santiago et al., 2007a; 2007b).  This intracellular expression was explained as a 
subsequence of the PS binding site in the Tim molecules. With mutation of this site, 
the protein preferentially expressed on the cell surface rather than intracellularly 
(Santiago et al., 2007a). PMA and ionomycin treatment can also induce protein 
trafficking to the cell surface; PMA and ionomycin drive an increase of intracellular 
calcium and subsequently facilitate the exposure of PS-bound Tim to the cell surface 
(Santiago et al., 2007a). As discussed in Chapter 3, chTim4L has two PS binding 
sites in the molecule. Therefore, they possibly cause full-length chTim4L to be 
expressed intracellularly instead of on the cell surface. 
The molecular size of the full length chTim proteins was determined by 
western blot analysis of the transfected COS-7 cell lysates. In the chTim1-transfected 
cell lysate, two bands at 50 and 130 kDa were detected and both are bigger than the 
predicted chTim1 molecular weight of 28 kDa, suggesting they may be highly 
glycosylated chTim1 proteins. Multiple molecular sizes of mammalian Tim1 protein 
have been observed. Human activated T cell lysate contained three bands at 40, 70 
and 110 kDa, which all are bigger than the predicted size of 36 kDa (Mesri et al., 
2006). Rat postischemic kidney extract also contained three sizes of Kim1 (Tim1) 
protein at 40, 50 and 70-80 kDa, all bigger than the predicted size of 31.3 kDa, but 
two sizes of Kim1 proteins, at 40 and 63 kDa, were expressed by transfected COS 
cells (Ichimura et al., 1998). The multiple sizes of Tim1 protein were explained to be 
as a result of glycosylation, and different cell types can alter protein modification 
because of their different glycosylation pathways (Ichimura et al., 1998). AEC 
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substrate revealed a 50 kDa band to be the major product of full-length chTim1 
protein expressed by transfected COS-7 cells (Figure 5.17).  
In immunostaining of transfected COS-7 cells, anti-chTim4L-hinge mAbs 
recognised the chTim4L antigen, but not the chTim4S antigen. However, anti-
chTim4S mAbs recognised both chTim4S and chTim4L antigens. Therefore, how 
can one distinguish chTim4S from chTim4L with anti-chTim4S mAbs?  Western 
blot was used to analyse the presence of full-length chTim4S and chTim4L proteins 
in transfected COS-7 cell lysates. The anti-chTim4S mAb, JH9, recognised not only 
a major 75 kDa band in the chTim4S-transfected cell lysate, but also a 95 kDa band 
in the chTim4L-transfected cell lysate, a similar product being detected by the anti-
chTim4L-hinge mAb, IE12 (Figure 5.17). This knowledge will be used in Chapter 6 
to detect and distinguish chTim4S and chTim4L expression on chicken primary 
immune cells. However, 33 kDa bands in the chTim4S- and chTim4L-transfected 
cell lysates were also detected by the anti-chTim4S mAbs (Figure 5.16), suggesting 
the full-length chTim4S and chTim4L proteins may be in different glycosylation 
states.  
To address if the anti-chTim mAbs specifically recognise their native form of 
antigens, stably transfected CHO cell lines were established. ChTim proteins, 
constitutively expressed on the cell surface, were analysed by flow cytometry. 
Consistent with ELISA and immunostaining of transfected COS-7 cells results, the 
anti-chTim1 and -chTim4L antibodies specifically recognised their own antigen 
expressed on the surface of transfected CHO cells, and anti-chTim4S antibodies not 
only bound to chTim4S-transfected CHO cells but also cross-reacted with chTim4L-
transfected CHO cells (Figure 5.18). The antibody binding efficiency (Figure 5.19) 
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was also analysed and the resultant ranking was consistent with the results from 
ELISA and immunostaining of transfected COS-7 cells. 
Based on the characterisation of the anti-chTim mAbs, including antibody 
specificity, binding efficiency and recognition of different forms of antigen, GG9 
(anti-chTim1), JH9 (anti-chTim4S) and IE12 (anti-Tim4L-hinge) were chosen to 






























Chapter  6.     Expression of chTim molecules on chicken   
primary cells. 
6.1  Introduction 
Tim molecules are membrane-anchored type I proteins and play 
immunological and physiological roles through interaction with their receptor 
expressed on the target cell surface. The Tim1 protein is preferentially expressed on 
Th2 cells to regulate the proliferation and immune function of these cells, and on 
tubular epithelial cells following kidney injury to clear dead cell debris, because 
Tim1 is also a receptor for PS. Tim1 also plays divergent roles on other immune 
cells. For example, Tim1 and Tim3 proteins are constitutively expressed on mast 
cells and mast cells activated through them enhance Th2 cytokine production, which 
subsequently worsens autoimmune and allergic disorders (Nakae et al., 2007).  Tim1 
expressed on invariant NKT cells enhances the cellular production of IL-4 and 
inhibits the production of IFN-γ in the presence of TCR stimulation (Kim et al., 
2010). Tim1 protein is highly expressed on splenic myeloid DCs and activated DCs, 
through Tim1 signalling, subsequently promote proinflammatory Th17 responses and 
inhibit Foxp3
+
 Treg generation (Xiao et al., 2011). Increasing expression levels of 
Tim1 on regulatory B cells can prolong allograft survival through regulation of 
production of IL-4 and IL-10 by the B cells (Ding et al., 2011). Tim1-deficient mice 
with a Tim1-mucin domain knock-out lack IL-10 production from regulatory B cells 
and are less likely to develop systemic autoimmune diseases (Xiao et al., 2012). 
Induction of Tim-1 expression on germinal centre B cells is B cell receptor (BCR) 
signalling-dependent. However, Tim1-deficient mice with an IgV domain knock-out 
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were used to show that Tim1 is not essential for responses of the germinal centre B 
cells (Wong et al., 2010). Tim1 transgenic mice with Tim1 over-expressed on T and 
B cells have normal B cell proliferation through BCR stimulation in comparison with 
cells from wild-type mice, suggesting that Tim1 may not be essential for B cell 
responses (Wong et al., 2010). Tim1 is expressed on CD19
+









 T cells from lung tissue. However, Tim1-deficient mice, 
lacking Tim1 expression on these cells, have the same responses in antigen-induced 
airway hyperreactivity as those of wild-type mice, suggesting Tim1 may not be 
essential for experimental allergic asthma. This finding is contrary to what was 
proposed in a number of other studies using neutralizing and activating antibodies. 
Therefore the clinical relevance of Tim1 for novel allergy therapies has been 
questioned (Barlow et al., 2011). 
As mentioned before, Tim4 is expressed primarily on APCs, including 
CD11c
+
 DCs, macrophages, and marginal metallophilic macrophages, and also on 
peritoneal B-1 B cells. Through its interaction with PS, Tim4 plays a role in 
clearance of dead cells. The biological and physiological roles of the Tim4 molecule 
were also studied in Tim4-deficient and transgenic mice. Tim4 transgenic mice with 
Tim4 overexpressed on APCs had reduced numbers of antigen-specific T cells after 
influenza infection, resulting in greatly reduced secondary T cell responses in ex vivo 
re-stimulation (Albacker et al., 2010). The resulting hypothesis was that Tim4-
expressing phagocytic cells efficiently engulf and clear PS-expressing, antigen-
specific T cells, eventually preventing T cells from proceeding into the memory cell 
compartment (Albacker et al., 2010). However, how overexpression of Tim4 might 
affect Th2 cells has not been addressed in Tim4 transgenic mice. Presumably, Tim4 
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can stimulate Th2 cell proliferation, but activated Th2 cells massively exposing PS 
on their cell surface are rapidly taken up by overexpressing-Tim4 APCs, eventually 
inhibiting Th2 expansion. Tim4-deficient mice have an impaired phagocytic activity 
for peritoneal cells, hyperactive T and B cells in response to antigen stimulation, and 
increased production of anti-dsDNA antibodies, a sign of an autoimmune response, 
suggesting that Tim4 plays a critical role in clearance of dead bodies in vivo and that 
lack of Tim4 resulted in aberrant persistence of apoptotic bodies leading to 
dysregulated lymphocyte activation and signs of systemic autoimmunity (Rodriguez-
Manzanet et al., 2010).  
The mRNAs of chTims are expressed at high levels in various chicken tissues 
and splenic cell subsets (Chapter 4). Anti-chTim mAbs have been generated and 
demonstrated to have antigen-specific activities (Chapter 5). In this Chapter, the anti-
chTim mAbs will be used to address if the expression patterns of chTim proteins on 
chicken primary cells are similar to those of their equivalents in mammals and to 
understand how their immunological and physiological functions, such as phagocytic 
and costimulatory activities as described in Chapter 4, are undertaken by chTim-
expressing chicken cells.  
6.2 Materials and Methods 
As described in Chapter 5, based on mAb specificity, affinity, recognition of 
denatured or native antigens and their epitopes, mAbs against chTim were chosen to 
study expression of chTim proteins on chicken primary cells. MAb GG9 was used to 
detect chTim1 expression. MAb JH9 was chosen to detect all chTim4 isoforms 
molecules, thereafter named as anti-chTim4 antibody, because its epitope was 
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mapped to the IgV domain of chTim4. MAb IE12 was mapped to exons 3 and 4 of 
chTim4; therefore, it was chosen to detect the isoforms chTim4eL, chTim4L and 
chTim4eS and thereafter named as anti-novel chTim4 mAb.  
6.3 Results 
6.3.1. Expression of chTim molecules on chicken splenocytes 
To determine the expression of chTim molecules on chicken primary cells, 
splenocytes isolated from J line birds were stained with the anti-chTim mAbs, GG9, 
JH9 and IE12, as shown in Figure 6.1A. Flow cytometric analysis indicated that 
there was no detectable positive event following staining by any of the anti-chTim 
mAbs when compared with staining with the isotype mAb controls, suggesting 
expression levels of chTim proteins are very low or undetectable on the surface of 
freshly-isolated chicken splenocytes.  
To determine if the chTim molecules are expressed intracellularly, 
permeabilised chicken splenocytes were double-stained with anti-chTim and CD4 or 




 populations were 
gated and anti-chTim mAb double staining of these cells measured, as shown in 





 splenocytes in comparison with isotype-matched control mAbs, but GG9 
and JH9 have no detectable staining, suggesting a sub-population of CD4
+
 T and B 























Figure 6.1. ChTim molecules expression on chicken splenocytes. (A). Surface 
staining of splenocytes with GG9 (anti-chTim1), JH9 (anti-chTim4), IE12 (anti-
novel chTim4) and isotype controls ILA12 (IgG2a) and GRi3.1 (IgG1) mAbs. (B). 
Double staining of permeablised splenocytes with anti-chTim and Bu-1 (upper panel) 




 cells are gated in dot plots (left side) 
and overlaid histograms analyse anti-chTim mAb double staining of the gated cells. 
FL4 shows the fluorescence of Alexa fluor 647.  The flow cytometric results 









6.3.2. Expression of chTim molecules on stimulated chicken 
splenocytes 
To determine if activation of chicken primary cells affects expression of 
chTim molecules, chicken splenocytes were cultured with or without ConA, PHA 
and PMA for 72 h, as described in section 2.3.5.4. The cells were then double-stained 
with the anti-chTim mAbs, GG9 (anti-chTim1), JH9 (anti-chTim4) and IE12 (anti-
novel chTim4) and antibodies to cell surface markers, including CD4 (CD4
+
 T cells), 
Bu-1 (B cells) and KUL01 (macrophages). The mAbs IC10 (IgG1) and ILA12 
(IgG2a) were also included as isotype controls. The resulting staining was analysed 
by flow cytometry, as shown in Figure 6.2.  
In non-stimulated splenocytes (Figure 6.2A), the mAb GG9 (anti-chTim1) 
did not stain splenocytes, as compared to the isotype control mAb (ILA12). 
However, when compared with the relevant isotype control mAb, more than 10% of 
the cells were stained positive (with JH9) for chTim4. One third of JH9 positive cells 
were CD4
+
 cells, two thirds CD4
-
. To see if mAb JH9 also stains B cells, these non-
stimulated splenocytes were double-stained with Bu-1 and either JH9 or an isotype 
control mAb (IC10). Few Bu-1
+
 cells were double-stained by JH9 when compared to 
the isotype control mAb. The mAb KUL01 was also used to double-stain these 
splenocytes with JH9 to address expression of chTim4 on splenic macrophages. 
Although the number of KUL01 positive cells was very low in non-stimulated 
splenocytes, the majority of the KUL01
+
 cells were JH9
+
 when compared to the 
isotype control mAb. Staining with the anti-chTim4 mAbs indicated that chTim4 
proteins are expressed on the surface of cultured splenocytes, which is different to 













































































































Figure 6.2. ChTim expression on conditional cultured splenocytes, stimulated with or 
without ConA, PHA or PMA for 72 h. The cells were then double-stained with GG9 
(anti-chTim1), JH9 (anti-chTim4), IE12 (anti-novel chTim4) or isotype controls, 
IC10 (IgG1) and ILA12 (IgG2a), shown on the vertical axis (FL4 for Alexa fluor 
647), and cell surface markers, CD4, Bu-1 or KUL01 antibody, shown on the 
horizontal axis (FL1 for FITC). The quadrants are drawn depending on the isotype 
control (horizontal quadrants) and cell surface markers (vertical quandrants). The 
flow cytometric results represent one experiment of three repeats. 
D. PMA-stimulated splenocytes 
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(Figure 6.1), suggesting in vitro culture of splenocytes may affect expression levels 
of chTim4 on the cell surface. To investigate expression of novel chTim4 isoforms 
(chTim4eL, chTim4L and chTim4eS), the non-stimulated splenocytes were also 
stained with the anti-novel chTim4 mAb IE12.  IE12 positively stained a higher 
number of cells compared to those stained with the isotype control mAb (ILA12), 
and, as predicted, much lower than that stained by the anti-chTim4 mAb JH9. 





that other splenocyte subsets may also express the novel chTim4 isoforms. However, 
double-staining with Bu-1 or KUL01 mAb indicated little obvious IE12 positive 
staining when compared to the isotype control mAb (ILA12) (Figure 6.2A), 
suggesting low or undetectable levels of novel chTim4 isoforms are expressed on B 
cells and macrophages at the protein level.  
In ConA- and PHA-stimulated splenocytes (Figures 6.2B and C), mAb GG9 
still detected no positive cells, suggesting ConA and PHA stimulation have no 
obvious effects on expression of chTim1 at the protein level. Although the frequency 
of JH9
+
 cells was similar to non-stimulated splenocytes, JH9 positive cells had a 
higher proportion of CD4
+
 cells than non-stimulated cells, suggesting ConA- or 
PHA-activated CD4
+
 splenocytes upregulated expression levels of chTim4, although 
both mitogens had little effect on overall expression levels of chTim4 in the total 
population of splenocytes. Similarly to non-stimulated cells, mAb IE12 detects few 
positive cells post-ConA or PHA stimulation, suggesting both mitogens had little 
effects on expression of the novel chTim4 isoforms. 
Again, PMA-stimulated splenocytes (Figure 6.2D) were negatively stained by 
mAb GG9 when compared with the isotype control mAb (ILA12). However, PMA 
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stimulation remarkably increased the population of JH9
+
 splenocytes in comparison 
with those of unstimulated and ConA- and PHA-stimulated splenocytes. Almost half 
of the PMA-stimulated splenocytes are JH9
+
. To address which splenic cell subsets 
are the major contributors of JH9
+
 cells, these cells were double-stained for CD4 to 
see if expression levels of chTim4 are upregulated on CD4
+





 cells, although higher than that with the isotype control mAb (IC10), is 
similar to that of non-stimulated splenocytes, suggesting PMA stimulation did not 
dramatically affect expression levels of chTim4 protein on CD4
+
 T cells. These cells 
were then double-stained with JH9 and Bu-1 mAbs to see if expression levels of 
chTim4 vary on B cells. Almost the entire population of Bu-1
+
 cells was positively 
stained by mAb JH9 in comparison with the isotype control mAb (IC10), a 
remarkable increase of positive events on Bu-1
+
 cells when compared with non-
stimulated splenocytes, suggesting PMA-stimulated B cells upregulate expression 
levels of chTim4 protein. Double-staining with the macrophage marker, KUL01, 
indicated that the majority of splenic macrophages were stained by JH9, but, as 
expected, they were a minor contributor of JH9
+
 cells because they are a small 
population in PMA-stimulated splenocytes. Notably, nearly half of JH9
+
 cells are not 
B cells, staining negatively for Bu-1, suggesting other splenic cell subsets also 
express chTim4 protein, such as perhaps CD8
+
 T cells.  
Expression of novel chTim4 isoforms (chTim4eL, chTim4L or chTim4eS) on 
PMA-stimulated splenocytes was also analysed using mAb IE12. Compared with 
unstimulated and ConA- and PHA-stimulated splenocytes, the frequency of IE12
+
 
cells was remarkably increased, with one fifth of PMA-stimulated splenocytes 
staining IE12
+
 in comparison with the isotype control mAb (ILA12). Double-staining 
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these cells with the B cell marker, mAb Bu-1, indicated more than half of the Bu-1
+
 
cells were also positively stained by mAb IE12, when compared with the isotype 
control mAb (ILA12), suggesting PMA stimulation increases expression levels of the 
novel chTim4 proteins on activated B cells. However, mAb IE12 stained a much 
lower frequency of PMA-stimulated splenocytes than JH9, consistent with the 
observations from non-stimulated splenocytes. Similarly to the JH9 staining, a small 
population of PMA-stimulated B cells did not stain with mAb IE12. To see if novel 
chTim4 isoforms are expressed on CD4
+
 T cells and macrophages, these cells were 









 cells were higher in number in comparison with the isotype control 
mAb (ILA12), the frequencies of these cells were similar to those of unstimulated 
and ConA- and PHA-stimulated splenocytes, suggesting PMA stimulation has no 
obvious effects on expression levels of the novel chTim4 proteins (chTim4eL, 




 splenocytes.  
6.3.3. ChTim protein expression on activated chicken bursal cells 
PMA stimulation increased chTim4 expression on splenic B cells. Chicken 
bursal cells are predominantly naïve B cells (80-90%) (Kothlow et al., 2008). To 
determine if activation can affect expression levels of chTim proteins on naïve B 
cells, bursal cells were isolated from J line birds and activated by culturing with 
PMA or rchCD40L for 48 h, as described in section 2.3.5.4.  Expression of chTim 
molecules on the cell surface was detected with anti-chTim mAbs, including GG9, 
JH9, IE12 and isotype control mAbs ILA12 (IgG2a) and GRi3.1 (IgG1), followed by 
flow cytometric analysis, as shown in Figure 6.3. The Bu-1 mAb was also included, 
















Figure 6.3. ChTim molecules expression on stimulated bursal cells. The bursal cells 
were stimulated with PMA or rchCD40L (labelled on left side) for 72 h. The cells 
were immunostained with GG9 (anti-chTim1), JH9 (anti-chTim4) and IE12 (anti-
novel chTim4). Bu-1 (B cell surface marker) and isotype controls, ILA12 (IgG2a) 
and GRi3.1 (IgG1), as labelled above each graph, followed by Alexa fluor 647-
labelled goat anti-mouse IgG antibody. Quadrants are drawn depending on isotype 
control mAb staining. Alexa flour 647 is on FL4 on x-axis. The y-axis shows FL1. 
Flow cytometric results represent one experiment of two repeats. 
PMA 
rchCD40L 




activated viable bursal B cells (Funk et al., 1997; Tregaskes et al., 2005; Kothlow et 
al., 2008). With PMA stimulation, a small population of bursal cells were Bu-1 
positive, suggesting they were activated proliferating B cells. A similar population of 
cells were also positively stained by mAbs JH9 and IE12, suggesting chTim4 
molecules are expressed on activated B cells, which is consistent with the 
observations from PMA-stimulated splenic B cells. However, GG9 had no detectable 
positive staining of PMA-stimulated bursal cells (Figure 6.3).  
It was shown previously that stimulation with rchCD40L protein varies the 
expression pattern of chTim4 mRNA in splenocytes (Figures 3.7 and 4.3). The 
rchCD40L fusion protein stimulates chicken B cells to proliferate and promotes 
survival of activated B cells (Tregaskes et al., 2005; Kothlow et al., 2008). It was 
therefore used to stimulate bursal cells (predominant naïve B cells) and the 
expression of chTim molecules on these cells was then measured by staining with the 
mAbs GG9, JH9, IE12, isotype controls (ILA12 and GRi3.1) and Bu-1 (B cell 
marker). The resultant staining was analysed by flow cytometry. As shown in Figure 
6.3, when compared with PMA stimulation, rchCD40L stimulation resulted in a 
higher frequency of proliferating bursal cells, which could be detected by Bu-1 mAb 
staining. However, rchCD40L-stimulated bursal cells were not stained by any anti-
chTim mAbs (Figure 6.3). This is not consistent with the previous observation from 
RT-PCR analysis that rchCD40L upregulated expression levels of chTim4 mRNA 
(Figures 3.7 and 4.3). It is not clear if increased chTim4 mRNA expression did not 
translate into protein or if the chTim4 proteins were expressed intracellularly, as 
shown in resting splenic B cells (Figure 6.1B). 
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6.3.4. ChTim4 expression on bone marrow-derived DCs and 
macrophages 
Mammalian peritoneal fluid has been used as a major source of macrophages 
for investigation of Tim4 expression and Tim4-dependant phagocytic activity 
(Miyanishi et al., 2007). Isolation of chicken macrophages from peripheral tissues 
(including normal peritoneal exudates) is difficult because of their low abundance. 
Chicken bone marrow is a source for obtaining large quantities of DCs (Wu et al., 
2010b) and macrophages (Garceau et al., 2010). To determine expression of the 
chicken Tim4 molecules on DCs and macrophages, these cells were differentiated 
from bone marrow cells of J line chickens by the addition of rchIL-4 and rchGM-
CSF for DCs or rchCSF-1 for macrophages, as described in sections 2.3.5.5 and 
2.3.5.6. The expression profiles of chTim4 on differentiated bone marrow cells were 
detected by immunostaining with JH9 (anti-chTim4) and IE12 (anti-novel chTim4 
isoforms) mAbs. KUL01 and isotype (ILA12 and GRi3.1) mAbs were also included 
as controls. The resultant staining was then analysed by flow cytometry, as shown in 
Figure 6.4. DCs were very weakly or negatively stained by mAbs JH9 and IE12 in 
comparison with isotype controls, although KUL01 positively stained the whole 
population of cells (Figure 6.4). By contrast, the entire population of rchCSF-1-
differentiated bone marrow cells were positively stained by mAbs JH9 and IE12, and 
a similar population of cells were also positively stained by the mAb KUL01 (Figure 
6.4). These results suggest that chTim4 molecules are expressed on immature bone 
marrow-derived macrophages but not on immature bone marrow-derived DCs.  
To determine if activation of macrophages affects expression of chTim4, the 

















Figure 6.4. ChTim4 expression on bone marrow-derived DCs and macrophages. 
Bone marrow cells were cultured with rchIL4 and rchGM-CSF for DCs or rchCSF-1 
for macrophages.  The cells were then immunostained with JH9 (anti-chTim4), IE12 
(anti-novel chTim4), KUL01 (myeloid cell surface marker) and ILA12 (IgG2a) and 
GRi3.1 (IgG1) as isotype controls. Secondary antibody was Alexa fluor 647-
conjugated goat anti-mouse IgG, as shown in FL4 on x-axis. Y-axis indicates the 





times. Expression of chTim4 proteins on the cell surface was detected with mAbs 
JH9 and IE12 and analysed by flow cytometry. KUL01 and isotype control (ILA12 
and GRi3.1) mAbs were included as controls. As shown in Figure 6.5, prior to PMA 
stimulation (0 h), the majority of cells were positively stained by mAbs JH9, IE12 
and KUL01. However, after 30 min of PMA stimulation, no positive cells were 
detected with mAbs JH9 and IE12, and cells remained negative until 14 h, when a 
very small population of cells were positive for IE12 staining. At 40 h stimulation, 
the number of IE12
+
 cells seemed increased but still not clearly to be detected, and at 
72 h post-PMA stimulation a clear population of IE12
+
 cells could be detected. The 
effects of PMA stimulation on cell surface molecules can also be observed by 
detecting expression levels of KUL01 on the cell surface (Figure 6.5). Flow 
cytometric analysis shows that KUL01
+
 cells appeared as a neat and sharp peak of 
fluorescence intensity from 0-1 h post-stimulation.  At 14 h, cells stained by KUL01 
had a spiky distribution, suggesting variable expression levels of KUL01 on different 
individual cells. At 40 h, the KUL01
+
 cells were divided into two populations with 
low and intermediate expression levels of KUL01 molecule. At 72 h post-PMA 
stimulation, there were no cells with KUL01 expression. However, JH9
+
 cells were 
not seen after 1 h post-PMA stimulation, even though the IE12 mAb positively 
stained a clear population of cells (Figure 6.5). 
6.3.5. Western blot analysis for the presence of chTim proteins in 
chicken primary cell lysates using anti-chTim mAb 
qRT-PCR and RT-PCR analyses showed that chTim4 mRNAs can be 
detected in various tissues and splenic subset cells (Figures 4.1-4.3). Flow cytometric 















                                                                                                                                
                                                                                                                                                            
Figure 6.5. Kinetic expression of chTim4 molecules on PMA-activated macrophages. 
Macrophages were obtained by culturing bone marrow cells with rchCSF-1 protein 
for 6 days.  The cells were then stimulated with PMA. The chTim4 expressed on 
cells were detected at different time-points by immunostaining with JH9 (anti-
chTim4) and IE12 (anti-novel chTim4) mAbs. KUL01 and isotype control mAbs 
ILA12 (IgG2a) and GRi3.1 (IgG1) were used as control mAbs. Secondary antibody 
was Alexa fluor 647-conjugated goat anti-mouse IgG, as shown on FL4 on x-axis. Y-
axis indicates the positive cell count. Flow cytometric results represent one 
experiment of three repeats. 
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and bursal cells (Figures 6.2 and 6.3). Western blot analysis was also used to detect 
the presence of chTim proteins in chicken primary cell lysates, aiming to distinguish 
expression of different chTim4 isoforms by their molecular weights. Chicken 
splenocytes, thymocytes and bursal cells were isolated from an 8-week-old J line bird 
(section 2.3.5) and lysed (section 5.2.8). The cell lysates were resolved on 4-12% 
SDS-PAGE gels (BioRad) (section 2.6.4) and transblotted to nitrocellulose 
membrane (section 2.6.6). ChTim proteins were probed with mAbs GG9 (anti-
chTim1), JH9 (anti-chTim4) and IE12 (anti-novel chTim4). As shown in Figure 6.6, 
anti-chTim1 mAb, GG9 (Figures 6.6A and D) did not recognise anything. However, 
mAb JH9 (Figure 6.6B) recognised major bands at 45 kDa (between 37-50 kDa), 
which is a molecular weight band never seen in any of the chTim4S and chTim4L 
proteins expressed by transfected COS-7 cells (Chapter 5). MAb IE12 (Figure 6.6C), 
detected bands at about 100 kDa in all cell lysates, which is a similar molecular size 
to that of full-length chTim4L protein expressed by transfected COS-7 cells (Figure 
5.15), and very faint bands at about 45 kDa (between 37-50 kDa) only in the 
splenocyte and thymocyte lysates. Detection with AEC substrate again identified a 
major product when probed by IE12 at 100 kDa in all cell lysates (Figure 6.6F), but 
JH9 again recognised bands at 45 kDa in all cell lysates (Figure 6.6E).  
6.3.6. Western blot analysis for the presence of chTim proteins in 
chicken primary cell lysates using polyclonal anti-chTim serum 
A major 75 kDa product of full-length chTim4S protein was detected by anti-
chTim4 mAb JH9 in transfected COS-7 cell lysates (Figure 5.15), but it was not 
detected in the chicken primary cell lysates. The anti-chTim1 mAb, GG9, did not 





Figure 6.6. Expression of chTim proteins in chicken cells analysed by western blot. 
Chicken primary cell lysates were resolved on a 4-12% SDS-page gel (BioRad). The 
chTim proteins were probed by (A) anti-chTim1 mAb, GG9, (B) anti-chTim4 mAb, 
JH9 and (C) anti-novel chTim4 mAb, IE12, and followed by detection of the bound 
primary antibodies with a goat anti-mouse IgG-HRP antibody. HRP activity was 
detected by ECL reagent. The membranes were again probed with AEC substrate, as 
shown in (D), (E) and (F). 1 = splenocyte lysate, 2 = thymocyte lysate, 3 = bursal cell 
lysate, M = Precision Plus protein standard (all blue, BioRad). All cells were isolated 




or western blot analysis (Figure 6.6). Modification of the mAb-targeted epitope may 
have caused the failure of these mAbs to detect chTim proteins. Therefore, to 
determine the expression of the chTim proteins in chicken primary cells, but 
avoiding any potential epitope modification problems, the chTim proteins in chicken 
primary cell lysates was detected by western blot using mouse anti-chTim sera 
obtained from the mice immunised to generate the anti-chTim mAbs in section 5.2.1. 
Transfected COS-7 cell lysates, containing full-length chTim4L and chTim4S 
proteins, were included as controls.   
Anti-chTim1 serum (Figure 6.7A) identified strong bands at 72 kDa in the 
bursal cell and splenocyte lysates, but nothing in the thymocyte lysate. As expected, 
anti-chTim1 serum did not cross-react with chTim4S and chTim4L proteins in the 
control transfected COS-7 cell lysates. Weak 45 kDa bands were also detected by the 
anti-chTim1 serum in all chicken cell lysates. 
Anti-chTim4S serum (Figure 6.7B) strongly bound to chTim4L and chTim4S 
proteins in transfected COS-7 cell lysates,  with the major bands at similar molecular 
weights to those detected with mAbs JH9 and IE12 (Figure 5.15). Strong and clear 
72 kDa bands in the bursal cell and splenocyte lysates were detected by the anti-
chTim4S serum, but nothing was detected in the thymocyte lysate. As with mAb JH9 
(Figures 6.6B and E), faint 45 kDa bands in all chicken cell lysates were also 



















Figure 6.7. Anti-chTim sera were used to detect chTim proteins in chicken primary 
cells by western blot. (A) Mouse anti-chTim1 serum and (B) mouse anti-chTim4S 
serum were used to probe chTim proteins in cell lysates from (1) thymocytes, (2) 
bursal cells and (3) splenocytes, as well as transfected COS-7 cells as controls, 
containing (4) chTim4L or (5) chTim4S protein. M = Precision Plus protein standard 





























6.4 Discussion  
The anti-chTim mAbs have been intensively characterised previously 
(Chapter 5) and they specifically recognise their own antigens, expressed by 
transfected cell lines, in native or denatured forms. Based on this knowledge, the 
expression of chTim molecules on chicken primary cells was examined in this 
Chapter.  
Transcription of the chicken Tim mRNAs, as analysed by qRT-PCR, 
suggested they were expressed in splenic cell subsets (Figure 4.2). To determine their 
expression at the protein level, chicken splenocytes were stained with the anti-chTim 
mAbs. However, flow cytometric analysis revealed very low or undetectable 
expression levels of the chTim proteins on the cell surface (Figure 6.1A). To 
determine intracellular expression patterns of the chTim molecules in chicken 
primary cells, and if they were similar to those previously observed with the 
chTim4L fusion protein, where soluble or membrane-anchored protein was 
restrained inside transfected COS-7 cells (Figures 3.16, 5.12 and 5.14), splenocytes 
were fixed and permeabilized to detect the presence of chTim proteins with the anti-
chTim mAbs. Staining with mAb IE12 for novel chTim4 proteins (chTim4eL, 





 splenocytes. ChTim4 is a cell membrane-anchored 
protein, as described in Chapter 3; it should be expressed on the cell surface with its 
extracellular domain sticking out to interact with its ligands, such as PS or chTim1. 
Intracellular expression of chTim4L protein, as detected with flow cytometry, would 
limit its interaction with its ligand(s) and thereby prevent chTim4-mediated 
phagocytosis of dead cells or activation of T cells by interaction with Tim1. It 
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remains to be determined if intracellular expression of chTim4 means that chTim4-
expressing cells are in a quiescent state with inactive biological roles. It is notable 
that the anti-chTim4 mAb JH9 recognised all isoforms of chTim4 molecules, but 
negatively stained IE12
+
 splenocytes (Figure 6.1B). This issue will be discussed 
below.  
Murine Tim4 is not expressed on T cells, but is expressed exclusively on 
APC (Kobayashi et al., 2007; Meyers et al., 2005a). Murine peritoneal macrophages 
express Tim4, but thioglycollate-elicited peritoneal macrophages lack Tim4 
expression (Miyanishi et al., 2007). Murine peritoneal B-1 cells express Tim4, but 
conventional B cells from the peritoneum have no detectable expression of Tim4 




 DCs and macrophages express Tim4. LPS and CD40L stimulation can 
upregulate Tim4 expression levels on splenic DCs. However, naïve and activated 
splenic T and B cells lack Tim4 expression (Mizui et al., 2008). In the chicken, 





express novel chTim4 isoforms (chTim4eL, chTim4L or chTim4eS) intracellularly. 
These novel chTim4-expressing CD4
+





macrophages can be found in the chicken spleen (Houssaint et al., 1989). It remains 
to be determined if the novel chTim4-expressing Bu-1
+
 splenocytes are B cells or 
macrophages, although Bu-1 is normally used as B cell marker. 
To determine if cell activation affects the expression of the chTim molecules, 
chicken splenocytes were stimulated in vitro with or without ConA, PHA or PMA. 
ConA and PHA are lectins, which non-specifically activate T cells, but have little 
effect on B cells (Stobo et al., 1972; Greaves et al., 1974). PMA was also included 
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for stimulation of T and B cells in a relatively specific way, because it is a small 
organic compound which diffuses through the cell membrane into the cytoplasm, 
where it directly activates the protein kinase C (PKC) pathway (Mizuguchi et al., 
1986; Chatila et al., 1989; Baier et al., 2009).   
Without any mitogen stimulation, in vitro culture alone dramatically 
increased the frequency of JH9
+
 splenocytes (Figure 6.2). In comparison with 
freshly-isolated splenocytes, chTim4 expression was upregulated on the surface of 
cultured splenocytes. This increased expression of chTim4 probably means that, 
during in vitro culture of the cells, chTim4-associated functions are activated. For 
example, phagocytes or cytotoxic lymphocytes could sense dying cells and initiate 
their physiological activity by increasing expression of chTim4 on the cell surface. 
To determine which types of cells express chTim4 protein, the cultured splenocytes 
were double-stained with anti-chTim4 mAbs and cell surface markers. Flow 
cytometry results indicated that CD4
+
 splenocytes can be stained by the anti-chTim4 
mAb, JH9 (detecting all chTim4 isoforms), but a small population of CD4
-
 
splenocytes were also stained by JH9.  However, B cells did not express chTim4 on 
their surface because the JH9 mAb did not stain Bu-1
+ 
cells. Splenic macrophages 









 splenocytes could be other splenocyte subsets, 
such as CD8
+
 splenocytes. ConA or PHA stimulation did not result in massive 
increases in JH9
+
 cells and had little effects on B (Bu-1
+
) cells and macrophages 
(KUL01
+









 cells (Figure 6.2). These 
results may suggest inducible expression of chTim4 on activated CD4
+
 T cells, 
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which is not seen in mammals, implying chTim4 may play a different role on these 
chicken cells to their equivalent in mammals.  
Surprisingly, PMA stimulation resulted in approximately 50% of splenocytes 
staining positive with JH9, and also a notable increase in IE12
+
 cells, suggesting 
expression levels of chTim4 are upregulated on these cells. Double staining of PMA-
stimulated cells revealed that activated splenic B cells predominantly express 
chTim4, but not CD4
+
 T cells. The PMA-targeted PKC kinases are a gene family of 
nine isotypes. According to their structure and cofactor dependency, they can be 
classified as conventional PKC isotypes α, β and γ; novel PKC isotypes δ, ε, η and θ; 
and the atypical PKC isotypes ζ and τ (Steinberg, 2008; Baier et al., 2009). 
Conventional PKCs require Ca
2+
 and diacylglycerol (DAG) for activation; novel 
PKCs are Ca
2+
-independent; and atypical PKCs require neither Ca
2+
 nor DAG for 
activation (Steinberg, 2008; Baier et al., 2009). Members of the protein kinase C 
(PKC) family are crucial in T cell signalling pathways, particularly PKC α, PKC β, 
and PKC θ (Baier et al., 2009). Murine primary splenic B cells highly express the 
novel PKCs δ and ε but only weakly express the θ isoform in comparison to murine 
T cells, and these novel PKCs play a critical role in B cell activation (Krappmann et 
al., 2001). The specific expression pattern of PKC isoforms and their physiological 
roles in chicken immune cells is not known. In this study, the PKC pathway can 
enhance expression levels of chTim4 on activated B cells, and this activation may be 
in a Ca
2+
-independent manner, because PMA can activate chicken B cells to 
upregulate chTim4 expression without the addition of ionomycin. Ionomycin, a Ca
2+
 
ionophore, elevates intracellular Ca
2+
 concentration in treated cells and is normally 
used with PMA to activate the conventional PKC isoenzymes (Chatila et al., 1989, 
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Liu and Hermann, 1978). However, expression of chTim4 did not change on PMA-
stimulated T cells, suggesting regulation of expression of chTim4 could be 
dependent on selective activation of PKC isoenzymes in chicken T and B cells.   
Previous results indicated that stimulation with rchCD40L fusion protein 
altered chTim4 mRNA transcription in in vitro cultured splenocytes (Figures 3.7 and 
4.3) with upregulation of chTim4L but downregulation of chTim4S. To determine if 
rchCD40L fusion protein also stimulates naïve B cells to express chTim4, bursal 
cells, which are predominantly naïve B cells, were stimulated with rchCD40L. PMA 
was also included to determine if it has a similar effect on naïve B cells as it did on 
splenic B cells. As with splenic B cells, the flow cytometry results (Figure 6.3) 
showed PMA-stimulated bursal cells express chTim4. However, rchCD40L-
stimulated cells downregulated chTim4. It remains to be determined if inducible 
expression of chTim4 proteins on B cells is associated with the PMA stimulatory 
signalling pathway, but more weakly regulated by the CD40-CD40L pathway. PMA, 
an analog of diacylglycerol, can stimulate B lymphocytes through activation of PKC, 
sharing similar signalling events with BCR-dependent signalling pathways 
(Mizuguchi et al., 1986, Krappmann et al., 2001). Therefore PMA is normally used 
to mimic antigen receptor-mediated B cell stimulation. However, CD40 is a member 
of the tumour necrosis factor receptor (TNFR) superfamily, and with its engagement, 
downstream signal transduction involves association of TNF receptor-associated 
factors (TRAFs) and subsequent IκB kinase (IKK) activation (Hu et al., 1994; Ishida 
et al., 1995; Krappmann et al., 2001). The differences between B cell activation 
through PMA and cross-linking CD40 have been compared in the literatures, because 
some crucial constituents in the signal pathways are differentially regulated. For 
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example, the transcription factor E-twenty-six (Ets)-1, a key regulator of the Ig heavy 
chain gene enhancer, is inhibited by PMA stimulation, but CD40-mediated activation 
has no effect on it (Raghunandan et al., 2013); CD40-mediated B cell proliferation 
results in upregulation of Src kinase production and activity, Src (or c-Src), a 
tyrosine kinase, was originally identified as a chicken cellular homology of v-Src 
discovered in chicken Rous sarcoma virus, which controls tumour formation 
(Oppermann et al., 1979), but PMA-treated B cells have little change in Src kinase 
activity or protein levels (Neron et al., 2006). Alternatively, rchCD40L stimulation 
may result in an increased expression of chTim4 proteins but intracellularly, as with 
staining of freshly-isolated splenocytes (Figure 6.1B). 
Inducible expression of mammalian Tim4 protein has been reported in 
mammalian APCs. Staphylococcal enterotoxin B enhances Tim4 expression in 
human DCs, which, in turn, drive Th2 cell polarisation (Liu et al., 2007). Murine 
Tim4 restrains expression of CD80, CD86 and MHCII on macrophages, which 
dampens the biological activities of macrophages in priming T cell responses, 
consequently leading to an attenuation of ConA-induced hepatitis (Xu et al., 2010). 
However, murine Tim4 is not expressed by immature DCs derived from bone 
marrow (Miyanishi et al., 2007). Chicken macrophages and DCs are present in low 
abundance in peripheral tissues and are difficult to isolate due to a lack of relevant 
reagents.  In vitro culture methods yielding relative pure and high numbers of 
macrophages and DCs from chicken bone marrow cells were recently established 
(Wu et al., 2010b; Garceau et al., 2010). Based on these methods, macrophages were 
differentiated from chicken bone marrow cells by culture with rchCSF-1 and DCs by 
culture with rchGM-CSF and rchIL-4. Similarly to murine bone marrow-derived 
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DCs, immature chicken bone marrow-derived DCs lack expression of chTim4 
(Figure 6.5). However, chTim4 proteins are expressed on immature bone marrow-
derived macrophages (Figure 6.5). The differential expression of chTim4 on 
macrophages and DCs may suggest that macrophages, armed with this PS receptor 
on the cell surface, may be in immune surveillance mode to capture apoptotic cells 
and thus maintain host body homeostasis, whereas DCs, as professional antigen 
presenting cells, presenting exogenous antigens, may be less important in clearance 
of apoptotic host cells.  
PMA is also a commonly-used activator of mammalian macrophages to 
stimulate them to differentiate and replicate (Greenberger et al., 1980; Huang et al., 
2002). In differentiation of human primary monocytes or the monocyte cell line 
THP-1 into macrophages, PMA has even stronger effects than LPS (Kohro et al., 
2004; Park et al., 2007; Daigneault et al., 2010). To determine if stimulation of bone 
marrow-derived macrophages affects the expression of chTim4 proteins, rchCSF-1-
differentiated bone marrow cells were stimulated with PMA. The kinetics of chTim4 
expression were measured by immunostaining the cells with anti-chTim4 mAbs, 





 cells quickly disappeared, and this negative staining lasted until 14 h, 
when a very small population of cells were IE12
+
. The number of IE12
+
 cells slightly 
increased at 40 h, and at 72 h post-PMA stimulation a clear population of IE12
+
 cells 
was detected. The kinetics of chTim4 expression may suggest that, at early stages of 
stimulation (30 min), the cells sense PMA stimulation and initiate internalisation of 
the receptor, leading to down-regulation of chTim4 expression on the cell surface. 
However, it is not clear if this internalisation of chTim4 is a specific or non-specific 
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response to PMA stimulation. Later, with continuous PMA stimulation, a small 
number of stimulated monocytes may differentiate into macrophages and express 
novel chTim4 isoforms (positively stained by the anti-novel chTim4 mAb IE12) on 
the cell surface, but it is not clear which novel chTim4 isoform was expressed latterly 
on PMA-stimulated macrophages. Alternatively, chickens may have two types of 
activated macrophages, as in mammals, which have two activated forms of 
macrophages, M1 and M2. The former are classically activated macrophages and 
immune effector cells that are aggressive against microbes and can engulf and digest 
them readily; the latter are more associated with a function in wound healing and 
tissue repair, but turn off activation of the immune system (Mosser et al., 2008). 
PMA stimulation could result in a different type of activated chicken macrophage 
with different expression levels of the novel chTim4 isoforms (chTim4eL, chTim4L 
or chTim4eS). PMA stimulation caused a decrease in expression levels of another 
cell surface protein, that recognised by the cell surface marker KUL01 (Figure 6.6), 
but in a much slower process when compared to disappearing of chTim4 expression 
after 30 min stimulation. Initially, the individual cells homogenously expressed 
KUL01, with a neat and sharp peak of fluorescent intensity. After 14 h of PMA 
stimulation, staining had a spiky distribution, indicating expression levels of KUL01 
are variable on different cell surfaces. A further differentiation resulted in two clear 
fluorescence intensity peaks of KUL01 staining at 40 h. Eventually the KUL01 
molecule disappeared from the cell surface at 72 h.  
Efforts were also made to investigate differential expression of chTim 
proteins on different chicken primary cells with western blot analysis. The cells 
isolated were splenocytes, thymocytes and bursal cells from J line birds; splenocytes 
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are a heterogeneous population with the majority being resting T and B cells and a 
low number of APCs; thymocytes are predominantly naïve T cells and bursal cells 
are mainly naïve B cells. The presence of chTim proteins in these cell lysates were 
detected by anti-chTim mAbs (Figure 6.7).  
IE12 mAb detected bands at approximately 100 kDa in all three cell lysates, 
which is a similar molecular weight as that of the full-length chTim4L protein 
(approximately 95 kDa) expressed by transfected COS-7 cells (Figure 5.15), 
suggesting the chTim4L protein may be expressed by chicken primary cells. This 
result is consistent with flow cytometric detection, where IE12 mAb could 
immunostain small numbers of splenocytes (Figure 6.1B). Differential glycosylation 
is thought to cause multiple molecular sizes of the full-length chTim4S and chTim4L 
proteins observed in transfected COS-7 cells (Figure 5.14). However, none of them 
match the 45 kDa bands detected by the JH9 mAb in chicken primary cell lysates 
(Figure 6.6); it remains to be determined if 45 kDa band is chTim4eS or other 
chTim4 isoforms of low molecular weight. 
  As mentioned previously, the epitope recognised by mAb JH9 was mapped to 
the chTim4 IgV domain, therefore it should recognise all chTim4 isoforms, whereas 
mAb IE12 was designed to recognise polypeptides encoded by exons 3 and 4 and 
therefore it should recognise chTim4eL, chTim4L and chTim4eS. As expected, mAb 
JH9 could recognise chTim4L protein in transfected COS-7 and CHO cells (Figures 
5.13 and 5.16). Consistently post-PMA stimulation, a higher number of splenocytes 
was positively stained with mAb JH9 than IE12 (Figure 6.2). However, it is 
intriguing that JH9 did not stain IE12
+
 splenocytes (Figure 6.1B), nor IE12
+
 
macrophages stimulated with PMA (Figure 6.5). This may be caused by modification 
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of chTim4 proteins, such as O- or N-linked glycosylation, leading to mAb JH9 
binding less well to chTim4. This was further demonstrated with western blot 
analysis, where mAb JH9 bound less well to a high molecular weight form of 
chTim4, but preferentially to a small molecular weight form of chTim4 (Figure 6.6).   
To reduce the possibility of the monoclonal antibodies failing to detect 
proteins of interest, anti-chTim sera from mice immunised for generation of anti-
chTim mAbs were used to probe the lysates from thymocyte, splenocyte and bursal 
cells by western blot analysis (Figure 6.7). The chTim4S and chTim4L proteins in 
transfected COS-7 cell lysates were used as controls. Similarly to the western blot 
analysis using anti-chTim4S mAbs in Chapter 5, polyclonal anti-chTim4S serum 
could strongly detect chTim4S and chTim4L proteins in transfected COS-7 cell 
lysates, with major products of approximately 75 and 95 kDa respectively. Anti-
chTim4S serum detected very strong bands at 72 kDa in bursal cell and splenocyte 
lysates, a similar molecular weight to full length chTim4S protein in control 
transfected COS-7 cell lysates, but also detected very weak bands at 45 kDa in all 
chicken cell lysates (Figure 6.7), a molecular weight consistent with detection of 
mAb JH9 in all chicken primary cell lysates (Figure 6.6). Anti-chTim4S serum 
detected strong 72 and weak 45 kDa bands, but not 100 kDa bands as detected with 
mAb IE12 in chicken primary cell lysates (Figure 6.6), suggesting chTim4S but not 
chTim4L may be predominantly expressed and chTim4eS or other chTim4 isoforms 
of low molecular weight expressed at low or intermediate levels.  
Anti-chTim1 serum detected very strong 72 kDa bands in bursal cell and 
splenocyte lysates. However, these bands are different in molecule weight to those of 
chTim1 proteins in transfected COS-7 cell lysates detected by the anti-chTim1 mAb 
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(Figure 5.17), suggesting that chicken primary cells and transfected COS-7 cells 
probably express differentially glycosylated chTim1 proteins. This differential 
glycosylation of chTim1 may also cause a modification of the epitope recognised by 
the anti-chTim1 mAb GG9, resulting in GG9 not detecting chTim1 protein in 
chicken cell lysates (Figure 6.6). Although a similar pattern of molecular weight 
bands in bursal cell and splenocyte lysates were detected by both anti-chTim1 and 
anti-chTim4S sera, the former detected much stronger 72 kDa bands than the latter 
and the former did not cross-react with chTim4S and chTim4L proteins in control 
transfected COS-7 cell lysates (Figure 6.7C), suggesting 72 kDa bands may 











Chapter 7.    General discussion. 
This project aims to determine if the chicken has Tim family molecules and if 
their biological and immunological activities are similar to those of mammalian 
counterparts. MAbs against chicken Tim molecules were also generated for further 
investigation of their expression patterns on chicken immune cell subsets, again in 
comparison to those seen in mammals. 
As described previously, mammalian Tim family molecules have specific 
expression patterns on immune cells, especially Tim1 on Th2 cells and Tim4 on 
APCs. Tim4 is a natural ligand of Tim1; through Tim1-Tim4 interactions, APCs 
drive Th2 cell proliferation. The chicken Th1/Th2 paradigm has been studied for 
many years, but little is known about specific Th1/Th2 cell surface molecules. 
Studying the chicken Tim family molecules will help to understand how the immune 
responses of chicken T helper subsets are regulated through their surface molecules 
and also provide immunological tools to further study these cells. 
7.1 Chicken Th2-biased immune responses  
As described in Chapter 1, the Th1/Th2 paradigm extends to the chicken to 
enable it to clear infections with a variety of pathogens, such as Th1 cells secrete the 
key Th1 cytokine, IFN-γ, to clear infections with intracellular pathogens, including 
bacterial (Kogut et al., 2005b; Beeckman et al., 2010) and viral (Degen et al, 2005; 
Eldaghayes et al, 2006) infections. Th2 cells produce the signature cytokines, IL-4, 
IL-13 and IL-5 (Avery et al., 2004) to clear infections with extracellular pathogens, 
such as parasites (Rothwell et al., 2004; Powell et al., 2009; Andersen et al., 2013). 
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In mammals, Th2 responses minimize the virulence of helminth infections by 
activating other intestinal cells, such as intestinal epithelial cells (IECs) and goblet 
cells, to repair damaged tissue, and reduce helminth numbers in the intestinal tract by 
increasing intestinal fluid volume, with the help of increased intestinal muscle 
contraction, to flush the worms out of the gut (Girgis et al., 2013). Mammalian Th2 
responses are typified by high IgE titres. During the disease process, activated Th2 
cells increase Th2 cytokine production. IL-13 and IL-4, in cooperation with the 
CD40-CD40L pathway, activate B cells and upregulate IgE production that can in 
turn activate the cells that express Fc receptors (FcRs), such as basophils, eosinophils, 
and mast cells, to amplify the type 2 response by producing more IL-4 (Girgis et al., 
2013). However, a deleterious effect of overwhelming Th2 responses is increased 
allergies and asthma in mammals.  
The chicken has few Th2 cytokine-targeted cells - eosinophils, mast cells and 
basophils - in peripheral blood. The eotaxins, critical chemokines for recruit of 
eosinophils in allergical responses, and their receptors are missing in the chicken 
(Kaiser et al., 2005). Chickens lack IgE. Th2-associated allergies are unknown for 
birds (Vegad and Katiyar, 1995). IL-5 is switched off during Th2 responses (Powell 
et al., 2009). All these facts suggest that the chicken Th2 immune responses have 
differentiated from those of mammals during their 300-million-year separation from 
a common ancestor. Interestingly, the chicken still maintains Tim1 and Tim4.  
7.2 Identification and characterisation of chicken Tim cDNAs 
Two clusters of chicken EST sequences homologous to mammalian Tim1 and 
Tim4 molecules were found by Blast searches of the chicken genome and EST 
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databases (Chapter 3). The chicken Tim family only has two genes, chTim1 and 
chTim4. There were no significant matches elsewhere in the chicken genome. The 
chicken Tim locus has conserved synteny with mammals, flanked by several 
conserved marker genes. Analysis of the Tim locus in other avian species indicated 
that the turkey has a similar Tim family to the chicken, with two members, Tim1 and 
Tim4, whereas the zebra finch has a Tim3-like gene as well as Tim1 and Tim4, 
suggesting domestic and wild birds may have differently evolved their Tim families.  
Based on information from the EST sequences, chTim1 and chTim4 cDNAs 
were amplified by RT-PCR. Like mammalian Tim1, chTim1 is a type I protein with 
a signal peptide, IgV, mucin and transmembrane domains and a cytoplasmic tail. The 
IgV domain of chTim1 molecule has 6 conserved cysteines, presumably involved in 
forming the correct secondary structure and a PS-binding motif associated with 
phagocytosis of dead cells. The chTim1 mucin domain has large numbers of serine, 
threonine and proline residues (T/S/P-rich), which are potential O-linked 
glycosylation sites. The cytoplasmic tail of chTim1 has a tyrosine kinase 
phosphorylation motif, which suggests that chTim1 is involved in signal transduction, 
as are its mammalian equivalents.  
Differently to mammalian Tim4, two isoforms of chTim4 - chTim4S and 
chTim4L - were initially cloned from RNA from a line 72 bird. Like chTim1, the 
chTim4S cDNA encodes a type I protein with a signal peptide, IgV, mucin and 
transmembrane domains and a cytoplasmic tail. The IgV domain also has a PS-
binding motif and the mucin domain is T/S/P-rich. However, chTim4 does not have a 
tyrosine kinase phosphorylation motif, suggesting it does not signal.  The chTim4S 
mRNA is encoded by 9 exons, lacking exons 3, 4 and 5 of chTim4L. The chTim4L 
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molecule, encoded by 12 exons, is almost identical to chTim4S in the signal peptide, 
mucin and transmembrane domains and the cytoplasmic tail. However, exons 2 and 5 
of chTim4L encode two almost identical IgV domains, which are linked by a short 
hinge encoded by exons 3 and 4.  Comparison of chTim4L cDNA with chicken 
genomic sequence by Blast searches indicated that either exons 4 or 8 of chTim4L 
were matched to two regions in chromosome 13 in an overlapping pattern. Further 
analysis indicated exons 4 and 8 are highly analogous. The intronic sequences 
flanked them were also analysed, including intron 3 (between exons 3 and 4), intron 
4 (exons 4 and 5), intron 7 (exons 7 and 8) and intron 8 (exons 8 and 9). Interestingly, 
intron 3 and 7 are highly homologous at their 3’ ends.  Intron 4 and 8 are also highly 
homologous at their 5’ ends.  Splicing of an exon is controlled by multiple elements, 
including the 3’ acceptor splice site at the 3’ end of the upstream intron and the 5’ 
donor splice site at the 5’ end of the downstream intron, as well as elements such as 
exonic splice enhancers and exonic silencers (Reed et al., 1986). The similarity of 
exons 4 and 8 of chTim4 and the proximal intronic sequences upstream and 
downstream of them suggests that both exons may have similar chances to be spliced 
during pre-mRNA splicing, implying different chTim4 splice variants should be 
present. As predicted, a new isoform of chTim4 was cloned from splenic cDNA from 
a J line bird. This new chTim4 variant is even shorter than chTim4S, and was named 
chTim4-extra-short (chTimeS), encoded by 8 exons with almost identical cDNA 
sequences to those of chTim4L, but lacking exons 5, 6, 7 and 8 of chTim4L.  
Alternatively spliced mRNA are found in multiple mammalian cell surface 
molecules, such as human CD80 (Inobe et al., 1996), CD86 (Jeannin et al., 2000), 
CD28 (Magistrelli et al., 1999a), CTLA-4 (Magistrelli et al., 1999b), CD44 (Konig et 
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al., 1998), CD83 (Dudziak et al., 2005), Fas (Jenkins et al., 2000) and murine Fas 
ligand (Ayroldi et al., 1999) and Tim3 (Geng et al., 2006). Although each of them is 
generated by different mechanisms, the alternative splicing results in soluble and 
membrane-bound forms for all of them. The soluble proteins generally antagonise 
the binding of the membrane-bound forms to their ligands. It remains to be 
determined if chTim4 also has a soluble form. If the excluded exons (5, 6, 7 and 8) of 
chTim4 could be spliced to exon 1 (which encodes signal peptide), a soluble form of 
chTim4 would be produced. This soluble form could also compete with membrane-
bound chTim4 for binding to its ligand, because it contains an IgV domain encoded 
by exon 5 and binding sites for the chTim4 ligand(s) on the IgV domain have been 
shown by flow cytometric analysis (Chapter 4). However, this splice form has not yet 
been demonstrated. 
Three chTim4 variants were identified thus far. Are there more chTim4 
variants? When the original RT-PCR gel picture for chTim4S and chTim4L cloning 
was re-examined (Figure 3.3), there was a very faint band close to but larger than the 
chTim4L band, implying a larger isoform of chTim4 which was ignored previously, 
due to its low abundance. In mammals, alternative splice events for certain molecules 
can vary their biological activities, but the transcriptional abundance of certain splice 
variants is highly associated with the tissue or cell types which undertake these 
activities (Kalsotra et al., 2011). Therefore, it is a reasonable hypothesis that some 
types of chicken cells or stimulated cells may abundantly express this predicted 
chTim4 variant. An attempt was then made to amplify it by RT-PCR from different 
RNA samples, including spleen and rchCD40L-stimulated splenocytes from a J line 
chicken. A new isoform of chTim4 was eventually identified from rchCD40L-
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stimulated adherent splenocytes (Chapter 3). As predicted, this isoform is even 
longer than chTim4L and was named chTim4-extra-long isoform (chTim4eL). It is 
encoded by the same 12 exons as chTim4L, but exon 3 is 198 bp longer at the 5’ end 
than that encoding chTim4L.  
Therefore, four chTim4 splice variants have been identified. How is the 
alternative splicing of chTim4 mRNA regulated?  There are 4 basic models of 
alternative splicing, based on global analysis of the human and mouse genomes 
(Matlin et al., 2005). 1) Exon skipping, where an exon or exons may be spliced out 
of the primary transcript or retained. This is the most common model in mammalian 
pre-mRNA splicing. 2) Mutually exclusive exons, where one of two exons is retained 
in mRNAs after splicing, but not both. 3) Alternative donor sites, where an 
alternative 5' splice junction (donor site) is used, changing the 3' boundary of the 
upstream exon. 4) Alternative acceptor sites, where an alternative 3' splice junction 
(acceptor site) is used, changing the 5' boundary of the downstream exon. From these 
models, chTim4S may be a result of exon skipping (model 1), splicing out exons 3, 4 
and 5 of chTim4 and rejoining between exons 2 and 6. ChTim4L may use an 
alternative 3’ acceptor site (model 4) in exon 3, resulting in a shorter exon 3 to rejoin 
to exon 2 when compared to chTim4eL.  
However, RT-PCR analysis indicated that chTim4S is a constitutive form of 
chTim4 because it is predominantly expressed in normal spleen tissue and variety of 
splenocyte subsets isolated from normal chickens (Chapter 3 and 4). Stimulation 
with rchCD40L downregulated expression levels of chTim4S in splenocytes, but 
increased expression levels of chTim4L in these cells (Chapter 3). ChTim4eL seems 
to be present in adherent splenocytes but may require rchCD40L induction (Chapter 
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3). ChTim4eS expression is even lower in normal spleen tissue (Chapter 3). Exon 3 
of chTim4eL is longer than in the other chTim4 variants. Elements, such as an 
exonic splice enhancer (ESE), may be present in the long form of exon 3, driving 
splicing of the shorter version in normal circumstances; however, stimulation (such 
as with rchCD40L) may trigger inhibitory elements, such as an exonic splice silencer 
(ESS), in some cell type (such as adherent splenocytes) to prevent exon 3 being 
spliced in the middle, resulting in the chTim4eL transcript.  
ChTim4eS mRNA is at low abundance in normal spleen tissue, suggesting it 
may be a rare alternative splicing event. Although chTim4eS also has a short exon 3, 
the exclusion of exons 5, 6, 7 and 8 means that the chTim4 splicing mechanisms are 
much more complicated. The homology between exons 4 and 8 and the proximal 
intronic sequences surrounding them could be a factor in the alternative chTim4eS 
splicing.  
The IgV domain of chTim4 interacts with its ligands, whereas the mucin 
domain has no particular ligands but seems to enhance interaction between IgV and 
its ligands, as described in Chapter 4. Through alternative mRNA splicing, a single 
chTim4 gene results in at least four membrane-anchored proteins. ChTim4S is 
probably the basic form of chTim4, with roles similar to those of mammalian Tim4 
molecules. ChTim4L and chTim4eL both have two IgV domains, and stimulation 
can upregulate their mRNA transcription. Does an extra IgV domain mean that 
chTim4L and chTim4eL have more effective biological roles than those of chTim4S 
and chTim4eS in emergency situations, such as increased phagocytosis of dead cells 
caused by microbial infection or increased induction of T cell responses? A longer 
exon 3 in chTim4eL results in a longer hinge between the two IgV domains than that 
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of chTim4L. Does the longer hinge in chTim4eL mean a more flexible IgV domain 
at the NH2-terminus, resulting in a higher binding affinity for its ligand than 
chTim4L? 
7.3 Biological roles of the chTim molecules 
7.3.1 ChTims act as PS receptors to mediate phagocytosis of dead 
cells  
The chicken Tim molecules are the first PS receptors to be identified in this 
species. Specific interaction between chTim and PS was demonstrated by in vitro 
protein-lipid overlay assays using chTim4S- and chTim1-Ig fusion proteins (Chapter 
4). Dying chicken cells expose PS on their cell surfaces, demonstrated by stimulation 
of splenocytes with high doses of ConA. Flow cytometric analysis indicated that the 
stimulated cells were strongly stained by a PS indicator, annexin V. ChTim4S-Ig can 
bind to ConA-stimulated chicken splenocytes, whereas pre-blocking with PS 
dramatically reduced chTim4S binding, suggesting the chTim4S molecule can 
recognise PS exposed on apoptotic chicken cells. Physiologically, chTim molecules 
binding to PS enhance dead cell phagocytosis. ChTim1- and chTim4-mediated 
phagocytic activity was also demonstrated with transfected fibroblast cells (3T3), 
where overexpression of chTim proteins on the surface of transfected cells resulted 
in increased uptake of apoptotic cells.  
Similarly to mammalian Tim4, the chTim4 molecule is expressed on the 
surface of chicken splenic and bone marrow-derived macrophages, suggesting a 
similar role for chTim4 to that of mammalian Tim4 in clearance of dead cells by 
macrophages through interaction with its ligand PS on dead cells. A variety of 
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apoptotic cell recognition receptors have been documented in mammals, falling into 
two categories: one involved in tethering the apoptotic cell and the other in triggering 
an uptake signal related to macropinocytosis. However, apoptotic cell receptors, such 
as CD36, αvβ5 integrin, CD14 and CD68, only tether aged-erythrocytes but promote 
little internalisation. PS receptors (PSRs) alone induce neither tethering nor uptake of 
PS-exposed erythrocytes. When tethering and PS receptors work together, dead cells 
can be effectively ingested by phagocytes. This is the so-called “tethering and 
tickling” model proposed by Hoffmann et al. (2001), where the “tethering” receptors 
help phagocytes capture dead cells through recognition of their ligands,  and ligation 
of PSR on phagocytes then delivers a “tickle” signal, which stimulates the 
internalization of apoptotic cells. 
Controversially, as a PSR, the Tim4 molecule lacks a cytoplasmic motif for 
signal transduction. Tim4 showed a “tethering” role in phagocytosis of apoptotic 
cells in a murine model proposed by Toda et al. (2011), where over-expression of 
Tim4 alone on the surface of Ba/F3 cells, a mouse pro-B cell line which has no 
phagocytic activity, efficiently bound apoptotic cells in a PS-dependent manner but 
did not engulf them; however, co-expressing Tim4 and the integrin αvβ3 in 
transfected Ba/F3 cells showed increased binding and engulfment of apoptotic cells 
in the presence of milk fat globule epidermal growth factor VIII (MFG-E8), a 
secreted protein that can bind PS and integrin αvβ3, suggesting a “tickling” role for 
phagocytotic signal transduction. However, it can not be excluded that Tim4 binds an 
unknown molecule to form a complex for transduction of engulfment signals (Toda 
et al., 2011).  
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ChTim1 also specifically binds to PS, suggesting it is a PS receptor. 
Overexpression of chTim1 on the surface of 3T3 cells also resulted in an enhanced 
uptake of apoptotic cells. However, Tim1-mediated phagocytosis of dead cell bodies 
has only been described on renal proximal tubular epithelial cells, where Tim1 
expression converts these epithelial cells into phagocytes for the repair process after 
kidney injury (Bonventre et al., 2010). Mammalian Tim1 is also widely expressed on 
other immune cells, such as T cells, B cells and DCs, but its role is to regulate 
immune responses of these cells rather than phagocytic activities. For example, Tim1 
expressing on activated Th2 cells positively regulates immune responses of these 
cells (de Souza et al., 2005). Murine DCs express Tim1, through Tim1 signalling to 
enhance upregulation of costimulatory molecule expression and proinflammatory 
cytokine production, which in turn promote effector T cell responses, but inhibit 
Foxp3
+
 Treg responses (Xiao et al, 2011). Regulatory B cells also express Tim1; 
acting through Tim1, these cells can be induced to promote tolerance in mice (Ding 
et al., 2011). The chTim1 was also expressed by T cells, B cells and DCs by qRT-
PCR analysis. Presumably, it has similar immunological roles to mammalian Tim1. 
However, as a PS receptor, chTim1 would inevitably bind to PS-exposed cells in the 
in vivo environment, especially when the body experiences damage by pathogens or 
environmental effects. As a result, chTim1 may bridge immune cells to apoptotic 
cells and form an inflammatory milieu, either to resolve inflammation or worsen it.   
7.3.2 Costimulatory activity of chTim4S 
ChTim4S-Ig fusion protein alone did not significantly stimulate chicken 
splenocyte proliferation. However, in the presence of anti-CD3 and -CD28 
antibodies, chTim4S-Ig increased splenocyte proliferation, suggesting that chTim4 is 
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a T cell costimulatory molecule requiring TCR and CD28 signalling. Several lines of 
evidence suggest that the costimulatory activities of chTim4S could be through its 
interaction with chTim1, as with mammalian Tim4. ChTim1 has a conserved 
tyrosine phosphorylation motif in its cytoplasmic domain for signal transduction 
(Chapter 3); chTim1 is also expressed by splenocyte subsets by qRT-PCR analysis 
(Chapter 4); thirdly, chTim1 protein is present in splenocyte lysates analysed by 
western blot using anti-chTim1 polyclonal serum, although it remains to be 
determined precisely which splenocyte subsets express chTim1 protein (Chapter 6).  
T cell activation requires at least two signals, TCR triggering and T cell 
costimulatory molecules. The latter are now categorized into three families with 
distinct and overlapping functions, including the CD28 family (CD28, CTLA-4, 
ICOS and PD-1) (Chen et al., 2004), the tumour necrosis factor family (CD40L, 
OX40, and 4-1BB) (Croft et al., 2003) and the signalling lymphocyte activation 
molecule (SLAM) family (CD2, SLAM (CD150) and 2B4 (CD244)) (Veillette et al., 
2003). In mammals, Tim1 costimulation functions require signals provided by the 
TCR and CD28 for T cell proliferation and cytokine production. Tim3, preferentially 
expressed on Th1 cells, is important in the development of autoimmune disease and 
tolerance. Tim3 may provide a negative costimulatory signal to the T cell, as the 
administration of a blocking antibody to Tim3 enhances the clinical and pathological 
severity of experimental autoimmune encephalomyelitis and Tim3-deficient mice are 
resistant to induction of high antigen dose tolerance. Therefore, Tim1 and Tim3 may 
together constitute a unique family of costimulatory molecules (Meyers et al., 2005b).  
However, as described before, the chicken only has chTim1 and chTim4; the 
latter stimulates splenocyte proliferation probably through chTim1. Therefore, how 
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does the chicken immune system balance chTim1-mediated T cell activation? An 
inhibitory molecule may exist to antagonise chTim1-mediated T cell responses.   
7.4 ChTim expression in chicken primary cells by flow cytometric 
analysis 
qRT-PCR analysis revealed that the chTim molecules were highly expressed 
at the mRNA level in a variety of chicken tissues and different splenocyte subsets 
(Chapter 4). To investigate expression of chTim proteins in chicken immune cells, 
anti-chTim mAbs were generated and characterised by ELISA, western blot, 
immunostaining and flow cytometry, as described in Chapter 5. The anti-chTim 
mAbs specifically recognised different forms of the chTim antigens, including 
purified chTim fusion proteins, chTim proteins overexpressed on the surface of 
transfected CHO cells and denatured chTim proteins on fixed COS-7 cells or in 
COS-7 cell lysates. MAbs were raised against the hinge part of chTim4L, encoded by 
exons 3 and 4, by design, which specifically recognise the chTim4L antigen but not 
chTim4S (Chapter 5). However, the anti-chTim4S mAbs recognised chTim4L 
antigens, because of the high similarities of their aa sequences across the entire 
molecules, as described in Chapter 3. Based on the information from in vitro 
characterisation, one anti-chTim1 mAb (GG9) was then chosen to analyse the 
expression of chTim1 in chicken immune cells. Two mAbs against chTim4 were also 
chosen, including a mAb (IE12) against the hinge part of chTim4, which would 
detect chTim4eL, chTim4L and chTim4eS which all contain the hinge part of 
chTim4, named anti-novel chTim4 antibody, and a mAb (JH9) with its epitope 
mapped to the IgV domain of chTim4, which would detect all chTim4 isoforms, 
named anti-chTim4 antibody.  
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Staining of unstimulated primary chicken splenocytes with these anti-chTim 
mAbs, followed by flow cytometric analysis, indicated that there was no obvious 
detection of chTim molecule expression on the cell surface. However, after 




 splenocytes were stained by 
the anti-novel chTim4 mAb (IE12), whereas the anti-chTim4 mAb (JH9) did not 
detect anything. This was inconsistent with the observations in Chapter 5, where JH9 
always recognised the chTim4L protein, either in its native form expressed on the 
surface of transfected CHO cells or in its denatured form on fixed COS-7 cells and in 
COS-7 cell lysates. As described in Chapter 3, the chTim4 molecule has multiple 
potential N- and O-linked glycosylation sites. Different modification of the chTim4 
protein in chicken primary cells may result in variation in the epitope recognised by 
the mAb JH9, but not the epitope recognised by the anti-chTim4L mAb (IE12).  
Anti-chTim mAbs were also used to investigate if stimulation affects chTim 
expression in chicken immune cells by flow cytometric analysis (Chaptor 6).  In 
unstimulated splenocytes, KUL01
+
 macrophages express chTim4 on surface, 
consistent with mammalian Tim4 expression on macrophages. However, CD4
+
 
splenocytes also express chTim4 on the cell surface. So far, there is no evidence of 
Tim4 protein expression on CD4
+
 T cells in mammals; therefore, these chTim4-
expressing CD4
+
 splenocytes could be splenic DCs, similarly to mammalian Tim4-
expressing splenic CD4
+
 DCs. Interestingly, in freshly-isolated splenocytes, a small 
number of cells was stained by the anti-novel chTim4 mAb IE12 intracellularly, but 
not by the anti-chTim4 mAb JH9, whereas in unstimulated splenocytes, both mAbs 
can bind to these cells on the cell surface. It could be a result that expression of the 
chTim4 protein on the cell surface facilitates access of mAb JH9 to its epitope. 
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Why is the chTim4 molecule expressed intracellularly in freshly-isolated 
splenocytes, but on the cell surface in cultured splenocytes? It could be a result of 
chTim4 proteins trafficking to the cell surface during in vitro culture, as described in 
a Tim molecule trafficking model proposed by Santiango et al. (2007a). In this model, 
after intracellular translation, Tim proteins are transported to the cell membrane. 
However, they are not directly expressed onto the surface, but bind to PS on the inner 
layer of the cell membrane. PS exposure to the outer layer of the membrane, due to 
alteration of cell membrane lipid asymmetry, results in co-transportation of Tim 
proteins onto the cell surface. The alteration of membrane lipid asymmetry in this 
model is initiated by activation of lipid scramblase, which requires influx of calcium 
into the cells. However, in this study, there had no any supplements, such as extra 
calcium iron, ionomycin etc., in growth medium to influence intracellular calcium 
concentration, suggesting cell membrane asymmetry may affect chTim4 expression 
on the cell surface, but less importantly.  
ConA and PHA had no significant effects on chTim expression on 
splenocytes (Chapter 6). However, PMA stimulation dramatically upregulated 
chTim4 expression levels on splenic Bu-1
+
 B cells (Chapter 6). PMA specifically 
targets the PKC signalling pathway for cell activation. PMA can block anti-IgM 
antibodies in the activation of normal and malignant B cells, suggesting that the PKC 
signal pathway is shared by the BCR (Mizuguchi et al., 1986). Therefore, PMA is 
normally used as a substitute for anti-IgM in B cell activation. The upregulation of 
chTim4 on PMA-stimulated B cells suggests that the IgM-associated BCR signalling 
pathway may also affect chTim4 expression on activated B cells. PMA-stimulated 
chicken naïve B cells also upregulated chTim4 expression. Chicken bursal cells, 
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predominantly naïve B cells, were stimulated with PMA and rchCD40L. Flow 
cytometric analysis indicated that PMA-stimulated bursal cells expressed high levels 
of chTim4, whereas rchCD40L-stimulated bursal cells had no detectable expression 
of chTim4, suggesting chTim4 expression may be pathway-dependent.  
KUL01
+
 macrophages from splenocytes also expressed chTim4, as analysed 
by flow cytometry (Chapter 6), but with cell numbers being low it was difficult to 
clearly show chTim4 expression on these cells. Bone marrow cells were then 
cultured with rchCSF-1 to derive macrophages, or with rchGM-CSF and rchIL-4 for 
DCs, followed by staining with the anti-chTim mAbs. Consistently, bone marrow-
derived macrophages highly expressed chTim4 on their cell surface. However, bone 
marrow-derived DCs had no obvious chTim4 expression. This may reflect divergent 
roles of chicken macrophages and DCs:  perhaps chTim4 expression on macrophages 
enhances phagocytosis of dead cells to maintain immune tolerance; however, the 
lack of chTim4 expression on DCs helps them avoid uptake of dead cells, resulting in 
a lower risk of DCs presenting self antigen. Stimulation of bone marrow-derived 
macrophages with PMA resulted in rapid downregulation of chTim4 levels on the 
surface of these cells, suggesting immature macrophages may be more important in 
the phagocytosis of self/dead cells than activated macrophages (Chapter 6). 
7.5 ChTim expression in chicken primary cells with western blot 
analysis 
A competitive ELISA revealed that the three anti-chTim1 mAbs recognised 
overlapping or closely related epitopes (Chapter 5). The anti-chTim1 mAb GG9 did 
not detect chTim1 expression on chicken primary cells, either permeablised 
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splenocytes or ConA-, PHA- or PMA-stimulated splenocytes (Chapter 6). Western 
blot analysis was also attempted to detect the presence of the chTim1 protein on 
thymocyte, splenocyte and bursal cell lysates; again, nothing was detected by mAb 
GG9 (Chapter 6). These results are inconsistent with observations that GG9 strongly 
reacted with chTim1 protein expressed by transfected COS-7 or CHO cells either in 
denatured or native form (Chapter 5). It could be that the protein structure of chTim1 
expressed by chicken primary cells differs from that of chTim1 expressed by cell 
lines (COS-7 and CHO), resulting in variation in the epitope recognised by GG9. 
Because the chTim1 molecule has high levels of potential N- and O -linked 
glycosylation sites in the protein (Chapter 3), differentially glycosylated chTim1 
protein in different cell types may be due to variable levels of the enzymes which 
control protein modification. This phenomenon has been observed with the murine 
Tim1 protein, in that different cell types expressed different glycosylated forms of 
murine Tim1 (Ichimura et al., 1998).  Therefore, a polyclonal anti-Tim1 serum was 
used to detect the chTim1 protein in chicken primary cell lysates with western blot 
analysis (Chapter 6). Differently to mAb GG9 (anti-chTim1), the polyclonal anti-
chTim1 serum detected strong and clear bands at 72 kDa in both bursal cell and 
splenocyte lysates. By contrast, the anti-chTim1 serum did not cross-react with 
chTim4S or chTim4L protein in control transfected COS-7 cell lysates. The presence 
of chTim1 in the bursal cell lysate is consistent with the observation of its mRNA 
expression in bursal tissue (Chapter 4), suggesting that naïve B cells express chTim1. 
ChTim1 protein in splenocyte lysate could also be a consequence of chTim1 
expression in different splenocyte subsets, as was measured by qRT-PCR.  
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To determine which chTim4 molecules are expressed in chicken primary 
cells, the anti-chTim4 (JH9) and anti-novel chTim4 (IE12) mAbs were used to detect 
the presence of chTim4 in chicken cell lysates with western blot analysis (Chapter 6). 
IE12 detected bands of approximately 100 kDa in thymocyte, bursal cell and 
splenocyte lysates, which is a molecular weight very close to that of full-length 
chTim4L (95 kDa) expressed by transfected COS-7 cells. However, mAb JH9 only 
detected 45 kDa bands in thymocyte, bursal cell and splenocyte lysates, which is a 
molecular weight much smaller than those of chTim4S (75 kDa) and chTim4L (95 
kDa) expressed by COS-7 cells. One explanation is that chicken primary cells 
express other molecular weight chTim4 proteins which may not be detected by the 
mAbs.  A polyclonal anti-chTim4S serum was then used to analyse chTim4 protein 
expression (Chapter 6). As expected, the anti-chTim4S serum strongly bound to 
chTim4S and chTim4L proteins in control transfected COS-7 cell lysates, resulting 
in major bands with similar molecular weights as those detected by the anti-chTim4 
mAbs (JH9) (Chapter 5).  Differently to JH9, besides recognition of 45 kDa bands in 
all chicken cell lysates, the anti-chTim4S serum also detected strong and clear bands 
at 72 kDa in bursal cell and splenocyte lysates, suggesting that chTim4S protein may 
be abundantly expressed by splenocytes and bursal cells, whereas the 45 kDa 
proteins could be chTim4eS or other chTim4 isoforms of low molecular weight. 
Close examination of western blot detection with the anti-chTim1 or anti-
chTim4S serum indicated that both of them recognised similar molecular weights 
and patterns of bands, especially in bursal cell and splenocyte lysates (Chapter 6). 
However, the 72 kDa bands detected by the anti-chTim1 serum in both cell lysates 
are much stronger when compared to those detected by the anti-chTim4S serum, and 
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the anti-chTim1 serum did not cross-react with chTim4 in control transfected COS-7 
cell lysates, suggesting a 72 kDa chTim1 protein could be genuinely expressed by 
bursal cells (predominantly naïve B cells) and splenocytes.  
7.6 Future plans  
Differently to what has been reported in mammals, the chicken has several 
chTim4 splice variants (Chapter 3). However, RT-PCR analysis (Chapter 3) 
indicated that chTim4S and chTim4L are the predominant forms expressed by 
chicken immune cells; chTim4S was the major form expressed in a variety of 
splenocyte subsets from an SPF line 72 chicken, whereas chTim4L expression was 
only upregulated in rchCD40L-stimulated splenocytes. Flow cytometric analysis 
indicated that freshly isolated splenocytes expressed chTim4L protein intracellularly 
rather than on the cell surface (Chapter 6), but, after stimulation, chTim4 proteins 
were expressed on the surface of splenocytes (Chapter 6). Therefore, how is the 
chTim4 molecule regulated in chicken immune cells? One hypothesis is that 
chTim4S is predominantly expressed in chicken immune cells when the chicken is 
less immunised and lives in a hygienic environment, whereas immunisation and 
environmental stimulation upregulates chTim4L expression. ChTim4L protein is 
therefore maintained inside of the cell when the chicken’s immune system is not 
threatened. ChTim4L can be rapidly expressed on the surface of chicken immune 
cells when they sense stimulation. However, this remains to be demonstrated in a 
disease model. 
ChTim1 mRNA is expressed in chicken immune organs and cell subsets, as 
detected by qRT-PCR (Chapter 4). ChTim1 protein can also be detected by 
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polyclonal anti-chTim1 serum in bursal cell and splenocyte lysates with western blot 
analysis (Chapter 6). However, the anti-chTim1 mAb generated in this study did not 
detect chTim1 protein in primary cells, although it strongly recognised the chTim1 
antigen expressed by transfected cells. It would worth generating further mAbs 
against chTim1, because Tim1 is so important for Th2 cell immune responses in 
mammals, and most of the biological roles of Tim1 in mammals were demonstrated 
by anti-Tim1 mAbs.  
7.7 Conclusions 
The chicken has fewer Tim family members than mammals, but alternative 
splicing of chTim4 can generate multiple transcripts which encode proteins with 
potentially subtle or opposing functional differences which could result in profound 
biological consequences, as has been demonstrated for other multiple splicing genes 
in mammals (Graveley et al., 2001). For example, CD45 is a receptor-like protein 
tyrosine phosphatase and serves as an obligate positive regulator of antigen receptor 
signalling to regulate T and B cell lineage development. It is encoded by 34 exons 
and alternative splicing leads to inclusion or exclusion of exons 4, 5, and 6 in its 
NH2-terminus, resulting in eight different isoforms. Five of these have been detected 
at the protein level in human, and different isoforms were differentially required at 
different stages of T and B cell development (Hermiston et al., 2003). A cognate pair, 
Fas and Fas ligand (FasL), are associated with induction of cell apoptosis and both 
have alternative splice forms, resulting in membrane-bound and soluble proteins. The 
soluble forms of Fas/FasL serve as inhibitors to disrupt membrane-bound Fas 
signalling-induced apoptosis (Jenkins et al., 2000; Ayroldi et al., 1999). Reagents 
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and methods established in this project provide useful tools for further study of the 
biological roles of the individual chTim4 variants in healthy and infected birds.  
The chicken lacks many important components of mammalian Th2-
associated responses and Th2-associated allergy is rarely seen in chicken. However, 
Tim1 and Tim4, which both are involved in Th2 immune responses in mammals, are 
present in the chicken. The studies of the chTim molecules presented in this thesis 
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spin miniprep kit (Qiagen) 
P1                                                     50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 100 
µg/ml RNAse A 
P2                                                     200 mM NaOH, 1% SDS 
N3                                                   3 M KAc (pH 5.5) 
PB                                                  Aqueous mix of isopropanol and guanidine 
hypochlorite 
PE                                             Aqueous mix of Tris-HCl, hydroxymethyl and 
amino methane 
EB                                                10 mM Tris-HCl (pH 8.5) 
EndoFree plasmid Maxi kit (Qiagen) 
P1 and P2 as above 
P3                                                 3 M KAc (pH5.5) 
QBT                                              750 mM NaCl, 50 mM MOP (pH 7.0), 15% 
isopropanol (v/v) and 0.15% Triton X-100 (v/v) 
ER                                   Details not provided by manufacturer 
QC                       1 M NaCl, 50 mM MOPS (pH 7.0) and 15% 
isopropanol (v/v) 
QF                        1.25 M NaCl, 50 mM Tris-HCl (pH 8.5) and 15% 
isopropanol (v/v) 
QN                        1.6 M NaCl, 50 mM MOPS (pH 7.0) and 15% 
isopropanol (v/v) 
TE                               10 Mm Tris-HCl (pH 8.0) and 1 mM EDTA 
QIAquick
®
 gel extraction kit (Qiagen) 
PE and EB as above 
QG                           Aqueous mix containing guanidine hypochlorite 
RNease
®
 mini kit (Qiagen) 
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RLT (RT)                  Aqueous mix containing guanidine thiocyanate 
RW1 (RT)                       Aqueous mix containing guanidine thiocyanate 
RPE (RT)  Details not provided by manufacturer 
Sequencing (Buckman Coulter) 
DTCS quick start master mix   dATP, dCTP, dGTP, dTTP, ddATP, ddCTP, 
ddGTP, ddTTP, Thermo sequenase DNA 
polymerase, pyrophosphatase 
CEQ sequencing reaction buffer    Tris-HCl, MgCl2, pH 8.9 
Stop solution                               2 volumes 100 mM EDTA, 2 volumes 3 M 
NaOAc, 1    volume glycogen 
Sample loading solution             Formamide 
Miscellaneous solutions 
LB broth                   10 g bacto tryptone, 5 g bacto yeast extract, 10 g 
NaCl, adjust to pH 7.0 with 5 M NaOH. Made up 
to 1 liter with Milli-Q water. 
LB agar                            As above with 1.5% bacto-agar 
PBS                          NaCl (10 g), KCl (0.25 g), Na2HPO4 (1.437 g) 
and KH2PO4 (0.25 g) were dissolved in 900 ml 
Milli-Q water, adjusted pH to 7.0 and made up to 
1 litre volume with Milli-Q water. 
PBST PBS with 0.05% Tween-20 
SOC medium                Dissolve 20 g bacto tryptone, 5 g bacto yeast 
extract, 0.5 g NaCl in 950 ml Milli-Q water, add 
10 ml 250 mM KCl, 20 ml of sterile glucose and 
adjust pH to 7.0 with NaOH. Make final volume 
to 1 litre. 
10× PCR buffer (Invitrogen)       200 mM Tris-HCl (pH 8.4), 500 mM KCl. 
10× TBE buffer 890 mM Tris, 890 mM Boric acid, 20 mM EDTA, 
pH 8.0 
50× HAT supplement (Life technologies) 
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                                           A liquid mixture of sodium hypoxanthine (5 mM), 
aminopterin (20 µM) and thymidine (0.8 mM) 
50× HT supplement (Sigma-Aldrich)  
                                      A liquid mixture of 100 μM hypoxanthine, 16 μM 
thymidine 
AEC substrate kit (BD Pharmingen) 
AEC buffer                          Aqueous mix of sodium acetate, dimethylulfoxide, 
methanol, and urea peroxide 
AEC chromogen                    3-Amino-9-Ethylcarbazole and N, N, 
dimethylformamide 
Mayer’s hemotoxlin solution (Sigma-Aldrich)   
                                            Haematoxylin (1.0 g/l), sodium iodate (0.2 g/l), 
aluminium ammonium sulfate·12 H2O (50 g/l), 
chloral hydrate (50 g/l) and citric acid (1 g/l). 
SDS-PAGE buffer 
4× resolving buffer                1.5 M Tris/HCl, pH 8.8 

















Appendix 2  Screening hybridomas producing anti-chTim1 
mAbs 
 
A total of 768 polyclonal hybridomas (eight 96-well plates) were screened by 
indirect ELISA.  
 
T1 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.069 0.062 0.061 0.061 0.061 0.071 0.089 0.168 0.101 0.096 0.078 0.062 
B 0.058 0.097 0.079 0.153 0.07 0.091 0.118 0.076 0.069 0.219 0.1 0.059 
C 0.06 0.066 0.092 0.074 0.068 0.082 0.072 0.068 0.066 0.065 0.068 0.058 
D 0.063 0.074 0.068 0.071 0.083 0.114 0.235 0.127 0.08 0.075 0.069 0.062 
E 0.059 0.063 0.088 0.082 0.084 0.089 0.082 0.086 0.105 0.087 0.079 0.062 
F 0.06 0.071 0.107 0.195 0.078 0.103 0.094 0.091 0.098 0.146 0.077 0.056 
G 0.064 0.065 0.089 0.082 0.089 0.087 0.082 0.093 0.241 0.101 0.074 0.068 
H 0.105 0.064 0.207 0.255 0.114 0.114 0.079 0.1 0.081 0.074 0.082 0.062 
 
T2 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.069 0.082 0.079 0.203 0.1 0.097 0.086 0.093 0.087 0.079 0.072 0.07 
B 0.094 0.097 0.094 0.085 0.099 0.092 0.098 0.079 0.092 0.085 0.084 0.075 
C 0.075 0.084 0.109 0.107 0.094 0.1 0.178 0.086 0.095 0.106 0.073 0.076 
D 0.081 0.11 0.1 0.1 0.109 0.095 0.091 0.115 0.084 0.076 0.075 0.068 
E 0.077 0.125 0.12 0.108 0.107 0.09 0.092 0.097 0.084 0.074 0.07 0.069 
F 0.12 0.1 0.102 0.098 0.106 0.087 0.113 0.089 0.094 0.088 0.133 0.07 
G 0.073 0.115 0.099 0.11 0.104 0.089 0.09 0.083 0.09 0.114 0.073 0.07 
H 0.069 0.077 0.115 0.074 0.184 0.086 0.092 0.085 0.075 0.098 0.07 0.089 
 
T3 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.11 0.096 0.105 0.116 0.141 0.14 0.205 0.208 0.125 0.107 0.082 0.071 
B 0.076 0.107 0.12 0.09 0.094 0.084 0.086 0.079 0.083 0.101 0.087 0.076 
C 0.073 0.075 0.232 0.218 0.247 0.186 0.219 0.198 0.141 0.09 0.084 0.089 
D 0.077 0.1 0.08 0.093 0.106 0.095 0.106 0.117 0.101 0.094 0.086 0.075 
E 0.072 0.086 0.093 0.107 0.086 0.118 0.105 0.109 0.101 0.091 0.086 0.07 
F 0.108 0.091 0.353 0.118 0.144 0.13 0.126 0.122 0.179 0.124 0.096 0.13 
G 0.104 0.085 0.108 0.184 0.269 0.088 0.109 0.151 0.105 0.1 0.082 0.072 
H 0.071 0.077 0.076 0.093 0.121 0.105 0.114 0.102 0.087 0.135 0.12 0.071 
 
T4 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.07 0.073 0.079 0.067 0.069 0.077 0.072 0.08 0.073 0.072 0.096 0.064 
B 0.073 0.111 0.1 0.107 0.095 0.092 0.089 0.091 0.099 0.077 0.066 0.069 
C 0.072 0.089 0.107 0.124 0.184 0.097 0.11 0.08 0.08 0.08 0.085 0.066 
D 0.075 0.125 0.13 0.12 0.187 0.091 0.09 0.097 0.096 0.073 0.067 0.063 
E 0.09 0.155 0.095 0.13 0.11 0.108 0.113 0.112 0.096 0.093 0.074 0.065 
F 0.074 0.152 0.137 0.349 0.087 0.132 0.094 0.084 0.124 0.072 0.091 0.064 
G 0.068 0.082 0.098 0.109 0.098 0.103 0.16 0.081 0.079 0.087 0.089 0.08 




T5 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.073 0.097 0.103 0.085 0.093 0.089 0.121 0.14 0.089 0.078 0.073 0.073 
B 0.106 0.072 0.075 0.137 0.088 0.136 0.095 0.124 0.078 0.081 0.073 0.077 
C 0.071 0.082 0.077 0.141 0.106 0.097 0.085 0.102 0.084 0.082 0.134 0.071 
D 0.12 0.078 0.094 0.158 0.116 0.374 0.11 0.14 0.078 0.077 0.093 0.131 
E 0.078 0.078 0.088 0.097 0.086 0.117 0.127 0.147 0.104 0.085 0.086 0.087 
F 0.082 0.078 0.096 0.1 0.086 0.165 0.103 0.092 0.091 0.25 0.093 0.071 
G 0.075 0.075 0.094 0.092 0.093 0.089 0.426 0.098 0.1 0.116 0.113 0.072 
H 0.072 0.07 0.084 0.114 0.108 0.133 0.089 0.186 0.097 0.115 0.088 0.094 
 
T6 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.118 0.07 0.075 0.076 0.088 0.151 0.1 0.095 0.087 0.073 0.071 0.067 
B 0.075 0.08 0.088 0.099 0.084 0.143 0.093 0.087 0.114 0.088 0.075 0.067 
C 0.072 0.076 0.097 0.097 0.122 0.098 0.107 0.12 0.088 0.078 0.095 0.069 
D 0.08 0.108 0.11 0.114 0.103 0.089 0.108 0.096 0.148 0.081 0.096 0.068 
E 0.071 0.09 0.096 0.196 0.095 0.088 0.143 0.122 0.105 0.122 0.091 0.09 
F 0.072 0.108 0.093 0.088 0.088 0.094 0.097 0.117 0.109 0.115 0.075 0.073 
G 0.075 0.087 0.093 0.117 0.084 0.086 0.102 0.078 0.109 0.096 0.075 0.082 
H 0.088 0.074 0.083 0.121 0.08 0.149 0.083 0.086 0.085 0.112 0.069 0.068 
 
T7 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.147 0.067 0.068 0.08 0.076 0.074 0.099 0.073 0.166 0.088 0.099 0.072 
B 0.066 0.111 0.085 0.127 0.097 0.084 0.078 0.117 0.086 0.074 0.071 0.085 
C 0.078 0.096 0.084 0.089 0.096 0.133 0.086 0.082 0.087 0.101 0.077 0.07 
D 0.125 0.086 0.082 0.102 0.136 0.097 0.094 0.085 0.088 0.109 0.082 0.071 
E 0.071 0.081 0.078 0.098 0.112 0.095 0.09 0.113 0.082 0.175 0.073 0.07 
F 0.07 0.083 0.091 0.09 0.123 0.119 0.216 0.094 0.112 0.088 0.078 0.075 
G 0.074 0.078 0.08 0.111 0.094 0.082 0.094 0.092 0.318 0.085 0.087 0.07 
H 0.071 0.077 0.086 0.132 0.1 0.082 0.084 0.081 0.089 0.11 0.089 0.076 
 
T8 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.08 0.079 0.078 0.079 0.083 0.122 0.11 0.111 0.081 0.1 0.114 0.085 
B 0.071 0.082 0.082 0.082 0.086 0.092 0.113 0.107 0.106 0.09 0.101 0.073 
C 0.093 0.09 0.154 0.151 0.089 0.088 0.086 0.119 0.115 0.104 0.084 0.09 
D 0.107 0.087 0.088 0.08 0.077 0.09 0.085 0.093 0.123 0.085 0.127 0.079 
E 0.07 0.082 0.081 0.084 0.088 0.145 0.1 0.082 0.082 0.081 0.171 0.076 
F 0.088 0.078 0.085 0.091 0.141 0.088 0.08 0.091 0.089 0.085 0.083 0.076 
G 0.076 0.144 0.142 0.125 0.087 0.101 0.089 0.101 0.092 0.081 0.081 0.076 
H 0.077 0.078 0.09 0.079 0.092 0.077 0.095 0.079 0.091 0.139 0.127 0.069 
 
Note: T means test plate. The fusion was carried out with the spleen from mouse 1. 
ELISA was performed as described in section 5.2.4. 102 positive hybridomas, as 




Appendix 3  Screening hybridomas producing anti-chTim4L-
hinge mAbs 
 
A total of 768 polyclonal hybridomas (eight 96-well plates) were screened by 
indirect ELISA.  
 
T1 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.123 0.08 0.064 0.105 0.086 0.071 0.149 0.095 0.16 0.087 0.092 0.065 
B 0.072 0.186 0.081 0.157 0.113 0.069 0.143 0.159 0.162 0.365 0.08 0.084 
C 0.484 0.133 0.449 0.173 0.104 0.121 0.156 0.141 0.178 0.103 0.075 0.08 
D 0.064 0.077 0.12 0.153 0.096 0.113 0.087 0.13 0.144 0.088 0.073 0.382 
E 0.075 0.11 0.175 0.212 0.181 0.183 0.125 0.124 0.129 0.147 0.083 0.062 
F 0.078 0.17 0.171 0.179 0.256 0.192 0.109 0.078 0.099 0.073 0.082 0.064 
G 0.065 0.095 0.192 0.143 0.297 0.219 0.104 0.101 0.075 0.14 0.075 0.084 
H 0.067 0.18 0.109 0.41 0.144 0.182 0.117 0.551 0.096 0.081 0.402 0.087 
 
C1 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.079 0.109 0.145 0.247 0.101 0.103 0.196 0.236 0.234 0.276 0.191 0.137 
B 0.121 0.429 0.212 0.267 0.275 0.146 0.207 0.234 0.201 0.599 0.288 0.189 
C 0.591 0.159 0.617 0.236 0.327 0.257 0.189 0.231 0.238 0.272 0.208 0.345 
D 0.111 0.195 0.178 0.13 0.116 0.17 0.12 0.366 0.237 0.265 0.266 0.153 
E 0.103 0.096 0.173 0.102 0.232 0.183 0.336 0.242 0.238 0.45 0.188 0.081 
F 0.089 0.085 0.129 0.123 0.122 0.296 0.263 0.377 0.28 0.253 0.21 0.194 
G 0.08 0.088 0.14 0.091 0.407 0.252 0.251 0.212 0.263 0.447 0.332 0.305 
H 0.078 0.374 0.114 0.411 0.125 0.105 0.135 0.592 0.307 0.289 0.286 0.219 
 
T2 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.093 0.104 0.105 0.15 0.101 0.235 0.117 0.135 0.115 0.15 0.148 0.146 
B 0.084 0.171 0.183 0.176 0.566 0.254 0.189 0.167 0.239 0.154 0.155 0.107 
C 0.088 0.288 0.194 0.196 0.22 0.413 0.115 0.121 0.132 0.172 0.122 0.108 
D 0.125 0.152 0.194 0.152 0.121 0.103 0.131 0.202 0.149 0.188 0.162 0.095 
E 0.09 0.197 0.123 0.11 0.118 0.167 0.186 0.201 0.205 0.187 0.536 0.115 
F 0.107 0.105 0.617 0.127 0.279 0.194 0.214 0.585 0.16 0.118 0.148 0.109 
G 0.242 0.09 0.134 0.11 0.182 0.204 0.174 0.204 0.223 0.133 0.146 0.143 
H 0.081 0.096 0.098 0.119 0.117 0.263 0.237 0.18 0.177 0.146 0.139 0.119 
 
C2 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.085 0.202 0.098 0.131 0.107 0.332 0.109 0.096 0.109 0.169 0.185 0.098 
B 0.118 0.1 0.19 0.138 0.53 0.101 0.116 0.139 0.304 0.117 0.165 0.137 
C 0.128 0.497 0.11 0.168 0.172 0.574 0.149 0.102 0.122 0.112 0.084 0.093 
D 0.189 0.208 0.086 0.105 0.238 0.125 0.102 0.391 0.275 0.094 0.063 0.09 
E 0.124 0.132 0.169 0.188 0.123 0.119 0.143 0.1 0.097 0.08 0.594 0.086 
F 0.297 0.18 0.157 0.169 0.135 0.1 0.092 0.595 0.102 0.082 0.078 0.076 
G 0.456 0.189 0.208 0.127 0.121 0.241 0.142 0.092 0.078 0.089 0.071 0.076 





T3 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.07 0.136 0.068 0.071 0.074 0.071 0.079 0.076 0.089 0.081 0.075 0.072 
B 0.063 0.065 0.079 0.145 0.088 0.068 0.068 0.066 0.256 0.081 0.067 0.064 
C 0.066 0.085 0.074 0.073 0.073 0.076 0.396 0.073 0.072 0.068 0.072 0.076 
D 0.065 0.064 0.087 0.076 0.07 0.07 0.075 0.076 0.084 0.079 0.072 0.068 
E 0.071 0.076 0.068 0.104 0.096 0.071 0.087 0.639 0.138 0.093 0.088 0.091 
F 0.065 0.064 0.105 0.537 0.155 0.074 0.073 0.102 0.099 0.098 0.08 0.067 
G 0.065 0.067 0.086 0.08 0.083 0.098 0.087 0.067 0.077 0.076 0.538 0.081 
H 0.141 0.069 0.066 0.063 0.123 0.069 0.072 0.079 0.176 0.066 0.094 0.063 
 
C3 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.067 0.245 0.067 0.066 0.069 0.092 0.149 0.067 0.081 0.08 0.082 0.068 
B 0.075 0.075 0.122 0.069 0.072 0.07 0.068 0.069 0.067 0.067 0.075 0.068 
C 0.088 0.12 0.073 0.073 0.076 0.07 0.086 0.067 0.063 0.063 0.064 0.066 
D 0.061 0.063 0.066 0.069 0.133 0.099 0.068 0.087 0.064 0.08 0.095 0.066 
E 0.063 0.061 0.063 0.15 0.071 0.067 0.065 0.108 0.064 0.063 0.071 0.078 
F 0.061 0.063 0.067 0.068 0.068 0.072 0.067 0.11 0.07 0.111 0.061 0.066 
G 0.06 0.061 0.062 0.069 0.072 0.131 0.063 0.063 0.078 0.064 0.103 0.063 
H 0.068 0.064 0.101 0.065 0.067 0.062 0.065 0.097 0.088 0.065 0.066 0.064 
 
T4 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.141 0.078 0.106 0.065 0.141 0.068 0.068 0.08 0.073 0.429 0.122 0.097 
B 0.07 0.079 0.061 0.281 0.068 0.067 0.065 0.213 0.075 0.126 0.417 0.072 
C 0.192 0.076 0.086 0.069 0.064 0.103 0.061 0.133 0.093 0.065 0.093 0.067 
D 0.069 0.065 0.077 0.064 0.066 0.074 0.061 0.121 0.142 0.066 0.099 0.085 
E 0.068 0.079 0.069 0.074 0.067 0.351 0.069 0.213 0.073 0.065 0.069 0.06 
F 0.057 0.088 0.189 0.175 0.075 0.077 0.083 0.427 0.314 0.069 0.069 0.068 
G 0.07 0.072 0.072 0.07 0.103 0.112 0.063 0.066 0.091 0.073 0.098 0.1 
H 0.302 0.125 0.315 0.098 0.095 0.073 0.091 0.327 0.532 0.086 0.077 0.085 
 
C4 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.075 0.069 0.128 0.123 0.165 0.058 0.088 0.081 0.056 0.072 0.057 0.057 
B 0.054 0.056 0.059 0.229 0.073 0.125 0.069 0.39 0.062 0.068 0.109 0.056 
C 0.061 0.056 0.073 0.079 0.096 0.305 0.089 0.23 0.078 0.056 0.057 0.054 
D 0.056 0.106 0.094 0.088 0.116 0.112 0.077 0.13 0.083 0.055 0.054 0.062 
E 0.064 0.074 0.062 0.091 0.115 0.373 0.107 0.116 0.096 0.063 0.058 0.059 
F 0.053 0.109 0.169 0.234 0.118 0.091 0.158 0.52 0.346 0.057 0.06 0.069 
G 0.052 0.059 0.07 0.097 0.154 0.114 0.105 0.12 0.077 0.053 0.075 0.06 











T5 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.069 0.072 0.07 0.072 0.118 0.071 0.063 0.201 0.089 0.115 0.305 0.107 
B 0.062 0.063 0.077 0.073 0.488 0.515 0.116 0.087 0.068 0.52 0.088 0.067 
C 0.074 0.083 0.074 0.268 0.068 0.065 0.079 0.07 0.42 0.113 0.08 0.066 
D 0.073 0.063 0.071 0.193 0.225 0.064 0.079 0.101 0.079 0.415 0.356 0.092 
E 0.521 0.245 0.198 0.139 0.113 0.106 0.086 0.08 0.082 0.068 0.337 0.081 
F 0.062 0.059 0.078 0.071 0.064 0.433 0.153 0.065 0.073 0.084 0.064 0.06 
G 0.065 0.408 0.522 0.121 0.083 0.197 0.075 0.07 0.124 0.098 0.071 0.062 
H 0.085 0.241 0.18 0.078 0.195 0.07 0.065 0.143 0.305 0.102 0.069 0.072 
 
C5 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.067 0.077 0.059 0.114 0.062 0.064 0.06 0.126 0.058 0.099 0.084 0.056 
B 0.053 0.057 0.063 0.121 0.109 0.364 0.082 0.061 0.055 0.064 0.134 0.057 
C 0.053 0.054 0.076 0.068 0.054 0.059 0.058 0.067 0.065 0.066 0.054 0.053 
D 0.056 0.068 0.108 0.104 0.143 0.057 0.066 0.071 0.055 0.441 0.206 0.062 
E 0.056 0.084 0.08 0.06 0.055 0.056 0.062 0.058 0.055 0.052 0.11 0.051 
F 0.055 0.058 0.058 0.057 0.088 0.492 0.13 0.103 0.059 0.066 0.076 0.055 
G 0.055 0.419 0.241 0.07 0.104 0.131 0.089 0.104 0.131 0.064 0.054 0.053 
H 0.051 0.076 0.077 0.052 0.131 0.062 0.054 0.108 0.084 0.081 0.068 0.058 
 
T6 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.071 0.092 0.125 0.413 0.154 0.109 0.323 0.079 0.072 0.116 0.087 0.067 
B 0.063 0.088 0.074 0.482 0.087 0.085 0.304 0.124 0.087 0.084 0.082 0.068 
C 0.077 0.067 0.268 0.123 0.068 0.155 0.108 0.13 0.097 0.107 0.108 0.066 
D 0.079 0.098 0.095 0.083 0.517 0.089 0.117 0.075 0.15 0.116 0.164 0.094 
E 0.127 0.215 0.375 0.115 0.114 0.102 0.111 0.153 0.087 0.071 0.365 0.064 
F 0.128 0.315 0.212 0.156 0.159 0.164 0.107 0.096 0.094 0.086 0.102 0.082 
G 0.108 0.18 0.133 0.166 0.125 0.09 0.168 0.45 0.26 0.111 0.422 0.291 
H 0.094 0.098 0.152 0.16 0.102 0.172 0.112 0.122 0.122 0.121 0.129 0.081 
 
C6 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.072 0.059 0.136 0.456 0.105 0.128 0.108 0.12 0.147 0.082 0.082 0.071 
B 0.06 0.073 0.064 0.539 0.129 0.105 0.316 0.123 0.103 0.087 0.073 0.076 
C 0.058 0.07 0.11 0.093 0.088 0.139 0.104 0.085 0.095 0.11 0.071 0.051 
D 0.072 0.076 0.088 0.089 0.563 0.093 0.083 0.087 0.102 0.066 0.088 0.063 
E 0.068 0.084 0.09 0.094 0.092 0.108 0.089 0.079 0.076 0.085 0.145 0.068 
F 0.073 0.092 0.15 0.12 0.216 0.107 0.085 0.111 0.074 0.086 0.081 0.116 
G 0.053 0.084 0.116 0.073 0.079 0.091 0.079 0.223 0.135 0.065 0.149 0.066 







T7 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.076 0.148 0.096 0.086 0.068 0.083 0.077 0.129 0.102 0.553 0.075 0.133 
B 0.064 0.073 0.08 0.073 0.072 0.074 0.07 0.077 0.133 0.159 0.1 0.57 
C 0.067 0.074 0.102 0.352 0.074 0.07 0.126 0.103 0.113 0.174 0.068 0.13 
D 0.574 0.243 0.135 0.259 0.108 0.186 0.107 0.213 0.17 0.08 0.08 0.068 
E 0.067 0.068 0.076 0.07 0.091 0.124 0.368 0.115 0.133 0.119 0.067 0.09 
F 0.066 0.065 0.07 0.084 0.121 0.15 0.155 0.193 0.115 0.087 0.107 0.067 
G 0.233 0.083 0.106 0.108 0.096 0.144 0.123 0.108 0.186 0.361 0.112 0.059 
H 0.06 0.091 0.398 0.073 0.122 0.358 0.092 0.072 0.561 0.219 0.076 0.074 
 
C7 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.084 0.223 0.229 0.112 0.127 0.108 0.085 0.202 0.094 0.626 0.102 0.067 
B 0.098 0.141 0.152 0.148 0.231 0.105 0.122 0.177 0.099 0.359 0.11 0.105 
C 0.085 0.149 0.296 0.158 0.144 0.145 0.262 0.173 0.215 0.346 0.133 0.119 
D 0.686 0.438 0.222 0.48 0.248 0.462 0.228 0.472 0.232 0.137 0.095 0.065 
E 0.131 0.173 0.213 0.161 0.217 0.125 0.446 0.115 0.12 0.151 0.079 0.055 
F 0.078 0.118 0.185 0.187 0.225 0.128 0.207 0.391 0.098 0.084 0.092 0.082 
G 0.58 0.168 0.178 0.158 0.163 0.337 0.1 0.097 0.159 0.438 0.097 0.065 
H 0.084 0.117 0.628 0.146 0.256 0.608 0.232 0.095 0.349 0.123 0.076 0.069 
 
T8 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.078 0.07 0.102 0.085 0.112 0.134 0.099 0.101 0.123 0.094 0.073 0.086 
B 0.073 0.174 0.076 0.197 0.188 0.187 0.112 0.122 0.473 0.173 0.098 0.055 
C 0.101 0.089 0.208 0.226 0.187 0.421 0.401 0.33 0.311 0.422 0.128 0.07 
D 0.203 0.133 0.483 0.242 0.274 0.25 0.585 0.232 0.283 0.164 0.102 0.083 
E 0.063 0.084 0.233 0.269 0.286 0.357 0.227 0.282 0.136 0.175 0.14 0.073 
F 0.062 0.102 0.253 0.284 0.273 0.434 0.095 0.098 0.128 0.101 0.056 0.066 
G 0.062 0.121 0.2 0.319 0.169 0.357 0.407 0.113 0.077 0.068 0.055 0.069 
H 0.062 0.082 0.082 0.087 0.121 0.136 0.101 0.074 0.069 0.168 0.077 0.07 
 
C8 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.123 0.077 0.091 0.13 0.093 0.158 0.131 0.089 0.143 0.088 0.083 0.082 
B 0.107 0.125 0.138 0.116 0.096 0.209 0.132 0.121 0.123 0.132 0.093 0.076 
C 0.102 0.086 0.094 0.138 0.127 0.776 0.373 0.262 0.197 0.489 0.102 0.062 
D 0.25 0.218 0.441 0.317 0.213 0.202 0.635 0.173 0.315 0.114 0.126 0.062 
E 0.079 0.115 0.121 0.164 0.198 0.371 0.166 0.303 0.208 0.17 0.065 0.056 
F 0.083 0.081 0.094 0.119 0.227 0.65 0.316 0.347 0.314 0.167 0.068 0.056 
G 0.075 0.093 0.082 0.339 0.18 0.522 0.472 0.245 0.136 0.096 0.058 0.058 
H 0.072 0.076 0.128 0.105 0.126 0.202 0.125 0.112 0.126 0.085 0.061 0.058 
 
Note: T and C mean test and control plates, respectively. The fusion was carried out 
with the spleen from mouse 1. ELISA was performed as described in section 5.2.4. 
143 positive supernatants, as shown in bold, were selected for rescreening with a 
competitive ELISA, as described in section 5.2.4. 
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Appendix 4  Screening hybridomas producing anti-
chTim4SmAbs 
 
Approximately 2,000 hybridomas (twenty 96-well plates) were screened by indirect 
ELISA.  
T1 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.132 0.143 0.069 0.074 0.138 0.347 0.097 0.208 0.078 0.142 0.058 0.052 
B 0.095 0.109 0.11 0.135 0.074 0.072 0.189 0.194 0.127 0.321 0.134 0.057 
C 0.093 0.18 0.087 0.068 0.068 0.065 0.065 0.06 0.09 0.07 0.058 0.054 
D 0.078 0.077 0.071 0.081 0.071 0.066 0.258 0.132 0.059 0.225 0.204 0.279 
E 0.073 0.081 0.113 0.077 0.094 0.062 0.063 0.087 0.1 0.077 0.056 0.135 
F 0.094 0.09 0.076 0.066 0.074 0.06 0.066 0.072 0.061 0.105 0.055 0.065 
G 0.091 0.097 0.266 0.08 0.076 0.068 0.163 0.065 0.133 0.151 0.073 0.055 
H 0.063 0.063 0.074 0.167 0.284 0.164 0.071 0.202 0.082 0.089 0.064 0.132 
 
T2 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.281 0.087 0.083 0.206 0.084 0.07 0.068 0.066 0.074 0.082 0.095 0.139 
B 0.083 0.119 0.092 0.079 0.146 0.077 0.074 0.069 0.066 0.08 0.059 0.057 
C 0.126 0.069 0.07 0.079 0.125 0.061 0.062 0.059 0.06 0.059 0.184 0.054 
D 0.062 0.062 0.071 0.08 0.187 0.063 0.061 0.057 0.063 0.059 0.056 0.059 
E 0.056 0.257 0.124 0.088 0.061 0.068 0.059 0.06 0.059 0.062 0.055 0.078 
F 0.066 0.072 0.083 0.059 0.116 0.058 0.18 0.077 0.106 0.059 0.126 0.105 
G 0.144 0.066 0.187 0.093 0.083 0.135 0.062 0.072 0.066 0.078 0.071 0.061 
H 0.066 0.065 0.054 0.056 0.055 0.064 0.072 0.087 0.062 0.306 0.063 0.073 
 
T3 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.115 0.088 0.063 0.07 0.076 0.068 0.062 0.059 0.129 0.063 0.057 0.056 
B 0.053 0.064 0.113 0.064 0.061 0.144 0.069 0.1 0.058 0.281 0.059 0.06 
C 0.19 0.062 0.147 0.058 0.162 0.066 0.065 0.106 0.065 0.102 0.064 0.054 
D 0.29 0.09 0.122 0.06 0.16 0.061 0.186 0.061 0.06 0.056 0.055 0.06 
E 0.25 0.17 0.082 0.06 0.095 0.062 0.061 0.061 0.1 0.056 0.082 0.203 
F 0.062 0.06 0.174 0.058 0.068 0.057 0.133 0.059 0.063 0.107 0.088 0.122 
G 0.147 0.151 0.107 0.156 0.099 0.085 0.059 0.062 0.064 0.24 0.108 0.11 
H 0.106 0.057 0.179 0.06 0.118 0.062 0.099 0.065 0.056 0.059 0.181 0.054 
 
T4 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.052 0.053 0.053 0.191 0.096 0.07 0.057 0.063 0.129 0.083 0.054 0.062 
B 0.056 0.069 0.063 0.066 0.106 0.092 0.095 0.07 0.217 0.069 0.08 0.084 
C 0.119 0.1 0.058 0.061 0.063 0.063 0.06 0.078 0.061 0.074 0.158 0.067 
D 0.118 0.125 0.072 0.06 0.095 0.062 0.097 0.086 0.108 0.06 0.06 0.056 
E 0.235 0.058 0.079 0.057 0.057 0.13 0.185 0.104 0.14 0.06 0.135 0.082 
F 0.053 0.054 0.06 0.057 0.059 0.058 0.244 0.218 0.105 0.057 0.077 0.069 
G 0.054 0.055 0.054 0.059 0.058 0.061 0.074 0.11 0.062 0.063 0.055 0.075 







T5 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.099 0.127 0.158 0.068 0.201 0.074 0.077 0.08 0.213 0.065 0.141 0.088 
B 0.07 0.058 0.065 0.071 0.233 0.067 0.07 0.17 0.065 0.143 0.065 0.065 
C 0.102 0.071 0.141 0.065 0.073 0.063 0.107 0.063 0.065 0.095 0.063 0.127 
D 0.061 0.058 0.06 0.172 0.063 0.064 0.07 0.119 0.1 0.216 0.171 0.088 
E 0.12 0.061 0.063 0.061 0.09 0.085 0.062 0.092 0.185 0.143 0.07 0.074 
F 0.134 0.063 0.059 0.067 0.061 0.081 0.096 0.229 0.064 0.11 0.091 0.057 
G 0.075 0.071 0.077 0.215 0.182 0.066 0.074 0.304 0.076 0.131 0.065 0.061 
H 0.057 0.059 0.185 0.091 0.076 0.129 0.067 0.067 0.083 0.149 0.086 0.058 
 
T6 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.308 0.064 0.286 0.09 0.074 0.068 0.073 0.089 0.073 0.084 0.072 0.21 
B 0.058 0.059 0.103 0.064 0.103 0.092 0.102 0.076 0.247 0.083 0.183 0.196 
C 0.061 0.062 0.073 0.13 0.129 0.074 0.134 0.064 0.063 0.134 0.063 0.15 
D 0.083 0.063 0.105 0.064 0.072 0.087 0.075 0.063 0.163 0.092 0.383 0.063 
E 0.096 0.064 0.105 0.077 0.067 0.133 0.07 0.079 0.071 0.062 0.086 0.056 
F 0.06 0.15 0.093 0.065 0.061 0.063 0.065 0.062 0.06 0.062 0.266 0.245 
G 0.055 0.083 0.059 0.086 0.073 0.096 0.069 0.085 0.136 0.084 0.189 0.059 
H 0.055 0.058 0.059 0.071 0.164 0.101 0.358 0.094 0.084 0.132 0.057 0.057 
 
T7 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.139 0.367 0.071 0.077 0.116 0.065 0.081 0.067 0.064 0.182 0.109 0.063 
B 0.085 0.059 0.068 0.115 0.128 0.067 0.142 0.064 0.075 0.307 0.062 0.18 
C 0.081 0.084 0.062 0.251 0.065 0.062 0.071 0.063 0.061 0.061 0.061 0.057 
D 0.18 0.059 0.21 0.092 0.086 0.064 0.063 0.059 0.06 0.059 0.059 0.058 
E 0.055 0.071 0.078 0.151 0.066 0.091 0.067 0.059 0.163 0.075 0.056 0.055 
F 0.054 0.06 0.272 0.063 0.06 0.133 0.214 0.1 0.082 0.203 0.061 0.061 
G 0.173 0.06 0.063 0.059 0.061 0.076 0.126 0.067 0.06 0.06 0.057 0.095 
H 0.081 0.057 0.064 0.152 0.077 0.175 0.066 0.063 0.169 0.152 0.06 0.053 
 
T8 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.076 0.109 0.131 0.09 0.304 0.079 0.307 0.088 0.146 0.291 0.147 0.068 
B 0.06 0.066 0.062 0.069 0.079 0.15 0.108 0.11 0.081 0.284 0.183 0.064 
C 0.086 0.111 0.063 0.065 0.101 0.065 0.207 0.074 0.071 0.068 0.087 0.092 
D 0.065 0.157 0.066 0.066 0.083 0.068 0.065 0.063 0.064 0.074 0.164 0.057 
E 0.059 0.158 0.077 0.1 0.256 0.346 0.067 0.069 0.075 0.085 0.064 0.072 
F 0.06 0.061 0.061 0.064 0.098 0.063 0.071 0.09 0.163 0.12 0.067 0.057 
G 0.059 0.07 0.061 0.064 0.16 0.085 0.082 0.192 0.071 0.095 0.076 0.109 









T9 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.221 0.061 0.116 0.064 0.123 0.07 0.07 0.15 0.077 0.072 0.057 0.069 
B 0.289 0.073 0.318 0.069 0.078 0.134 0.173 0.108 0.074 0.099 0.063 0.381 
C 0.054 0.128 0.08 0.068 0.322 0.123 0.177 0.092 0.061 0.166 0.06 0.155 
D 0.079 0.074 0.077 0.071 0.062 0.069 0.074 0.063 0.131 0.064 0.169 0.279 
E 0.075 0.098 0.059 0.082 0.06 0.064 0.074 0.101 0.061 0.117 0.106 0.084 
F 0.24 0.138 0.323 0.177 0.064 0.075 0.061 0.073 0.062 0.061 0.089 0.058 
G 0.098 0.192 0.099 0.077 0.083 0.062 0.061 0.062 0.241 0.12 0.096 0.066 
H 0.15 0.083 0.072 0.075 0.075 0.08 0.114 0.197 0.059 0.118 0.055 0.065 
 
T10 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.141 0.058 0.059 0.078 0.057 0.061 0.11 0.059 0.072 0.198 0.057 0.057 
B 0.059 0.068 0.064 0.061 0.079 0.057 0.054 0.057 0.072 0.168 0.054 0.054 
C 0.142 0.104 0.055 0.07 0.056 0.267 0.061 0.056 0.131 0.056 0.12 0.055 
D 0.056 0.086 0.088 0.056 0.056 0.225 0.057 0.062 0.099 0.097 0.053 0.054 
E 0.057 0.055 0.057 0.058 0.057 0.146 0.156 0.061 0.204 0.06 0.053 0.057 
F 0.14 0.061 0.056 0.181 0.059 0.219 0.065 0.056 0.067 0.068 0.052 0.056 
G 0.059 0.053 0.053 0.187 0.093 0.064 0.086 0.054 0.071 0.055 0.052 0.058 
H 0.121 0.058 0.25 0.073 0.07 0.069 0.056 0.123 0.102 0.109 0.055 0.058 
 
T11 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.151 0.309 0.139 0.087 0.164 0.112 0.228 0.24 0.207 0.165 0.173 0.407 
B 0.094 0.264 0.106 0.308 0.119 0.17 0.215 0.205 0.323 0.194 0.268 0.283 
C 0.134 0.083 0.162 0.259 0.379 0.079 0.109 0.109 0.223 0.118 0.118 0.127 
D 0.088 0.071 0.074 0.083 0.172 0.101 0.083 0.082 0.31 0.27 0.205 0.263 
E 0.148 0.077 0.196 0.142 0.151 0.107 0.112 0.083 0.068 0.12 0.072 0.143 
F 0.119 0.122 0.076 0.064 0.347 0.105 0.122 0.335 0.352 0.177 0.293 0.109 
G 0.125 0.069 0.097 0.199 0.121 0.067 0.084 0.102 0.106 0.128 0.448 0.412 
H 0.114 0.147 0.069 0.213 0.105 0.091 0.47 0.111 0.249 0.146 0.146 0.231 
 
T12 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.169 0.186 0.112 0.187 0.377 0.107 0.181 0.176 0.248 0.209 0.282 0.397 
B 0.323 0.124 0.198 0.127 0.132 0.22 0.071 0.092 0.323 0.088 0.246 0.21 
C 0.346 0.107 0.077 0.141 0.105 0.121 0.099 0.934 0.243 0.232 0.151 0.24 
D 0.202 0.251 0.143 0.204 0.066 0.065 0.094 0.174 0.089 0.117 0.066 0.556 
E 0.196 0.218 0.11 0.166 0.073 0.295 0.069 0.102 0.069 0.066 0.094 0.333 
F 0.23 0.268 0.267 0.138 0.107 0.103 0.195 0.154 0.06 0.282 0.066 0.253 
G 0.083 0.123 0.079 0.206 0.1 0.386 0.123 0.35 0.132 0.074 0.162 0.219 










T13 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.181 0.171 0.072 0.243 0.116 0.071 0.457 0.092 0.081 0.244 0.153 0.096 
B 0.075 0.179 0.06 0.073 0.149 0.099 0.166 0.082 0.104 0.155 0.516 0.101 
C 0.113 0.099 0.248 0.105 0.136 0.16 0.092 0.105 0.067 0.104 0.159 0.222 
D 0.14 0.154 0.136 0.153 0.106 0.069 0.119 0.109 0.153 0.081 0.07 0.164 
E 0.09 0.108 0.141 0.117 0.059 0.255 0.129 0.07 0.064 0.077 0.1 0.353 
F 0.086 0.158 0.074 0.197 0.06 0.218 0.075 0.202 0.106 0.089 0.107 0.167 
G 0.138 0.092 0.224 0.339 0.12 0.114 0.062 0.121 0.132 0.199 0.208 0.116 
H 0.104 0.247 0.106 0.229 0.154 0.076 0.11 0.262 0.111 0.117 0.162 0.109 
 
T14 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.144 0.26 0.108 0.228 0.136 0.137 0.119 0.122 0.092 0.401 0.108 0.402 
B 0.2 0.183 0.147 0.172 0.114 0.273 0.221 0.101 0.249 0.281 0.186 0.17 
C 0.165 0.221 0.144 0.097 0.146 0.249 0.145 0.089 0.7 0.236 0.114 0.239 
D 0.225 0.107 0.21 0.156 0.163 0.288 0.298 0.105 0.137 0.138 0.146 0.28 
E 0.129 0.088 0.161 0.198 0.161 0.22 0.121 0.095 0.3 0.155 0.148 0.229 
F 0.168 0.117 0.257 0.34 0.203 0.183 0.304 0.105 0.115 0.139 0.114 0.149 
G 0.231 0.164 0.078 0.161 0.117 0.141 0.172 0.143 0.123 0.38 0.422 0.242 
H 0.135 0.169 0.483 0.129 0.132 0.168 0.118 0.216 0.249 0.397 0.133 0.303 
 
T15 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.466 0.159 0.146 0.105 0.089 0.168 0.23 0.382 0.496 0.327 0.323 0.139 
B 0.149 0.14 0.809 0.106 0.204 0.181 0.195 0.387 0.226 0.18 0.254 0.179 
C 0.196 0.356 0.178 0.11 0.451 0.31 0.395 0.218 0.449 0.1 0.193 0.365 
D 0.249 0.31 0.242 0.481 0.225 0.123 0.212 0.28 0.263 0.179 0.135 0.169 
E 0.256 0.189 0.299 0.072 0.331 0.086 0.073 0.147 0.106 0.127 0.411 0.28 
F 0.178 0.31 0.113 0.145 0.217 0.076 0.108 0.362 0.196 0.21 0.778 0.268 
G 0.141 0.134 0.269 0.114 0.225 0.348 0.512 0.185 0.158 0.095 0.383 0.27 
H 0.263 0.225 0.116 0.226 0.19 0.394 0.28 0.384 0.099 0.227 0.253 0.305 
 
T16 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.120 0.397 0.383 0.296 0.39 0.519 0.415 0.391 0.386 0.332 0.34 0.502 
B 0.498 0.437 0.34 0.319 0.373 0.36 0.332 0.341 0.411 0.372 0.275 0.304 
C 0.446 0.376 0.344 0.581 0.365 0.359 0.366 0.372 0.376 0.196 0.203 0.289 
D 0.389 0.365 0.366 0.342 0.11 0.363 0.435 0.471 0.315 0.235 0.211 0.295 
E 0.38 0.4 0.439 0.434 0.362 0.365 1.008 0.13 0.383 0.336 0.576 0.385 
F 0.515 0.687 0.431 0.415 0.323 0.377 1.072 0.327 0.468 0.391 0.342 0.092 
G 0.372 0.374 0.395 0.394 0.426 0.351 0.365 0.359 0.259 0.269 0.371 0.143 








T17 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.228 0.266 0.19 0.387 0.35 0.368 0.271 0.084 0.357 0.361 0.351 0.381 
B 0.285 0.379 0.241 0.347 0.252 0.369 0.278 0.346 0.387 0.364 0.23 0.434 
C 0.29 0.543 0.258 0.219 0.332 0.307 0.302 0.353 0.534 0.371 0.325 0.491 
D 0.465 0.233 0.302 0.341 0.352 0.534 0.333 0.439 0.559 0.366 0.611 0.549 
E 0.353 0.321 0.339 0.463 0.368 0.37 0.339 0.285 0.37 0.258 0.388 0.338 
F 0.191 0.172 0.241 0.164 0.477 0.342 0.349 0.715 0.602 0.263 0.28 0.264 
G 0.38 0.396 0.327 0.215 0.368 0.424 0.335 0.36 0.407 0.367 0.217 0.353 
H 0.135 0.272 0.352 0.21 0.128 0.159 0.263 0.197 0.568 0.498 0.124 0.356 
 
T18 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.362 0.15 0.251 0.071 0.128 0.46 0.074 0.331 0.143 0.354 0.104 0.124 
B 0.098 0.136 0.113 0.189 0.131 0.134 0.207 0.067 0.069 0.093 0.078 0.623 
C 0.212 0.151 0.07 0.072 0.214 0.109 0.159 0.094 0.167 0.134 0.097 0.132 
D 0.108 0.163 0.119 0.449 0.126 0.166 0.219 0.16 0.07 0.187 0.134 0.195 
E 0.161 0.351 0.184 0.172 0.291 0.074 0.136 0.238 0.075 0.144 0.124 0.111 
F 0.123 0.208 0.133 0.105 0.148 0.427 0.11 0.162 0.178 0.129 0.137 0.081 
G 0.168 0.292 0.747 0.094 0.117 0.15 0.326 0.146 0.192 0.356 0.117 0.11 
H 0.255 0.12 0.176 0.55 0.174 0.257 0.342 0.141 0.311 0.174 0.116 0.096 
 
T19 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.169 0.101 0.309 0.113 0.267 0.105 0.105 0.376 0.156 0.536 0.208 0.369 
B 0.174 0.091 0.074 0.099 0.154 0.118 0.121 0.375 0.082 0.098 0.127 0.159 
C 0.244 0.21 0.096 0.094 0.091 0.093 0.142 0.364 0.078 0.212 0.335 0.131 
D 0.153 0.097 0.175 0.152 0.437 0.33 0.143 0.12 0.288 0.219 0.135 0.236 
E 0.078 0.08 0.156 0.075 0.15 0.291 0.308 0.205 0.225 0.142 0.205 0.534 
F 0.089 0.135 0.206 0.166 0.247 0.172 0.1 0.377 0.219 0.267 0.169 0.135 
G 0.38 0.108 0.125 0.113 0.134 0.331 0.344 0.108 0.099 0.114 0.142 0.111 
H 0.337 0.252 0.282 0.122 0.248 0.314 0.22 0.245 0.141 0.391 0.171 0.133 
 
T20 1 2 3 4 5 6 7 8 9 10 11 12 
A 0.138 0.118 0.101 0.284 0.154 0.165 0.334 0.197 0.144 0.097 0.116 0.277 
B 0.132 0.225 0.269 0.225 0.159 0.188 0.115 0.129 0.135 0.222 0.234 0.268 
C 0.118 0.166 0.296 0.295 0.177 0.121 0.191 0.197 0.617 0.166 0.154 0.275 
D 0.156 0.326 0.171 0.097 0.159 0.222 0.198 0.261 0.165 0.157 0.22 0.192 
E 0.157 0.24 0.237 0.192 0.122 0.097 0.216 0.135 0.29 0.31 0.183 0.265 
F 1.255 0.2 0.172 0.221 0.163 0.13 0.112 0.391 0.108 0.343 0.164 0.377 
G 0.364 0.545 0.125 0.111 0.123 0.548 0.199 1.206 0.163 0.317 0.137 0.349 
H 0.243 0.101 0.123 0.171 0.214 0.107 0.129 0.264 0.133 0.183 0.243 0.331 
 
Note: T means test plate. Test plates 1-10 were a fusion with the spleen from mouse 
1 and test plates 11-20 a fusion with the spleen from mouse 2. ELISA was performed 
as described in section 5.2.4. Based on the ELISA readings, 256 positive hybridomas, 
as shown in bold, were obtained and then grown up in 24-well plates. 
